
<html lang="en"     class="pb-page"  data-request-id="d06d8c0b-0c11-4cdc-beaa-d9fb6398c950"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.8b00960;issue:issue:10.1021/jmcmar.2018.61.issue-21;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like Receptor 7 Agonist That Elicits Potent Immune Responses" /></meta><meta name="dc.Creator" content="Thomas  Szekely" /></meta><meta name="dc.Creator" content="Olivier  Roy" /></meta><meta name="dc.Creator" content="Edith  Dériaud" /></meta><meta name="dc.Creator" content="Aurélie  Job" /></meta><meta name="dc.Creator" content="Richard  Lo-Man" /></meta><meta name="dc.Creator" content="Claude  Leclerc" /></meta><meta name="dc.Creator" content="Claude  Taillefumier" /></meta><meta name="dc.Description" content="We present here for the first time the synthesis and immunological evaluation of a fully synthetic three-component anticancer vaccine candidate that consists of a β-glycotripeptoid core mimicking a..." /></meta><meta name="Description" content="We present here for the first time the synthesis and immunological evaluation of a fully synthetic three-component anticancer vaccine candidate that consists of a β-glycotripeptoid core mimicking a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 23, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00960" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00960" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00960" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00960" /></link>
        
    
    

<title>Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like Receptor 7 Agonist That Elicits Potent Immune Responses | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00960" /></meta><meta property="og:title" content="Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like Receptor 7 Agonist That Elicits Potent Immune Responses" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0010.jpeg" /></meta><meta property="og:description" content="We present here for the first time the synthesis and immunological evaluation of a fully synthetic three-component anticancer vaccine candidate that consists of a β-glycotripeptoid core mimicking a cluster of Tn at the surface of tumor cells (B epitope), conjugated to the OVA 323–339 peptide (T-cell epitope) and a Toll-like receptor 7 (TLR7) agonist for potent adjuvanticity. The immunological evaluation of this construct and of precursor components demonstrated the synergistic activity of the components within the conjugate to stimulate innate and adaptive immune cells (DCs, T-helper, and B-cells). Surprisingly, immunization of mice with the tricomponent GalNAc-based construct elicited a low level of anti-Tn IgG but elicited a very high level of antibodies that recognize the TLR7 agonist. This finding could represent a potential vaccine therapeutic approach for the treatment of some autoimmune diseases such as lupus." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00960"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00960">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00960&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00960&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00960&amp;href=/doi/10.1021/acs.jmedchem.8b00960" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9568-9582</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00873" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01044" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like Receptor 7 Agonist That Elicits Potent Immune Responses</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Thomas Szekely</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas Szekely</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Szekely">Thomas Szekely</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Olivier Roy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Olivier Roy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Olivier++Roy">Olivier Roy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Edith Dériaud</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edith Dériaud</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Unité Régulation Immunitaire et Vaccinologie, Equipe Labellisée Ligue Contre le Cancer, Institut Pasteur, 75015 Paris, France</div><div class="loa-info-affiliations-info">INSERM U1041, 75724 Paris Cedex 15, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edith++D%C3%A9riaud">Edith Dériaud</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aurélie Job</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aurélie Job</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aur%C3%A9lie++Job">Aurélie Job</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard Lo-Man</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Lo-Man</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Unité Régulation Immunitaire et Vaccinologie, Equipe Labellisée Ligue Contre le Cancer, Institut Pasteur, 75015 Paris, France</div><div class="loa-info-affiliations-info">INSERM U1041, 75724 Paris Cedex 15, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Lo-Man">Richard Lo-Man</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claude Leclerc</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claude Leclerc</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Unité Régulation Immunitaire et Vaccinologie, Equipe Labellisée Ligue Contre le Cancer, Institut Pasteur, 75015 Paris, France</div><div class="loa-info-affiliations-info">INSERM U1041, 75724 Paris Cedex 15, France</div></div><span class="conrtib-corresp"><strong>*</strong>C.L.: e-mail, <a href="/cdn-cgi/l/email-protection#0f6c636e7a6b6a21636a6c636a7d6c4f7f6e7c7b6a7a7d21697d"><span class="__cf_email__" data-cfemail="6e0d020f1b0a0b40020b0d020b1c0d2e1e0f1d1a0b1b1c40081c">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claude++Leclerc">Claude Leclerc</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Claude Taillefumier</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claude Taillefumier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France</div></div><span class="conrtib-corresp"><strong>*</strong>C.T.: e-mail, <a href="/cdn-cgi/l/email-protection#d9bab5b8acbdbcf7adb8b0b5b5bcbfacb4b0bcab99acbab8f7bfab"><span class="__cf_email__" data-cfemail="5d3e313c28393873293c343131383b283034382f1d283e3c733b2f">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claude++Taillefumier">Claude Taillefumier</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3126-495X" title="Orcid link">http://orcid.org/0000-0003-3126-495X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00960&amp;href=/doi/10.1021%2Facs.jmedchem.8b00960" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9568–9582</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 23, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 June 2018</li><li><span class="item_label"><b>Published</b> online</span>23 October 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00960" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00960</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9568%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DThomas%2BSzekely%252C%2BOlivier%2BRoy%252C%2BEdith%2BD%25C3%25A9riaud%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D21%26contentID%3Dacs.jmedchem.8b00960%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BImmunological%2BEvaluation%2Bof%2Ba%2BMulticomponent%2BConstruct%2BBased%2Bon%2Ba%2BGlycotripeptoid%2BCore%2BComprising%2BB%2Band%2BT%2BCell%2BEpitopes%2Band%2Ba%2BToll-like%2BReceptor%2B7%2BAgonist%2BThat%2BElicits%2BPotent%2BImmune%2BResponses%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9582%26publicationDate%3DNovember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00960"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1212</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00960" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like Receptor 7 Agonist That Elicits Potent Immune Responses&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Szekely&quot;},{&quot;first_name&quot;:&quot;Olivier&quot;,&quot;last_name&quot;:&quot;Roy&quot;},{&quot;first_name&quot;:&quot;Edith&quot;,&quot;last_name&quot;:&quot;Dériaud&quot;},{&quot;first_name&quot;:&quot;Aurélie&quot;,&quot;last_name&quot;:&quot;Job&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Lo-Man&quot;},{&quot;first_name&quot;:&quot;Claude&quot;,&quot;last_name&quot;:&quot;Leclerc&quot;},{&quot;first_name&quot;:&quot;Claude&quot;,&quot;last_name&quot;:&quot;Taillefumier&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9568-9582&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00960&quot;},&quot;abstract&quot;:&quot;We present here for the first time the synthesis and immunological evaluation of a fully synthetic three-component anticancer vaccine candidate that consists of a β-glycotripeptoid core mimicking a cluster of Tn at the surface of tumor cells (B epitope), conjugated to the OVA 323–339 peptide (T-cell epitope) and a Toll-like receptor 7 (TLR7) agonist for potent adjuvanticity. The immunological evaluation of this construct and of precursor components demonstrated the synergistic activity of the components within the conjugate to stimulate innate and adaptive immune cells (DCs, T-helper, and B-cells). Surprisingly, immunization of mice with the tricomponent GalNAc-based construct elicited a low level of anti-Tn IgG but elicited a very high level of antibodies that recognize the TLR7 agonist. This finding could represent a potential vaccine therapeutic approach for the treatment of some autoimmune diseases such as lupus.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00960&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00960" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00960&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00960" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00960&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00960" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00960&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00960&amp;href=/doi/10.1021/acs.jmedchem.8b00960" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00960" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00960" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00960%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DSzekely%26date%3D2018%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BImmunological%2BEvaluation%2Bof%2Ba%2BMulticomponent%2BConstruct%2BBased%2Bon%2Ba%2BGlycotripeptoid%2BCore%2BComprising%2BB%2Band%2BT%2BCell%2BEpitopes%2Band%2Ba%2BToll-like%2BReceptor%2B7%2BAgonist%2BThat%2BElicits%2BPotent%2BImmune%2BResponses%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D21%26spage%3D9568%26epage%3D9582%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291909" title="Immunology">Immunology</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291720" title="Antigens">Antigens</a>,</li><li><a href="/action/doSearch?ConceptID=290975" title="Biopolymers">Biopolymers</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/jmcmar.2018.61.issue-21/20181108/jmcmar.2018.61.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We present here for the first time the synthesis and immunological evaluation of a fully synthetic three-component anticancer vaccine candidate that consists of a β-glycotripeptoid core mimicking a cluster of Tn at the surface of tumor cells (B epitope), conjugated to the OVA 323–339 peptide (T-cell epitope) and a Toll-like receptor 7 (TLR7) agonist for potent adjuvanticity. The immunological evaluation of this construct and of precursor components demonstrated the synergistic activity of the components within the conjugate to stimulate innate and adaptive immune cells (DCs, T-helper, and B-cells). Surprisingly, immunization of mice with the tricomponent GalNAc-based construct elicited a low level of anti-Tn IgG but elicited a very high level of antibodies that recognize the TLR7 agonist. This finding could represent a potential vaccine therapeutic approach for the treatment of some autoimmune diseases such as lupus.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81210" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81210" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Anticancer immunotherapy represents a powerful new strategy in medicine. In particular, the administration of cancer vaccines<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> to harness the capacity of patient’s immune system to eliminate tumor cells could represent an efficient alternative to usual antitumor treatments which are often unselective, accompanied by many side effects, and which may have difficulties in eradicating metastatic cells.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Malignant transformations of normal cells are characterized by the overexpression of altered mucin-type glycoproteins or glycolipids. Aberrant glycosylations have been shown to contribute to the development of clustered tumor-associated carbohydrate antigens (TACAs),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> such as (1) the glycoprotein antigens including the Tn (T nouvelle), Thomsen–Friedenreich (TF), and sialyl Tn (sTn) linked to serine or threonine residues and (2) glycolipid antigens including the gangliosides, the globo class, and the blood group determinants. TACAs represent attractive targets for antibody-mediated anticancer vaccines; however, as they are regarded as “autoantigens” or “self-antigens”, they cannot alone activate helper T cells. Therefore, they exhibit weak immunogenicity, leading to difficulties in providing high affinity IgG to eliminate TACA-expressing human tumor cells. To circumvent these issues, intensive research has focused on the design and synthesis of a first generation of vaccine prototypes in which TACAs were conjugated to a foreign carrier protein (e.g., KLH or BSA) and used with a nonspecific immunoadjuvant to enhance helper T cell responses.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The notable contributions of Livingston and Danishefsky are key milestones in this research area. Particularly, based on the demonstration that Tn antigens are exposed on adjacent Ser/Thr residues in repeating clusters of 3–5, monovalent clustered vaccine candidates, wherein a mucin-derived glycopeptide-KLH conjugate contained three Tn antigens, have been developed.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These constructs, coadministrated with the QS-21 adjuvant, advanced to phase I clinical trials against prostate cancer and proved to elicit significant antibody responses in patients.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Nevertheless, in most cases, the structural heterogeneity of this generation of vaccine candidates and the potential immunogenicity of carrier proteins and linkers<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> resulted in suboptimal antibody responses against the TACA epitope, a critical issue for therapeutic efficacy of these cancer vaccines.</div><div class="NLM_p">With the aim of improving the presentation of the carbohydrate antigens in the absence of a carrier protein, a number of laboratories have designed fully synthetic multicomponent vaccines.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8−11)</a> Considerable attention has been paid to the choice of scaffolds for the presentation of clustered antigenic units. Calix[4]arene,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> cyclic decapeptides (RAFTs),<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> or dendrimeric polylysine fragments extended with glycopeptidic arms (MAG-Tn<sub>3</sub>) have been chosen to develop multivalent vaccines.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The last, designed by the groups of Leclerc and Bay, exhibited four arms, composed of a CD4<sup>+</sup> peptide T-helper epitope and a trimeric Tn cluster. In the presence of a mild adjuvant, this construction elicited high level of anti-Tn IgG antibodies which have the ability to mediate the killing of Tn-positive tumor cells in mice<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and non-human primates.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> They also demonstrated that targeting macrophage galactose-type C-type lectins (MGL) by Tn tumor-associated antigens constitutes a promising approach for enhancing vaccine effectiveness.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Moreover, advances in the knowledge of the coordination of innate and adaptive immune systems also offer new avenues for the design of anticancer vaccines. Indeed, the innate system detects large classes of highly conserved molecules that are integral parts of pathogens or abnormal cells. Their recognition through a set of pattern-recognition receptors (PRRs), such as Toll-like receptors (TLRs),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> provides appropriate “danger signals” for the maturation of dendritic cells, which are fundamental targets for many clinical situations.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> In this respect, the resulting production of proinflammatory cytokines influences innate and adaptive responses.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Some of these immune mediators are crucial for the differentiation of helper T cells toward a Th-1 or Th-2 phenotype. Efforts have thus been made to develop conjugates of tumor antigens and TLR ligands.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> The Boons<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and Payne<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> groups have for example developed multicomponent glycosylated MUC-1 based vaccine candidates incorporating a T-cell helper peptide and an immunostimulating lipopeptide TLR2 ligand. These vaccines presented remarkably high immunogenicity establishing the importance of TLR signaling for optimal immune responses.</div><div class="NLM_p">Herein, following a similar approach, we report the synthesis and immunological evaluation of a structurally well-defined, fully synthetic three-component construct <b>35</b> that combines all the features required for a focused and effective activation of DCs, T- and B-cells and to elicit relevant IgG immune responses (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). This construct is composed of an original glycotripeptoid core with α-O-linked GalNAc moieties (B epitope). To strengthen its presentation to the immune system and to overcome the acquired immunotolerance to TACAs and their inherently T-cell independent nature, the glycopeptoid trimer was conjugated to the OVA 323–339 peptide (T<sub>H</sub> epitope) and to a Toll-like receptor 7 (TLR7) heterocyclic agonist (immunoadjuvant).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The intracellular TLR7s act as innate immune sensors of microbial nucleic acids.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a>TLR7 (and TLR9) have also been proven to be implicated in the development of some autoimmune diseases, such as systemic lupus erythematosus (SLE),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> as a consequence of the aberrant transportation of self-derived nucleic acids. Cell surface TLR7s were also recently revealed on bone marrow-derived macrophages.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> As TLR7-dependent signaling is believed to promote autoimmune pathologies, constructs incorporating a TLR7 agonist can also be useful tools with respect to this type of disease. As immunoadjuvant, the major benefit of TLR7 agonists is their capacity to stimulate several cell types (APCs, CD4 and CD8 T cells, and NK cells) resulting in a broad spectrum of activated immune cells, cytokines, and chemokines at the tumor site.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> A tricomponent construct analogue (<b>36</b>) in which the three GalNac were replaced by three mannoses, was also synthesized as a negative control with respect to the production of anti-Tn IgG. A β-peptoid platform was chosen for bringing together all the components of the constructs <b>35</b> and <b>36</b>. β-Peptoids (N-substituted β-alanine oligomers) are a class of homologous peptoids,<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> being defined as N-substituted glycine oligomers.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> In other words, what distinguishes peptoids from peptides is the fact that the side chains are located on the nitrogen atoms of the backbone amides instead of being attached to the main chain carbons atoms. This structural change confers advantages over peptides, notably an enhanced metabolic stability<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> and a greater cell-permeability,<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40−42)</a> two important factors for their use as peptidomimetics or chemical platforms. The presence of peptoid tertiary amide bonds, prone to cis/trans isomerism,<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43−45)</a> is also responsible for a greater backbone flexibility. Different strategies aimed at promoting either the cis- or trans-amide bond conformations have been developed in the recent past,<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46−48)</a> notably by our group.<a onclick="showRef(event, 'ref49 ref50 ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref52 ref53">(49−53)</a> These strategies might be harnessed in the future to reduce flexibility of peptoid-based vaccine constructs. For the initial design, we have selected a conformationally flexible glycopeptoid moiety, assuming that this design will increase the binding of the constructs to C-type lectin receptors (CLRs) at the surface of DCs. In addition, the flexibility of B cell epitopes plays a major role in their capacity to induce antibody responses.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> It is also for that reason that we chose a β-peptoid backbone rather than the more common α-peptoid backbone.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Strategy for the synthesis of the three-component carbohydrate-based constructs <b>35</b> and <b>36</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To date, this is the first time that a peptidomimetic structure and a TLR7 adjuvant were used and attached together in an anticancer vaccine prototype. The adjuvanticity and the T-antigenicity of the construct were first investigated in vitro by ELISA and T-cell stimulation assays, respectively. Its immunogenicity, i.e., the ability to elicit anti-Tn IgG, was then analyzed in vivo in mice. The synthetic and biological results are reported in detail in this paper.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design of the Three-Component Constructs <b>35</b> and <b>36</b> Based on a TLR7 Agonist and Multivalent B/CD4<sup>+</sup> T-Cell Epitopes</h3><div class="NLM_p">We developed a convergent solution-phase synthetic approach for the construction of the synthetic targets <b>35</b> and <b>36</b>, based on two amide bond forming reactions and a chemoselective copper azide–alkyne cycloaddtion (CuAAC) reaction (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The synthetic targets were composed of four modules that were assembled sequentially: the TLR7 agonist <b>24</b> equipped with a carboxylic acid function, a 6-aminocaproyl group used as a spacer, the glycopeptoid cores <b>15</b> and <b>16</b> ended by a propargyl amide function, and the OVA 323–339 peptide bearing a 6-azidohexanoyl arm. In this modular approach, the TLR7 agonist <b>24</b> was first coupled to the aminocaproic acid spacer, which in turn was coupled to the N-terminus of the glycopeptoid cores. Finally, the resulting constructs were conjugated to the OVA peptide by a CuAAC reaction.</div><div class="NLM_p">Two approaches were envisaged to access the conformationally flexible glycopeptoids<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> cores <b>15</b> and <b>16</b>: a monomer approach consisting of the peptide coupling of orthogonally protected glycosylated β-alanine monomers and the so-called submonomer approach initially developed for the synthesis of α-peptoid oligomers<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and adapted for β-peptoid synthesis.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The submonomer synthesis consists of creating each new monomer in two steps, which are, in the case of β-peptoid synthesis, acylation of the N-terminus of the growing chain with acryloyl chloride followed by the aza-Michael addition of a primary amine to the formed acrylamide system. It is known that this two-step methodology is not as effective as the submonomer synthesis of α-peptoids,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> but it could reasonably be considered for the synthesis of the short glycosyl-β-peptoid trimers <b>15</b> and <b>16</b>. Both monomer and submonomer methodologies entailed the synthesis of the peracetylated building blocks <b>1</b> and <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_001.pdf" class="ext-link">Scheme 1, Supporting Information</a>).<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> The solution-phase submonomer synthesis of β-peptoids has been optimized in our group, notably when volatile amines are used in the Michael addition steps.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60,61)</a> Application of our optimized protocol to form β-glycopeptoids trimers was however unsuccessful. We subsequently turned to the use of the “monomer method” for preparing trimers <b>15</b> and <b>16</b>.</div><div class="NLM_p last">The adenine-like heterocyclic moiety <b>24</b> is a potent immunoadjuvant eliciting its activity through the interaction with Toll-like receptor 7.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> This leads to maturation of DCs and production of cytokines which promote the development and activation of T helper cells. Moreover, its pharmacological potency is improved after conjugation to chemical entities that facilitate endocytosis.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> Aminocaproic acid was used as a spacer between the TLR7 agonist <b>24</b> and glycopeptoid components. The choice of the peptide fragment OVA 323–339 (ISQAVHAAHAEINEAGR) from ovalbumin protein was guided by past work showing that it contains multiple T helper epitopes involved in high affinity humoral responses.<a onclick="showRef(event, 'ref64 ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66 ref67">(64−67)</a> The CuAAC was envisioned as a convenient strategy for chemoselective assembling of OVA 323–339 to the TLR7-glycopeptoid conjugates.<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a> Indeed, this very popular ligation method allows in a single step for the formation of an amide bioisostere<a onclick="showRef(event, 'ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref70 ref71 ref72">(70−72)</a> between unprotected fragments and is compatible with a plethora of chemical functions. In this respect, the OVA 323–339 moiety was purchased with an azide-functionalized arm at the N-terminus and the glycoconjugates <b>15</b> and <b>16</b> were engineered with a C-terminal alkyne function.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis of the Core Glycopeptoids <b>15</b> and <b>16</b></h3><div class="NLM_p">Various strategies have been developed for synthesizing glycopeptoids including postmodifications of functionalized side chains for the anchoring of carbohydrate moieties.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> A “submonomer” approach has been adapted for the synthesis of β-peptoid oligomers in which the side chains are incorporated by aza-Michael addition to acrylamide intermediates.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In the present work, the strategy that has proved the most effective in synthesizing the core glycopeptoids <b>15</b> and <b>16</b> is the peptide coupling of the synthesized N-substituted β-alanine monomers <b>1</b> and <b>2</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). They were prepared in six steps from <span class="smallcaps smallerCapital">d</span>-GalNAc and <span class="smallcaps smallerCapital">d</span>-mannose, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_001.pdf" class="ext-link">Supporting Information</a>). First, monomers <b>1</b> and <b>2</b> were protected as Fmoc carbamates by treatment with Fmoc-Cl and saturated NaHCO<sub>3</sub> in dioxane to provide <b>3</b> (84%) and <b>4</b> (91%), respectively. With these orthogonally protected monomers in hand, the construction of trimers <b>15</b> and <b>16</b> was then accomplished using an iterative sequence, consisting of forming the free acid partners and their subsequent coupling with the amine <b>1</b> or <b>2</b>. From monomers <b>3</b> and <b>4</b>, the corresponding free carboxylic acids were quantitatively produced by hydrolysis of the <sup><i>t</i></sup>Bu esters (TFA/CH<sub>2</sub>Cl<sub>2</sub>, 1:1, v/v) and coupled with their amine partner (<b>1</b> or <b>2)</b> with HATU/DIEA-optimized conditions (CH<sub>2</sub>Cl<sub>2</sub>/DMF (7:3, v/v)). Glycopeptoids dimers <b>5</b> and <b>6</b> were isolated in 81% and 90%, respectively, after silica gel column chromatography. Reiteration of the deprotection–coupling process furnished glycotripeptoids <b>7</b> and <b>8</b> in 75% and 87%, respectively. One portion of each of them was further deprotected at the N-terminus (Et<sub>2</sub>NH/CH<sub>3</sub>CN, 1:2, v/v) followed by Zemplén deacetylation of the carbohydrate moieties for biological testing (compounds <b>11</b> and <b>12</b>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the C-Terminus Alkyne-Functionalized β-Glycotripeptoids <b>15</b> and <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Fmoc-Cl, NaHCO<sub>3</sub>, 1,4-dioxane, rt, 4 h, 84% (<b>3</b>), 91% (<b>4</b>); (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub> (1:1, v/v), rt, 1 h, quantitative, then <b>1</b> or <b>2</b>, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, DMF, rt, overnight, 81% (<b>5</b> from <b>1</b> and <b>3</b>), 90% (<b>6</b> from <b>2</b> and <b>4</b>); (iii) TFA, CH<sub>2</sub>Cl<sub>2</sub> (1:1, v/v), rt, 1 h, quantitative, then <b>1</b> or <b>2</b>, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, DMF, rt, overnight, 75% (<b>7</b> from <b>1</b> and <b>5</b>), 87% (<b>8</b> from <b>2</b> and <b>6</b>); (iv) Et<sub>2</sub>NH, CH<sub>3</sub>CN (1:2, v/v), rt, 4 h, quantitative; (v) NaOMe, MeOH, rt, 1 h, quantitative; (vi) <b>7</b> or <b>8</b>, TFA, CH<sub>2</sub>Cl<sub>2</sub> (1:1, v/v), rt, 1 h, quantitative then H<sub>2</sub>NCH<sub>2</sub>CCH, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, CH<sub>3</sub>CN, rt, overnight, 95% (<b>13</b>), 86% (<b>14</b>).</p></p></figure><div class="NLM_p">As the strategy for conjugation of the core glycopeptoid trimers <b>7</b> and <b>8</b> with the OVA 323–339 peptide was based on the non-native CuAAC reaction, it was therefore necessary to equip the C-termini of trimers <b>7</b> and <b>8</b> with a terminal alkyne arm. Accordingly, the two trimers were treated with TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:1, v/v) for removal of the <sup><i>t</i></sup>Bu esters, followed by a peptide coupling with propargylamine by employing HATU-DIEA conditions to give <b>13</b> (95%) and <b>14</b> (86%). <b>13</b> and <b>14</b> were further deprotected at the N-terminus (Et<sub>2</sub>NH/CH<sub>3</sub>CN, 1:2, v/v) to yield compounds <b>15</b> and <b>16</b> ready for conjugation with the TLR7 agonist moiety <b>26</b>.</div><div class="NLM_p">At this stage of the synthetic work, the TLR7 agonist (<b>24</b>) and glycopeptoids components (<b>9</b>, <b>10</b>) were biotinylated for enzyme-linked immunosorbent assay (ELISA) aimed at analyzing the specificity of the antibodies induced by the constructs (<a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a>, <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Biotinylation of Glycopeptoid Platforms <b>9</b> and <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <b>9</b> or <b>10</b>, HO<sub>2</sub>C(CH<sub>2</sub>)<sub>5</sub>NH-Fmoc, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, DMF, rt, 14 h, 50% (<b>9</b>), 90% (<b>10</b>); (ii) <b>17</b> or <b>18</b>, Et<sub>2</sub>NH, CH<sub>3</sub>CN (1:2, v/v), rt, 4 h; (iii) biotin <i>N</i>-hydroxysuccinimide, Et<sub>3</sub>N, DMF, rt, 16 h, 81% (<b>17</b>), 37% (<b>18</b>); (iv) NaOMe, MeOH, rt, 1 h, quantitative.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Biotinylation of TLR7 Agonist <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) biotin (1 equiv), IBCF 1.2 equiv, Bu<sub>3</sub>N 1.3 equiv., DMF, rt, then 0 °C, BocNH(CH<sub>2</sub>)<sub>4</sub>NH<sub>2</sub> in DMF, 4h, rt; (ii) TFA/DCM 1/1; (iii) HATU 2 equiv, DIEA 5 equiv, <b>24</b> (1 equiv) DMF.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Conjugation to the TLR7 Agonist and OVA 323–339 Peptide</h3><div class="NLM_p">The TLR7 heterocyclic agonist <b>24</b>, chosen in the present work, was prepared from xanthine following adaptations of published procedures (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The TLR7 heterocyclic agonist <b>24</b> was first coupled to aminocaproic acid, used as a spacer, employing IBCF and N(Bu)<sub>3</sub> in DMF/H<sub>2</sub>O (3:1, v/v) (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The formed compound <b>26</b> was then conjugated to the glycotripeptoid scaffolds <b>9</b>, <b>10</b>, <b>15</b>, and <b>16</b> to yield glycoconjugates <b>27</b> (53%), <b>28</b> (53%), <b>29</b> (48%), and <b>30</b> (50%), respectively. All of them were deacetylated, giving compounds <b>31</b>, <b>32</b>, <b>33</b>, and <b>34</b> in essentially quantitative yields and high purity.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Three-Component Carbohydrate-Based Constructs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) aminocaproic acid, IBCF, N(Bu)<sub>3</sub>, DMF, H<sub>2</sub>O (3:1, v/v), 0 °C, 24 h, 55%; (ii) <b>9</b> or <b>10</b> or <b>15</b> or <b>16</b>, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, DMF, rt, overnight, 53% (<b>27</b> from <b>9</b>), 53% (<b>28</b> from <b>10</b>), 48% (<b>29</b> from <b>15</b>), 50% (<b>30</b> from <b>16</b>); (iii) NaOMe, MeOH, rt, 1 h, quantitative; (iv) N<sub>3</sub>-OVA 323–339, THPTA, aminoguanidine hydrochloride, HEPES buffer (100 mM, pH 7.5), H<sub>2</sub>O, HFIP, 1–3 h, 80% (<b>35</b> from <b>33</b>), 77% (<b>36</b> from <b>34</b>).</p></p></figure><div class="NLM_p">The deacetylated conjugates <b>31</b> and <b>32</b> made of only two components of the three composing the final constructs (<b>35</b>, <b>36</b>) were intended to be subject to the immunological tests. On the other hand, the deacetylated oligomers <b>33</b> and <b>34</b> bearing an alkynyl group were intended to be used for the conjugation to the azide-functionalized OVA 323–339 peptide employing the CuAAC reaction. The OVA peptide was indeed purchased with a 6-azidohexanoyl arm at its N-terminus to allow the CuAAC to proceed. An air-free procedure developed by Finn et al.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> was applied to avoid damage of the peptide due to copper-mediated production of reactive oxygen species. In addition to the CuSO<sub>4</sub>/sodium ascorbate reagents, the THPTA copper(I) stabilizing ligand, and aminoguanidine hydrochloride, an additive known to intercept byproducts of ascorbate oxidation was also used.</div><div class="NLM_p last">The CuAAC ligations were conducted under an argon atmosphere, and all the solvents were carefully degassed. For the first attempt, <b>34</b> and the N<sub>3</sub>-OVA 323–339 peptide were engaged (1:1 ratio, ∼5 mM) in a HFIP/HEPES buffer mixture at pH 7.5. The catalytic solution was composed of CuSO<sub>4</sub> (2 equiv), sodium ascorbate (4 equiv), THPTA (6 equiv), and aminoguanidine (5 equiv). Under these conditions, <b>34</b> and OVA were not totally consumed after 1 h. Another catalytic solution was added with the same amount of each compound except for CuSO<sub>4</sub> (4 equiv) and sodium ascorbate (8 equiv). After 2 h of reaction, CuSO<sub>4</sub> and sodium ascorbate were added again. Finally, a complete conversion was observed within 3 h and a C18 SPE cartridge purification afforded the pure O-mannosylated three-component construct <b>36</b> in a good 77% yield. In order to reduce the reaction time between <b>33</b> and N<sub>3</sub>-OVA 323–339, we envisioned directly introducing a catalytic solution with more significant amounts of CuSO<sub>4</sub> (4 equiv), sodium ascorbate (8 equiv), and aminoguanidine (10 equiv) but with the same amount of THPTA. Hence, a complete conversion was obtained within 1 h. After a C18 SPE cartridge purification, the <i>O</i>-GalNAc three-component construct <b>35</b> was provided in high purity and in good 80% yield.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Immunology</h3><div class="NLM_p">We first evaluated in vitro the capacity of the constructs to retain the immunological properties of the original components, through the analysis of the adjuvant activity of the TLR7 ligand and the T cell antigenicity of the OVA 323–339 peptide. The adjuvant property of the various constructs was analyzed for their capacity to trigger the production of cytokines by murine DC (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Compounds <b>31</b>, <b>35</b>, and <b>36</b>, containing a TLR7 agonist, induced strong and comparable IL-12 and IL-6 secretion (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). In contrast, the GalNAc glycopeptoid trimer <b>11</b> and TLR7 agonist <b>24</b> alone were unable to induce the production of cytokines. Taken together, these results confirm the functional role of the TLR7 agonist moiety to stimulate mouse BMDCs and highlight the importance of the conjugation of this TLR7 ligand to the glycopeptoid moiety for the activation of the TLR7 endosomal receptors. Recruitment of MGL receptors is likely to promote DC activation.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Further, it has been documented that the immunostimulatory activity of a TLR7 ligand can be amplified by conjugation.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> We next tested the IFN-γ production by OVA-specific OT-II T cells in response to the constructs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). Compounds <b>35</b> and <b>36</b>, which contain the OVA 323–339 peptide but not <b>31</b>, potently activated OT-II T cells in the presence of DCs.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. In vitro adjuvanticity and T-antigenicity of the glycoconjugates <b>31</b>, <b>35</b>, and <b>36</b>. Mouse BMDCs (10<sup>5</sup>) were cultured at 37 °C either with increasing concentrations of <b>11</b>, <b>24</b>, <b>31</b>, <b>35</b>, or <b>36</b> for 48 h or with increasing concentrations of the same compounds for 3 days in the presence of OT-II CD4<sup>+</sup> T lymphocytes isolated from OT-II transgenic mice. IL-12p40 (A), IL-6 (B), and IFN-γ (C) were measured in cell supernatants by ELISA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The in vivo immunogenicity of the constructs was then evaluated. C57BL/6 mice received OT-II cells specific for the OVA 323–339 peptide and were then immunized with compounds <b>24</b>, <b>31</b>, <b>35</b>, <b>36</b> or with the OVA 323–339 peptide. Five days later, we analyzed the OT-II T cell responses in spleen and lymph nodes (LN). In the spleen of mice immunized with the compounds <b>35</b> and <b>36</b>, we detected 30-fold more OT-II T cells, as compared to the mice immunized with the OVA 323–339 peptide (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). These results showed that the TLR7 agonist, whatever the GalNAc or Man glycosylation, potently enhanced the activation of OT-II cells by the OVA T cell epitope, most likely through DC activation. Lymph node IFN-γ producing T cells were then analyzed by intracellular cytokine staining using flow cytometry (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). In mice immunized with the OVA 323–339 peptide in the absence of adjuvant, no IFN-γ production was detected despite the proliferation of OT-II cells. In contrast, in mice immunized with compounds <b>35</b> and <b>36</b>, we observed a high and comparable IFN-γ production by LN OT-II T cells, demonstrating no major influence of the type of glycosylation. In vitro stimulation by the OVA peptide of the splenocytes of mice immunized with the compounds <b>35</b> and <b>36</b> induced the production of high level of IFN-γ but not of IL-5 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D), suggesting a Th1 phenotype of the activated T cells, in agreement with the capacity of these compounds to induce the production of IL-12 by DC (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Control <b>24</b> and <b>31</b> compounds, devoid of the OVA peptide, did not induce any T cell proliferation or activation (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, all panels).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vivo T-immunogenicity of the three-component glycopeptoids <b>35</b> and <b>36</b>. After administration of 2 × 10<sup>5</sup> OT-II CD4<sup>+</sup> T cells, C57BL/6 mice (<i>n</i> = 3 per group) were intradermally immunized with <b>24</b>, <b>31</b>, <b>35</b>, <b>36</b>, or OVA 323–339 (11.7 nmol per mouse). After 5 days, mice were sacrificed and then the spleen and draining lymph node were collected. OT-II CD4<sup>+</sup> T cells proliferation (A) was detected by flow cytometry using FITC labeled antibodies anti-CD4, anti-Vα2, and anti-Vβ5. Among CD4<sup>+</sup> population, the number of OT-II CD4<sup>+</sup> T cells in lymph node that produce IFN-γ (Β) was determined using FITC labeled antibody anti-IFN-γ. The splenocytes were cultured (5 × 10<sup>5</sup>) in the presence or not of OVA 323–339 (1 μg/mL) at 37 °C for 48 h, and IFN-γ (C) and IL-5 (D) levels were measured in the supernatants by ELISA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We then assessed the antibody responses of mice immunized twice at days 0 and 21 with <b>31</b>, <b>35</b>, or peptide OVA 323–339 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). No antibody response was detected against the OVA peptide or against the biotinylated Tn3G7K.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> However, in the group immunized with compound <b>35</b>, high antibody responses were detected against compound <b>31</b>, demonstrating the B cell immunogenicity of the immunogen containing glycans, the peptoid moiety, and the TLR7 agonist (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo B-immunogenicity of the three-component glycopeptoids <b>35</b>. C57BL/6 mice (<i>n</i> = 3 per group) were intradermally immunized on days 0 and 21 with 11.7 nmol of <b>31</b>, <b>35</b>, or OVA 323–339. Sera were collected on day 0 and before (day 20) or after (day 28) the second injection and were tested for IgG antibodies by ELISA using <b>31</b>, OVA 323–339, or biotinylated Tn3G7K coated at 1 μg/mL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further investigate the fine specificity of the antibodies induced by the immunogen <b>35</b> and <b>36</b>, we analyzed their reactivity by ELISA against the compounds <b>21</b>, <b>22</b>, and <b>25</b>. For this purpose, the serum of mice immunized by the constructs <b>35</b> and <b>36</b> or by the controls <b>24</b> and <b>31</b> were collected and analyzed at days 0 and 21 for their capacity to recognize the glycan biotinylated Tn3G7K, the peptoid moiety <b>21</b> and <b>22</b> or the TR7 agonist <b>25</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A–D). Mice also received a third injection of the compounds at day 92 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>E–H), and their sera were analyzed at day 111.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Superior efficacy of the three-component glycopeptoids <b>35</b> and <b>36</b> in their ability to induce anti-TLR7 agonist IgG. (A–H) C57BL/6 mice (<i>n</i> = 3 per group) were intradermally immunized on days 1 and 20 and then intravenously on day 92 with 11.7 nmol of the compounds <b>24</b>, <b>31</b>, <b>35</b>, <b>36</b> or the peptide OVA 323–339. Sera were collected after the second (A–D, day 27) and the third (E–H, day 111) injections and were analyzed for IgG antibodies by ELISA using <b>21</b>, <b>22</b>, <b>25</b>, or biotinylated Tn3G7K coated at 1 μg/mL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Both compounds <b>21</b> and <b>22</b> were recognized by the sera of mice immunized by <b>35</b> and <b>36</b>, showing that independent of the glycosidic part, the peptoid backbone is slightly immunogenic (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B,E,F). However, the recognition of the peptoid remained low as compared to the very high level of antibodies (up to 100 000) directed against the TLR7 agonist (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>G). Tn3G7K, expressing the Tn antigen, was not recognized by the sera of mice immunized by <b>35</b> and <b>36</b>, in contrast to the 9A7 monoclonal antibody used as a positive control, demonstrating that the antibody responses induced by these compounds are in large part directed against the TLR7 agonist (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>H)</div><div class="NLM_p last">Thus, in the present study, we have validated in vitro and in vivo the functionality and efficiency of the three conjugated components (TLR7 agonist, glycoclusters, and OVA 323–339). The novel synthetic constructs <b>35</b> and <b>36</b> are highly immunogenic but induce unexpected immunological responses. Indeed, instead of the production of IgG antibodies against the Tn trimeric cluster as observed with other synthetic constructs, these compounds elicited in mice low titers of anti-glycopeptoid (mannose and GalNAc) IgG but very high levels of IgG antibodies that recognize the TLR7 agonist. The lack of Tn reactivity probably reflects the absence of natural Ser/Thr amino acid backbone for the GalNAc within the constructs (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>F). As the TLR7 (and TLR9) have been implicated in the development of some autoimmune pathologies, such as systemic lupus erythematosus,<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> the vaccination against TLR7 agonists could represent a potential therapeutic approach for the treatment of lupus and other autoimmune diseases. Several compounds that bind to endosomal TLR7 and/or TLR9 are indeed being developed with the goal to inhibit IFN production and activation of autoimmune B cells.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a>Thus, circulating antibodies capable of capturing TLR7 activating molecules could represent an alternative strategy to inhibit TLR7 stimulation. The capacity of constructs to induce the production of antibodies against TLR7 agonists was never analyzed and thus clearly deserves further investigations.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have designed, synthesized, and evaluated the three-component construct <b>35</b> as a novel potential anticancer vaccine candidate. In this respect, we have investigated the use of a β-peptoid scaffold for the preparation of this three-component construct. By sequential amide bond forming reactions and a CuAAC ligation, a β-glycotripeptoid molecule (B epitope), displaying clustered Tn antigen analogues to mimic the epithelial tumor surface, a TLR7 immunoadjuvant and an OVA 323–337 peptide (T-helper epitope) were conjugated together. To the best of our knowledge, this structure represents the first example of a self-adjuvanted vaccine candidate built on a β-peptoid platform. The immunological evaluation of our original multiepitopic glycoconjugate <b>35</b> clearly demonstrated an effective activation of innate and adaptive immune cells (DCs, T-helper, and B-cells), leading to robust IgG antibody responses. We can conclude from these results that compound <b>35</b> is highly immunogenic and that the functionality of the three components within the conjugate has been validated in vitro and in vivo. We have also demonstrated that the incorporation of a TLR7 agonist is crucial for the immunogenicity of the construct, providing the expected cytokines to induce maturation of DCs.</div><div class="NLM_p">However, a surprising finding was that, instead of the production of IgG antibodies against the target Tn antigen, <b>35</b> elicited very high levels of IgG antibodies against the TLR7 agonist. Altogether, these preliminary studies could suggest that the organization of the Tn Ag analogs on the flexible β-peptoid scaffold does not provide a convenient clustered conformation for eliciting such antibodies responses. Alternatively, it could be suggested that the conformation of compound <b>35</b> is favorable for the presentation of the TLR7 agonist to specific B cells. This could be exploited for the induction of powerful antibody responses against circulating DNA. The TLR7 and TLR9 have indeed been implicated in the development of some autoimmune pathologies, such as systemic lupus erythematosus.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> The vaccination against TLR7 agonists could represent a potential therapeutic approach for the treatment of lupus and other autoimmune diseases.</div><div class="NLM_p last">Several improvements must be made to the tricomponent vaccine candidate presented here to induce antibody responses against the Tn antigen. The modularity of our construct and the efficiency of the synthetic strategy have to be further exploited to improve the anti-Tn response from a novel design of glycopeptoids displaying clustered Tn Ags, possibly closer to the modified mucins comprising other heterocyclic TLR7 immunoadjuvants.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry. Materials and Methods</h3><div class="NLM_p last">All anhydrous reactions were performed under an argon atmosphere. CH<sub>2</sub>Cl<sub>2</sub> was distilled from CaH<sub>2</sub> under argon before use. MeOH was distilled from MgI<sub>2</sub> under argon before use. THF was distilled from sodium/benzophenone under argon before use. DMF and CH<sub>3</sub>CN were obtained from commercial sources and stored over 4 Å molecular sieves. EtOAc was distilled and stored over 4 Å molecular sieves. MeOH, EtOAc, cyclohexane, and CH<sub>2</sub>Cl<sub>2</sub> for column chromatography were distilled before use. Et<sub>3</sub>N was distilled from KOH and stored over 4 Å molecular sieves. All other solvents and chemicals were obtained from commercial sources and used as supplied. The N<sub>3</sub>-OVA 323–339 peptide (immunograde purity) equipped with a 6-azidohexanoyl arm was purchased from Polypeptide Laboratories, France. TLC was performed on Merck TLC aluminum sheets, silica gel 60, F<sub>254</sub>. The extent of reactions was, when applicable, followed by TLC and/or HPLC. Components were made visual with UV light and/or vanilline in EtOH/H<sub>2</sub>SO<sub>4</sub> and/or 30% sulfuric acid in MeOH. Flash chromatography was performed with Merck silica gel 60, 40–63 μm. IR spectra were recorded on a Shimadzu FITR-8400S spectrometer equipped with a Pike Technologies MIRacle ATR, and wavenumbers (ν) are expressed in cm<sup>–1</sup>. NMR spectra were recorded on a 400 MHz Bruker Avance 400 spetrometer. Chemical shifts, reported in δ ppm, are referenced to the residual solvent peak. The following multiplicity abbreviations are used: (s) singlet, (d) doublet, (t) triplet, (quint) quintuplet, (dd) doublet of doublets, (dt) doublet of triplets, (ddd) doublet of doublet of doublets, (m) multiplet. All NMR spectral data for glycopeptoids are of rotameric mixtures. HRMS were recorded on a Micromass Q-Tof Micro (3000V) apparatus. RP-HPLC analyses were performed on a Dionex instrument equipped with an Uptisphere strategy column (C18, 5 μm, 100 Å, 4.6 mm × 250 mm) and a UVD340U detector. All tested compounds had purity of ≥95% as determined by analytical HPLC.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <i>N</i>-Fmoc Protected <i>O</i>-GalNAc Glycoside <b>3</b></h3><div class="NLM_p last">Compound <b>1</b> (360 mg, 0.7 mmol) was suspended in 1,4-dioxane (1.4 mL) and saturated NaHCO<sub>3</sub> solution (3.7 mL) at 0 °C under an argon atmosphere. Then, Fmoc-Cl (350 mg, 1.3 mmol) in 1,4-dioxane (1 mL) was added and the mixture was stirred at room temperature for 4 h. The reaction was dissolved in AcOEt (30 mL). The organic layer was washed with H<sub>2</sub>O (3 × 10 mL), dried (MgSO<sub>4</sub>), and concentrated under reduced pressure. The crude was purified by column chromatography (AcOEt/cyclohexane, 95:5) to give compound <b>3</b> as a yellow oil (422 mg, 84%). RP-HPLC <i>t</i><sub>R</sub>, 20.5 min (91.7%) and 22.6 min (8.2%), MeOH/H<sub>2</sub>O 80:20, 99.9% purity, 210 nm. IR (ATR): 3353, 3323, 2979, 2927, 1747, 1728, 1700, 1695, 1679, 1560, 1529, 1479, 1458, 1451, 1369, 1224, 1221, 1153, 1131, 1075, 1044, 953, 739, 737 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.42 (m, 9H, <i>t</i>-Bu), 1.67–1.81 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.93–2.19 (m, 13H, 3 × OAc, NHAc, 0.5 × C<i>H</i><sub>2</sub>CO<sub>2</sub><sup><i>t</i></sup>Bu), 2.45 (m, 1H, 0.5 × C<i>H</i><sub>2</sub>CO<sub>2</sub><sup><i>t</i></sup>Bu), 3.06–3.66 (m, 6H, 2 × C<i>H</i><sub>2</sub>-N, C<i>H</i><sub>2</sub>-O-GalNAc), 4.03–4.22 (m, 4H, H<sub>5′</sub>, 2 × H<sub>6′</sub>, CH Fmoc), 4.50 (m, 2H, CH<sub>2</sub> Fmoc), 4.60 (m, 1H, H<sub>2′</sub>), 4.80 (m, 1H, H<sub>1′</sub>), 5.13 (dd, 1H, <i>J</i> = 3.0, 11.7 Hz, H<sub>3′</sub>), 5.37 (d, 1H, <i>J</i> = 3.0 Hz, H<sub>4′</sub>), 6.19–6.79 (m, 1H, N<i>H</i>Ac), 7.32 (t, 2H, <i>J</i> = 7.6 Hz, 2 × CH aromatic), 7.39 (t, 2H, <i>J</i> = 7.6 Hz, 2 × CH aromatic), 7.55 (m, 2H, 2 × CH aromatic), 7.75 (d, 2H, <i>J</i> = 7.6 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>39</sub>H<sub>51</sub>N<sub>2</sub>O<sub>13</sub> [M + H]<sup>+</sup>, 755.3391; found, 755.3402.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>N</i>-Fmoc Protected O-Mannosylated Glycoside <b>4</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>3</b> was used to obtain compound <b>4</b> as a yellow oil (535 mg, 91%) from <b>2</b>. RP-HPLC <i>t</i><sub>R</sub>, 26.1 min, MeOH/H<sub>2</sub>O 80:20, 100% purity, 214 nm. IR (ATR): 2964, 2939, 2920, 1747, 1701, 1479, 1450, 1423, 1368, 1220, 1151, 1136, 1084, 1047, 980, 760, 742 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.43 (m, 9H, <i>t</i>-Bu), 1.50–1.80 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.98 (s, 3H, OAc), 2.01 (s, 3H, OAc), 2.08 (s, 3H, OAc), 2.14 (s, 3H, OAc), 2.23 (t, 1H, <i>J</i> = 6.4 Hz, 0.5 × C<i>H</i><sub>2</sub>CO<sub>2</sub><sup><i>t</i></sup>Bu), 2.43 (t, 1H, <i>J</i> = 6.4 Hz, 0.5 × C<i>H</i><sub>2</sub>CO<sub>2</sub><sup><i>t</i></sup>Bu), 3.11–3.69 (m, 6H, 2 × C<i>H</i><sub>2</sub>-N, C<i>H</i><sub>2</sub>-O-Man), 3.95 (m, 1H, H<sub>5′</sub>), 4.07 (dd, 1H, <i>J</i> = 2.1, 12.1 Hz, 0.5 × H<sub>6′</sub>), 4.25 (m, 2H, C<i>H</i> Fmoc, 0.5 × H<sub>6′</sub>), 4.52 (m, 2H, C<i>H</i><sub>2</sub> Fmoc), 4.75 (m, 1H, H<sub>1′</sub>), 5.25 (m, 3H, H<sub>2′</sub>, H<sub>3′</sub>, H<sub>4′</sub>), 7.30 (t, 2H, <i>J</i> = 7.4 Hz, 2 × CH aromatic), 7.38 (t, 2H, <i>J</i> = 7.4 Hz, 2 × CH aromatic), 7.56 (m, 2H, 2 × CH aromatic), 7.75 (d, 2H, <i>J</i> = 7.4 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>39</sub>H<sub>50</sub>NO<sub>14</sub> [M + H]<sup>+</sup>, 756.3231; found, 756.3228.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> β-Dipeptoid <i>O</i>-GalNAc Scaffold <b>5</b></h3><div class="NLM_p last">Compound <b>3</b> (355 mg, 0.5 mmol) was dissolved in TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:1, 6.8 mL) at 0 °C and the reaction was stirred for 1 h at room temperature under an argon atmosphere and then concentrated to dryness. The excess of TFA was removed by coevaporation with CH<sub>2</sub>Cl<sub>2</sub> under reduced pressure to give the acid as a yellow foam (328 mg, quantitative), used in the next step without further purification. A stirred solution of the previous acid (328 mg, 0.5 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (3.0 mL) and DMF (1.8 mL) was treated with DIEA (0.2 mL, 1.2 mmol) for 10 min at room temperature under an argon atmosphere. HATU (358 mg, 0.94 mmol) was added, and the reaction mixture was stirred for an additional 10 min. After that, the monomer amine <b>1</b> (251 mg, 0.5 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) was added, and the mixture was stirred overnight at the same temperature. After evaporation of the solvent, the crude material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL), washed with 5% citric acid solution (2 × 30 mL), saturated NaHCO<sub>3</sub> solution (2 × 30 mL), H<sub>2</sub>O (2 × 30 mL), and brine (2 × 30 mL). The organic layer was dried (MgSO<sub>4</sub>) and concentrated under reduced pressure and the crude was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 97:3) to provide compound <b>5</b> (480 mg, 81%) as a white foam. RP-HPLC <i>t</i><sub>R</sub>, 16.7 min (77.7%) and 18.1 min (19.9%), MeOH/H<sub>2</sub>O 80:20, 97.6% purity, 210 nm. IR (ATR): 3307, 2953, 1745, 1715, 1676, 1648, 1555, 1522, 1479, 1426, 1370, 1223, 1153, 1132, 1047, 1044, 944, 769, 745 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.42 (m, 9H, <i>t</i>-Bu), 1.49–1.84 (m, 4H, 2 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.93–2.14 (m, 24H, 6 × OAc, 2 × NHAc), 2.26–2.71 (m, 4H, 2 × C<i>H</i><sub>2</sub>C═O), 3.06–3.76 (m, 12H, 4 × C<i>H</i><sub>2</sub>-N, 2 × C<i>H</i><sub>2</sub>-O-GalNAc), 3.98–4.23 (m, 7H, 2 × H<sub>5′</sub>, 4 × H<sub>6′</sub>, CH Fmoc), 4.38–4.63 (m, 4H, 2 × H<sub>2′</sub>, CH<sub>2</sub> Fmoc), 4.84 (m, 2H, 2 × H<sub>1′</sub>), 5.13 (m, 2H, 2 × H<sub>3′</sub>), 5.35 (m, 2H, 2 × H<sub>4′</sub>), 6.34–7.10 (m, 2H, 2 × N<i>H</i>Ac), 7.30 (t, 2H, <i>J</i> = 7.4 Hz, 2 × CH aromatic), 7.38 (t, 2H, <i>J</i> = 7.4 Hz, 2 × CH aromatic), 7.54 (m, 2H, 2 × CH aromatic), 7.75 (d, 2H, <i>J</i> = 7.4 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>59</sub>H<sub>81</sub>N<sub>4</sub>O<sub>23</sub> [M + H]<sup>+</sup>, 1213.5292; found, 1213.5251.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> β-Dipeptoid O-Mannosylated Scaffold <b>6</b></h3><div class="NLM_p last">Compound <b>4</b> was conjugated to monomer amine <b>2</b> following the procedure described for <b>5</b> to yield compound <b>6</b> (690 mg, 90%) as a white foam. RP-HPLC <i>t</i><sub>R</sub>, 22.3 min, MeOH/H<sub>2</sub>O 80:20, 96.9% purity, 214 nm. IR (ATR): 2947, 1746, 1698, 1643, 1479, 1450, 1440, 1422, 1368, 1220, 1136, 1084, 1047, 980, 743 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.43 (m, 9H, <i>t</i>-Bu), 1.57–1.83 (m, 4H, 2 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.95–2.14 (m, 24H, 8 × OAc), 2.30–2.60 (m, 4H, 2 × C<i>H</i><sub>2</sub>C═O), 3.10–3.71 (m, 12H, 4 × C<i>H</i><sub>2</sub>-N, 2 × C<i>H</i><sub>2</sub>-O-Man), 3.96 (m, 2H, 2 × H<sub>5′</sub>), 4.1 (m, 2H, 2 × H<sub>6′</sub>), 4.27 (m, 3H, 2 × H<sub>6′</sub>, CH Fmoc), 4.52 (m, 2H, CH<sub>2</sub> Fmoc), 4.77 (m, 2H, 2 × H<sub>1′</sub>), 5.25 (m, 6H, 2 × H<sub>2′</sub>, 2 × H<sub>3′</sub>, 2 × H<sub>4′</sub>), 7.3 (m, 2H, 2 × CH aromatic), 7.38 (t, 2H, <i>J</i> = 7.5 Hz, 2 × CH aromatic), 7.57 (d, 2H, <i>J</i> = 7.5 Hz, 2 × CH aromatic), 7.75 (d, 2H, <i>J</i> = 7.5 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>59</sub>H<sub>79</sub>N<sub>2</sub>O<sub>25</sub> [M + H]<sup>+</sup>, 1215.4972; found, 1215.4957.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> β-Tripeptoid <i>O</i>-GalNAc Scaffold <b>7</b></h3><div class="NLM_p last">Compound <b>5</b> was conjugated to monomer amine <b>1</b> following the procedure described for <b>5</b> to yield compound <b>7</b> (380 mg, 75%) as a white foam. RP-HPLC <i>t</i><sub>R</sub>, 14.3 min (70.2%) and 15.4 min (27.5%), MeOH/H<sub>2</sub>O 80:20, 97.7% purity, 210 nm. IR (ATR): 3342, 2954, 1747, 1703, 1680, 1634, 1626, 1555, 1531, 1480, 1452, 1435, 1371, 1223, 1155, 1131, 1047, 1044, 949, 734 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.42 (m, 9H, <i>t</i>-Bu), 1.72–2.13 (m, 42H, 9 × OAc, 3 × NHAc, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 2.18–2.65 (m, 6H, 3 × C<i>H</i><sub>2</sub>C═O), 3.06–3.69 (m, 18H, 6 × C<i>H</i><sub>2</sub>-N, 3 × C<i>H</i><sub>2</sub>-O-GalNAc), 4.04–4.27 (m, 10H, 3 × H<sub>5′</sub>, 6 × H<sub>6′</sub>, CH Fmoc), 4.47–4.62 (m, 5H, 3 × H<sub>2′</sub>, CH<sub>2</sub> Fmoc), 4.88 (m, 3H, 3 × H<sub>1′</sub>), 5.13 (m, 3H, 3 × H<sub>3′</sub>), 5.36 (m, 3H, 3 × H<sub>4′</sub>), 6.23–7.09 (m, 3H, 3 × N<i>H</i>Ac) 7.29 (t, 2H, <i>J</i> = 7.2 Hz, 2 × CH aromatic), 7.38 (t, 2H, <i>J</i> = 7.2 Hz, 2 × CH aromatic), 7.53 (m, 2H, 2 × CH aromatic), 7.74 (d, 2H, <i>J</i> = 7.2 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>79</sub>H<sub>112</sub>N<sub>6</sub>O<sub>33</sub> [M + H]<sup>2+</sup>, 836.3630; found, 836.3607.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> β-Tripeptoid O-Mannosylated Scaffold <b>8</b></h3><div class="NLM_p last">Compound <b>6</b> was conjugated to monomer amine <b>2</b> following the procedure described for <b>5</b> to yield compound <b>8</b> (738 mg, 87%) as a white foam. RP-HPLC <i>t</i><sub>R</sub>, 21.4 min, MeOH/H<sub>2</sub>O 80:20, 96.6% purity, 214 nm. IR (ATR): 2937, 1749, 1699, 1645, 1640, 1480, 1458, 1441, 1423, 1370, 1223, 1136, 1084, 1047, 970 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.4 (m, 9H, <i>t</i>-Bu), 1.60–1.80 (m, 6H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.91–2.15 (m, 36H, 12 × OAc), 2.40–2.62 (m, 6H, 3 × C<i>H</i><sub>2</sub>C═O), 3.10–3.70 (m, 18H, 6 × C<i>H</i><sub>2</sub>-N, 3 × C<i>H</i><sub>2</sub>-O-Man), 3.94 (m, 3H, 3 × H<sub>5′</sub>), 4.06 (m, 3H, 3 × H<sub>6′</sub>), 4.25 (m, 4H, 3 × H<sub>6′</sub>, CH Fmoc), 4.47 (m, 2H, CH<sub>2</sub> Fmoc), 4.75 (m, 3H, 3 × H<sub>1′</sub>), 5.25 (m, 9H, 3 × H<sub>2′</sub>, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>), 7.29 (m, 2H, 2 × CH aromatic), 7.36 (t, 2H, <i>J</i> = 7.5 Hz, 2 × CH aromatic), 7.56 (d, 2H, <i>J</i> = 7.5 Hz, 2 × CH aromatic), 7.73 (d, 2H, <i>J</i> = 7.5 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>79</sub>H<sub>109</sub>N<sub>3</sub>O<sub>36</sub> [M + H]<sup>2+</sup>, 837.8395; found, 837.8367.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> β-Tripeptoid <i>O</i>-GalNAc Scaffold <b>9</b></h3><div class="NLM_p last">A stirred solution of compound <b>7</b> (50 mg, 0.03 mmol) in CH<sub>3</sub>CN (0.8 mL) was treated with Et<sub>2</sub>NH (0.4 mL) at 0 °C for 30 min and at room temperature for 4 h. After concentration to dryness, the excess of Et<sub>2</sub>NH was removed by coevaporation with CH<sub>2</sub>Cl<sub>2</sub> and the crude was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 95:5 to 85:15) to obtain compound <b>9</b> (46 mg, quantitative) as a yellow oil. IR (ATR): 3322, 2942, 1745, 1732, 1654, 1636, 1542, 1536, 1432, 1426, 1371, 1222, 1225, 1156, 1130, 1048, 1036 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.39–1.42 (m, 9H, m, <i>t</i>-Bu), 1.70–2.13 (m, 43H, 9 × OAc, 3 × NHAc, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>, N<i>H</i> peptoid), 2.18–2.83 (m, 6H, 3 × C<i>H</i><sub>2</sub>C═O), 2.90–4.01 (m, 18H, 6 × C<i>H</i><sub>2</sub>-N, 3 × C<i>H</i><sub>2</sub>-O-GalNAc), 4.03–4.36 (m, 9H, 3 × H<sub>5′</sub>, 6 × H<sub>6′</sub>), 4.58 (m, 3H, 3 × H<sub>2′</sub>), 4.82–5.00 (m, 3H, 3 × H<sub>1′</sub>), 5.13 (m, 3H, 3 × H<sub>3′</sub>), 5.36 (m, 3H, 3 × H<sub>4′</sub>), 6.54–7.45 (m, 3H, 3 × N<i>H</i>Ac). HRMS (ESI): calculated for C<sub>64</sub>H<sub>102</sub>N<sub>6</sub>O<sub>31</sub> [M + H]<sup>2+</sup>, 725.3295; found, 725.3262.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> β-Tripeptoid O-Mannosylated Scaffold <b>10</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>9</b> was used. The product <b>10</b> (33 mg, quantitative) was obtained as a yellow oil from <b>8</b>. IR (ATR): 2949, 2916, 1745, 1741, 1641, 1452, 1440, 1431, 1371, 1224, 1137, 1082, 1045 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.42 (m, 9H, <i>t</i>-Bu), 1.78–2.14 (m, 42H, 12 × OAc, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 2.24 (m, 1H, N<i>H</i> peptoid), 2.47–2.79 (m, 4H, 2 × C<i>H</i><sub>2</sub>C═O), 2.93–3.86 (m, 20H, 0.5 × C<i>H</i><sub>2</sub>C═O, 6 × C<i>H</i><sub>2</sub>-N, 3 × C<i>H</i><sub>2</sub>-O-Man), 3.96 (m, 3H, 3 × H<sub>5′</sub>), 4.07 (m, 3H, 3 × H<sub>6′</sub>), 4.27 (dd, 3H, <i>J</i> = 5.2, 12.0 Hz, 3 × H<sub>6′</sub>), 4.77–4.84 (m, 3H, 3 × H<sub>1′</sub>), 5.17–5.34 (m, 9H, 3 × H<sub>2′</sub>, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>). HRMS (ESI): calculated for C<sub>64</sub>H<sub>99</sub>N<sub>3</sub>O<sub>34</sub> [M + H]<sup>2+</sup>, 726.8055; found, 726.8067.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> β-Tripeptoid <i>O</i>-GalNAc Scaffold <b>11</b></h3><div class="NLM_p last">A stirred solution of compound <b>9</b> (7.10 mg, 0.0049 mmol) in dry MeOH (1.3 mL) was treated with a solution of NaOMe (130 μL) in dry MeOH for 1 h at room temperature under an argon atmosphere. The reaction mixture was neutralized with Dowex 50W-X8 (H+) resin and then filtered to give the compound <b>11</b> (5.2 mg, quantitative) as a white solid. IR (ATR): 3514, 3160, 2926, 2853, 1710, 1653, 1634, 1623, 1554, 1467, 1342, 1233, 1154, 1123, 1058, 1041 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.42 (m, 9H, <i>t</i>-Bu), 1.80–2.09 (m, 15H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>, 3 × NHAc), 2.50–3.00 (m, 6H, 3 × C<i>H</i><sub>2</sub>C═O), 3.20–3.90 (m, 33H, 3 × C<i>H</i><sub>2</sub>CH<sub>2</sub>C═O, 3 × C<i>H</i><sub>2</sub>N, 3 × OC<i>H</i><sub>2</sub>CH<sub>2</sub>, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>, 3 × H<sub>5′</sub>, 6 × H<sub>6′</sub>), 4.30 (m, 3H, 3H<sub>2′</sub>), 4.70 (m, 3H, 3H<sub>1′</sub>). HRMS (ESI): calculated for C<sub>46</sub>H<sub>83</sub>N<sub>6</sub>O<sub>22</sub> [M + H]<sup>+</sup>, 536.2819; found, 536.2825.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> β-Dipeptoid O-Mannosylated Scaffold <b>12</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>11</b> was used. The product <b>12</b> was obtained (8.0 mg, quantitative) as a white foam from <b>10</b>. IR (ATR): 3517, 3168, 2926, 2857, 1715, 1656, 1630, 1625, 1555, 1475, 1345, 1233, 1154, 1123, 1060, 1047 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.42 (m, 9H, <i>t</i>-Bu), 1.80–2.09 (m, 6H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 2.50–3.00 (m, 6H, 3 × C<i>H</i><sub>2</sub>C═O), 3.20–3.90 (m, 36H, 3 × C<i>H</i><sub>2</sub>CH<sub>2</sub>C═O, 3 × C<i>H</i><sub>2</sub>N, 3 × OC<i>H</i><sub>2</sub>CH<sub>2</sub>, 3 × H<sub>2′</sub>, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>, 3 × H<sub>5′</sub>, 6 × H<sub>6′</sub>), 4.70 (m, 3H, 3 × H<sub>1′</sub>). HRMS (ESI): calculated for C<sub>40</sub>H<sub>74</sub>N<sub>3</sub>O<sub>22</sub> [M + H]<sup>+</sup>, 948.4764; found, 948.4776.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> β-Tripeptoid <i>O</i>-GalNAc Scaffold <b>13</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>5</b> was used. The reaction was carried out with compound <b>7</b> (1.0 equiv), conjugated to propargyl amine (3.0 equiv) to yield compound <b>13</b> (138 mg, 95%) as a white foam. RP-HPLC <i>t</i><sub>R</sub>, 10.0 min (75.8%) and 10.5 min (24.1%), MeOH/H<sub>2</sub>O 80:20, 99.9% purity, 210 nm. IR (ATR): 3289, 2948, 2371, 1745, 1675, 1671, 1648, 1637, 1570, 1541, 1478, 1456, 1424, 1371, 1224, 1166, 1131, 1073, 1047, 948, 923, 742 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.70–2.21 (m, 43H, 9 × OAc, 3 × NHAc, C≡C<i>H</i>, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 2.24–2.68 (m, 6H, 3 × C<i>H</i><sub>2</sub>C═O), 3.11–3.72 (m, 18H, 6 × C<i>H</i><sub>2</sub>-N, 3 × C<i>H</i><sub>2</sub>-O-GalNAc), 3.96–4.26 (m, 12H, C<i>H</i><sub>2</sub>-NH, 3 × H<sub>5′</sub>, 6 × H<sub>6′</sub>, CH Fmoc), 4.56 (m, 5H, 3 × H<sub>2′</sub>, CH<sub>2</sub> Fmoc), 4.86 (m, 3H, 3 × H<sub>1′</sub>), 5.14 (m, 3H, 3 × H<sub>3′</sub>), 5.35 (m, 3H, 3 × H<sub>4′</sub>), 6.54–7.18 (m, 4H, 3 × N<i>H</i>Ac, N<i>H</i>-CH<sub>2</sub>C≡CH), 7.27 (m, 2H, 2 × CH aromatic), 7.37 (m, 2H, 2 × CH aromatic), 7.53 (m, 2H, 2 × CH aromatic), 7.73 (m, 2H, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>78</sub>H<sub>107</sub>N<sub>7</sub>O<sub>32</sub> [M + H]<sup>2+</sup>, 826.8475; found, 826.8450.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> β-Tripeptoid O-Mannosylated Scaffold <b>14</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>5</b> was used. The reaction was carried out with compound <b>8</b> (1.0 equiv), conjugated to propargyl amine (3.0 equiv) to yield compound <b>14</b> (278 mg, 86%) as a white foam. RP-HPLC <i>t</i><sub>R</sub>, 12.8 min, MeOH/H<sub>2</sub>O 80:20, 98.0% purity, 214 nm. IR (ATR): 2941, 2360, 1744, 1693, 1672, 1635, 1477, 1456, 1445, 1426, 1369, 1219, 1135, 1083, 1047, 979, 747 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.56–1.82 (m, 6H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.94–2.12 (m, 36H, 12 × OAc), 2.20 (m, 1H, C≡C<i>H</i>), 2.45–2.7 (m, 6H, 3 × C<i>H</i><sub>2</sub>C═O), 3.15–3.7 (m, 18H, 6 × C<i>H</i><sub>2</sub>-N, 3 × C<i>H</i><sub>2</sub>-O-Man), 3.94 (m, 5H, C<i>H</i><sub>2</sub>-NH, 3 × H<sub>5′</sub>), 4.07 (m, 3H, 3 × H<sub>6′</sub>), 4.25 (m, 4H, 3 × H<sub>6′</sub>, CH Fmoc), 4.47 (m, 2H, CH<sub>2</sub> Fmoc), 4.75 (m, 3H, 3 × H<sub>1′</sub>), 5.22 (m, 9H, 3 × H<sub>2′</sub>, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>), 7.22 (m, 1H, N<i>H</i>-CH<sub>2</sub>C≡CH), 7.29 (m, 2H, 2 × CH aromatic), 7.36 (t, 2H, <i>J</i> = 7.1 Hz, 2 × CH aromatic), 7.56 (d, 2H, <i>J</i> = 7.1 Hz, 2 × CH aromatic), 7.73 (d, 2H, <i>J</i> = 7.1 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>78</sub>H<sub>104</sub>N<sub>4</sub>O<sub>35</sub> [M + H]<sup>2+</sup>, 828.3241; found, 828.3207.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> β-Tripeptoid <i>O</i>-GalNAc Scaffold <b>15</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>9</b> was used. The product <b>15</b> (53 mg, quantitative) was obtained as a yellow oil from <b>13</b>. IR (ATR): 3262, 2914, 2378, 1746, 1673, 1654, 1648, 1637, 1577, 1539, 1528, 1451, 1430, 1372, 1220, 1223, 1167, 1170, 1133, 1142, 1048, 1037 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.73–2.92 (m, 45H, 9 × OAc, 3 × NHAc, C≡C<i>H</i>, 3 × C<i>H</i><sub>2</sub>C═O, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>, N<i>H</i> peptoid), 3.10–4.05 (20H, m, NH–C<i>H</i><sub>2</sub>-C≡CH, 6 × C<i>H</i><sub>2</sub>-N, 3 × C<i>H</i><sub>2</sub>-O-GalNAc), 4.07–4.47 (m, 9H, 3 × H<sub>5′</sub>, 6 × H<sub>6′</sub>), 4.59 (m, 3H, 3 × H<sub>2′</sub>), 4.92 (m, 3H, 3 × H<sub>1′</sub>), 5.12 (m, 3H, 3 × H<sub>3′</sub>), 5.36 (m, 3H, 3 × H<sub>4′</sub>), 6.67–8.00 (m, 4H, 3 × N<i>H</i>Ac, N<i>H</i>-CH<sub>2</sub>C≡CH). HRMS (ESI): calculated for C<sub>63</sub>H<sub>97</sub>N<sub>7</sub>O<sub>30</sub> [M + H]<sup>2+</sup>, 715.8135; found, 715.8030.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> β-Tripeptoid O-Mannosylated Scaffold <b>16</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>9</b> was used. Product <b>16</b> (51 mg, quantitative) was obtained as a yellow oil from <b>14</b>. IR (ATR): 2954, 2360, 1744, 1674, 1668, 1550, 1452, 1432, 1370, 1223, 1135, 1084, 1047 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.81 (m, 6H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.94–2.11 (m, 36H, 12 × OAc), 2.20 (m, 2H, C≡C<i>H</i>, N<i>H</i> peptoid), 2.49–3.02 (m, 6H, 3 × C<i>H</i><sub>2</sub>C═O), 3.08–3.77 (m, 18H, 6 × C<i>H</i><sub>2</sub>-N, 3 × C<i>H</i><sub>2</sub>-O-Man), 3.95 (m, 5H, NH–C<i>H</i><sub>2</sub>-C≡CH, 3 × H<sub>5′</sub>), 4.07 (m, 3H, 6 × H<sub>6′</sub>), 4.25 (m, 3H, 6 × H<sub>6′</sub>), 4.80 (m, 3H, 3 × H<sub>1′</sub>), 5.22 (m, 9H, 3 × H<sub>2′</sub>, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>), 7.75 (m, 1H, N<i>H</i>-CH<sub>2</sub>C≡CH). HRMS (ESI): calculated for C<sub>63</sub>H<sub>94</sub>N<sub>4</sub>O<sub>33</sub> [M + H]<sup>2+</sup>, 717.2900; found, 717.2973.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> TLR7 Agonist–Spacer Conjugate <b>26</b></h3><div class="NLM_p last">A stirred solution of agonist TLR7 <b>24</b> (70 mg, 0.2 mmol) in dry DMF (4 mL) was treated with tributylamine (70 μL, 0.3 mmol) for 10 min at room temperature under an argon atmosphere, and then isobutyl chloroformate (38 μL, 0.3 mmol) was added. After 10 min again, aminocaproic acid (128 mg, 0.98 mmol) in DMF/H<sub>2</sub>O (1:1, 4 mL) was added at 0 °C and the mixture was stirred for an additional 28 h. The reaction mixture was concentrated, dissolved in H<sub>2</sub>O (7 mL), and acidified with 1.0 M HCl to pH 1.0. The mixture was cooled down to 0 °C and then filtered to give compound <b>26</b> (51 mg, 55%) as a white solid. IR (ATR): 3419, 3103, 3039, 2935, 2858, 1705, 1636, 1616, 1553, 1506, 1452, 1419, 1375, 1348, 1327, 1125, 1092, 949, 779, 717 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.26 (m, 2H, C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>CO<sub>2</sub>H), 1.50 (m, 4H, NHCH<sub>2</sub>CH<sub>2</sub>, C<i>H</i><sub>2</sub>CH<sub>2</sub>CO<sub>2</sub>H), 2.19 (t, 2H, <i>J</i> = 7.2 Hz, C<i>H</i><sub>2</sub>CO<sub>2</sub>H), 3.21 (m, 2H, NHC<i>H</i><sub>2</sub>), 3.26 (s, 3H, C<i>H</i><sub>3</sub>-O), 3.56 (t, 2H, <i>J</i> = 4.5 Hz, C<i>H</i><sub>2</sub>-O), 4.24 (t, 2H, <i>J</i> = 4.5 Hz, C<i>H</i><sub>2</sub>-O), 4.89 (s, 2H, C<i>H</i><sub>2</sub>-C<sub>6</sub>H<sub>4</sub>C═O), 6.53 (s, 2H, NH<sub>2</sub>), 7.34 (d, 2H, <i>J</i> = 8.0 Hz, 2 × CH aromatic), 7.76 (d, 2H, <i>J</i> = 8.0 Hz, 2 × CH aromatic), 8.39 (t, 1H, <i>J</i> = 5.0 Hz, N<i>H</i>C═O), 10.0 (s, 1H, N<i>H</i> cycle), 12.0 (s, 1H, CO<sub>2</sub><i>H</i>). HRMS (ESI): calculated for C<sub>22</sub>H<sub>29</sub>N<sub>6</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 473.2149; found, 473.2146.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> TLR7 Agonist–Spacer–<i>O</i>-GalNAc β-Tripeptoid Conjugate <b>27</b></h3><div class="NLM_p last">A stirred solution of the acid <b>26</b> (10.4 mg, 0.022 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) and DMF (0.45 mL) was treated with DIEA (10 μL, 0.051 mmol) for 10 min at room temperature under an argon atmosphere. HATU (16.7 mg, 0.044 mmol) was added, and the reaction mixture was stirred for an additional 10 min. After that, the monomer amine <b>9</b> (31.9 mg, 0.022 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (0.55 mL) and the mixture were stirred for 40 h at the same temperature. After evaporation of the solvent, the crude material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (15 mL), washed with 5% citric acid solution (2 × 15 mL), saturated NaHCO<sub>3</sub> solution (2 × 15 mL), H<sub>2</sub>O (2 × 15 mL), and brine (2 × 15 mL). The organic layer was dried (MgSO<sub>4</sub>) and concentrated under reduced pressure and the crude was purified by column chromatography (AcOEt/MeOH, 90:10 to 80:20) to provide compound <b>27</b> (22 mg, 53%) as a white foam. IR (ATR): 3354, 3330, 2960, 2923, 2853, 1746, 1733, 1656, 1649, 1640, 1633, 1622, 1615, 1570, 1541, 1460, 1436, 1428, 1371, 1259, 1233, 1227, 1158, 1153, 1129, 1081, 1075, 1035, 800 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.43 (s, 9H, <i>t</i>-Bu), 1.54–1.85 (m, 12H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>, C<i>H</i><sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>NH spacer), 1.90–2.16 (m, 36H, 9 × OAc, 3 × NHAc), 2.20–2.70 (m, 8H, 3 × C<i>H</i><sub>2</sub>CO<sub>2</sub><sup><i>t</i></sup>Bu, C<i>H</i><sub>2</sub>C═O spacer), 3.30–3.74 (m, 25H, 6 × C<i>H</i><sub>2</sub>N peptoid, 3 × C<i>H</i><sub>2</sub>-O-GalNAc, C<i>H</i><sub>2</sub>NH spacer, C<i>H</i><sub>2</sub>-O, C<i>H</i><sub>3</sub>-O), 4.05–4.27 (m, 9H, 3 × H<sub>5′</sub>, 6 × H<sub>6′</sub>), 4.43 (m, 2H, C<i>H</i><sub>2</sub>-O), 4.53–4.64 (m, 3H, 3 × H<sub>2′</sub>), 4.85–5.08 (m, 5H, 3 × H<sub>1′</sub>, C<i>H</i><sub>2</sub>N agonist), 5.15 (m, 3H, 3 × H<sub>3′</sub>), 5.37 (m, 3H, 3 × H<sub>4′</sub>), 5.77 (m, 2H, NH<sub>2</sub>), 6.76–7.73 (m, 8H, 4 × C<i>H</i> aromatic, N<i>H</i> spacer, 3 × N<i>H</i>Ac), 10.16 (m, 1H, NH cycle). HRMS (ESI): calculated for C<sub>86</sub>H<sub>128</sub>N<sub>12</sub>O<sub>36</sub> [M + H]<sup>2+</sup>, 952.4277; found, 952.4245.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> TLR7 Agonist–Spacer–O-Mannosylated β-Tripeptoid Conjugate <b>28</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>27</b> was used. Compound <b>26</b> was conjugated to the glycopeptoid <b>10</b> to yield compound <b>28</b> (23 mg, 53%) as a white foam. IR (ATR): 3352, 3329, 2962, 2925, 2858, 1745, 1733, 1657, 1645, 1640, 1633, 1628, 1617, 1571, 1541, 1460, 1438, 1428, 1378, 1260, 1233, 1222, 1159, 1153, 1130, 1081, 1076, 1034, 800 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.42 (s, 1H, <i>t</i>-Bu), 1.58–1.90 (m, 12H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>, C<i>H</i><sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>NH spacer), 1.93–2.15 (m, 36H, 12 × OAc), 2.25–2.72 (m, 8H, 3 × C<i>H</i><sub>2</sub>CO<sub>2</sub><sup><i>t</i></sup>Bu, C<i>H</i><sub>2</sub>C═O spacer), 3.34–3.76 (m, 25H, 6 × C<i>H</i><sub>2</sub>N peptoid, 3 × C<i>H</i><sub>2</sub>-O-Man, C<i>H</i><sub>2</sub>N spacer, C<i>H</i><sub>2</sub>-O, C<i>H</i><sub>3</sub>-O), 3.97 (m, 3H, 3 × H<sub>5′</sub>), 4.09 (m, 3H, 3 × H<sub>6′</sub>), 4.28 (dd, 3H, <i>J</i> = 4.7, 12.1 Hz, 3 × H<sub>6′</sub>), 4.41 (m, 2H, C<i>H</i><sub>2</sub>-O), 4.81 (m, 3H, 3 × H<sub>1′</sub>), 5.00 (m, 2H, C<i>H</i><sub>2</sub>N agonist), 5.16–5.31 (m, 9H, 3 × H<sub>2′</sub>, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>), 5.73 (m, 2H, NH<sub>2</sub>), 7.36–7.44 (m, 3H, 2 × CH aromatic, NH spacer), 7.80 (d, 2H, <i>J</i> = 7.9 Hz, 2 × CH aromatic), 10.07 (m, 1H, N<i>H</i> cycle). HRMS (ESI): calculated for C<sub>86</sub>H<sub>125</sub>N<sub>9</sub>O<sub>39</sub> [M + H]<sup>2+</sup>, 953.9037; found, 953.9047.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> TLR7 Agonist–Spacer–<i>O</i>-GalNAc β-Tripeptoid Conjugate <b>29</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>27</b> was used. Compound <b>26</b> was conjugated to the glycopeptoid <b>15</b> to yield compound <b>29</b> (20 mg, 48%) as a white foam. RP-HPLC <i>t</i><sub>R</sub>, 9.0 min, MeOH/H<sub>2</sub>O 70:30, 98.4% purity, 254 nm. IR (ATR): 3306, 3230, 2960, 2923, 2853, 2354, 1745, 1731, 1648, 1639, 1615, 1571, 1546, 1466, 1426, 1415, 1371, 1343, 1229, 1162, 1130, 1129, 1075, 1045, 781 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.39–1.88 (m, 12H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>, C<i>H</i><sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>NH spacer), 1.94–2.16 (m, 39H, 9 × OAc, 3 × NHAc, C≡C<i>H</i>, C<i>H</i><sub>2</sub>C═O spacer), 2.3–2.68 (m, 6H, 3 × C<i>H</i><sub>2</sub>C═O peptoid), 3.30–3.74 (m, 25H, 6 × C<i>H</i><sub>2</sub>N peptoid, 3 × C<i>H</i><sub>2</sub>-O-GalNAc, C<i>H</i><sub>2</sub>NH spacer, C<i>H</i><sub>2</sub>-O agonist, C<i>H</i><sub>3</sub>-O), 3.94–4.19 (m, 11H, NH–C<i>H</i><sub>2</sub>-C≡CH, 3 × H<sub>5′</sub>, 6 × H<sub>6′</sub>), 4.43 (m, 2H, C<i>H</i><sub>2</sub>-O agonist), 4.58 (m, 3H, 3 × H<sub>2′</sub>), 4.83–5.04 (m, 5H, 3 × H<sub>1′</sub>, C<i>H</i><sub>2</sub>N agonist), 5.09–5.22 (m, 3H, 3 × H<sub>3′</sub>), 5.38 (m, 3H, 3 × H<sub>4′</sub>), 5.76 (m, 2H, N<i>H</i><sub>2</sub>), 6.86–7.72 (m, 9H, 4 × CH aromatic, N<i>H</i> spacer, 3 × N<i>H</i>Ac, N<i>H</i>-CH<sub>2</sub>C≡H), 10.16 (m, 1H, N<i>H</i> cycle). HRMS (ESI): calculated for C<sub>85</sub>H<sub>123</sub>N<sub>13</sub>O<sub>35</sub> [M + H]<sup>2+</sup>, 942.9122; found, 942.9157.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> TLR7 Agonist–Spacer–O-Mannosylated β-Tripeptoid Conjugate <b>30</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>27</b> was used. Compound <b>26</b> was conjugated to the glycopeptoid <b>16</b> to yield compound <b>30</b> (22 mg, 50%) as a white foam. RP-HPLC <i>t</i><sub>R</sub>, 11.7 min, MeOH/H<sub>2</sub>O 70:30, 92.6% purity, 210 nm. IR (ATR): 3355, 3333, 2957, 2924, 1746, 1647, 1644, 1618, 1575, 1540, 1458, 1440, 1419, 1370, 1342, 1225, 1134, 1090, 1047, 932, 899 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.58–1.88 (m, 12H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>, C<i>H</i><sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>NH spacer), 1.95–2.15 (m, 39H, 12 × OAc, C≡C<i>H</i>, C<i>H</i><sub>2</sub>C═O spacer), 2.19–2.71 (m, 6H, 3 × C<i>H</i><sub>2</sub>C═O peptoid), 3.27–3.76 (m, 25H, 6 × C<i>H</i><sub>2</sub>N peptoid, 3 × C<i>H</i><sub>2</sub>-O-Man, C<i>H</i><sub>2</sub>NH spacer, C<i>H</i><sub>2</sub>-O agonist, C<i>H</i><sub>3</sub>-O), 3.9–4.01 (m, 5H, NH–C<i>H</i><sub>2</sub>-C≡CH, 3 × H<sub>5′</sub>), 4.1 (m, 3H, 3 × H<sub>6′</sub>), 4.28 (dd, 3H, <i>J</i> = 4.8, 12.2 Hz, 3 × H<sub>6′</sub>), 4.41 (m, 2H, C<i>H</i><sub>2</sub>-O agonist), 4.81 (m, 3H, 3 × H<sub>1′</sub>), 5.00 (m, 2H, C<i>H</i><sub>2</sub>N agonist), 5.17–5.32 (m, 9H, 3 × H<sub>2′</sub>, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>), 5.82 (m, 2H, N<i>H</i><sub>2</sub>), 7.39–7.88 (m, 6H, 4 × CH aromatic, N<i>H</i> spacer, N<i>H</i>-CH<sub>2</sub>C≡H), 10.1 (m, 1H, N<i>H</i> cycle). HRMS (ESI): calculated for C<sub>85</sub>H<sub>120</sub>N<sub>10</sub>O<sub>38</sub> [M + H]<sup>2+</sup>, 944.3882; found, 944.3833.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> TLR7 Agonist–Spacer–<i>O</i>-GalNAc β-Tripeptoid Conjugate <b>31</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>11</b> was used. The product <b>31</b> was obtained (12.6 mg, quantitative) as a white foam from <b>27</b>. RP-HPLC <i>t</i><sub>R</sub>, 7.4 min, MeOH/H<sub>2</sub>O 60:40, 95.9% purity, 214 nm. IR (ATR): 3501, 3181, 2928, 2853, 1720, 1642, 1625, 1615, 1555, 1465, 1374, 1340, 1153, 1123, 1060, 1039, 971 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.42–1.45 (m, 9H, <i>t</i>-Bu), 1.55–1.71 (m, 6H, m, C<i>H</i><sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>NH spacer), 1.75–1.93 (m, 6H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub> peptoid), 1.99–2.03 (m, 9H, 3 × NHAc), 2.38–2.88 (m, 8H, 3 × C<i>H</i><sub>2</sub>CO<sub>2</sub><sup><i>t</i></sup>Bu, C<i>H</i><sub>2</sub>C═O spacer), 3.33–3.90 (m, 40H, 6 × C<i>H</i><sub>2</sub>N peptoid, 3 × C<i>H</i><sub>2</sub>-O-GalNAc, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>, 3 × H<sub>5′</sub>, 6 × H<sub>6′</sub>, C<i>H</i><sub>2</sub>NH spacer, C<i>H</i><sub>2</sub>-O, C<i>H</i><sub>3</sub>-O), 4.28 (m, 3H, 3 × H<sub>2′</sub>), 4.45 (m, 2H, C<i>H</i><sub>2</sub>-O), 4.75–4.83 (m, 3H, 3 × H<sub>1′</sub>), 5.01 (s, 2H, C<i>H</i><sub>2</sub>N agonist), 7.47 (d, 2H, <i>J</i> = 8.2 Hz, 2 × CH aromatic), 7.78 (d, 2H, <i>J</i> = 8.2 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>68</sub>H<sub>110</sub>N<sub>12</sub>O<sub>27</sub> [M + H]<sup>2+</sup>, 763.3802; found, 763.3774.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> TLR7 Agonist–Spacer–O-Mannosylated β-Tripeptoid Conjugate <b>32</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>11</b> was used. The product <b>32</b> was obtained (3.9 mg, quantitative) as a white foam from <b>28</b>. IR (ATR): 3508, 3175, 2928, 2859, 1710, 1645, 1630, 1620, 1560, 1465, 1373, 1345, 1155, 1120, 1061, 1040, 971 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.42–1.45 (m, 9H, <i>t</i>-Bu), 1.57–1.71 (m, 6H, C<i>H</i><sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>NH spacer), 1.78–1.95 (m, 6H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub> peptoid), 2.32–2.84 (m, 8H, 3 × C<i>H</i><sub>2</sub>CO<sub>2</sub><sup><i>t</i></sup>Bu, C<i>H</i><sub>2</sub>C═O spacer), 3.39–3.98 (m, 43H, 6 × C<i>H</i><sub>2</sub>N peptoid, 3 × C<i>H</i><sub>2</sub>-O-Man, 3 × H<sub>2′</sub>, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>, 3 × H<sub>5′</sub>, 6 × H<sub>6′</sub>, C<i>H</i><sub>2</sub>NH spacer, C<i>H</i><sub>2</sub>-O, C<i>H</i><sub>3</sub>-O), 4.45 (m, 2H, C<i>H</i><sub>2</sub>-O), 4.72 (m, 3H, 3 × H<sub>1′</sub>), 5.07 (s, 2H, C<i>H</i><sub>2</sub>N agonist), 7.50 (d, 2H, <i>J</i> = 8.1 Hz, 2 × CH aromatic), 7.80 (d, 2H, <i>J</i> = 7.7 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>62</sub>H<sub>101</sub>N<sub>9</sub>O<sub>27</sub> [M + H]<sup>2+</sup>, 701.8403; found, 701.8415.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> TLR7 Agonist–Spacer–<i>O</i>-GalNAc β-Tripeptoid Conjugate <b>33</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>11</b> was used. The product <b>33</b> was obtained (12.1 mg, quantitative) as a white foam from <b>29</b>. RP-HPLC <i>t</i><sub>R</sub>, 11.0 min, 10–60% MeOH/H<sub>2</sub>O, 85.6% purity, 205 nm. IR (ATR): 3342, 3264, 2950, 2925, 2853, 2364, 1718, 1710, 1648, 1637, 1618, 1560, 1545, 1460, 1450, 1439, 1419, 1377, 1342, 1154, 1121, 1039, 787 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1,58–1,71 (m, 6H, C<i>H</i><sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>NH spacer), 1.78–1.93 (m, 6H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.99–2,05 (m, 9H, 3 × NHAc), 2.39–2.85 (m, 9H, C≡C<i>H</i>, 3× C<i>H</i><sub>2</sub>C═O peptoid, C<i>H</i><sub>2</sub>C═O spacer), 3.36–3.95 (m, 42H, NH–C<i>H</i><sub>2</sub>-C≡CH, 6 × C<i>H</i><sub>2</sub>N peptoid, 3 × C<i>H</i><sub>2</sub>-O-GalNAc, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>, 3 × H<sub>5′</sub>, 3 × H<sub>5′</sub>, C<i>H</i><sub>2</sub>NH spacer, C<i>H</i><sub>2</sub>-O agonist, O–C<i>H</i><sub>3</sub>), 4.28 (m, 3H, 3 × H<sub>2′</sub>), 4.40 (m, 2H, C<i>H</i><sub>2</sub>-O agonist), 4.76–4.84 (m, 3H, 3 × H<sub>1′</sub>), 5.04 (s, 2H, C<i>H</i><sub>2</sub>N agonist), 7.47 (d, 2H, <i>J</i> = 8.2 Hz, 2 × CH aromatic), 7.78 (d, 2H, <i>J</i> = 8.2 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>67</sub>H<sub>105</sub>N<sub>13</sub>O<sub>26</sub> [M + H]<sup>2+</sup>, 753.8642; found, 753.8641.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> TLR7 Agonist–Spacer–O-Mannosylated β-Tripeptoid Conjugate <b>34</b></h3><div class="NLM_p last">A procedure similar to that for compound <b>11</b> was used. The product <b>34</b> was obtained (10.8 mg, quantitative) as a white foam from <b>30</b>. RP-HPLC <i>t</i><sub>R</sub>, 10.6 min, 10–60% MeOH/H<sub>2</sub>O, 89.8% purity, 210 nm. IR (ATR): 3532, 3120, 2924, 2855, 2359, 1727, 1707, 1663, 1617, 1564, 1465, 1419, 1343, 1200, 1132, 1062, 1030, 1028, 972 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.57–1.71 (m, 6H, C<i>H</i><sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C═O spacer, C<i>H</i><sub>2</sub>CH<sub>2</sub>NH spacer), 1.77–1.92 (m, 6H, 3 × CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 2.35–2.84 (m, 9H, C≡C<i>H</i>, 3× C<i>H</i><sub>2</sub>C═O peptoid, C<i>H</i><sub>2</sub>C═O spacer), 3.36–3.97 (m, 45H, NH–C<i>H</i><sub>2</sub>-C≡CH, 6 × C<i>H</i><sub>2</sub>N peptoid, 3 × C<i>H</i><sub>2</sub>-O-Man, 3 × H<sub>2′</sub>, 3 × H<sub>3′</sub>, 3 × H<sub>4′</sub>, 3 × H<sub>5′</sub>, 3 × H<sub>5′</sub>, C<i>H</i><sub>2</sub>NH spacer, C<i>H</i><sub>2</sub>-O agonist, O–C<i>H</i><sub>3</sub>), 4.41 (m, 2H, C<i>H</i><sub>2</sub>-O agonist), 4.74 (3H, m, 3 × H<sub>1′</sub>), 5.04 (m, 2H, C<i>H</i><sub>2</sub>N agonist), 7.46 (d, 2H, <i>J</i> = 8.1 Hz, 2 × CH aromatic), 7.78 (d, 2H, <i>J</i> = 7.7 Hz, 2 × CH aromatic). HRMS (ESI): calculated for C<sub>61</sub>H<sub>96</sub>N<sub>10</sub>O<sub>26</sub> [M + H]<sup>2+</sup>, 692.3243; found, 692.3209.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Three-Component <i>O</i>-GalNAc Construct <b>35</b></h3><div class="NLM_p last">All solvents were degassed by several vacuum (15 mbar)/argon cycles. A stirred solution of compound <b>33</b> (3.9 mg, 0.0026 mmol) and OVA 323–339 peptide (5.0 mg, 0.0026 mmol) was dissolved in HFIP (150 μL), H<sub>2</sub>O (50 μL), and HEPES buffer (100 μL, 100 mM, pH 7.5) at room temperature under an argon atmosphere. This solution was neutralized to pH 7.5 with 0.5 N NaOH. Then, a catalytic solution (350 μL) composed of CuSO<sub>4</sub>·5H<sub>2</sub>O (2.6 mg, 0.01 mmol), THPTA (6.8 mg, 0.016 mmol), aminoguanidine hydrochloride (2.9 mg, 0.026 mmol), and sodium ascorbate (4.2 mg, 0.02 mmol) was added. The reaction mixture was stirred for 1 h, quenched with 0.5% aqueous TFA, and purified on SPE cartridge (H<sub>2</sub>O/CH<sub>3</sub>CN, 100:0 to 0:100) to afford the three-component <i>O</i>-GalNAc <b>35</b> (7.1 mg, 80%) as a white solid after lyophilization. RP-HPLC <i>t</i><sub>R</sub>, 7.1 min, CH<sub>3</sub>CN/H<sub>2</sub>O (0.1% TFA) 30:70, 96.5% purity, 214 nm. HRMS (ESI): calculated for C<sub>147</sub>H<sub>235</sub>N<sub>42</sub>O<sub>52</sub> [M + H]<sup>3+</sup>, 1140.2340; found, 1140.5516; for C<sub>147</sub>H<sub>236</sub>N<sub>42</sub>O<sub>52</sub> [M + H]<sup>4+</sup>, 855.4273; found, 855.6634. MALDI-TOF: calculated for [M + H]<sup>+</sup> 3418.6874; found,3418.6375.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Three-Component O-Mannosylated Construct <b>36</b></h3><div class="NLM_p last">All solvent were degassed by several vacuum (15 mbar)/argon cycles. A stirred solution of compound <b>34</b> (3.6 mg, 0.0026 mmol) and OVA 323–339 peptide (5.0 mg, 0.0026 mmol) was dissolved in HFIP (150 μL), H<sub>2</sub>O (50 μL) and HEPES buffer (100 μL, 100 mM, pH 7.5) at room temperature under an argon atmosphere. This solution was neutralized to pH 7.5 with 0.5 N NaOH. Then, a catalytic solution (350 μL) composed of CuSO<sub>4</sub>·5H<sub>2</sub>O (1.3 mg, 0.013 mmol), THPTA (6.8 mg, 0.016 mmol), aminoguanidine hydrochloride (1.4 mg, 0.013 mmol), and sodium ascorbate (2.1 mg, 0.01 mmol) was added. Under these conditions, <b>34</b> and OVA were not totally consumed after 1 h. Another catalytic solution was added with the same amount of each compound except for CuSO<sub>4</sub>·5H<sub>2</sub>O (2.6 mg, 0.026 mmol) and sodium ascorbate (4.2 mg, 0.02 mmol). After 2 h of reaction, the same amounts of CuSO<sub>4</sub>·5H<sub>2</sub>O and sodium ascorbate were added again. Finally, a complete conversion was observed within 3 h and the reaction mixture was quenched with 0.5% aqueous TFA and purified on SPE cartridge (H<sub>2</sub>O/CH<sub>3</sub>CN, 100:0 to 0:100) to afford the three-component O-mannosylated <b>36</b> (6.6 mg, 80%) as a white solid after lyophilization. RP-HPLC <i>t</i><sub>R</sub>, 7.2 min, CH<sub>3</sub>CN/H<sub>2</sub>O (0.1% TFA) 30:70, 95.8% purity, 214 nm. HRMS (ESI): calculated for C<sub>141</sub>H<sub>226</sub>N<sub>39</sub>O<sub>52</sub> [M + H]<sup>3+</sup>, 1099.2074; found, 1099.5420; for C<sub>141</sub>H<sub>227</sub>N<sub>39</sub>O<sub>52</sub> [M + H]<sup>4+</sup>, 824.6574; found, 824.8961. MALDI-TOF: calculated for [M + H]<sup>+</sup>, 3295.6077; found, 3295,6024.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Immunology: Experimental Part. Stimulation of Mouse Bone Marrow-Derived DCs (BMDCs) by the Compounds (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B)</h3><div class="NLM_p last">Bone marrow-derived DCs were generated from bone marrow precursors from C57BL/6 mice in RPMI medium (Gibco) containing 50 mM 2-ME (Gibco), 10% fetal calf serum (Thermo Hyclone), antibiotics, and 1% of a GM-CSF-containing supernatant. Cells were recovered on day 6 with PBS EDTA and usually contained 60–70% of CD11c<sup>+</sup>CD11b<sup>+</sup> cells. They were then incubated at 37 °C with increasing concentrations of the various compounds (<b>11</b>, <b>24</b>, <b>31</b>, <b>35</b>, and <b>36</b>) for 48 h. IL-12p40 and IL-6 were measured in cell supernatants by ELISA.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> IFN-γ Production by OVA-Specific OT-II T Cells in Response to the Constructs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C)</h3><div class="NLM_p last">C57BL/6 bone marrow-derived DC were incubated in RPMI medium (Gibco) containing 50 mM 2-ME (Gibco), 10% fetal calf serum (Thermo Hyclone), and antibiotics at 37 °C with increasing concentrations of the compound <b>31</b>, <b>35</b>, or <b>36</b>. CD4<sup>+</sup> T lymphocytes isolated from OT-II Rag2 T cell receptor-transgenic knockout mice, bred at the animal facilities of the Institut Pasteur, and specific for the I-A<sup>b</sup>-OVA<sub>323–339</sub> epitopes were added to the cultures for 3 days. IFN-γ was then measured in cell supernatants by ELISA.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> In Vivo T-Immunogenicity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>)</h3><div class="NLM_p last">C57BL/6 mice from Charles River Laboratories (Les Oncins, France) were used at 6–10 weeks of age. OT-II cells were harvested from OT-II Rag2 T cell receptor-transgenic knockout mice, bred at the animal facilities of the Pasteur Institute. OT-2 cells are specific for the OVA<sub>323–339</sub> T-cell epitope presented by I-A<sup>b</sup> molecules. After administration of 2 × 10<sup>5</sup> OT-II CD4<sup>+</sup> T cells, C57BL/6 mice (<i>n</i> = 3 per group) were intradermally immunized with <b>24</b>, <b>31</b>, <b>35</b>, <b>36</b>, or OVA 323–339 compounds (11.7 nmol per mouse).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> OT-II CD4<sup>+</sup> T Cells Proliferation (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A)</h3><div class="NLM_p last">Five days after immunization, C57BL/6 mice were sacrificed and the spleen was collected. The in vivo proliferation of OT-II CD4<sup>+</sup> T cells was analyzed by flow cytometry using anti-CD4 (e-bioscience 25-0042-82), anti-Vα2 (e-bioscience 47-5812-82) and anti-Vβ5 (e-bioscience 46-5796-82). Cells were acquired on a Fortessa flow cytometer and analyzed using FlowJo software.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Measurement of T Cell Response by Intracellular Staining (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B)</h3><div class="NLM_p last">For the detection of IFNγ-producing CD8 T cells by intracellular staining (ICS), mice were sacrificed 5 days after immunization and isolated lymph node cells were set up in 96-well plates at a concentration of 5 × 10<sup>5</sup> cells per well in RPMI medium (Gibco) containing 50 mM 2-ME (Gibco), 10% fetal calf serum (Thermo Hyclone), and antibiotics and incubated with 50 μg/mL of the OVA 323–339 peptide in the presence of BD GolgiPlug (BD Biosciences) for 2 h at 37 °C. Cells were fixed, permeabilized, and stained using the BD Cytofix/Cytoperm kit (BD Biosciences). Intracellular staining (ICS) was performed according to the manufacturer’s instructions, with anti-CD4-FITC, anti-CD3-APC-eFluor780, and anti-IFNγ from eBioscience. Cells were acquired on a Fortessa flow cytometer and analyzed using FlowJo software.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Measurement of T Cell Response by ELISA (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D)</h3><div class="NLM_p last">Mice were sacrificed 5 days after immunization, and the splenocytes were cultured in RPMI medium (Gibco) containing 50 mM 2-ME (Gibco), 10% fetal calf serum (Thermo Hyclone), and antibiotics (5 × 10<sup>5</sup> cells per well), in the presence or not of OVA 323–339 (1 μg/mL) at 37 °C for 48 h. IFN-γ and IL-5 levels were measured in the supernatants by ELISA using antibodies against IFN-γ and IL-5 (BD Biosciences).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Immunization of Mice (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>)</h3><div class="NLM_p last">Six-week-old female C57BL/6 mice were purchased from Charles River Laboratories. Mice were kept in the Pasteur Institute animal house and supplied with water and food ad libitum. All procedures involving mice were in accordance with the French ethical committee CETEA (Comité d’Ethique en Expérimentation Animale) (Project No. 2013-126). Mice were intramuscularly (IM) or intradermally (ID) immunized with 11.7 nmol of the various compounds on days 0 and 21. Sera were collected at days 1, 21, and 28. In the experiment depicted on <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, mice also received a third injection of the compounds at day 92 and their sera were collected at day 111</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Analysis of Antibody Response by ELISA (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>)</h3><div class="NLM_p last">Sera from immunized mice were tested for the presence of antibodies by ELISA, using MaxiSorp plates (Nunc) coated with the various compounds. For the detection of anti-Tn antibodies, the biotinylated Tn3-G6K(Biot)G peptide (1 μg/mL) was incubated for 1 h at 37 °C on streptavidin-coated microtiter plates (Pierce). Then, serial dilutions of sera were performed and bound Abs were revealed using anti-mouse-IgG-HRP peroxidase conjugate (Sigma) and <i>o</i>-phenyldiamine/H<sub>2</sub>O<sub>2</sub> substrates. Plates were read photometrically at 492 nm in an ELISA autoreader (Dynatech, Marnes la Coquette, France). The negative control consisted of naive mouse sera diluted 100-fold. ELISA Ab titers were determined by linear regression analysis, plotting dilution vs absorbance at 492 nm. The titers were calculated to be the log<sub>10</sub> highest dilution that gave twice the absorbance of normal mouse sera diluted 1/100. Titers were given as the arithmetic mean ± SD of the log<sub>10</sub> titers.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00960" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40345" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40345" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00960" class="ext-link">10.1021/acs.jmedchem.8b00960</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis of compounds <b>1</b> and <b>2</b> and TLR7 agonist <b>24</b>; HPLC chromatograms for compounds <b>3</b>–<b>8</b>, <b>13</b>, <b>14</b>, <b>29</b>, <b>30</b>, <b>31</b>, <b>33</b>–<b>36</b>; HRMS results for compounds <b>3</b>, <b>4</b>, <b>6</b>, <b>9</b>, <b>10</b>, <b>12</b>, <b>13</b>, <b>15</b>–<b>17</b>, <b>19</b>–<b>22</b>, <b>24</b>, <b>26</b>–<b>36</b>; HSQC spectra for compounds <b>3</b>, <b>4</b>, <b>6</b>, <b>9</b>, <b>11</b>, <b>13</b>, <b>15</b>, <b>16</b>, <b>27</b>, <b>29</b>, <b>30</b>, <b>31</b>, <b>33</b>, <b>34</b>, and MALDI-TOF spectra for <b>35</b> and <b>36</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_001.pdf">jm8b00960_si_001.pdf (3.52 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_002.csv">jm8b00960_si_002.csv (8.36 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00960" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claude Leclerc</span> - <span class="hlFld-Affiliation affiliation">Unité
Régulation Immunitaire et Vaccinologie, Equipe Labellisée
Ligue Contre le Cancer, Institut Pasteur, 75015 Paris, France</span>; 
    <span class="hlFld-Affiliation affiliation">INSERM
U1041, 75724 Paris Cedex 15, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2e4d424f5b4a4b00424b4d424b5c4d6e5e4f5d5a4b5b5c00485c"><span class="__cf_email__" data-cfemail="72111e130716175c1e17111e17001132021301061707005c1400">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claude Taillefumier</span> - <span class="hlFld-Affiliation affiliation">Université
Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3126-495X" title="Orcid link">http://orcid.org/0000-0003-3126-495X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b8dbd4d9cddcdd96ccd9d1d4d4dddecdd5d1ddcaf8cddbd996deca"><span class="__cf_email__" data-cfemail="72111e130716175c06131b1e1e1714071f1b1700320711135c1400">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Szekely</span> - <span class="hlFld-Affiliation affiliation">Université
Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olivier Roy</span> - <span class="hlFld-Affiliation affiliation">Université
Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edith Dériaud</span> - <span class="hlFld-Affiliation affiliation">Unité
Régulation Immunitaire et Vaccinologie, Equipe Labellisée
Ligue Contre le Cancer, Institut Pasteur, 75015 Paris, France</span>; 
    <span class="hlFld-Affiliation affiliation">INSERM
U1041, 75724 Paris Cedex 15, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aurélie Job</span> - <span class="hlFld-Affiliation affiliation">Université
Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Lo-Man</span> - <span class="hlFld-Affiliation affiliation">Unité
Régulation Immunitaire et Vaccinologie, Equipe Labellisée
Ligue Contre le Cancer, Institut Pasteur, 75015 Paris, France</span>; 
    <span class="hlFld-Affiliation affiliation">INSERM
U1041, 75724 Paris Cedex 15, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>T.S., C.L. and C.T. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53774" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53774" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Dr.Vincent Aucagne for helpful discussions and advice regarding conjugation of the OVA 323–339 peptide. Also, we kindly thank Prof. Bernadette Bouchon for the MALDI-TOF analyses. This work was supported by funding from the French Ministry of Higher Education and Research (MESR to T.S.) for the chemical syntheses and by the Ligue Nationale Contre le Cancer (Equipe Labellisée 2017) to C.L. for the immunological analyses.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">CLR</td><td class="NLM_def"><p class="first last">C-type lectin receptor</p></td></tr><tr><td class="NLM_term">CuAAC</td><td class="NLM_def"><p class="first last">copper azide–alkyne cycloaddition</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DC</td><td class="NLM_def"><p class="first last">dendritic cell</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">Fmoc</td><td class="NLM_def"><p class="first last">9-fluorenylmethoxycarbonyl</p></td></tr><tr><td class="NLM_term">GalNAc</td><td class="NLM_def"><p class="first last"><i>N</i>-acetylgalactosamine</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">azabenzotriazoletetramethyluranium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HFIP</td><td class="NLM_def"><p class="first last">hexafluoroisopropanol</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">IBCF</td><td class="NLM_def"><p class="first last">isobutyl chloroformate</p></td></tr><tr><td class="NLM_term">MGL</td><td class="NLM_def"><p class="first last">macrophage galactose-type C-type lectin</p></td></tr><tr><td class="NLM_term">Man</td><td class="NLM_def"><p class="first last">mannose</p></td></tr><tr><td class="NLM_term">OVA</td><td class="NLM_def"><p class="first last">ovalbumin</p></td></tr><tr><td class="NLM_term">NHS</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxysuccinimide</p></td></tr><tr><td class="NLM_term">PRR</td><td class="NLM_def"><p class="first last">pattern-recognition receptor</p></td></tr><tr><td class="NLM_term">SLE</td><td class="NLM_def"><p class="first last">lupus erythematosus</p></td></tr><tr><td class="NLM_term">TACA</td><td class="NLM_def"><p class="first last">tumor-associated carbohydrate antigen</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">Toll-like receptor</p></td></tr><tr><td class="NLM_term">TF</td><td class="NLM_def"><p class="first last">Thomsen–Friedenreich</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 77 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span>; <span class="NLM_string-name">Manjili, M. H.</span>; <span class="NLM_string-name">Subjeck, J. R.</span>; <span class="NLM_string-name">Sarkar, D.</span>; <span class="NLM_string-name">Fisher, P. B.</span>; <span class="NLM_string-name">Wang, X. Y.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Cancer Vaccines: Past, Present, and Future</span>. In  <i>Advances in Cancer Research</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, K. D.</span>, <span class="NLM_string-name">Fisher, P. B.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">119</span>, Chapter 7, pp  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-407190-2.00007-1</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2FB978-0-12-407190-2.00007-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=421-475&author=C.+Guo&author=M.+H.+Manjili&author=J.+R.+Subjeck&author=D.+Sarkar&author=P.+B.+Fisher&author=X.+Y.+Wangauthor=K.+D.+Tew&author=P.+B.+Fisher&title=Advances+in+Cancer+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-407190-2.00007-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-407190-2.00007-1%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DC.%26atitle%3DTherapeutic%2520Cancer%2520Vaccines%253A%2520Past%252C%2520Present%252C%2520and%2520Future%26btitle%3DAdvances%2520in%2520Cancer%2520Research%26aulast%3DTew%26aufirst%3DK.%2BD.%26pub%3DAcademic%2520Press%26date%3D2013%26volume%3D119%26spage%3D421%26epage%3D475%26doi%3D10.1016%2FB978-0-12-407190-2.00007-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. d.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. h.</span></span> <span> </span><span class="NLM_article-title">Therapeutic cancer vaccines: From initial findings to prospects</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2018.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.imlet.2018.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=29407608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2018&pages=11-21&author=Q.+Songauthor=C.+d.+Zhangauthor=X.+h.+Wu&title=Therapeutic+cancer+vaccines%3A+From+initial+findings+to+prospects&doi=10.1016%2Fj.imlet.2018.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic cancer vaccines: From initial findings to prospects</span></div><div class="casAuthors">Song, Qian; Zhang, Cheng-dong; Wu, Xiang-hua</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-21</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With the approval of the first therapeutic cancer vaccine by US Food and Drug Administration, numerous therapeutic cancer vaccines have been under clin. trials with an inspiring antitumor immune response in cancer patients.  Though there is no therapeutic cancer vaccine showing clin. efficacy in phase III trials, recent advances in personalized cancer vaccine based on neoantigens have emerged as an efficient way to induce tumor regression.  In this review, we discuss the selection methods of tumor specific antigen and mainly focus on the development of therapeutic cancer vaccine strategies.  Besides, we highlight the newly developed personalized cancer vaccine as a novel therapeutic approach for cancer patients.  Finally, we outline the recent development of therapeutic cancer vaccine in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAVsFvJGfZCbVg90H21EOLACvtfcHk0lgq5MkUIjF8xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOrtLg%253D&md5=388c83100cd941a32c2250e7ccdd13f4</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2018.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2018.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%2Bd.%26aulast%3DWu%26aufirst%3DX.%2Bh.%26atitle%3DTherapeutic%2520cancer%2520vaccines%253A%2520From%2520initial%2520findings%2520to%2520prospects%26jtitle%3DImmunol.%2520Lett.%26date%3D2018%26volume%3D196%26spage%3D11%26epage%3D21%26doi%3D10.1016%2Fj.imlet.2018.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W. W.</span></span> <span> </span><span class="NLM_article-title">Overview of research and development for anticancer drugs</span>. <i>J. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.4236/jct.2016.710077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.4236%2Fjct.2016.710077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFWjsLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=762-772&author=J.+J.+Xuauthor=W.+W.+Mao&title=Overview+of+research+and+development+for+anticancer+drugs&doi=10.4236%2Fjct.2016.710077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of research and development for anticancer drugs</span></div><div class="casAuthors">Xu, Junjie; Mao, Wenwei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">762-772</span>CODEN:
                <span class="NLM_cas:coden">JCTOBF</span>;
        ISSN:<span class="NLM_cas:issn">2151-1942</span>.
    
            (<span class="NLM_cas:orgname">Scientific Research Publishing, Inc.</span>)
        </div><div class="casAbstract">Anticancer drugs research and development have been the largest market area in the pharmaceutical industry in terms of the no. of project, clin. trials and spending.  In the last 10 - 30 years, targeting therapy for cancers has been developed and achieved enormous clin. effectiveness by transforming some previously deadly malignancies into chronically manageable conditions, but cure problem still remains.  This mini review outlined the current status of anticancer drugs development and hinted the opinions of how to further increase the accuracy and efficacy of discovery for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0NJgYBS4S-bVg90H21EOLACvtfcHk0lgq5MkUIjF8xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFWjsLnM&md5=25cbfa273ff779cc503f9a8bc5fa8275</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4236%2Fjct.2016.710077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fjct.2016.710077%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%2BJ.%26aulast%3DMao%26aufirst%3DW.%2BW.%26atitle%3DOverview%2520of%2520research%2520and%2520development%2520for%2520anticancer%2520drugs%26jtitle%3DJ.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D7%26spage%3D762%26epage%3D772%26doi%3D10.4236%2Fjct.2016.710077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, M.</span></span> <span> </span><span class="NLM_article-title">Possible roles of tumor-associated carbohydrate antigens</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2237</span>– <span class="NLM_lpage">2244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=8625291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK28XivF2rtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=2237-2244&author=M.+Fukuda&title=Possible+roles+of+tumor-associated+carbohydrate+antigens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Possible roles of tumor-associated carbohydrate antigens</span></div><div class="casAuthors">Fukuda, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2237-2244</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review with 92 refs.  Recent progress in the studies on the roles of carbohydrates has brought about crit. discoveries, which allow the development of working hypotheses for understanding the roles of tumor-assocd. carbohydrate antigens.  In this report, the author focuses on 3 different aspects of this progress.  (1) The immunol. response to oligosaccharides aberrantly expressed under pathol. conditions; (2) possible roles of carbohydrate-dependent cell adhesion during tumor metastasis; and (3) the roles of carbohydrates in modulating the functions of proteins that attach those carbohydrates.  These 3 areas in the roles of carbohydrates will likely be the target for continuous research efforts to reveal the roles of tumor-assocd. carbohydrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNzJG8k-m2qrVg90H21EOLACvtfcHk0liwbkRut6cxLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivF2rtbo%253D&md5=6f38724f27b221f93c85ab1e2fedf6ee</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukuda%26aufirst%3DM.%26atitle%3DPossible%2520roles%2520of%2520tumor-associated%2520carbohydrate%2520antigens%26jtitle%3DCancer%2520Res.%26date%3D1996%26volume%3D56%26spage%3D2237%26epage%3D2244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hakomori, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Glycosphingolipid antigens and cancer therapy</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(97)90253-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2FS1074-5521%2897%2990253-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=9190292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK2sXitVygt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=97-104&author=S.-I.+Hakomoriauthor=Y.+Zhang&title=Glycosphingolipid+antigens+and+cancer+therapy&doi=10.1016%2FS1074-5521%2897%2990253-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Glycosphingolipid antigens and cancer therapy</span></div><div class="casAuthors">Hakomori, Sen-itiroh; Zhang, Yongmin</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-104</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 47 refs.  Specific types of glycosphingolipid (GSL), which are chem. detectable in normal cells, are more highly expressed in tumors.  The high level of expression on the surfaces of tumor cells causes antibody response to these GSLs, which can therefore be described as tumor-assocd. antigens.  Some of these GSLs have been shown to be adhesion mols. involved in tumor cell metastasis, and to be modulators of signal transduction controlling tumor cell growth and motility.  Tumor-assocd. GSL antigens have been used in the development of antitumor vaccines.  GSLs and sphingolipids involved in adhesion and signaling are therefore targets for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS-QevOK-PY7Vg90H21EOLACvtfcHk0liwbkRut6cxLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitVygt7o%253D&md5=783df93cd6ace5757184ac8f9a150999</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2897%2990253-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252897%252990253-2%26sid%3Dliteratum%253Aachs%26aulast%3DHakomori%26aufirst%3DS.-I.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DGlycosphingolipid%2520antigens%2520and%2520cancer%2520therapy%26jtitle%3DChem.%2520Biol.%26date%3D1997%26volume%3D4%26spage%3D97%26epage%3D104%26doi%3D10.1016%2FS1074-5521%2897%2990253-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span> <span> </span><span class="NLM_article-title">Recent advance in tumor-associated carbohydrate antigens (TACAs)-based antitumor vaccines</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">850</span>– <span class="NLM_lpage">863</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00084</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00084" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=850-863&author=D.+Fengauthor=A.+S.+Shaikhauthor=F.+Wang&title=Recent+advance+in+tumor-associated+carbohydrate+antigens+%28TACAs%29-based+antitumor+vaccines&doi=10.1021%2Facschembio.6b00084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines</span></div><div class="casAuthors">Feng, Danyang; Shaikh, Abdul Sami; Wang, Fengshan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">850-863</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cancer cells can be distinguished from normal cells by displaying aberrant levels and types of carbohydrate structures on their surfaces.  These carbohydrate structures are known as tumor-assocd. carbohydrate antigens (TACAs).  TACAs were considered as promising targets for the design of anticancer vaccines.  Unfortunately, carbohydrates alone can only evoke poor immunogenicity because they are unable to induce T-cell-dependent immune responses, which is crit. for cancer therapy.  Moreover, immunotolerance and immunosuppression are easily induced by using natural occurring TACAs as antigens due to their endogenous property.  This review summarizes the recent strategies to overcome these obstacles: (1) covalently coupling TACAs to proper carriers to improve immunogenicity, including clustered or multivalent conjugate vaccines, (2) coupling TACAs to T-cell peptide epitopes or the built-in adjuvant to form multicomponent glycoconjugate vaccines, and (3) developing vaccines based on chem. modified TACAs, which is combined with metabolic engineering of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ASHeSykribVg90H21EOLACvtfcHk0li9wRM7M19Law"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVSgtLo%253D&md5=d9dfadd80fc9d72e7ed2bd1ec9b0b29b</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00084%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DShaikh%26aufirst%3DA.%2BS.%26aulast%3DWang%26aufirst%3DF.%26atitle%3DRecent%2520advance%2520in%2520tumor-associated%2520carbohydrate%2520antigens%2520%2528TACAs%2529-based%2520antitumor%2520vaccines%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D850%26epage%3D863%26doi%3D10.1021%2Facschembio.6b00084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slovin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keding, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragupathi, G.</span></span> <span> </span><span class="NLM_article-title">Carbohydrate vaccines as immunotherapy for cancer</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">418</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1111/j.1440-1711.2005.01350.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1111%2Fj.1440-1711.2005.01350.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=16033538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVars74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2005&pages=418-428&author=S.+F.+Slovinauthor=S.+J.+Kedingauthor=G.+Ragupathi&title=Carbohydrate+vaccines+as+immunotherapy+for+cancer&doi=10.1111%2Fj.1440-1711.2005.01350.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate vaccines as immunotherapy for cancer</span></div><div class="casAuthors">Slovin, Susan F.; Keding, Stacy J.; Ragupathi, Govind</div><div class="citationInfo"><span class="NLM_cas:title">Immunology and Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">418-428</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">0818-9641</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Carbohydrates have established themselves as the most clin. relevant antigens of those tested and subsequently developed for vaccines against infectious diseases.  However, in cancer patients, many of the defined carbohydrate antigens are really altered 'self' antigens and for unclear reasons, the body does not react to them immunol.  Although these self antigens have been found to be potentially suitable targets for immune recognition and killing, the development of vaccines for cancer treatment is actually more challenging compared with those for infectious diseases mainly because of the difficulty assocd. with breaking the body's immunol. tolerance to the antigen.  These antigens lack the inherent immunogenicity assocd. with bacterial antigens and, therefore, methods to enhance immunol. recognition and induction of immunity in vivo are under investigation.  These include defining the appropriate tumor-assocd. antigen, successfully synthesizing the antigen to mimic the original mol., inducing an immune response, and subsequently enhancing the immunol. reactivity so that all components can work together.  This has been successfully accomplished with several glycolipid and glycoprotein antigens using carriers such as keyhole limpet haemocyanin (KLH) together with a saponin adjuvant, QS-21.  Not only can high titer IgM and IgG antibodies be induced, which are specific for the antigen used for immunization, but the antibodies can mediate complement lysis.  The approaches for synthesis, conjugation, clin. administration and immunol. potential are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiS9v7I16EzLVg90H21EOLACvtfcHk0li9wRM7M19Law"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVars74%253D&md5=b2c969e6d5dbb50c89dbf40ce6a4d35a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1711.2005.01350.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1711.2005.01350.x%26sid%3Dliteratum%253Aachs%26aulast%3DSlovin%26aufirst%3DS.%2BF.%26aulast%3DKeding%26aufirst%3DS.%2BJ.%26aulast%3DRagupathi%26aufirst%3DG.%26atitle%3DCarbohydrate%2520vaccines%2520as%2520immunotherapy%2520for%2520cancer%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2005%26volume%3D83%26spage%3D418%26epage%3D428%26doi%3D10.1111%2Fj.1440-1711.2005.01350.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kuduk, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glunz, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragupathi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span> <span> </span><span class="NLM_article-title">Synthetic and immunological studies on clustered modes of mucin-related Tn and TF O-linked antigens: the preparation of a glycopeptide-based vaccine for clinical trials against prostate cancer</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">12474</span>– <span class="NLM_lpage">12485</span>, <span class="refDoi"> DOI: 10.1021/ja9825128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9825128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK1cXnsVaqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=12474-12485&author=S.+D.+Kudukauthor=J.+B.+Schwarzauthor=X.-T.+Chenauthor=P.+W.+Glunzauthor=D.+Samesauthor=G.+Ragupathiauthor=P.+O.+Livingstonauthor=S.+J.+Danishefsky&title=Synthetic+and+immunological+studies+on+clustered+modes+of+mucin-related+Tn+and+TF+O-linked+antigens%3A+the+preparation+of+a+glycopeptide-based+vaccine+for+clinical+trials+against+prostate+cancer&doi=10.1021%2Fja9825128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic and immunological studies on clustered modes of mucin-related Tn and TF O-linked antigens: The preparation of a glycopeptide-based vaccine for clinical trials against prostate cancer</span></div><div class="casAuthors">Kuduk, Scott D.; Schwarz, Jacob B.; Chen, Xiao-Tao; Glunz, Peter W.; Sames, Dalibor; Ragupathi, Govindaswami; Livingston, Philip O.; Danishefsky, Samuel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">12474-12485</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The syntheses of two tumor-assocd. carbohydrate antigens, Tn and TF, have been achieved using glycal assembly and cassette methodologies.  These synthetic antigens were subsequently clustered (c) and immunoconjugated to a carrier protein (KLH or BSA) or a synthetic lipopeptide (pam) for immunol. study.  Three Tn conjugates were used to vaccinate groups of mice, and all prepns. proved to be immunogenic.  The Tn(c) covalently linked to KLH (27-KLH) plus the adjuvant QS-21 was the optimal vaccine, inducing high median IgM and IgG titers against Tn(c) by ELISA.  These antibodies were strongly reactive with the Tn(c) pos. human colon cancer cell line LS-C but not the Tn(c) neg. colon cancer cell line LS-B by FACS.  The antibody reactivities with natural antigens were inhibited with synthetic Tn(c) but not with structurally unrelated compds.  On the basis of these results, vaccines contg. 27-KLH and 30-pam plus QS-21 are being tested in patients with prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrtZH2AMtJ7Vg90H21EOLACvtfcHk0liFAr6KJ_X2BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsVaqsLs%253D&md5=2e5d2f149079292339a75ab475815b42</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1021%2Fja9825128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9825128%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DX.-T.%26aulast%3DGlunz%26aufirst%3DP.%2BW.%26aulast%3DSames%26aufirst%3DD.%26aulast%3DRagupathi%26aufirst%3DG.%26aulast%3DLivingston%26aufirst%3DP.%2BO.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26atitle%3DSynthetic%2520and%2520immunological%2520studies%2520on%2520clustered%2520modes%2520of%2520mucin-related%2520Tn%2520and%2520TF%2520O-linked%2520antigens%253A%2520the%2520preparation%2520of%2520a%2520glycopeptide-based%2520vaccine%2520for%2520clinical%2520trials%2520against%2520prostate%2520cancer%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D12474%26epage%3D12485%26doi%3D10.1021%2Fja9825128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragupathi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildersleeve, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, P. O.</span></span> <span> </span><span class="NLM_article-title">Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1007/s00262-004-0584-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1007%2Fs00262-004-0584-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=15625606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFyrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=424-430&author=E.+Kaganauthor=G.+Ragupathiauthor=S.+S.+Yiauthor=C.+A.+Reisauthor=J.+Gildersleeveauthor=D.+Kahneauthor=H.+Clausenauthor=S.+J.+Danishefskyauthor=P.+O.+Livingston&title=Comparison+of+antigen+constructs+and+carrier+molecules+for+augmenting+the+immunogenicity+of+the+monosaccharide+epithelial+cancer+antigen+Tn&doi=10.1007%2Fs00262-004-0584-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn</span></div><div class="casAuthors">Kagan, Ella; Ragupathi, Govind; Yi, San San; Reis, Celso A.; Gildersleeve, Jeff; Kahne, Daniel; Clausen, Henrik; Danishefsky, Samuel J.; Livingston, Philip O.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">424-430</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">The authors have demonstrated previously that the optimal method for inducing an antibody response against defined cancer antigens is covalent conjugation of the antigen to keyhole limpet hemocyanin (KLH) and use of the potent saponin adjuvant QS-21.  Single mols. of glycolipids (tetrasaccharides, pentasaccharides, or hexasaccharides) and MUC1 peptides (contg. between 1 and 5 MUC1 tandem repeats) conjugated to KLH have proven sufficient for antibody recognition and vaccine construction.  However, cancer specificity of monoclonal antibodies against the monosaccharide Tn and disaccharide sTn comes largely from recognition of clusters (c) of these mols. on the cell surface.  Tn consists of a monosaccharide (GalNAc) O-linked to serine or threonine on epithelial cancer mucins which are uniquely rich in serines and threonines.  The authors tested here several Tn constructs: Tn monosaccharide, Tn(c) prepd. on a triple threonine backbone, and Tn prepd. on a partially or fully glycosylated MUC1 backbone.  They det. that Tn(c) is more effective than Tn, and conjugation to KLH is more effective than conjugation to BSA or polystyrene beads for inducing ELISA reactivity against Tn, and FACS reactivity against Tn-pos. tumor cells.  Surprisingly, MUC1 glycosylated with Tn at 3 or 5 sites per 20 amino acid MUC1 tandem repeat and conjugated to KLH, induced the strongest antibody response against Tn and tumor cells expressing Tn, and had the addnl. advantage of inducing antibodies against MUC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX272MGCVGvrVg90H21EOLACvtfcHk0liFAr6KJ_X2BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFyrsbk%253D&md5=011cd6ba4f64ff9f83a341dfb2a31ff9</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1007%2Fs00262-004-0584-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-004-0584-y%26sid%3Dliteratum%253Aachs%26aulast%3DKagan%26aufirst%3DE.%26aulast%3DRagupathi%26aufirst%3DG.%26aulast%3DYi%26aufirst%3DS.%2BS.%26aulast%3DReis%26aufirst%3DC.%2BA.%26aulast%3DGildersleeve%26aufirst%3DJ.%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DClausen%26aufirst%3DH.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DLivingston%26aufirst%3DP.%2BO.%26atitle%3DComparison%2520of%2520antigen%2520constructs%2520and%2520carrier%2520molecules%2520for%2520augmenting%2520the%2520immunogenicity%2520of%2520the%2520monosaccharide%2520epithelial%2520cancer%2520antigen%2520Tn%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2005%26volume%3D54%26spage%3D424%26epage%3D430%26doi%3D10.1007%2Fs00262-004-0584-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slovin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragupathi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musselli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olkiewicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuduk, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span> <span> </span><span class="NLM_article-title">Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with α-<i>n</i>-acetylgalactosamine-<i>o</i>-serine/threonine conjugate vaccine</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4292</span>– <span class="NLM_lpage">4298</span>, <span class="refDoi"> DOI: 10.1200/JCO.2003.04.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1200%2FJCO.2003.04.112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=14645418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVWqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=4292-4298&author=S.+F.+Slovinauthor=G.+Ragupathiauthor=C.+Musselliauthor=K.+Olkiewiczauthor=D.+Verbelauthor=S.+D.+Kudukauthor=J.+B.+Schwarzauthor=D.+Samesauthor=S.+J.+Danishefskyauthor=P.+O.+Livingstonauthor=H.+I.+Scher&title=Fully+synthetic+carbohydrate-based+vaccines+in+biochemically+relapsed+prostate+cancer%3A+clinical+trial+results+with+%CE%B1-n-acetylgalactosamine-o-serine%2Fthreonine+conjugate+vaccine&doi=10.1200%2FJCO.2003.04.112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with α-N-acetylgalactosamine-O-serine/threonine conjugate vaccine</span></div><div class="casAuthors">Slovin, Susan F.; Ragupathi, Govindaswami; Musselli, Cristina; Olkiewicz, Krystyna; Verbel, David; Kuduk, Scott D.; Schwarz, Jacob B.; Sames, Dalibor; Danishefsky, Samuel; Livingston, Philip O.; Scher, Howard I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4292-4298</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Reported is the synthesis of a mucin-related O-linked glycopeptide, α-N-acetylgalactosamine-O-serine/ threonine (Tn), which is highly simplistic in its structure and can induce a relevant humoral response when given in a trimer or clustered (c) formation.  The authors tested it for an antitumor effect, in the form of a change in the posttreatment vs. pretreatment prostate-specific antigen (PSA) slopes, that might serve as a surrogate for effectiveness of vaccines in delaying the time to radiog. progression.  The antibody response was compared to immunization with 2 conjugates, Tn(c)-keyhole limpet hemocyanin (KLH) and Tn(c)-palmitic acid (PAM) with the saponin immune adjuvant QS21, in a phase I clin. trial in patients with biochem. relapsed prostate cancer.  Patients received Tn(c)-KLH vaccine contg. either 3, 7, or 15 μg of Tn(c) per vaccination.  Ten patients received 100 μg of Tn(c)-PAM.  QS21 was included in all vaccines.  Five vaccinations were administered s.c. during 26 wk with an addnl. booster vaccine at week 50.  Tn(c), when given with the carrier mol. KLH and QS21, stimulated the prodn. of high-titer IgM and IgG antibodies.  Inferior antibody responses were seen with T(c)-PAM.  There was no evidence of enhanced immunogenicity with increasing doses of vaccine.  An antitumor effect in the form of a decline in posttreatment vs. pretreatment PSA slopes was also obsd.  Thus, a safe synthetic conjugate vaccine in a trimer formation was developed that can break immunol. tolerance by inducing specific humoral responses.  It seemed to affect the biochem. progression of the disease as detd. by a change in PSA log slope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc21sECCCiL7Vg90H21EOLACvtfcHk0li3ckr8dv2Ffg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVWqu7o%253D&md5=10b4ef9ca865d7ced343ad29ff0e58fc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1200%2FJCO.2003.04.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2003.04.112%26sid%3Dliteratum%253Aachs%26aulast%3DSlovin%26aufirst%3DS.%2BF.%26aulast%3DRagupathi%26aufirst%3DG.%26aulast%3DMusselli%26aufirst%3DC.%26aulast%3DOlkiewicz%26aufirst%3DK.%26aulast%3DVerbel%26aufirst%3DD.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DSames%26aufirst%3DD.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DLivingston%26aufirst%3DP.%2BO.%26aulast%3DScher%26aufirst%3DH.%2BI.%26atitle%3DFully%2520synthetic%2520carbohydrate-based%2520vaccines%2520in%2520biochemically%2520relapsed%2520prostate%2520cancer%253A%2520clinical%2520trial%2520results%2520with%2520%25CE%25B1-n-acetylgalactosamine-o-serine%252Fthreonine%2520conjugate%2520vaccine%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2003%26volume%3D21%26spage%3D4292%26epage%3D4298%26doi%3D10.1200%2FJCO.2003.04.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buskas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G.-J.</span></span> <span> </span><span class="NLM_article-title">The immunogenicity of the tumor-associated antigen lewis<sup>y</sup> may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3517</span>– <span class="NLM_lpage">3524</span>, <span class="refDoi"> DOI: 10.1002/chem.200400074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fchem.200400074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=15252797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFKrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3517-3524&author=T.+Buskasauthor=Y.+Liauthor=G.-J.+Boons&title=The+immunogenicity+of+the+tumor-associated+antigen+lewisy+may+be+suppressed+by+a+bifunctional+cross-linker+required+for+coupling+to+a+carrier+protein&doi=10.1002%2Fchem.200400074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The immunogenicity of the tumor-associated antigen Lewisy may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein</span></div><div class="casAuthors">Buskas, Therese; Li, Yanhong; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3517-3524</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A Lewisy (Ley) tetrasaccharide modified by an artificial amino-Pr spacer was synthesized by a highly convergent approach that employed a levulinoyl ester and a 9-fluorenylmethoxycarbonate for temporary protection of the hydroxy groups and a trichloroethyloxycarbonyl as an amino protecting group.  The artificial amino-Pr moiety was modified by a thioacetyl group, which allowed efficient conjugation to keyhole limpet hemocyanin (KLH) modified by electrophilic 4-(maleimidomethyl)cyclohexane-1-carboxylate (MI).  Mice were immunized with the KLH-MI-Ley antigen.  A detailed anal. of sera by ELISA established that a strong IgG (IgG) antibody response was elicited against the linker region.  The use of a smaller and more flexible 3-(bromoacetamido)propionate for the attachment of Ley to KLH not only reduced the IgG antibody response against the linker but also led to a significantly improved immune response against the Ley antigen.  This study shows that highly antigenic linkers suppress antibody responses to weak antigens such as self-antigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoERazblnNOibVg90H21EOLACvtfcHk0li3ckr8dv2Ffg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFKrtbg%253D&md5=99a4659d3fbbee0508f1a318d6d49659</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fchem.200400074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200400074%26sid%3Dliteratum%253Aachs%26aulast%3DBuskas%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBoons%26aufirst%3DG.-J.%26atitle%3DThe%2520immunogenicity%2520of%2520the%2520tumor-associated%2520antigen%2520lewisy%2520may%2520be%2520suppressed%2520by%2520a%2520bifunctional%2520cross-linker%2520required%2520for%2520coupling%2520to%2520a%2520carrier%2520protein%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2004%26volume%3D10%26spage%3D3517%26epage%3D3524%26doi%3D10.1002%2Fchem.200400074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buskas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G.-J.</span></span> <span> </span><span class="NLM_article-title">Immunotherapy for cancer: synthetic carbohydrate-based vaccines</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_fpage">5335</span>– <span class="NLM_lpage">5349</span>, <span class="refDoi"> DOI: 10.1039/b908664c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1039%2Fb908664c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=19724783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOntL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=5335-5349&author=T.+Buskasauthor=P.+Thompsonauthor=G.-J.+Boons&title=Immunotherapy+for+cancer%3A+synthetic+carbohydrate-based+vaccines&doi=10.1039%2Fb908664c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy for cancer: synthetic carbohydrate-based vaccines</span></div><div class="casAuthors">Buskas, Therese; Thompson, Pamela; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">5335-5349</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Aberrant glycosylation of glycoproteins and glycolipids of cancer cells, which correlates with poor survival rates, is being exploited for the development of immunotherapies for cancer.  In particular, advances in the knowledge of cooperation between the innate and adaptive system combined with the implementation of efficient synthetic methods for assembly of oligosaccharides and glycopeptides is providing avenues for the rationale design of vaccine candidates.  In this respect, fully synthetic vaccine candidates show great promise because they incorporate only those elements requires for relevant immune responses, and hence do not suffer from immune suppression obsd. with classical carbohydrate-protein conjugate vaccines.  Such vaccines are chem. well-defined and it is to be expected that they can be produced in a reproducible fashion.  In this feature article, recent advances in the development of fully synthetic sub-unit carbohydrate-based cancer vaccines will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7lAV5HqWTRLVg90H21EOLACvtfcHk0lgjJTGD02VG6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOntL3M&md5=4da7e01785f9dfd0c17bf243f833613a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1039%2Fb908664c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb908664c%26sid%3Dliteratum%253Aachs%26aulast%3DBuskas%26aufirst%3DT.%26aulast%3DThompson%26aufirst%3DP.%26aulast%3DBoons%26aufirst%3DG.-J.%26atitle%3DImmunotherapy%2520for%2520cancer%253A%2520synthetic%2520carbohydrate-based%2520vaccines%26jtitle%3DChem.%2520Commun.%26date%3D2009%26spage%3D5335%26epage%3D5349%26doi%3D10.1039%2Fb908664c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span> <span> </span><span class="NLM_article-title">A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinic</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">14462</span>– <span class="NLM_lpage">14472</span>, <span class="refDoi"> DOI: 10.1021/ja405932r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja405932r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OjtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=14462-14472&author=R.+M.+Wilsonauthor=S.+J.+Danishefsky&title=A+vision+for+vaccines+built+from+fully+synthetic+tumor-associated+antigens%3A+from+the+laboratory+to+the+clinic&doi=10.1021%2Fja405932r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A Vision for Vaccines Built from Fully Synthetic Tumor-Associated Antigens: From the Laboratory to the Clinic</span></div><div class="casAuthors">Wilson, Rebecca M.; Danishefsky, Samuel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">14462-14472</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Cancer cells may be distinguished from normal cells by cell surface displays of aberrant levels and types of carbohydrate domains.  Accordingly, these tumor-assocd. carbohydrate antigens (TACAs) represent promising target structures for the design of anticancer vaccines.  Over the past 20 years, the authors' lab. has sought to use the tools of chem. synthesis to develop TACA-based anticancer vaccine candidates.  The authors provide herein a personal accounting of the authors' lab.'s progress toward the long-standing goal of developing clin. viable fully synthetic carbohydrate-based anticancer vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCIfwl0ydsrLVg90H21EOLACvtfcHk0lgjJTGD02VG6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OjtbnF&md5=5d3a7dd5fcbf3d34744cfd65c6ee50e3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fja405932r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja405932r%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DR.%2BM.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26atitle%3DA%2520vision%2520for%2520vaccines%2520built%2520from%2520fully%2520synthetic%2520tumor-associated%2520antigens%253A%2520from%2520the%2520laboratory%2520to%2520the%2520clinic%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D14462%26epage%3D14472%26doi%3D10.1021%2Fja405932r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westerlind, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidzik, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span> <span> </span><span class="NLM_article-title">Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">7551</span>– <span class="NLM_lpage">7556</span>, <span class="refDoi"> DOI: 10.1002/anie.200802102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fanie.200802102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Sju7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=7551-7556&author=U.+Westerlindauthor=A.+Hobelauthor=N.+Gaidzikauthor=E.+Schmittauthor=H.+Kunz&title=Synthetic+vaccines+consisting+of+tumor-associated+MUC1+glycopeptide+antigens+and+a+T-cell+epitope+for+the+induction+of+a+highly+specific+humoral+immune+response&doi=10.1002%2Fanie.200802102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response</span></div><div class="casAuthors">Westerlind, Ulrika; Hobel, Alexandra; Gaidzik, Nikola; Schmitt, Edgar; Kunz, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">7551-7556</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selective response: The fully synthetic vaccine shown, which contains a glycopeptide antigen from the tumor-assocd. mucin MUC1 and an immunostimulating T-cell epitope from ovalbumin, induces a highly specific immune response in mice.  The induced antibody reacts with the glycopeptides and analogs that carry addnl. tumor-assocd. TN antigen monosaccharides in their sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOC7boYRUe6bVg90H21EOLACvtfcHk0liHydCJ0JhLaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Sju7nP&md5=187b508536642af782088ded756d135e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fanie.200802102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200802102%26sid%3Dliteratum%253Aachs%26aulast%3DWesterlind%26aufirst%3DU.%26aulast%3DHobel%26aufirst%3DA.%26aulast%3DGaidzik%26aufirst%3DN.%26aulast%3DSchmitt%26aufirst%3DE.%26aulast%3DKunz%26aufirst%3DH.%26atitle%3DSynthetic%2520vaccines%2520consisting%2520of%2520tumor-associated%2520MUC1%2520glycopeptide%2520antigens%2520and%2520a%2520T-cell%2520epitope%2520for%2520the%2520induction%2520of%2520a%2520highly%2520specific%2520humoral%2520immune%2520response%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D7551%26epage%3D7556%26doi%3D10.1002%2Fanie.200802102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cremer, G.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bureaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piller, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piller, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmas, A. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a multiantigenic Tn/TF-containing glycopeptide mimic of the tumor-related MUC1 glycoprotein</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200600104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fcmdc.200600104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=965-968&author=G.-A.+Cremerauthor=N.+Bureaudauthor=V.+Pillerauthor=H.+Kunzauthor=F.+Pillerauthor=A.+F.+Delmas&title=Synthesis+and+biological+evaluation+of+a+multiantigenic+Tn%2FTF-containing+glycopeptide+mimic+of+the+tumor-related+MUC1+glycoprotein&doi=10.1002%2Fcmdc.200600104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600104%26sid%3Dliteratum%253Aachs%26aulast%3DCremer%26aufirst%3DG.-A.%26aulast%3DBureaud%26aufirst%3DN.%26aulast%3DPiller%26aufirst%3DV.%26aulast%3DKunz%26aufirst%3DH.%26aulast%3DPiller%26aufirst%3DF.%26aulast%3DDelmas%26aufirst%3DA.%2BF.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520multiantigenic%2520Tn%252FTF-containing%2520glycopeptide%2520mimic%2520of%2520the%2520tumor-related%2520MUC1%2520glycoprotein%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D965%26epage%3D968%26doi%3D10.1002%2Fcmdc.200600104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geraci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Consoli, G. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galante, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bousquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappalardo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadaro, A.</span></span> <span> </span><span class="NLM_article-title">Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">758</span>, <span class="refDoi"> DOI: 10.1021/bc700411w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc700411w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlOmtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=751-758&author=C.+Geraciauthor=G.+M.+L.+Consoliauthor=E.+Galanteauthor=E.+Bousquetauthor=M.+Pappalardoauthor=A.+Spadaro&title=Calix%5B4%5Darene+decorated+with+four+Tn+antigen+glycomimetic+units+and+P3CS+immunoadjuvant%3A+synthesis%2C+characterization%2C+and+anticancer+immunological+evaluation&doi=10.1021%2Fbc700411w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Calix[4]arene Decorated with Four Tn Antigen Glycomimetic Units and P3CS Immunoadjuvant: Synthesis, Characterization, and Anticancer Immunological Evaluation</span></div><div class="casAuthors">Geraci, Corrada; Consoli, Grazia M. L.; Galante, Eva; Bousquet, Ennio; Pappalardo, Maria; Spadaro, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">751-758</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel anticancer vaccine candidate built on a nonpeptidic scaffold has been synthesized.  Four S-Tn tumor-assocd. glycomimetic antigens have been clustered onto a calix[4]arene scaffold bearing an immunoadjuvant moiety (P3CS).  The immunogenicity of the synthetic construct has been investigated by immunization of mice in vivo.  ELISA assay has evidenced that the tetravalent construct stimulates a higher prodn. of anti-Tn antigen IgG antibodies when compared to an analogous monovalent compd.  This result is ascribable to an antigen cluster effect and makes the reported vaccine candidate a good mimic of the natural motifs present on the mucine surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKLOhDRAYZ9bVg90H21EOLACvtfcHk0liHydCJ0JhLaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlOmtr4%253D&md5=480c518b15c9025b2443200fb03f7964</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fbc700411w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700411w%26sid%3Dliteratum%253Aachs%26aulast%3DGeraci%26aufirst%3DC.%26aulast%3DConsoli%26aufirst%3DG.%2BM.%2BL.%26aulast%3DGalante%26aufirst%3DE.%26aulast%3DBousquet%26aufirst%3DE.%26aulast%3DPappalardo%26aufirst%3DM.%26aulast%3DSpadaro%26aufirst%3DA.%26atitle%3DCalix%255B4%255Darene%2520decorated%2520with%2520four%2520Tn%2520antigen%2520glycomimetic%2520units%2520and%2520P3CS%2520immunoadjuvant%253A%2520synthesis%252C%2520characterization%252C%2520and%2520anticancer%2520immunological%2520evaluation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D751%26epage%3D758%26doi%3D10.1021%2Fbc700411w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grigalevicius, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chierici, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaudet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Man, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dériaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumy, P.</span></span> <span> </span><span class="NLM_article-title">Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.1021/bc050010v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc050010v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsleqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=1149-1159&author=S.+Grigaleviciusauthor=S.+Chiericiauthor=O.+Renaudetauthor=R.+Lo-Manauthor=E.+D%C3%A9riaudauthor=C.+Leclercauthor=P.+Dumy&title=Chemoselective+assembly+and+immunological+evaluation+of+multiepitopic+glycoconjugates+bearing+clustered+Tn+antigen+as+synthetic+anticancer+vaccines&doi=10.1021%2Fbc050010v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective Assembly and Immunological Evaluation of Multiepitopic Glycoconjugates Bearing Clustered Tn Antigen as Synthetic Anticancer Vaccines</span></div><div class="casAuthors">Grigalevicius, Saulius; Chierici, Sabine; Renaudet, Olivier; Lo-Man, Richard; Deriaud, Edith; Leclerc, Claude; Dumy, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1149-1159</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper the authors investigated the use of regioselectively addressable functionalized templates (RAFTs) as new scaffolds for the design of anticancer vaccine candidates.  The authors report the synthesis of well-defined multiepitopic RAFT scaffolds and their immunol. evaluation.  These conjugates exhibit clustered Tn analog as tumor-assocd. carbohydrate antigen (TACA, B-cell epitope) and the CD4+ helper T-cell peptide from the type 1 poliovirus.  The saccharidic and peptidic epitopes were both synthesized sep. and combined regioselectively to the RAFT core using a sequential oxime bond formation strategy.  B- and T-antigenicity and immunogenicity of the vaccine candidates were investigated in vitro and in vivo.  These studies clearly demonstrate that the saccharidic part of the conjugates is recognized by Tn-specific monoclonal antibodies.  Moreover, the antibodies elicited by immunization of mice with the authors' vaccine candidates recognize the native form of Tn epitope expressed on human tumor cells.  Together with oxime ligation technique, these results suggest that the RAFT scaffold provides a promising and suitable tool for engineering potent synthetic anticancer vaccine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6L1fae8AZmLVg90H21EOLACvtfcHk0lg-F-x1Kbadtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsleqsr0%253D&md5=60553713d78e1cd915e3b82b7cf10995</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbc050010v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc050010v%26sid%3Dliteratum%253Aachs%26aulast%3DGrigalevicius%26aufirst%3DS.%26aulast%3DChierici%26aufirst%3DS.%26aulast%3DRenaudet%26aufirst%3DO.%26aulast%3DLo-Man%26aufirst%3DR.%26aulast%3DD%25C3%25A9riaud%26aufirst%3DE.%26aulast%3DLeclerc%26aufirst%3DC.%26aulast%3DDumy%26aufirst%3DP.%26atitle%3DChemoselective%2520assembly%2520and%2520immunological%2520evaluation%2520of%2520multiepitopic%2520glycoconjugates%2520bearing%2520clustered%2520Tn%2520antigen%2520as%2520synthetic%2520anticancer%2520vaccines%26jtitle%3DBioconjugate%2520Chem.%26date%3D2005%26volume%3D16%26spage%3D1149%26epage%3D1159%26doi%3D10.1021%2Fbc050010v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Renaudet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BenMohamed, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettahi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumy, P.</span></span> <span> </span><span class="NLM_article-title">Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycopeptide cancer vaccine</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fcmdc.200700315" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=737-741&author=O.+Renaudetauthor=L.+BenMohamedauthor=G.+Dasguptaauthor=I.+Bettahiauthor=P.+Dumy&title=Towards+a+self-adjuvanting+multivalent+B+and+T+cell+epitope+containing+synthetic+glycopeptide+cancer+vaccine&doi=10.1002%2Fcmdc.200700315"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700315%26sid%3Dliteratum%253Aachs%26aulast%3DRenaudet%26aufirst%3DO.%26aulast%3DBenMohamed%26aufirst%3DL.%26aulast%3DDasgupta%26aufirst%3DG.%26aulast%3DBettahi%26aufirst%3DI.%26aulast%3DDumy%26aufirst%3DP.%26atitle%3DTowards%2520a%2520self-adjuvanting%2520multivalent%2520B%2520and%2520T%2520cell%2520epitope%2520containing%2520synthetic%2520glycopeptide%2520cancer%2520vaccine%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D737%26epage%3D741%26doi%3D10.1002%2Fcmdc.200700315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Man, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vichier-Guerre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dériaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantacuzène, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span> <span> </span><span class="NLM_article-title">Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">2849</span>– <span class="NLM_lpage">2854</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.166.4.2849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.4049%2Fjimmunol.166.4.2849" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2001&pages=2849-2854&author=R.+Lo-Manauthor=S.+Vichier-Guerreauthor=S.+Bayauthor=E.+D%C3%A9riaudauthor=D.+Cantacuz%C3%A8neauthor=C.+Leclerc&title=Anti-tumor+immunity+provided+by+a+synthetic+multiple+antigenic+glycopeptide+displaying+a+tri-Tn+glycotope&doi=10.4049%2Fjimmunol.166.4.2849"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.166.4.2849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.166.4.2849%26sid%3Dliteratum%253Aachs%26aulast%3DLo-Man%26aufirst%3DR.%26aulast%3DVichier-Guerre%26aufirst%3DS.%26aulast%3DBay%26aufirst%3DS.%26aulast%3DD%25C3%25A9riaud%26aufirst%3DE.%26aulast%3DCantacuz%25C3%25A8ne%26aufirst%3DD.%26aulast%3DLeclerc%26aufirst%3DC.%26atitle%3DAnti-tumor%2520immunity%2520provided%2520by%2520a%2520synthetic%2520multiple%2520antigenic%2520glycopeptide%2520displaying%2520a%2520tri-Tn%2520glycotope%26jtitle%3DJ.%2520Immunol.%26date%3D2001%26volume%3D166%26spage%3D2849%26epage%3D2854%26doi%3D10.4049%2Fjimmunol.166.4.2849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Man, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vichier-Guerre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perraut, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dériaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huteau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BenMohamed, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diop, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span> <span> </span><span class="NLM_article-title">A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">4987</span>– <span class="NLM_lpage">4994</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-0252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1158%2F0008-5472.CAN-04-0252" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4987-4994&author=R.+Lo-Manauthor=S.+Vichier-Guerreauthor=R.+Perrautauthor=E.+D%C3%A9riaudauthor=V.+Huteauauthor=L.+BenMohamedauthor=O.+M.+Diopauthor=P.+O.+Livingstonauthor=S.+Bayauthor=C.+Leclerc&title=A+fully+synthetic+therapeutic+vaccine+candidate+targeting+carcinoma-associated+Tn+carbohydrate+antigen+induces+tumor-specific+antibodies+in+nonhuman+primates&doi=10.1158%2F0008-5472.CAN-04-0252"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-0252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-0252%26sid%3Dliteratum%253Aachs%26aulast%3DLo-Man%26aufirst%3DR.%26aulast%3DVichier-Guerre%26aufirst%3DS.%26aulast%3DPerraut%26aufirst%3DR.%26aulast%3DD%25C3%25A9riaud%26aufirst%3DE.%26aulast%3DHuteau%26aufirst%3DV.%26aulast%3DBenMohamed%26aufirst%3DL.%26aulast%3DDiop%26aufirst%3DO.%2BM.%26aulast%3DLivingston%26aufirst%3DP.%2BO.%26aulast%3DBay%26aufirst%3DS.%26aulast%3DLeclerc%26aufirst%3DC.%26atitle%3DA%2520fully%2520synthetic%2520therapeutic%2520vaccine%2520candidate%2520targeting%2520carcinoma-associated%2520Tn%2520carbohydrate%2520antigen%2520induces%2520tumor-specific%2520antibodies%2520in%2520nonhuman%2520primates%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4987%26epage%3D4994%26doi%3D10.1158%2F0008-5472.CAN-04-0252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freire, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dériaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vichier-Guerre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azria, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Man, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span> <span> </span><span class="NLM_article-title">Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">3526</span>– <span class="NLM_lpage">3536</span>, <span class="refDoi"> DOI: 10.1182/blood-2010-04-279133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1182%2Fblood-2010-04-279133" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=3526-3536&author=T.+Freireauthor=X.+Zhangauthor=E.+D%C3%A9riaudauthor=C.+Ganneauauthor=S.+Vichier-Guerreauthor=E.+Azriaauthor=O.+Launayauthor=R.+Lo-Manauthor=S.+Bayauthor=C.+Leclerc&title=Glycosidic+Tn-based+vaccines+targeting+dermal+dendritic+cells+favor+germinal+center+B-cell+development+and+potent+antibody+response+in+the+absence+of+adjuvant&doi=10.1182%2Fblood-2010-04-279133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-04-279133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-04-279133%26sid%3Dliteratum%253Aachs%26aulast%3DFreire%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DD%25C3%25A9riaud%26aufirst%3DE.%26aulast%3DGanneau%26aufirst%3DC.%26aulast%3DVichier-Guerre%26aufirst%3DS.%26aulast%3DAzria%26aufirst%3DE.%26aulast%3DLaunay%26aufirst%3DO.%26aulast%3DLo-Man%26aufirst%3DR.%26aulast%3DBay%26aufirst%3DS.%26aulast%3DLeclerc%26aufirst%3DC.%26atitle%3DGlycosidic%2520Tn-based%2520vaccines%2520targeting%2520dermal%2520dendritic%2520cells%2520favor%2520germinal%2520center%2520B-cell%2520development%2520and%2520potent%2520antibody%2520response%2520in%2520the%2520absence%2520of%2520adjuvant%26jtitle%3DBlood%26date%3D2010%26volume%3D116%26spage%3D3526%26epage%3D3536%26doi%3D10.1182%2Fblood-2010-04-279133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Medzhitov, R.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors and innate immunity</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1038/35100529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2F35100529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=11905821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=135-145&author=R.+Medzhitov&title=Toll-like+receptors+and+innate+immunity&doi=10.1038%2F35100529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors and innate immunity</span></div><div class="casAuthors">Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-145</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors have a crucial role in the detection of microbial infection in mammals and insects.  In mammals, these receptors have evolved to recognize conserved products unique to microbial metab.  This specificity allows the Toll proteins to detect the presence of infection and to induce activation of inflammatory and antimicrobial innate immune responses.  Recognition of microbial products by Toll-like receptors expressed on dendritic cells triggers functional maturation of dendritic cells and leads to initiation of antigen-specific adaptive immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouf0HceqTgkrVg90H21EOLACvtfcHk0ljR4Kbk-GNfVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qu74%253D&md5=d88de3ef802486ba2611b056bcfd0c41</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F35100529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35100529%26sid%3Dliteratum%253Aachs%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DToll-like%2520receptors%2520and%2520innate%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2001%26volume%3D1%26spage%3D135%26epage%3D145%26doi%3D10.1038%2F35100529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banchereau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, R. M.</span></span> <span> </span><span class="NLM_article-title">Dendritic cells and the control of immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>392</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1038/32588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2F32588" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=9521319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK1cXitFWrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=1998&pages=245-252&author=J.+Banchereauauthor=R.+M.+Steinman&title=Dendritic+cells+and+the+control+of+immunity&doi=10.1038%2F32588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic cells and the control of immunity</span></div><div class="casAuthors">Banchereau, Jacques; Steinman, Ralph M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">392</span>
        (<span class="NLM_cas:issue">6673</span>),
    <span class="NLM_cas:pages">245-252</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">A review with 103 refs.  B and T lymphocytes are the mediators of immunity, but their function is under the control of dendritic cells.  Dendritic cells in the periphery capture and process antigens, express lymphocyte co-stimulatory mols., migrate to lymphoid organs, and secrete cytokines to initiate immune responses.  They not only activate lymphocytes, they also tolerize T cells to antigens that are innate to the body (self-antigens), thereby minimizing autoimmune reactions.  Once a neglected cell type, dendritic cells can now be readily obtained in sufficient quantities to allow mol. and cell biol. anal.  With knowledge comes the realization that these cells are a powerful tool for manipulating the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3cFu9pwhnSrVg90H21EOLACvtfcHk0lgySZ-ynTxnMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFWrsr8%253D&md5=af17ace619fc543c7260cb04146d4c30</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2F32588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F32588%26sid%3Dliteratum%253Aachs%26aulast%3DBanchereau%26aufirst%3DJ.%26aulast%3DSteinman%26aufirst%3DR.%2BM.%26atitle%3DDendritic%2520cells%2520and%2520the%2520control%2520of%2520immunity%26jtitle%3DNature%26date%3D1998%26volume%3D392%26spage%3D245%26epage%3D252%26doi%3D10.1038%2F32588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banchereau, J.</span></span> <span> </span><span class="NLM_article-title">Taking dendritic cells into medicine</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1038/nature06175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2Fnature06175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=17898760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtV2is7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2007&pages=419-426&author=R.+M.+Steinmanauthor=J.+Banchereau&title=Taking+dendritic+cells+into+medicine&doi=10.1038%2Fnature06175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Taking dendritic cells into medicine</span></div><div class="casAuthors">Steinman, Ralph M.; Banchereau, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue">7161</span>),
    <span class="NLM_cas:pages">419-426</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dendritic cells (DCs) orchestrate a repertoire of immune responses that bring about resistance to infection and silencing or tolerance to self.  In the settings of infection and cancer, microbes and tumors can exploit DCs to evade immunity, but DCs also can generate resistance, a capacity that is readily enhanced with DC-targeted vaccines.  During allergy, autoimmunity and transplant rejection, DCs instigate unwanted responses that cause disease, but again, DCs can be harnessed to silence these conditions with novel therapies.  Here we present some medical implications of DC biol. that account for illness and provide opportunities for prevention and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTxgb4Ibv24LVg90H21EOLACvtfcHk0lgySZ-ynTxnMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtV2is7%252FI&md5=3cfe810550de853b1189ed73cc062846</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature06175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06175%26sid%3Dliteratum%253Aachs%26aulast%3DSteinman%26aufirst%3DR.%2BM.%26aulast%3DBanchereau%26aufirst%3DJ.%26atitle%3DTaking%2520dendritic%2520cells%2520into%2520medicine%26jtitle%3DNature%26date%3D2007%26volume%3D449%26spage%3D419%26epage%3D426%26doi%3D10.1038%2Fnature06175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, R. M.</span></span> <span> </span><span class="NLM_article-title">Dendritic cells in vivo: A key target for a new vaccine science</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2008.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.immuni.2008.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=18799140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2jtLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=319-324&author=R.+M.+Steinman&title=Dendritic+cells+in+vivo%3A+A+key+target+for+a+new+vaccine+science&doi=10.1016%2Fj.immuni.2008.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic cells in vivo: a key target for a new vaccine science</span></div><div class="casAuthors">Steinman, Ralph M.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-324</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Dendritic cells (DCs) are the antigen presenting cells that initiate and regulate immunity.  By studying these cells in vivo, we will be able to move beyond std. approaches and design vaccines that directly harness the elaborate properties of DCs to control immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN4RNZGWc0z7Vg90H21EOLACvtfcHk0lhw6F4HsDCQBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2jtLvI&md5=d296ae55e7542a23956b1074269ce518</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2008.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2008.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DSteinman%26aufirst%3DR.%2BM.%26atitle%3DDendritic%2520cells%2520in%2520vivo%253A%2520A%2520key%2520target%2520for%2520a%2520new%2520vaccine%2520science%26jtitle%3DImmunity%26date%3D2008%26volume%3D29%26spage%3D319%26epage%3D324%26doi%3D10.1016%2Fj.immuni.2008.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">TLR signaling</span>. <i>Semin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.smim.2006.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.smim.2006.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=17275323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjslGrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=24-32&author=T.+Kawaiauthor=S.+Akira&title=TLR+signaling&doi=10.1016%2Fj.smim.2006.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">TLR signaling</span></div><div class="casAuthors">Kawai, Taro; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-32</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The TLR family senses the mol. signatures of microbial pathogens, and plays a fundamental role in innate immune responses.  TLRs signal via a common pathway that leads to the expression of diverse inflammatory genes.  In addn., each TLR elicits specific cellular responses to pathogens owing to differential usage of intracellular adapter proteins.  Recent studies have revealed the importance of the subcellular localization of TLRs in pathogen recognition and signaling.  TLR signaling pathways is neg. regulated by a no. of cellular proteins to attenuate inflammation.  Here, we describe recent advances in our understanding of the regulation of TLR-mediated signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3eiABFM-DQrVg90H21EOLACvtfcHk0lhw6F4HsDCQBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjslGrsLY%253D&md5=78f43a7a817574b6c8688f6e442b4701</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.smim.2006.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.smim.2006.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DKawai%26aufirst%3DT.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DTLR%2520signaling%26jtitle%3DSemin.%2520Immunol.%26date%3D2007%26volume%3D19%26spage%3D24%26epage%3D32%26doi%3D10.1016%2Fj.smim.2006.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaisho, T.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors: critical proteins linking and acquired immunity</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1038/90609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2F90609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=11477402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=675-680&author=S.+Akiraauthor=K.+Takedaauthor=T.+Kaisho&title=Toll-like+receptors%3A+critical+proteins+linking+and+acquired+immunity&doi=10.1038%2F90609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors: Critical proteins linking innate and acquired immunity</span></div><div class="casAuthors">Akira, Shizuo; Takeda, Kiyoshi; Kaisho, Tsuneyasu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">675-680</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A review with 84 refs.  Recognition of pathogens is mediated by a set of germline-encoded receptors that are referred to as pattern-recognition receptors (PRRs).  These receptors recognize conserved mol. patterns (pathogen-assocd. mol. patterns), which are shared by large groups of microorganisms.  Toll-like receptors (TLRs) function as the PRRs in mammals and play an essential role in the recognition of microbial components.  The TLRs may also recognize endogenous ligands induced during the inflammatory response.  Similar cytoplasmic domains allow TLRs to use the same signaling mols. used by the interleukin 1 receptors (IL-1Rs): these include MyD88, IL-1R-assocd. protein kinase and tumor necrosis factor receptor-activated factor 6.  However, evidence is accumulating that the signaling pathways assocd. with each TLR are not identical and may, therefore, result in different biol. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom8I2sSl7FK7Vg90H21EOLACvtfcHk0lhw6F4HsDCQBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D&md5=3fd5a975d63e0384c8cffa960159b063</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2F90609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F90609%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26atitle%3DToll-like%2520receptors%253A%2520critical%2520proteins%2520linking%2520and%2520acquired%2520immunity%26jtitle%3DNat.%2520Immunol.%26date%3D2001%26volume%3D2%26spage%3D675%26epage%3D680%26doi%3D10.1038%2F90609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span> <span> </span><span class="NLM_article-title">Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant</span>. <i>Chin. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/j.cclet.2017.09.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.cclet.2017.09.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1egsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=19-26&author=Z.+Zhouauthor=H.+Linauthor=C.+Liauthor=Z.+Wu&title=Recent+progress+of+fully+synthetic+carbohydrate-based+vaccine+using+TLR+agonist+as+build-in+adjuvant&doi=10.1016%2Fj.cclet.2017.09.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant</span></div><div class="casAuthors">Zhou, Zhifang; Lin, Han; Li, Chen; Wu, Zhimeng</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-26</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Fully synthetic vaccine, in which one or multi-mol. antigens are conjugated to a synthetic carrier with well-defined chem. structure, is a new direction to develop carbohydrate-based vaccine against cancer and pathogens.  Toll like receptor (TLR) agonists with the ability to stimulate immune response have been widely investigated and been applied as build-in adjuvants to construct fully synthetic vaccines.  In particular, remarkable progress has been achieved in recent years in the development of vaccines constructed with the agonists of TLR1/2, TLR2/6 and TLR4 and tumor-assocd. carbohydrate antigens (TACAs).  These di-, tri- or multi-component vaccine candidates showed attractive immunol. properties.  This review highlights recent advances in developing full synthetic carbohydrate antigen based vaccines, with an emphasis on the structure-activity relationships that provide a primary basis for future vaccine design and immunotherapy developing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvdlC50ATOC7Vg90H21EOLACvtfcHk0lgmxW0J0-9I-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1egsbfL&md5=297461b2b1543e0fcb0cd5a2603a92b0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cclet.2017.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cclet.2017.09.047%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DZ.%26atitle%3DRecent%2520progress%2520of%2520fully%2520synthetic%2520carbohydrate-based%2520vaccine%2520using%2520TLR%2520agonist%2520as%2520build-in%2520adjuvant%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D29%26spage%3D19%26epage%3D26%26doi%3D10.1016%2Fj.cclet.2017.09.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Toyokuni, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boivin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakomori, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhal, A. K.</span></span> <span> </span><span class="NLM_article-title">Synthetic vaccines: synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1021/ja00080a055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00080a055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=395-396&author=T.+Toyokuniauthor=B.+Deanauthor=S.+Caiauthor=D.+Boivinauthor=S.-I.+Hakomoriauthor=A.+K.+Singhal&title=Synthetic+vaccines%3A+synthesis+of+a+dimeric+Tn+antigen-lipopeptide+conjugate+that+elicits+immune+responses+against+Tn-expressing+glycoproteins&doi=10.1021%2Fja00080a055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fja00080a055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00080a055%26sid%3Dliteratum%253Aachs%26aulast%3DToyokuni%26aufirst%3DT.%26aulast%3DDean%26aufirst%3DB.%26aulast%3DCai%26aufirst%3DS.%26aulast%3DBoivin%26aufirst%3DD.%26aulast%3DHakomori%26aufirst%3DS.-I.%26aulast%3DSinghal%26aufirst%3DA.%2BK.%26atitle%3DSynthetic%2520vaccines%253A%2520synthesis%2520of%2520a%2520dimeric%2520Tn%2520antigen-lipopeptide%2520conjugate%2520that%2520elicits%2520immune%2520responses%2520against%2520Tn-expressing%2520glycoproteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26spage%3D395%26epage%3D396%26doi%3D10.1021%2Fja00080a055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kudryashov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glunz, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, K. O.</span></span> <span> </span><span class="NLM_article-title">Toward optimized carbohydrate-based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis<sup>y</sup> conjugates in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">3264</span>– <span class="NLM_lpage">3269</span>, <span class="refDoi"> DOI: 10.1073/pnas.051623598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1073%2Fpnas.051623598" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=3264-3269&author=V.+Kudryashovauthor=P.+W.+Glunzauthor=L.+J.+Williamsauthor=S.+Hintermannauthor=S.+J.+Danishefskyauthor=K.+O.+Lloyd&title=Toward+optimized+carbohydrate-based+anticancer+vaccines%3A+Epitope+clustering%2C+carrier+structure%2C+and+adjuvant+all+influence+antibody+responses+to+Lewisy+conjugates+in+mice&doi=10.1073%2Fpnas.051623598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.051623598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.051623598%26sid%3Dliteratum%253Aachs%26aulast%3DKudryashov%26aufirst%3DV.%26aulast%3DGlunz%26aufirst%3DP.%2BW.%26aulast%3DWilliams%26aufirst%3DL.%2BJ.%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DLloyd%26aufirst%3DK.%2BO.%26atitle%3DToward%2520optimized%2520carbohydrate-based%2520anticancer%2520vaccines%253A%2520Epitope%2520clustering%252C%2520carrier%2520structure%252C%2520and%2520adjuvant%2520all%2520influence%2520antibody%2520responses%2520to%2520Lewisy%2520conjugates%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D3264%26epage%3D3269%26doi%3D10.1073%2Fpnas.051623598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aal, A.
B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Naggar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batzloff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, I.</span></span> <span> </span><span class="NLM_article-title">Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based toll-like receptor 2 ligand</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6968</span>– <span class="NLM_lpage">6974</span>, <span class="refDoi"> DOI: 10.1021/jm300822g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300822g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVemtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6968-6974&author=A.%0AB.+Abdel-Aalauthor=D.+El-Naggarauthor=M.+Zamanauthor=M.+Batzloffauthor=I.+Toth&title=Design+of+fully+synthetic%2C+self-adjuvanting+vaccine+incorporating+the+tumor-associated+carbohydrate+Tn+antigen+and+lipoamino+acid-based+toll-like+receptor+2+ligand&doi=10.1021%2Fjm300822g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Fully Synthetic, Self-Adjuvanting Vaccine Incorporating the Tumor-Associated Carbohydrate Tn Antigen and Lipoamino Acid-Based Toll-like Receptor 2 Ligand</span></div><div class="casAuthors">Abdel-Aal, Abu-Baker M.; El-Naggar, Dina; Zaman, Mehfuz; Batzloff, Michael; Toth, Istvan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6968-6974</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of certain tumor-assocd. carbohydrate antigens (TACA) caused by malignant transformation offers promising targets to develop novel antitumor vaccines, provided the ability to break their inherent low immunogenicity and overcome the tolerance of the immune system.  The authors designed, synthesized, and immunol. evaluated a no. of fully synthetic new chimeric constructs incorporating a cluster of the most common TACA (known as Tn antigen) covalently attached to T-cell peptide epitopes derived from polio virus and ovalbumin and included a synthetic built-in adjuvant consisting of two 16-carbon lipoamino acids.  Vaccine candidates were able to induce significantly strong antibody responses in mice without the need for any addnl. adjuvant, carrier protein, or special pharmaceutical prepn. (e.g., liposomes).  Vaccine constructs were assembled either in a linear or in a branched architecture, which demonstrated the intervening effects of the incorporation and arrangement of T-cell epitopes on antibody recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YLaYPOuPbrVg90H21EOLACvtfcHk0lhdKWCzM7Ltng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVemtbfE&md5=6ccc4ff15dd4183b2cab970fdf55cf8d</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm300822g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300822g%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Aal%26aufirst%3DA.%2BB.%26aulast%3DEl-Naggar%26aufirst%3DD.%26aulast%3DZaman%26aufirst%3DM.%26aulast%3DBatzloff%26aufirst%3DM.%26aulast%3DToth%26aufirst%3DI.%26atitle%3DDesign%2520of%2520fully%2520synthetic%252C%2520self-adjuvanting%2520vaccine%2520incorporating%2520the%2520tumor-associated%2520carbohydrate%2520Tn%2520antigen%2520and%2520lipoamino%2520acid-based%2520toll-like%2520receptor%25202%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6968%26epage%3D6974%26doi%3D10.1021%2Fjm300822g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malins, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, C. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, R. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of MUC1-lipopeptide chimeras</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">6249</span>– <span class="NLM_lpage">6251</span>, <span class="refDoi"> DOI: 10.1039/c0cc01360a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1039%2Fc0cc01360a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=6249-6251&author=B.+L.+Wilkinsonauthor=L.+R.+Malinsauthor=C.+K.+Y.+Chunauthor=R.+J.+Payne&title=Synthesis+of+MUC1-lipopeptide+chimeras&doi=10.1039%2Fc0cc01360a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1039%2Fc0cc01360a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cc01360a%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DB.%2BL.%26aulast%3DMalins%26aufirst%3DL.%2BR.%26aulast%3DChun%26aufirst%3DC.%2BK.%2BY.%26aulast%3DPayne%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520of%2520MUC1-lipopeptide%2520chimeras%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D6249%26epage%3D6251%26doi%3D10.1039%2Fc0cc01360a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Synthetic MUC1 antitumor vaccine candidates with varied glycosylation pattern bearing R/S-configured Pam3CysSerLys4</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1415</span>, <span class="refDoi"> DOI: 10.1002/cbic.201600206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fcbic.201600206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=27188544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1412-1415&author=L.+Shiauthor=H.+Caiauthor=Z.+Huangauthor=Z.+Sunauthor=Y.+Chenauthor=Y.+Zhaoauthor=H.+Kunzauthor=Y.+Li&title=Synthetic+MUC1+antitumor+vaccine+candidates+with+varied+glycosylation+pattern+bearing+R%2FS-configured+Pam3CysSerLys4&doi=10.1002%2Fcbic.201600206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26cR"><div class="casContent"><span class="casTitleNuber">26c</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic MUC1 Antitumor Vaccine Candidates with Varied Glycosylation Pattern Bearing R/S-configured Pam3CysSerLys4</span></div><div class="casAuthors">Shi, Lei; Cai, Hui; Huang, Zhi-Hua; Sun, Zhan-Yi; Chen, Yong-Xiang; Zhao, Yu-Fen; Kunz, Horst; Li, Yan-Mei</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1412-1415</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The Toll-like receptor 2 ligand Pam3CysSer is of particular interest for the construction synthetic vaccines because of its ability to stimulate of the innate immune system.  Such vaccines usually comprise Pam3CysSer with the natural R-configuration at the glycerol 2-position.  Pam3CysSer peptide vaccines with natural configuration have been shown to be more efficient than the corresponding R/S diastereomers.  In order to clarify whether the effect of the configuration of Pam3Cys on the immune response also applies to glycopeptide vaccines, MUC1 glycopeptide-lipopeptide vaccines bearing either R- or R/S-configured Pam3CysSerLys4 were compared for their immunol. effects.  In order to find out whether glycosylated MUC1 tandem repeat domains comprise not only B-cell epitopes but also T-cell epitopes, two-component vaccines contg. the Pam3CysSerLys4 lipopeptide and MUC1 glycopeptides with various glycosylation patterns were synthesized, and their immune reactions in mice were studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3xao-AnfR3LVg90H21EOLACvtfcHk0lh5nO3qub09VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFeqtrk%253D&md5=05b43ca881281de75651738cf0b1ba79</span></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201600206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201600206%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DKunz%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DSynthetic%2520MUC1%2520antitumor%2520vaccine%2520candidates%2520with%2520varied%2520glycosylation%2520pattern%2520bearing%2520R%252FS-configured%2520Pam3CysSerLys4%26jtitle%3DChemBioChem%26date%3D2016%26volume%3D17%26spage%3D1412%26epage%3D1415%26doi%3D10.1002%2Fcbic.201600206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ingale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaekwad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buskas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G.-J.</span></span> <span> </span><span class="NLM_article-title">Robust immune responses elicited by a fully synthetic three-component vaccine</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2007.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2Fnchembio.2007.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=17767155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=663-667&author=S.+Ingaleauthor=M.+A.+Wolfertauthor=J.+Gaekwadauthor=T.+Buskasauthor=G.-J.+Boons&title=Robust+immune+responses+elicited+by+a+fully+synthetic+three-component+vaccine&doi=10.1038%2Fnchembio.2007.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Robust immune responses elicited by a fully synthetic three-component vaccine</span></div><div class="casAuthors">Ingale, Sampat; Wolfert, Margreet A.; Gaekwad, Jidnyasa; Buskas, Therese; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The overexpression of saccharides such as globo-H, LewisY, and Tn antigen is a common feature of oncogenic transformed cells.  Endeavors to exploit this aberrant glycosylation for cancer vaccine development have been complicated by difficulties in eliciting high titers of IgG antibodies against classical conjugates of tumor-assocd. carbohydrates to carrier proteins.  The authors designed, chem. synthesized, and immunol. evaluated a no. of fully synthetic vaccine candidates to establish strategies to overcome the poor immunogenicity of tumor-assocd. carbohydrates and glycopeptides.  The have found that a 3-component vaccine composed of a TLR2 agonist, a promiscuous peptide T-helper epitope, and a tumor-assocd. glycopeptide can elicit in mice exceptionally high titers of IgG antibodies that can recognize cancer cells expressing the tumor-assocd. carbohydrate.  The superior properties of the vaccine candidate are attributed to the local prodn. of cytokines, upregulation of co-stimulatory proteins, enhanced uptake by macrophages and dendritic cells, and avoidance of epitope suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdz62dPelB7Vg90H21EOLACvtfcHk0lh5nO3qub09VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtrnO&md5=43cb22b797d84c8b60bedca1a5aee7ea</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2007.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2007.25%26sid%3Dliteratum%253Aachs%26aulast%3DIngale%26aufirst%3DS.%26aulast%3DWolfert%26aufirst%3DM.%2BA.%26aulast%3DGaekwad%26aufirst%3DJ.%26aulast%3DBuskas%26aufirst%3DT.%26aulast%3DBoons%26aufirst%3DG.-J.%26atitle%3DRobust%2520immune%2520responses%2520elicited%2520by%2520a%2520fully%2520synthetic%2520three-component%2520vaccine%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D663%26epage%3D667%26doi%3D10.1038%2Fnchembio.2007.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ingale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buskas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G.-J.</span></span> <span> </span><span class="NLM_article-title">Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting toll-like receptors</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">463</span>, <span class="refDoi"> DOI: 10.1002/cbic.200800596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fcbic.200800596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=19145607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1amsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=455-463&author=S.+Ingaleauthor=M.+A.+Wolfertauthor=T.+Buskasauthor=G.-J.+Boons&title=Increasing+the+antigenicity+of+synthetic+tumor-associated+carbohydrate+antigens+by+targeting+toll-like+receptors&doi=10.1002%2Fcbic.200800596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors</span></div><div class="casAuthors">Ingale, Sampat; Wolfert, Margreet A.; Buskas, Therese; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-463</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Epithelial cancer cells often overexpress mucins that are aberrantly glycosylated.  Although it has been realized that these compds. offer exciting opportunities for the development of immunotherapy for cancer, their use is hampered by the low antigenicity of classical immunogens composed of a glycopeptide derived from a mucin conjugated to a foreign carrier protein.  We have designed, chem. synthesized, and immunol. evaluated a no. of fully synthetic vaccine candidates to establish a strategy to overcome the poor immunogenicity of tumor-assocd. carbohydrates and glycopeptides.  The compds. were also designed to allow study of the importance of Toll-like receptor (TLR) engagement for these antigenic responses in detail.  We have found that covalent attachment of a TLR2 agonist, a promiscuous peptide T-helper epitope, and a tumor-assocd. glycopeptide gives a compd. (1) that elicits in mice exceptionally high titers of IgG antibodies that recognize MCF7 cancer cells expressing the tumor-assocd. carbohydrate.  Immunizations with glycolipopeptide 2, which contains lipidated amino acids instead of a TLR2 ligand, gave significantly lower titers of IgG antibodies; this demonstrates that TLR engagement is crit. for optimum antigenic responses.  Although mixts. of compd. 2 with Pam3CysSK4 (3) or monophosphoryl lipid A (4) elicited titers of IgG antibodies similar to those seen with 1, the resulting antisera had impaired ability to recognize cancer cells.  It was also found that covalent linkage of the helper T-epitope to the B-epitope is essential, probably because internalization of the helper T-epitope by B-cells requires assistance of the B-epitope.  The results presented here show that synthetic vaccine development is amenable to structure-activity relationship studies for successful optimization of carbohydrate-based cancer vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4OtTwjYj5B7Vg90H21EOLACvtfcHk0lg8OR_FwfTCbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1amsL4%253D&md5=d5fc76855b718ae347d13f2dbd484d52</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200800596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200800596%26sid%3Dliteratum%253Aachs%26aulast%3DIngale%26aufirst%3DS.%26aulast%3DWolfert%26aufirst%3DM.%2BA.%26aulast%3DBuskas%26aufirst%3DT.%26aulast%3DBoons%26aufirst%3DG.-J.%26atitle%3DIncreasing%2520the%2520antigenicity%2520of%2520synthetic%2520tumor-associated%2520carbohydrate%2520antigens%2520by%2520targeting%2520toll-like%2520receptors%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D455%26epage%3D463%26doi%3D10.1002%2Fcbic.200800596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malins, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apostolopoulos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, R. J.</span></span> <span> </span><span class="NLM_article-title">Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the toll-like receptor 2 agonist Pam3CysSer</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1635</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.1002/anie.201006115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fanie.201006115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslygs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=1635-1639&author=B.+L.+Wilkinsonauthor=S.+Dayauthor=L.+R.+Malinsauthor=V.+Apostolopoulosauthor=R.+J.+Payne&title=Self-adjuvanting+multicomponent+cancer+vaccine+candidates+combining+per-glycosylated+MUC1+glycopeptides+and+the+toll-like+receptor+2+agonist+Pam3CysSer&doi=10.1002%2Fanie.201006115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer</span></div><div class="casAuthors">Wilkinson, Brendan L.; Day, Stephanie; Malins, Lara R.; Apostolopoulos, Vasso; Payne, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1635-1639, S1635/1-S1635/55</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The aberrant glycosylation of cell surface mucin glycoproteins such as MUCl and the overexpression of highly truncated, tumor-assocd. carbohydrate antigens (TACAs) are strongly correlated with tumor metastasis and poor prognosis.  Such TACAs, including the well-studied TN and T antigens and their sialylated derivs., are important targets for the development of antigen-specific carbohydrate vaccines.  However, these structures are self antigens that generally elicit T-cell independent immune responses which are tolerated by the immune system and lead to poor immunogenicity.  One approach aimed at enhancing the immune recognition of TACAs utilizes conjugation of tumor-assocd. MUCl glycopeptides or TACAs alone to foreign carrier proteins such as keyhole limpet hemocyanin (KLH) or bovine serum albumin (BSA).  Kunz and coworkers have described several impressive examples of MUCl glycopeptide carrier protein vaccine candidates which have elicited significant antibody responses in murine models.  While conjugate vaccines have shown promise in tumor vaccinol., the inherent immunogenicity of the carrier protein has been assocd. with suppression of the immune response towards the desired carbohydrate/glycopeptide epitope.  Self-adjuvanting, multicomponent vaccines however, avoid anti-carrier immune responses while incorporating the necessary structural features for evoking an essential class switch from low-affinity and short lived IgM antibodies, to high-affinity IgG antibodies.  Here, we exploit this strategy for the convergent assembly and immunol. investigation of dicomponent vaccines, comprised of multiple copies of TN or T antigens conjugated to the TLR2 ligand Pam3CysSer, and tricomponent vaccines incorporating the tetanus toxin-derived helper T-cell epitope1131 between a per-glycosylated MUCl B-cell epitope and Pam3CysSer.  We chose to install flexible, immunogenically silent ethylene glycol spacer units between each component to minimize conformational distortion and to allow for optimal display of each recognition element to the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYKL6cJxj1xbVg90H21EOLACvtfcHk0lg8OR_FwfTCbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslygs7Y%253D&md5=22e7aa8cea662cc5a1d5f7986f8e99eb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fanie.201006115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201006115%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DB.%2BL.%26aulast%3DDay%26aufirst%3DS.%26aulast%3DMalins%26aufirst%3DL.%2BR.%26aulast%3DApostolopoulos%26aufirst%3DV.%26aulast%3DPayne%26aufirst%3DR.%2BJ.%26atitle%3DSelf-adjuvanting%2520multicomponent%2520cancer%2520vaccine%2520candidates%2520combining%2520per-glycosylated%2520MUC1%2520glycopeptides%2520and%2520the%2520toll-like%2520receptor%25202%2520agonist%2520Pam3CysSer%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D1635%26epage%3D1639%26doi%3D10.1002%2Fanie.201006115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuy, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrasidlo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1194</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1021/bc900054q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc900054q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFCrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1194-1200&author=M.+Chanauthor=T.+Hayashiauthor=C.+S.+Kuyauthor=C.+S.+Grayauthor=C.+C.+N.+Wuauthor=M.+Corrauthor=W.+Wrasidloauthor=H.+B.+Cottamauthor=D.+A.+Carson&title=Synthesis+and+immunological+characterization+of+toll-like+receptor+7+agonistic+conjugates&doi=10.1021%2Fbc900054q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates</span></div><div class="casAuthors">Chan, Michael; Hayashi, Tomoko; Kuy, Crystal S.; Gray, Christine S.; Wu, Christina C. N.; Corr, Maripat; Wrasidlo, Wolfgang; Cottam, Howard B.; Carson, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1194-1200</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of toll-like receptors (TLRs) on cells of the innate immune system initiates, amplifies, and directs the antigen-specific acquired immune response.  Ligands that stimulate TLRs, therefore, represent potential immune adjuvants.  In this study, a potent TLR7 agonist was conjugated to phospholipids, poly(ethylene glycol) (PEG), or phospholipid-PEG via a versatile benzoic acid functional group.  Compared to the unmodified TLR7 agonist, each conjugate displayed a distinctive immunol. profile in vitro and in vivo.  In mouse macrophages and human peripheral blood mononuclear cells, the phospholipid TLR7 agonist conjugate was at least 100-fold more potent than the free TLR7 ligands, while the potency of PEG-phospholipid conjugate was similar to that of the unmodified TLR7 agonist.  When administered systemically in mice, the phospholipid and phospholipid-PEG TLR7 conjugates induced prolonged increases in the levels of proinflammatory cytokines in serum, compared to the unmodified TLR7 activator.  When the conjugates were used as adjuvants during vaccination, only the phospholipid TLR7 agonist conjugates induced both Th1 and Th2 antigen-specific immune responses.  These data show that the immunostimulatory activity of a TLR7 ligand can be amplified and focused by conjugation, thus broadening the potential therapeutic application of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXiX-Vp0VhrrVg90H21EOLACvtfcHk0lg8OR_FwfTCbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFCrs7Y%253D&md5=945810b3e5d1a5ab14fc998ce1c0989d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbc900054q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc900054q%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DKuy%26aufirst%3DC.%2BS.%26aulast%3DGray%26aufirst%3DC.%2BS.%26aulast%3DWu%26aufirst%3DC.%2BC.%2BN.%26aulast%3DCorr%26aufirst%3DM.%26aulast%3DWrasidlo%26aufirst%3DW.%26aulast%3DCottam%26aufirst%3DH.%2BB.%26aulast%3DCarson%26aufirst%3DD.%2BA.%26atitle%3DSynthesis%2520and%2520immunological%2520characterization%2520of%2520toll-like%2520receptor%25207%2520agonistic%2520conjugates%26jtitle%3DBioconjugate%2520Chem.%26date%3D2009%26volume%3D20%26spage%3D1194%26epage%3D1200%26doi%3D10.1021%2Fbc900054q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blasius, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beutler, B.</span></span> <span> </span><span class="NLM_article-title">Intracellular toll-like receptors</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2010.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.immuni.2010.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=20346772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=305-315&author=A.+L.+Blasiusauthor=B.+Beutler&title=Intracellular+toll-like+receptors&doi=10.1016%2Fj.immuni.2010.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular toll-like receptors</span></div><div class="casAuthors">Blasius, Amanda L.; Beutler, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-315</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Foreign nucleic acids, the signature of invading viruses and certain bacteria, are sensed intracellularly.  The nucleic acid-specific Toll-like receptors (TLRs) detect and signal within endolysosomal compartments, triggering the induction of cytokines essential for the innate immune response.  These cytokines include proinflammatory mols. produced mainly by macrophages and conventional dendritic cells, as well as type I interferons, which are produced in great quantities by plasmacytoid dendritic cells.  The cellular and mol. pathways by which nucleic acids and TLRs meet within the endosome assure host protection yet also place the host at risk for the development of autoimmunity.  Here, we review the latest findings on the intracellular TLRs, with special emphasis on ligand uptake, receptor trafficking, signaling, and regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5-SJKSbEwurVg90H21EOLACvtfcHk0lioA69Rl7HKDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSntr4%253D&md5=84f54e99249e52a6424c7c3975e8c7ea</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2010.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2010.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DBlasius%26aufirst%3DA.%2BL.%26aulast%3DBeutler%26aufirst%3DB.%26atitle%3DIntracellular%2520toll-like%2520receptors%26jtitle%3DImmunity%26date%3D2010%26volume%3D32%26spage%3D305%26epage%3D315%26doi%3D10.1016%2Fj.immuni.2010.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shupe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashgarian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shlomchik, M. J.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2006.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.immuni.2006.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=16973389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOjtLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=417-428&author=S.+R.+Christensenauthor=J.+Shupeauthor=K.+Nickersonauthor=M.+Kashgarianauthor=R.+Flavellauthor=M.+J.+Shlomchik&title=Toll-like+receptor+7+and+TLR9+dictate+autoantibody+specificity+and+have+opposing+inflammatory+and+regulatory+roles+in+a+murine+model+of+lupus&doi=10.1016%2Fj.immuni.2006.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31aR"><div class="casContent"><span class="casTitleNuber">31a</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus</span></div><div class="casAuthors">Christensen, Sean R.; Shupe, Jonathan; Nickerson, Kevin; Kashgarian, Michael; Flavell, Richard A.; Shlomchik, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">417-428</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Antibodies (Abs) to RNA- and DNA-contg. autoantigens are characteristic of systemic lupus erythematosus (SLE).  The authors showed previously that Toll-like receptor (TLR) 9, recognizing DNA, is required for the spontaneous generation of DNA autoantibodies, but not for the development of lupus nephritis in susceptible mice.  The authors report that lupus-prone mice deficient in TLR7, a receptor for ssRNA, failed to generate Abs to RNA-contg. antigens (Ags) such as Smith (Sm) Ag.  TLR9 and TLR7 also had dramatic effects on clin. disease in lupus-prone mice.  In the absence of TLR9, autoimmune disease was exacerbated, lymphocytes and plasmacytoid DCs were more activated, and serum IgG and IFN-α were increased.  In contrast, TLR7-deficient mice had ameliorated disease, decreased lymphocyte activation, and decreased serum IgG.  These findings reveal opposing inflammatory and regulatory roles for TLR7 and TLR9, despite similar tissue expression and signaling pathways.  These results have important implications for TLR-directed therapy of autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsGKX6qua9FLVg90H21EOLACvtfcHk0lioA69Rl7HKDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOjtLzN&md5=8c062e4f69b246777598249d500da41b</span></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2006.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2006.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DS.%2BR.%26aulast%3DShupe%26aufirst%3DJ.%26aulast%3DNickerson%26aufirst%3DK.%26aulast%3DKashgarian%26aufirst%3DM.%26aulast%3DFlavell%26aufirst%3DR.%26aulast%3DShlomchik%26aufirst%3DM.%2BJ.%26atitle%3DToll-like%2520receptor%25207%2520and%2520TLR9%2520dictate%2520autoantibody%2520specificity%2520and%2520have%2520opposing%2520inflammatory%2520and%2520regulatory%2520roles%2520in%2520a%2520murine%2520model%2520of%2520lupus%26jtitle%3DImmunity%26date%3D2006%26volume%3D25%26spage%3D417%26epage%3D428%26doi%3D10.1016%2Fj.immuni.2006.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Santiago-Raber, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunand-Sauthier, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reith, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotzin, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izui, S.</span></span> <span> </span><span class="NLM_article-title">Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice</span>. <i>J. Autoimmun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1016/j.jaut.2009.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.jaut.2009.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=19944565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltF2ms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=339-348&author=M.+L.+Santiago-Raberauthor=I.+Dunand-Sauthierauthor=T.+Wuauthor=Q.+Z.+Liauthor=S.+Uematsuauthor=S.+Akiraauthor=W.+Reithauthor=C.+Mohanauthor=B.+L.+Kotzinauthor=S.+Izui&title=Critical+role+of+TLR7+in+the+acceleration+of+systemic+lupus+erythematosus+in+TLR9-deficient+mice&doi=10.1016%2Fj.jaut.2009.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31bR"><div class="casContent"><span class="casTitleNuber">31b</span><div class="casTitle"><span class="NLM_cas:atitle">Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice</span></div><div class="casAuthors">Santiago-Raber, Marie-Laure; Dunand-Sauthier, Isabelle; Wu, Tianfu; Li, Quan-Zhen; Uematsu, Satoshi; Akira, Shizuo; Reith, Walter; Mohan, Chandra; Kotzin, Brian L.; Izui, Shozo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Autoimmunity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">339-348</span>CODEN:
                <span class="NLM_cas:coden">JOAUEP</span>;
        ISSN:<span class="NLM_cas:issn">0896-8411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Accumulating evidence supports the idea that TLR7 and TLR9 play pathogenic and protective roles, resp., in the development of murine systemic lupus erythematosus (SLE).  However, the mol. mechanism responsible for the accelerated development of SLE resulting from the deletion of TLR9 and the resp. contributions of TLR7 and TLR9 to the development of different autoimmune responses against nuclear and non-nuclear autoantigens implicated in lupus nephritis have not been well defined.  In the present study, the authors addressed these questions by assessing the effect of the TLR9 and/or TLR7 deletion on the prodn. of various autoantibodies and the development of lupus nephritis in C57BL/6 mice congenic for the Nba2 (NZB autoimmunity 2) locus (B6.Nba2).  TLR9-deficient B6.Nba2 mice displayed increased prodn. of autoantibodies against nuclear antigens, serum retroviral gp70 and glomerular matrix antigens, and developed a markedly accelerated form of lupus nephritis.  Enhanced disease was assocd. with functionally upregulated expression of TLR7, as documented by an increased TLR7-dependent activation of B cells and plasmacytoid dendritic cells.  Notably, disease exacerbation in TLR9-deficient mice was completely suppressed by the deletion of TLR7.  The authors' results indicate that TLR7 has a pivotal role in a wide variety of autoimmune responses against DNA- and RNA-contg. nuclear antigens, retroviral gp70 and glomerular matrix antigens implicated in murine SLE, and that enhanced TLR7 activity is crit. for the accelerated development of SLE in TLR9-deficient lupus-prone mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ-44-46k3FrVg90H21EOLACvtfcHk0lioA69Rl7HKDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltF2ms7g%253D&md5=d7553a8823cbf199b73cf4bfed6fb0c3</span></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=10.1016%2Fj.jaut.2009.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaut.2009.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DSantiago-Raber%26aufirst%3DM.%2BL.%26aulast%3DDunand-Sauthier%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DQ.%2BZ.%26aulast%3DUematsu%26aufirst%3DS.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DReith%26aufirst%3DW.%26aulast%3DMohan%26aufirst%3DC.%26aulast%3DKotzin%26aufirst%3DB.%2BL.%26aulast%3DIzui%26aufirst%3DS.%26atitle%3DCritical%2520role%2520of%2520TLR7%2520in%2520the%2520acceleration%2520of%2520systemic%2520lupus%2520erythematosus%2520in%2520TLR9-deficient%2520mice%26jtitle%3DJ.%2520Autoimmun.%26date%3D2010%26volume%3D34%26spage%3D339%26epage%3D348%26doi%3D10.1016%2Fj.jaut.2009.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimozato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara-Tobinai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, S. i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span> <span> </span><span class="NLM_article-title">Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">6119</span>, <span class="refDoi"> DOI: 10.1038/ncomms7119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2Fncomms7119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=25648980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlGlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6119&author=A.+Kannoauthor=N.+Tanimuraauthor=M.+Ishizakiauthor=K.+Ohkoauthor=Y.+Motoiauthor=M.+Onjiauthor=R.+Fukuiauthor=T.+Shimozatoauthor=K.+Yamamotoauthor=T.+Shibataauthor=S.+Sanoauthor=A.+Sugahara-Tobinaiauthor=T.+Takaiauthor=U.+Ohtoauthor=T.+Shimizuauthor=S.+i.+Saitohauthor=K.+Miyake&title=Targeting+cell+surface+TLR7+for+therapeutic+intervention+in+autoimmune+diseases&doi=10.1038%2Fncomms7119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases</span></div><div class="casAuthors">Kanno, Atsuo; Tanimura, Natsuko; Ishizaki, Masayuki; Ohko, Kentaro; Motoi, Yuji; Onji, Masahiro; Fukui, Ryutaro; Shimozato, Takaichi; Yamamoto, Kazuhide; Shibata, Takuma; Sano, Shigetoshi; Sugahara-Tobinai, Akiko; Takai, Toshiyuki; Ohto, Umeharu; Shimizu, Toshiyuki; Saitoh, Shin-ichiroh; Miyake, Kensuke</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6119</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) senses microbial-derived RNA but can also potentially respond to self-derived RNA.  To prevent autoimmune responses, TLR7 is thought to localize in endolysosomes.  Contrary to this view, we show here that TLR7 is present on the cell surface of immune cells and that TLR7 responses can be inhibited by an anti-TLR7 antibody.  The anti-TLR7 antibody is internalized with TLR7 and accumulates in endolysosomes as an immune complex.  TLR7 responses in dendritic cells, macrophages and B cells are all inhibited by the anti-TLR7 antibody.  Furthermore, the anti-TLR7 antibody inhibits in vivo cytokine prodn. induced by a TLR7 ligand.  Spontaneous TLR7 activation in Unc93b1D34A/D34A mice causes lethal inflammation.  Progressive inflammation such as splenomegaly, thrombocytopenia and chronic active hepatitis are ameliorated by anti-TLR7 antibody treatment.  These results demonstrate that cell surface TLR7 is a promising target for therapeutic intervention in autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO9GMC9fjDKLVg90H21EOLACvtfcHk0lgPIp9wxir7QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlGlur8%253D&md5=6d508a5137d5c47103be9c4f53690416</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fncomms7119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7119%26sid%3Dliteratum%253Aachs%26aulast%3DKanno%26aufirst%3DA.%26aulast%3DTanimura%26aufirst%3DN.%26aulast%3DIshizaki%26aufirst%3DM.%26aulast%3DOhko%26aufirst%3DK.%26aulast%3DMotoi%26aufirst%3DY.%26aulast%3DOnji%26aufirst%3DM.%26aulast%3DFukui%26aufirst%3DR.%26aulast%3DShimozato%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DSano%26aufirst%3DS.%26aulast%3DSugahara-Tobinai%26aufirst%3DA.%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DSaitoh%26aufirst%3DS.%2Bi.%26aulast%3DMiyake%26aufirst%3DK.%26atitle%3DTargeting%2520cell%2520surface%2520TLR7%2520for%2520therapeutic%2520intervention%2520in%2520autoimmune%2520diseases%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6119%26doi%3D10.1038%2Fncomms7119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hamm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgartner, R.</span></span> <span> </span><span class="NLM_article-title">Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists</span>. <i>J. Immunotoxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.3109/15476910903286733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.3109%2F15476910903286733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=19848448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=257-265&author=S.+Hammauthor=S.+Rathauthor=S.+Michelauthor=R.+Baumgartner&title=Cancer+immunotherapeutic+potential+of+novel+small+molecule+TLR7+and+TLR8+agonists&doi=10.3109%2F15476910903286733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists</span></div><div class="casAuthors">Hamm, Svetlana; Rath, Sandra; Michel, Susanne; Baumgartner, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunotoxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">257-265</span>CODEN:
                <span class="NLM_cas:coden">JIOMAP</span>;
        ISSN:<span class="NLM_cas:issn">1547-691X</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR)-mediated signaling is proposed as an immunotherapeutic target against tumorigenesis.  Natural killer (NK) cells play a crit. role in host defense against tumors.  Specifically, formation of tumor metastasis in various organs can be suppressed by the local activity of NK cells.  In this study, we present a novel TLR7 agonist (termed SC-1) that induces pro-inflammatory cytokines in human blood cells, activates NK cell function, and is highly efficient in preventing lung metastases in a pulmonary metastatic Renca model.  Furthermore, a second compd. (termed SC-2), acting as dual-specific TLR7 and TLR8 agonist, was evaluated with respect to its immunostimulatory and NK cell-activating capacities.  The release of pro-inflammatory cytokines was shown to be even more pronounced with this compd.  Addnl. expts. showed a significant up-regulation of activation marker CD69 on NK cells and increased cytolytic activity of peripheral blood cells compared to the effect of a monospecific TLR7 agonist SC-1.  Normally, TLR7 and TLR8 are expressed on different immune cell subpopulations.  TLR7 expression on antigen-presenting cells is detected in plasmacytoid dendritic cells, CD34+-derived dendritic cells, and B-cells, whereas TLR8 is mainly expressed on cells of the myeloid lineage, such as monocytes, macrophages, and myeloid dendritic cells.  Therefore, a compd. that activates both TLR7 and TLR8 would result in a highly efficient immune system activation and may give rise to an enhanced anti-tumor activity in vivo compared to that elicited by a monospecific TLR7 agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjZBxf5X74dbVg90H21EOLACvtfcHk0lgPIp9wxir7QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7jJ&md5=3e97727ac2866bef69244a1a627ec319</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.3109%2F15476910903286733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F15476910903286733%26sid%3Dliteratum%253Aachs%26aulast%3DHamm%26aufirst%3DS.%26aulast%3DRath%26aufirst%3DS.%26aulast%3DMichel%26aufirst%3DS.%26aulast%3DBaumgartner%26aufirst%3DR.%26atitle%3DCancer%2520immunotherapeutic%2520potential%2520of%2520novel%2520small%2520molecule%2520TLR7%2520and%2520TLR8%2520agonists%26jtitle%3DJ.%2520Immunotoxicol.%26date%3D2009%26volume%3D6%26spage%3D257%26epage%3D265%26doi%3D10.3109%2F15476910903286733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smits, E. L. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponsaerts, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berneman, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tendeloo, V. F. I.</span></span> <span> </span><span class="NLM_article-title">The Use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">875</span>, <span class="refDoi"> DOI: 10.1634/theoncologist.2008-0097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1634%2Ftheoncologist.2008-0097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=18701762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2qs7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=859-875&author=E.+L.+J.+M.+Smitsauthor=P.+Ponsaertsauthor=Z.+N.+Bernemanauthor=V.+F.+I.+Van+Tendeloo&title=The+Use+of+TLR7+and+TLR8+ligands+for+the+enhancement+of+cancer+immunotherapy&doi=10.1634%2Ftheoncologist.2008-0097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy</span></div><div class="casAuthors">Smits, Evelien L. J. M.; Ponsaerts, Peter; Berneman, Zwi N.; van Tendeloo, Viggo F. I.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">859-875</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review.  The importance of Toll-like receptors (TLRs) in stimulating innate and adaptive immunity is now well established.  In view of this, TLR ligands have become interesting targets to use as stand-alone immunotherapeutics or vaccine adjuvants for cancer treatment.  TLR7 and TLR8 were found to be closely related, sharing their intracellular endosomal location, as well as their ligands.  In this review, we describe the agonists of TLR7 and TLR8 that are known so far, as well as their contribution to antitumor responses by affecting immune cells, tumor cells, and the tumor microenvironment.  The major benefit of TLR7/8 agonists as immune response enhancers is their simultaneous stimulation of several cell types, resulting in a mix of activated immune cells, cytokines and chemokines at the tumor site.  We discuss the studies that used TLR7/8 agonists as stand-alone immunotherapeutics or cancer vaccine adjuvants, as well as the potential of TLR7/8 ligands to enhance antitumor responses in passive immunotherapy approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9kjvmUDLKcLVg90H21EOLACvtfcHk0lgPIp9wxir7QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2qs7vL&md5=7deddd96b00b6c7dfe657f942e72184e</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2008-0097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2008-0097%26sid%3Dliteratum%253Aachs%26aulast%3DSmits%26aufirst%3DE.%2BL.%2BJ.%2BM.%26aulast%3DPonsaerts%26aufirst%3DP.%26aulast%3DBerneman%26aufirst%3DZ.%2BN.%26aulast%3DVan%2BTendeloo%26aufirst%3DV.%2BF.%2BI.%26atitle%3DThe%2520Use%2520of%2520TLR7%2520and%2520TLR8%2520ligands%2520for%2520the%2520enhancement%2520of%2520cancer%2520immunotherapy%26jtitle%3DOncologist%26date%3D2008%26volume%3D13%26spage%3D859%26epage%3D875%26doi%3D10.1634%2Ftheoncologist.2008-0097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamper, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolodziej, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scates, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortez, E.</span></span> <span> </span><span class="NLM_article-title">Solid phase synthesis of β-Peptoids: N-Substituted β-aminopropionic acid oligomers</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1021/jo971675w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971675w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK1cXksFCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=708-718&author=B.+C.+Hamperauthor=S.+A.+Kolodziejauthor=A.+M.+Scatesauthor=R.+G.+Smithauthor=E.+Cortez&title=Solid+phase+synthesis+of+%CE%B2-Peptoids%3A+N-Substituted+%CE%B2-aminopropionic+acid+oligomers&doi=10.1021%2Fjo971675w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Solid Phase Synthesis of β-Peptoids: N-Substituted β-Aminopropionic Acid Oligomers</span></div><div class="casAuthors">Hamper, Bruce C.; Kolodziej, Stephen A.; Scates, Angela M.; Smith, Ronald G.; Cortez, Enriqueta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">708-718</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A solid-phase org. synthesis method has been developed for the prepn. of N-substituted-β-aminopropionic acid oligomers or β-peptoids I.  Treatment of polymer-bound 4-(benzyloxy)benzyl acrylate with primary amines afforded N-substituted β-alanines.  Polymer loadings and product conversions were detd. by direct cleavage of resin-bound materials and measurement by 1H NMR with an internal std.  The NMR method was used to establish loading of all resin-bound intermediates including acrylic acid.  Acylation with acryloyl chloride followed by Michael addn. of primary amines to the acrylamide allowed prepn. of di-β-peptoids.  By a linear set of seven reactions, trimeric N-benzyl-β-aminopropionic acid was prepd. in 67% overall yield.  Single-bead FT-IR microspectroscopy was used to acquire spectra of the resin bound mono-β-peptoids, di-β-peptoids, and acrylamide intermediates.  A combinatorial library of defined mixts. of tri-β-peptoids was prepd. by mixing equimolar amts. of the mono-β-peptoid resins and carrying them through two sequences of the acylation-Michael addn.  The identity of a sample mixt. II (R = Me, CH2Ph, CH2CH2Ph, CH2C6H4OMe-4, allyl, CH2CHMe2, CHMeEt, CHMe2) was detd. by LC-MS anal. of the cleavage product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopnt4vnxPi4rVg90H21EOLACvtfcHk0ljam5-IaZn4xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksFCltg%253D%253D&md5=3cf025948e0425ce6f72bcb817f051b4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo971675w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971675w%26sid%3Dliteratum%253Aachs%26aulast%3DHamper%26aufirst%3DB.%2BC.%26aulast%3DKolodziej%26aufirst%3DS.%2BA.%26aulast%3DScates%26aufirst%3DA.%2BM.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DCortez%26aufirst%3DE.%26atitle%3DSolid%2520phase%2520synthesis%2520of%2520%25CE%25B2-Peptoids%253A%2520N-Substituted%2520%25CE%25B2-aminopropionic%2520acid%2520oligomers%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D708%26epage%3D718%26doi%3D10.1021%2Fjo971675w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel-Andreasen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, C. A.</span></span> <span> </span><span class="NLM_article-title">β-Peptoid foldamers at last</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2696</span>– <span class="NLM_lpage">2704</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.5b00257</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.5b00257" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyqsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=2696-2704&author=J.+S.+Laursenauthor=J.+Engel-Andreasenauthor=C.+A.+Olsen&title=%CE%B2-Peptoid+foldamers+at+last&doi=10.1021%2Facs.accounts.5b00257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">β-Peptoid foldamers at last</span></div><div class="casAuthors">Laursen, Jonas S.; Engel-Andreasen, Jens; Olsen, Christian A.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2696-2704</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  For a long time, peptides were considered unsuitable for drug development due to their inherently poor pharmacokinetic properties and proteolytic susceptibility.  However, this paradigm has changed significantly in the past decade with the approval of numerous antibodies and proteins as drugs.  In parallel, research in the field of synthetic mols. that are able to mimic or complement folding patterns exhibited by biopolymers, but are not recognized by proteases, have received considerable attention as well.  Such entities were coined "foldamers" by S. H. Gellman (1998).  Oligomers of N-alkylated 3-aminopropionic acid residues have been called β-peptoids due to their structural similarity to β-peptides and peptoids (N-alkylglycines), resp.  Because bona fide foldamer behavior has been demonstrated for both parent architectures, the authors wondered if the β-peptoids could serve as a successful addn. to the known ensemble of peptidomimetic foldamers.  When the authors entered this field, only the seminal description of libraries of β-peptoid dimers and trimers by B. C. Hamper et al. (1998) had been published a no. of years earlier.  Perhaps somewhat naively in retrospect, the authors envisioned that elongation of chain length combined with introduction of bulky α-chiral side-chains would deliver folded structures as reported for the α-peptoid counterparts.  Initially, the authors, and others, were unsuccessful in obtaining stable secondary structures of β-peptoid oligomers, and instead, these residues were either incorporated in cyclic structures or in combination with other types of residues to give peptidomimetic constructs with heterogeneous backbones.  Amphiphilic architectures with various membrane-targeting activities, such as mimics of antimicrobial peptides or cell-penetrating peptides, have thus been particularly successful.  The introduction of β-peptoid residues in histone deacetylase inhibitors mimicking non-ribosomal cyclotetrapeptides have also been reported.  Here, the authors sketch the scientific journey that ultimately delivered robustly folded β-peptoid oligomers.  Contributions involving biol. evaluation of peptidomimetic constructs contg. β-peptoid residues, as mentioned above, which were investigated leading up to these recently reported high-resoln. helical structures, are discussed.  On the basis of the work described here, the authors envision that β-peptoids will find future utility as peptidomimetics for biomedical investigation contg. both heterogeneous and homogeneous backbones.  The recent demonstration of control over the secondary structure of a homogeneous β-peptoid backbone now enables structure-based design of scaffolds with predictable display of desired functionalities in 3 dimensions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT21EhTRrT-rVg90H21EOLACvtfcHk0ljam5-IaZn4xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyqsr%252FO&md5=61ec8510e6cf821887c1af9695ad22b8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.5b00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.5b00257%26sid%3Dliteratum%253Aachs%26aulast%3DLaursen%26aufirst%3DJ.%2BS.%26aulast%3DEngel-Andreasen%26aufirst%3DJ.%26aulast%3DOlsen%26aufirst%3DC.%2BA.%26atitle%3D%25CE%25B2-Peptoid%2520foldamers%2520at%2520last%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26spage%3D2696%26epage%3D2704%26doi%3D10.1021%2Facs.accounts.5b00257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckermann, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huebner, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlowe, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spellmeyer, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santi, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, P. A.</span></span> <span> </span><span class="NLM_article-title">Peptoids: a modular approach to drug discovery</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">9367</span>– <span class="NLM_lpage">9371</span>, <span class="refDoi"> DOI: 10.1073/pnas.89.20.9367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1073%2Fpnas.89.20.9367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1409642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK3sXhtFKhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=9367-9371&author=R.+J.+Simonauthor=R.+S.+Kaniaauthor=R.+N.+Zuckermannauthor=V.+D.+Huebnerauthor=D.+A.+Jewellauthor=S.+Banvilleauthor=S.+Ngauthor=L.+Wangauthor=S.+Rosenbergauthor=C.+K.+Marloweauthor=D.+C.+Spellmeyerauthor=R.+Tanauthor=A.+D.+Frankelauthor=D.+V.+Santiauthor=F.+E.+Cohenauthor=P.+A.+Bartlett&title=Peptoids%3A+a+modular+approach+to+drug+discovery&doi=10.1073%2Fpnas.89.20.9367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Peptoids:  a modular approach to drug discovery</span></div><div class="casAuthors">Simon, Reyna J.; Kania, Robert S.; Zuckermann, Ronald N.; Huebner, Verena D.; Jewell, David A.; Banville, Steven; Ng, Simon; Wang, Liang; Rosenberg, Steven; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9367-71</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Peptoids, oligomers of N-substituted glycines, are described as a motif for the generation of chem. diverse libraries of novel mols.  Ramachandran-type plots were calcd. and indicate a greater diversity of conformational states available for peptoids than for peptides.  The monomers incorporate t-butyl-based side-chain and 9-fluorenylmethoxy-carbonyl α-amine protection.  The controlled oligomerization of the peptoid monomers was performed manually and robotically with in situ activation by either benzotriazol-1-yloxytris(pyrrolidino)phosphonium hexafluorophosphate or bromotris(pyrrolidino)phosphonium hexafluorophosphate.  Other steps were identical to peptide synthesis using α-(9-fluorenylmethoxycarbonyl)amino acids.  A total of 15 monomers and 10 oligomers (peptoids) are described.  Preliminary data are presented on the stability of a representative oligopeptoid to enzymic hydrolysis.  Peptoid versions of peptide ligands of three biol. systems (bovine pancreatic α-amylase, hepatitis A virus 3C proteinase, and human immunodeficiency virus transactivator-responsive element RNA) were found with affinities comparable to those of the corresponding peptides.  The potential use of libraries of these compds. in receptor- or enzyme-based assays is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqjYjAnzlZWbVg90H21EOLACvtfcHk0ljam5-IaZn4xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtFKhsro%253D&md5=072eed656364cd7cf06c71aa9fb001c3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.20.9367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.20.9367%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DR.%2BJ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DZuckermann%26aufirst%3DR.%2BN.%26aulast%3DHuebner%26aufirst%3DV.%2BD.%26aulast%3DJewell%26aufirst%3DD.%2BA.%26aulast%3DBanville%26aufirst%3DS.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRosenberg%26aufirst%3DS.%26aulast%3DMarlowe%26aufirst%3DC.%2BK.%26aulast%3DSpellmeyer%26aufirst%3DD.%2BC.%26aulast%3DTan%26aufirst%3DR.%26aulast%3DFrankel%26aufirst%3DA.%2BD.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DCohen%26aufirst%3DF.%2BE.%26aulast%3DBartlett%26aufirst%3DP.%2BA.%26atitle%3DPeptoids%253A%2520a%2520modular%2520approach%2520to%2520drug%2520discovery%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26spage%3D9367%26epage%3D9371%26doi%3D10.1073%2Fpnas.89.20.9367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dohm, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barron, A. E.</span></span> <span> </span><span class="NLM_article-title">Peptoids: bio-inspired polymers as potential pharmaceuticals</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2732</span>– <span class="NLM_lpage">2747</span>, <span class="refDoi"> DOI: 10.2174/138161211797416066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.2174%2F138161211797416066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=21728985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2732-2747&author=M.+T.+Dohmauthor=R.+Kapoorauthor=A.+E.+Barron&title=Peptoids%3A+bio-inspired+polymers+as+potential+pharmaceuticals&doi=10.2174%2F138161211797416066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Peptoids: bio-inspired polymers as potential pharmaceuticals</span></div><div class="casAuthors">Dohm, Michelle T.; Kapoor, Rinki; Barron, Annelise E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2732-2747</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Peptoids are a developing class of peptide-like oligomers originally invented for drug discovery in the early 1990s.  While peptides hold great promise for therapeutic applications, current development of peptide-based pharmaceuticals is hindered by their potential for misfolding and aggregation, and particularly, for rapid in vivo degrdn. post-administration.  Researchers have investigated alternative peptide-like constructs that may be able to circumvent such complications.  Peptoids comprise a peptide-based backbone and N-substituted glycines for side-chain residues, resulting in complete protease-resistance.  The synthesis of peptoid sequences of ≥50 units in length allows for controlled sequence compn. and incorporation of diverse side-chain chemistries.  Although the landscape of peptoid structure is not clearly defined, secondary, tertiary, loop, turn, and random structures have been identified.  As protease-resistant isomers of peptides, peptoids are being developed as versatile mol. tools in biochem. and biophysics, and are becoming attractive candidates for therapeutic and diagnostic applications.  Peptoids have thus far demonstrated bioactivity as protein mimics and as replacements for small mol. drugs.  Here, the authors discuss the most recent advances in peptoid research on the therapeutic front in the last few years, including in vitro and in vivo studies in the fields of lung surfactant therapy, antimicrobial agents, diagnostics, and cancer.  The authors particularly focus on the biophys. activity of lipid-assocd. peptoids and their potential therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiBxZGVggsOrVg90H21EOLACvtfcHk0ljUfSVY-mXk7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7vP&md5=82bd66d1f8aca7f39df8c7a2b312f967</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F138161211797416066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211797416066%26sid%3Dliteratum%253Aachs%26aulast%3DDohm%26aufirst%3DM.%2BT.%26aulast%3DKapoor%26aufirst%3DR.%26aulast%3DBarron%26aufirst%3DA.%2BE.%26atitle%3DPeptoids%253A%2520bio-inspired%2520polymers%2520as%2520potential%2520pharmaceuticals%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D2732%26epage%3D2747%26doi%3D10.2174%2F138161211797416066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckermann, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moos, W. H.</span></span> <span> </span><span class="NLM_article-title">Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2657</span>– <span class="NLM_lpage">2662</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)80691-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2FS0960-894X%2801%2980691-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK2MXisVWgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=2657-2662&author=S.+M.+Millerauthor=R.+J.+Simonauthor=S.+Ngauthor=R.+N.+Zuckermannauthor=J.+M.+Kerrauthor=W.+H.+Moos&title=Proteolytic+studies+of+homologous+peptide+and+N-substituted+glycine+peptoid+oligomers&doi=10.1016%2FS0960-894X%2801%2980691-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers</span></div><div class="casAuthors">Miller, Susan M.; Simon, Reyna J.; Ng, Simon; Zuckermann, Ronald N.; Kerr, Janice M.; Moos, Walter H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2657-62</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Homologous L-amino acid, D-amino acid, and parallel and anti-parallel (retro) sequence N-substituted glycine peptide and peptoid oligomers were prepd. and incubated with proteases from each major class.  The L-amino acid contg. peptides were readily cleaved by the appropriate enzymes, while equiv. D-amino acid contg. and N-substituted glycine contg. oligomers were essentially untouched.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYEcOwl9xkKLVg90H21EOLACvtfcHk0ljUfSVY-mXk7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXisVWgsrY%253D&md5=e4d7f92ec34aef019f8e21999667b867</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2980691-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252980691-0%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%2BM.%26aulast%3DSimon%26aufirst%3DR.%2BJ.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DZuckermann%26aufirst%3DR.%2BN.%26aulast%3DKerr%26aufirst%3DJ.%2BM.%26aulast%3DMoos%26aufirst%3DW.%2BH.%26atitle%3DProteolytic%2520studies%2520of%2520homologous%2520peptide%2520and%2520N-substituted%2520glycine%2520peptoid%2520oligomers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D2657%26epage%3D2662%26doi%3D10.1016%2FS0960-894X%2801%2980691-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckermann, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moos, W. H.</span></span> <span> </span><span class="NLM_article-title">Comparison of the proteolytic susceptibilities of homologous L-amino-Acid, D-amino-Acid, and N-substituted glycine peptide and peptoid oligomers</span>. <i>Drug Dev. Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1002/ddr.430350105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fddr.430350105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK2MXlvFyqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1995&pages=20-32&author=S.+M.+Millerauthor=R.+J.+Simonauthor=S.+Ngauthor=R.+N.+Zuckermannauthor=J.+M.+Kerrauthor=W.+H.+Moos&title=Comparison+of+the+proteolytic+susceptibilities+of+homologous+L-amino-Acid%2C+D-amino-Acid%2C+and+N-substituted+glycine+peptide+and+peptoid+oligomers&doi=10.1002%2Fddr.430350105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide and peptoid oligomers</span></div><div class="casAuthors">Miller, Susan M.; Simon, Reyna J.; Ng, Simon; Zuckermann, Ronald N.; Kerr, Janice M.; Moos, Walter H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-32</span>CODEN:
                <span class="NLM_cas:coden">DDREDK</span>;
        ISSN:<span class="NLM_cas:issn">0272-4391</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">A series of homologous L-amino acid, D-amino acid, and both parallel and antiparallel (retro) sequence N-substituted glycine peptide and peptoid oligomers were prepd. and incubated with a series of enzymes representative of the major classes of proteases.  Each resp. L-amino acid contg. peptide sequence was readily cleaved by the appropriate enzyme.  In contrast, equiv. D-amino acid contg. and N-substituted glycine contg. oligomers were cleaved minimally or not at all by the resp. enzymes.  The N-substituted glycine peptoids represent a new class of combinatorial diversity for lead discovery with improved pharmaceutical characteristics relative to L-amino acid contg. peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Jas0JrkWiLVg90H21EOLACvtfcHk0ljUfSVY-mXk7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlvFyqt7s%253D&md5=222dfee4425a13e008ccf17343485329</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fddr.430350105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.430350105%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%2BM.%26aulast%3DSimon%26aufirst%3DR.%2BJ.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DZuckermann%26aufirst%3DR.%2BN.%26aulast%3DKerr%26aufirst%3DJ.%2BM.%26aulast%3DMoos%26aufirst%3DW.%2BH.%26atitle%3DComparison%2520of%2520the%2520proteolytic%2520susceptibilities%2520of%2520homologous%2520L-amino-Acid%252C%2520D-amino-Acid%252C%2520and%2520N-substituted%2520glycine%2520peptide%2520and%2520peptoid%2520oligomers%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1995%26volume%3D35%26spage%3D20%26epage%3D32%26doi%3D10.1002%2Fddr.430350105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodadek, T.</span></span> <span> </span><span class="NLM_article-title">Quantitative evaluation of the relative cell permeability of peptoids and peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1508</span>– <span class="NLM_lpage">1509</span>, <span class="refDoi"> DOI: 10.1021/ja0668623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0668623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsVyntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1508-1509&author=Y.+U.+Kwonauthor=T.+Kodadek&title=Quantitative+evaluation+of+the+relative+cell+permeability+of+peptoids+and+peptides&doi=10.1021%2Fja0668623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative evaluation of the relative cell permeability of peptoids and peptides</span></div><div class="casAuthors">Kwon, Yong-Uk; Kodadek, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1508-1509</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We evaluated quant. the relative cell permeability of peptoids and peptides using a cell-based reporter gene-based assay.  Generally, peptoids were much more cell permeable than the corresponding peptides, though the difference decreased with increasing length.  These results suggest that peptoids may be useful reagents for manipulating the activities of intracellular proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXlBNGq3RO2rVg90H21EOLACvtfcHk0ljUfSVY-mXk7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsVyntA%253D%253D&md5=1eda9f9a2e73a1d43dda65b33447fdeb</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja0668623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0668623%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DY.%2BU.%26aulast%3DKodadek%26aufirst%3DT.%26atitle%3DQuantitative%2520evaluation%2520of%2520the%2520relative%2520cell%2520permeability%2520of%2520peptoids%2520and%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D1508%26epage%3D1509%26doi%3D10.1021%2Fja0668623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodadek, T.</span></span> <span> </span><span class="NLM_article-title">High-throughput evaluation of relative cell permeability between peptoids and peptides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5853</span>– <span class="NLM_lpage">5861</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.04.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.bmc.2008.04.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=18490170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFegtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=5853-5861&author=N.+C.+Tanauthor=P.+Yuauthor=Y.+U.+Kwonauthor=T.+Kodadek&title=High-throughput+evaluation+of+relative+cell+permeability+between+peptoids+and+peptides&doi=10.1016%2Fj.bmc.2008.04.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput evaluation of relative cell permeability between peptoids and peptides</span></div><div class="casAuthors">Tan, Niclas C.; Yu, Peng; Kwon, Yong-Uk; Kodadek, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5853-5861</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Peptides are limited in their use as drugs due to low cell permeability and vulnerability to proteases.  In contrast, peptoids are immune to enzymic degrdn. and some peptoids have been shown to be relatively cell permeable.  In order to facilitate future design of peptoid libraries for screening expts., it would be useful to have a high-throughput method to est. the cell permeability of peptoids contg. different residues.  In this paper, the authors report the strengths and limitations of a high-throughput cell-based permeability assay that registers the relative ability of steroid-conjugated peptides and peptoids to enter a cell.  A comparative investigation of the physicochem. properties and side chain compn. of peptoids and peptides is described to explain the obsd. higher cell permeability of peptoids over peptides.  These data suggest that the conversion of the monomeric residues in peptides to an N-alkylglycine moiety in peptoids reduced the hydrogen-bonding potential of the mols. and is the main contributor to the obsd. permeability improvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2wizMpfmhVrVg90H21EOLACvtfcHk0ljTemGjFMf2SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFegtr8%253D&md5=be7c6b4b6fb01319af99315758045387</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.04.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.04.074%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DN.%2BC.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DKwon%26aufirst%3DY.%2BU.%26aulast%3DKodadek%26aufirst%3DT.%26atitle%3DHigh-throughput%2520evaluation%2520of%2520relative%2520cell%2520permeability%2520between%2520peptoids%2520and%2520peptides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D5853%26epage%3D5861%26doi%3D10.1016%2Fj.bmc.2008.04.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwochert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkeley, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponkey, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khunte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span> <span> </span><span class="NLM_article-title">Peptide to peptoid substitutions increase cell permeability in cyclic hexapeptides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2928</span>– <span class="NLM_lpage">2931</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.5b01162</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.5b01162" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps1arsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=2928-2931&author=J.+Schwochertauthor=R.+Turnerauthor=M.+Thangauthor=R.+F.+Berkeleyauthor=A.+R.+Ponkeyauthor=K.+M.+Rodriguezauthor=S.+S.+F.+Leungauthor=B.+Khunteauthor=G.+Goetzauthor=C.+Limberakisauthor=A.+S.+Kalgutkarauthor=H.+Engauthor=M.+J.+Shapiroauthor=A.+M.+Mathiowetzauthor=D.+A.+Priceauthor=S.+Lirasauthor=M.+P.+Jacobsonauthor=R.+S.+Lokey&title=Peptide+to+peptoid+substitutions+increase+cell+permeability+in+cyclic+hexapeptides&doi=10.1021%2Facs.orglett.5b01162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide to Peptoid Substitutions Increase Cell Permeability in Cyclic Hexapeptides</span></div><div class="casAuthors">Schwochert, Joshua; Turner, Rushia; Thang, Melissa; Berkeley, Ray F.; Ponkey, Alexandra R.; Rodriguez, Kelsie M.; Leung, Siegfried S. F.; Khunte, Bhagyashree; Goetz, Gilles; Limberakis, Chris; Kalgutkar, Amit S.; Eng, Heather; Shapiro, Michael J.; Mathiowetz, Alan M.; Price, David A.; Liras, Spiros; Jacobson, Matthew P.; Lokey, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2928-2931</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The effect of peptide-to-peptoid substitutions on the passive membrane permeability of an N-methylated cyclic hexapeptide is examd.  In general, substitutions maintained permeability but increased conformational heterogeneity.  Diversification with nonproteinogenic side chains increased permeability up to 3-fold.  Addnl., the conformational impact of peptoid substitutions within a β-turn are explored.  Based on these results, the strategic incorporation of peptoid residues into cyclic peptides can maintain or improve cell permeability, while increasing access to diverse side-chain functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofUG1_hYdVn7Vg90H21EOLACvtfcHk0ljTemGjFMf2SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps1arsrs%253D&md5=156985175ddcafd34a67e81713934040</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.5b01162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.5b01162%26sid%3Dliteratum%253Aachs%26aulast%3DSchwochert%26aufirst%3DJ.%26aulast%3DTurner%26aufirst%3DR.%26aulast%3DThang%26aufirst%3DM.%26aulast%3DBerkeley%26aufirst%3DR.%2BF.%26aulast%3DPonkey%26aufirst%3DA.%2BR.%26aulast%3DRodriguez%26aufirst%3DK.%2BM.%26aulast%3DLeung%26aufirst%3DS.%2BS.%2BF.%26aulast%3DKhunte%26aufirst%3DB.%26aulast%3DGoetz%26aufirst%3DG.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26atitle%3DPeptide%2520to%2520peptoid%2520substitutions%2520increase%2520cell%2520permeability%2520in%2520cyclic%2520hexapeptides%26jtitle%3DOrg.%2520Lett.%26date%3D2015%26volume%3D17%26spage%3D2928%26epage%3D2931%26doi%3D10.1021%2Facs.orglett.5b01162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterfoss, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renfrew, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhlman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirshenbaum, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, R.</span></span> <span> </span><span class="NLM_article-title">A Preliminary survey of the peptoid folding landscape</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">16798</span>– <span class="NLM_lpage">16807</span>, <span class="refDoi"> DOI: 10.1021/ja905267k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja905267k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtleisL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=16798-16807&author=G.+L.+Butterfossauthor=P.+D.+Renfrewauthor=B.+Kuhlmanauthor=K.+Kirshenbaumauthor=R.+Bonneau&title=A+Preliminary+survey+of+the+peptoid+folding+landscape&doi=10.1021%2Fja905267k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A preliminary survey of the peptoid folding landscape</span></div><div class="casAuthors">Butterfoss, Glenn L.; Renfrew, P. Douglas; Kuhlman, Brian; Kirshenbaum, Kent; Bonneau, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16798-16807</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an anal. of the conformational preferences of N-substituted glycine peptoid oligomers.  We survey the backbone conformations obsd. in exptl. detd. peptoid structures and provide a comparison with high-level quantum mechanics calcns. of short peptoid oligomers.  The dominant sources of structural variation derive from: side-chain dependent cis/trans isomerization of backbone amide bonds, side chain stereochem., and flexibility in the psi dihedral angle.  We find good agreement between the clustering of exptl. detd. peptoid torsion angles and local torsional min. predicted by theory for a disarcosine model.  The calcns. describe a well-defined conformational map featuring distinct energy min.  The general features of the peptoid backbone conformational landscape are consistent across a range of N-alkyl glycine side chains.  Alteration of side chain types, however, creates subtle but potentially significant variations in local folding propensities.  We identify a limited no. of low energy local conformations, which may be preferentially favored by incorporation of particular monomer units.  Greater variation in backbone dihedral angles are accessible in peptoids featuring trans amide bond geometries.  These results confirm that computational approaches can play a valuable role in guiding the design of complex peptoid architectures and may lead to strategies for introducing constraints that select among a limited no. of low energy local conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaQxvmt0lvKbVg90H21EOLACvtfcHk0ljTemGjFMf2SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtleisL3P&md5=f9cf6f5b10ff0b5607bd1d00d94a6a50</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja905267k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja905267k%26sid%3Dliteratum%253Aachs%26aulast%3DButterfoss%26aufirst%3DG.%2BL.%26aulast%3DRenfrew%26aufirst%3DP.%2BD.%26aulast%3DKuhlman%26aufirst%3DB.%26aulast%3DKirshenbaum%26aufirst%3DK.%26aulast%3DBonneau%26aufirst%3DR.%26atitle%3DA%2520Preliminary%2520survey%2520of%2520the%2520peptoid%2520folding%2520landscape%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D16798%26epage%3D16807%26doi%3D10.1021%2Fja905267k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sui, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabenstein, D. L.</span></span> <span> </span><span class="NLM_article-title">Kinetics and equilibria of cis/trans isomerization of backbone amide bonds in peptoids</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">12042</span>– <span class="NLM_lpage">12048</span>, <span class="refDoi"> DOI: 10.1021/ja0740925</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0740925" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvFOhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=12042-12048&author=Q.+Suiauthor=D.+Borchardtauthor=D.+L.+Rabenstein&title=Kinetics+and+equilibria+of+cis%2Ftrans+isomerization+of+backbone+amide+bonds+in+peptoids&doi=10.1021%2Fja0740925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics and Equilibria of Cis/Trans Isomerization of Backbone Amide Bonds in Peptoids</span></div><div class="casAuthors">Sui, Qiang; Borchardt, Dan; Rabenstein, Dallas L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">12042-12048</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The biol. activities of N-substituted glycine oligomers (peptoids) have been the subject of extensive research.  As compared to peptides, both the cis and trans conformations of the backbone amide bonds of peptoids can be significantly populated.  Thus, peptoids are mixts. of configurational isomers, with the no. of isomers increasing by a factor of 2 with each addnl. monomer residue.  Here, the authors report the results of a study of the kinetics and equil. of cis/trans isomerization of the amide bonds of N-acetylated peptoid monomers, dipeptoids, and tripeptoids by NMR spectroscopy.  Resonance intensities indicate the cis conformation of the backbone amide bonds of the peptoids studied is more populated than is generally the case for the analogous secondary amide bond to proline residues in acyclic peptides.  Rate consts. were measured by inversion-magnetization transfer techniques over a range of temps., and activation parameters were derived from the temp. dependence of the rate consts.  The rate of cis/trans isomerization by rotation around the amide bonds in the peptoids studied is generally slower than that around amide bonds to proline residues and takes place on the NMR inversion-magnetization transfer time scale only by rotation around the amide bond to the C-terminal peptoid residue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYolNa9NHLi7Vg90H21EOLACvtfcHk0lh2rsncw12gzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvFOhs70%253D&md5=f9c41f1342aa801b453a37fbf215acab</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fja0740925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0740925%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DQ.%26aulast%3DBorchardt%26aufirst%3DD.%26aulast%3DRabenstein%26aufirst%3DD.%2BL.%26atitle%3DKinetics%2520and%2520equilibria%2520of%2520cis%252Ftrans%2520isomerization%2520of%2520backbone%2520amide%2520bonds%2520in%2520peptoids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D12042%26epage%3D12048%26doi%3D10.1021%2Fja0740925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel-Andreasen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fristrup, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, C. A.</span></span> <span> </span><span class="NLM_article-title">Cis–trans amide bond rotamers in β-peptoids and peptoids: evaluation of stereoelectronic effects in backbone and side chains</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">2835</span>– <span class="NLM_lpage">2844</span>, <span class="refDoi"> DOI: 10.1021/ja312532x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja312532x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtleltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=2835-2844&author=J.+S.+Laursenauthor=J.+Engel-Andreasenauthor=P.+Fristrupauthor=P.+Harrisauthor=C.+A.+Olsen&title=Cis%E2%80%93trans+amide+bond+rotamers+in+%CE%B2-peptoids+and+peptoids%3A+evaluation+of+stereoelectronic+effects+in+backbone+and+side+chains&doi=10.1021%2Fja312532x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cis-Trans Amide Bond Rotamers in β-Peptoids and Peptoids: Evaluation of Stereoelectronic Effects in Backbone and Side Chains</span></div><div class="casAuthors">Laursen, Jonas S.; Engel-Andreasen, Jens; Fristrup, Peter; Harris, Pernille; Olsen, Christian A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2835-2844</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonnatural peptide analogs have significant potential for the development of new materials and pharmacol. active ligands.  One such architecture, the β-peptoids (N-alkyl-β-alanines), found use in a variety of biol. active compds. but was sparsely studied with respect to folding propensity.  Thus, the authors here report a study of the effect of structural variations on the cis-trans amide bond rotamer equil. in a selection of monomer model systems.  In addn. to various side chain effects, which correlated well with previous studies of α-peptoids, the authors present the synthesis and study of cis-trans isomerism in the first examples of peptoids and β-peptoids contg. thioamide bonds as well as trifluoroacetylated peptoids and β-peptoids.  These systems revealed an increase in the preference for cis-amides as compared to their parent compds. and thus provide novel strategies for affecting the folding of peptoid constructs.  By using NMR spectroscopy, x-ray crystallog. anal., and d. functional theory calcns., the authors present evidence for the presence of thioamide-arom. interactions through Csp2 -H···Samide hydrogen bonding, which stabilize certain peptoid conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdqXidNft09rVg90H21EOLACvtfcHk0lh2rsncw12gzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtleltL0%253D&md5=5af65208996e55a516a95461a1c728db</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fja312532x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja312532x%26sid%3Dliteratum%253Aachs%26aulast%3DLaursen%26aufirst%3DJ.%2BS.%26aulast%3DEngel-Andreasen%26aufirst%3DJ.%26aulast%3DFristrup%26aufirst%3DP.%26aulast%3DHarris%26aufirst%3DP.%26aulast%3DOlsen%26aufirst%3DC.%2BA.%26atitle%3DCis%25E2%2580%2593trans%2520amide%2520bond%2520rotamers%2520in%2520%25CE%25B2-peptoids%2520and%2520peptoids%253A%2520evaluation%2520of%2520stereoelectronic%2520effects%2520in%2520backbone%2520and%2520side%2520chains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D2835%26epage%3D2844%26doi%3D10.1021%2Fja312532x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorske, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastian, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwell, H. E.</span></span> <span> </span><span class="NLM_article-title">New strategies for the design of folded peptoids revealed by a survey of noncovalent interactions in model systems</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">16555</span>– <span class="NLM_lpage">16567</span>, <span class="refDoi"> DOI: 10.1021/ja907184g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja907184g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWmu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=16555-16567&author=B.+C.+Gorskeauthor=J.+R.+Stringerauthor=B.+L.+Bastianauthor=S.+A.+Fowlerauthor=H.+E.+Blackwell&title=New+strategies+for+the+design+of+folded+peptoids+revealed+by+a+survey+of+noncovalent+interactions+in+model+systems&doi=10.1021%2Fja907184g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">New strategies for the design of folded peptoids revealed by a survey of noncovalent interactions in model systems</span></div><div class="casAuthors">Gorske, Benjamin C.; Stringer, Joseph R.; Bastian, Brent L.; Fowler, Sarah A.; Blackwell, Helen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">16555-16567</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Controlling the equil. between backbone cis- and trans-amides in peptoids, or N-substituted glycine oligomers, constitutes a significant challenge in the construction of discretely folded peptoid structures.  Through the anal. of a set of monomeric peptoid model systems, we have developed new and general strategies for controlling peptoid conformation that utilize local noncovalent interactions to regulate backbone amide rotameric equil., including n→π*, steric, and hydrogen bonding interactions.  The chem. functionalities required to implement these strategies are typically confined to the peptoid side chains, preserve chirality at the side chain N-α-carbon known to engender peptoid structure, and are fully compatible with std. peptoid synthesis techniques.  Our examns. of peptoid model systems have also elucidated how solvents affect various side chain-backbone interactions, revealing fundamental aspects of these noncovalent interactions in peptoids that were largely uncharacterized previously.  As validation of our monomeric model systems, we extended the scope of this study to include peptoid oligomers and have now demonstrated the importance of local steric and n→π* interactions in dictating the structures of larger, folded peptoids.  This new, modular design strategy has guided the construction of peptoids contg. 1-naphthylethyl side chains, which we show can be utilized to effectively eliminate trans-amide rotamers from the peptoid backbone, yielding the most conformationally homogeneous class of peptoid structures yet reported in terms of amide rotamerism.  Overall, this research has afforded a valuable and expansive set of design tools for the construction of both discretely folded peptoids and structurally biased peptoid libraries and should shape our understanding of peptoid folding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSttiMduihm7Vg90H21EOLACvtfcHk0lh2rsncw12gzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWmu7rF&md5=42055d12a773d30bd21a344906c4e6ce</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja907184g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja907184g%26sid%3Dliteratum%253Aachs%26aulast%3DGorske%26aufirst%3DB.%2BC.%26aulast%3DStringer%26aufirst%3DJ.%2BR.%26aulast%3DBastian%26aufirst%3DB.%2BL.%26aulast%3DFowler%26aufirst%3DS.%2BA.%26aulast%3DBlackwell%26aufirst%3DH.%2BE.%26atitle%3DNew%2520strategies%2520for%2520the%2520design%2520of%2520folded%2520peptoids%2520revealed%2520by%2520a%2520survey%2520of%2520noncovalent%2520interactions%2520in%2520model%2520systems%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D16555%26epage%3D16567%26doi%3D10.1021%2Fja907184g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, J.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fristrup, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, C. A.</span></span> <span> </span><span class="NLM_article-title">Triangular prism-shaped β-peptoid helices as unique biomimetic scaffolds</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7013</span>, <span class="refDoi"> DOI: 10.1038/ncomms8013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2Fncomms8013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=25943784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFylt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7013&author=J.%0AS.+Laursenauthor=P.+Harrisauthor=P.+Fristrupauthor=C.+A.+Olsen&title=Triangular+prism-shaped+%CE%B2-peptoid+helices+as+unique+biomimetic+scaffolds&doi=10.1038%2Fncomms8013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Triangular prism-shaped β-peptoid helices as unique biomimetic scaffolds</span></div><div class="casAuthors">Laursen, Jonas S.; Harris, Pernille; Fristrup, Peter; Olsen, Christian A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7013</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Peptoids are peptidomimetics based on N-alkylated β-aminopropionic acid residues (or N-alkyl-β-alanines).  This type of peptide mimic has previously been incorporated in biol. active ligands and has been hypothesized to be able to exhibit foldamer properties.  Here we show, for the first time, that β-peptoids can be tuned to fold into stable helical structures.  We provide high-resoln. X-ray crystal structures of homomeric β-peptoid hexamers, which reveal right-handed helical conformations with exactly three residues per turn and a helical pitch of 9.6-9.8 Å between turns.  The presence of folded conformations in soln. is supported by CD spectroscopy showing length- and solvent dependency, and mol. dynamics simulations provide further support for a stabilized helical secondary structure in org. solvent.  We thus outline a framework for future design of novel biomimetics that display functional groups with high accuracy in three dimensions, which has potential for development of new functional materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEynUbb3geprVg90H21EOLACvtfcHk0lgnpdYSrziJzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFylt7jN&md5=2ae2ab87cd0f7faf8eab3774ed77ca42</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fncomms8013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8013%26sid%3Dliteratum%253Aachs%26aulast%3DLaursen%26aufirst%3DJ.%2BS.%26aulast%3DHarris%26aufirst%3DP.%26aulast%3DFristrup%26aufirst%3DP.%26aulast%3DOlsen%26aufirst%3DC.%2BA.%26atitle%3DTriangular%2520prism-shaped%2520%25CE%25B2-peptoid%2520helices%2520as%2520unique%2520biomimetic%2520scaffolds%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7013%26doi%3D10.1038%2Fncomms8013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crapster, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzei, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwell, H. E.</span></span> <span> </span><span class="NLM_article-title">Extraordinarily robust polyproline type I peptoid helices generated via the incorporation of alpha-chiral aromatic N-1-naphthylethyl side chains</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">15559</span>– <span class="NLM_lpage">15567</span>, <span class="refDoi"> DOI: 10.1021/ja204755p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja204755p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKrs7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=15559-15567&author=J.+R.+Stringerauthor=J.+A.+Crapsterauthor=I.+A.+Guzeiauthor=H.+E.+Blackwell&title=Extraordinarily+robust+polyproline+type+I+peptoid+helices+generated+via+the+incorporation+of+alpha-chiral+aromatic+N-1-naphthylethyl+side+chains&doi=10.1021%2Fja204755p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Extraordinarily robust polyproline type I peptoid helices generated via the incorporation of α-chiral aromatic N-1-naphthylethyl side chains</span></div><div class="casAuthors">Stringer, Joseph R.; Crapster, J. Aaron; Guzei, Ilia A.; Blackwell, Helen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">15559-15567</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptoids, or oligomers of N-substituted glycines, are a class of foldamers that have shown extraordinary functional potential since their inception nearly two decades ago.  However, the generation of well-defined peptoid secondary structures remains a difficult task.  This challenge is due, in part, to the lack of a thorough understanding of peptoid sequence-structure relationships and, consequently, an incomplete understanding of the peptoid folding process.  We seek to delineate sequence-structure relationships through the systematic study of noncovalent interactions in peptoids and the design of novel amide side chains capable of such interactions.  Herein, we report the synthesis and detailed structural anal. of a series of (S)-N-(1-naphthylethyl)glycine (Ns1npe) peptoid homo-oligomers by X-ray crystallog., NMR spectroscopy, and CD spectroscopy.  Four of these peptoids were found to adopt well-defined structures in the solid state, with dihedral angles similar to those obsd. in polyproline type I (PPI) peptide helixes and in peptoids with α-chiral side chains.  The X-ray crystal structure of a representative Ns1npe tetramer revealed an all cis-amide helix, with approx. three residues per turn, and a helical pitch of approx. 6.0 Å.  2D-NMR anal. of the length-dependent Ns1npe series showed that these peptoids have very high overall backbone amide Kcis/trans values in acetonitrile, indicative of conformationally homogeneous structures in soln.  Addnl., CD spectroscopy studies of the Ns1npe homo-oligomers in acetonitrile and methanol revealed a striking length-dependent increase in ellipticity per amide.  These Ns1npe helixes represent the most robust peptoid helixes to be reported, and the incorporation of (S)-N-(1-naphthylethyl)glycines provides a new approach for the generation of stable helical structure in this important class of foldamers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWOAhoe5DJ0bVg90H21EOLACvtfcHk0lgnpdYSrziJzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKrs7vO&md5=58c83f67e4dc7954a39bb09f8120dbfb</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fja204755p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja204755p%26sid%3Dliteratum%253Aachs%26aulast%3DStringer%26aufirst%3DJ.%2BR.%26aulast%3DCrapster%26aufirst%3DJ.%2BA.%26aulast%3DGuzei%26aufirst%3DI.%2BA.%26aulast%3DBlackwell%26aufirst%3DH.%2BE.%26atitle%3DExtraordinarily%2520robust%2520polyproline%2520type%2520I%2520peptoid%2520helices%2520generated%2520via%2520the%2520incorporation%2520of%2520alpha-chiral%2520aromatic%2520N-1-naphthylethyl%2520side%2520chains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D15559%26epage%3D15567%26doi%3D10.1021%2Fja204755p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thery, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didierjean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic β-peptoids</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1021/ol7030763</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol7030763" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=921-924&author=O.+Royauthor=S.+Faureauthor=V.+Theryauthor=C.+Didierjeanauthor=C.+Taillefumier&title=Cyclic+%CE%B2-peptoids&doi=10.1021%2Fol7030763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic β-Peptoids</span></div><div class="casAuthors">Roy, Olivier; Faure, Sophie; Thery, Vincent; Didierjean, Claude; Taillefumier, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">921-924</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first synthesis of functionalized β-peptoid macrocycles, cyclo{[-N(CH2C≡CH)CH2CH2CO-]n} (n = 2-6), is reported.  X-ray crystallog. structure of the tetramer, cyclo{[-N(CH2C≡CH)CH2CH2CO-]4}, reveals a C2-sym. deriv. with unexpected all-cis-amide bonds and spatial disposition of the appendages toward the two opposite faces of the ring.  Quantum calcns. suggest that the tetramer is locked in this layout.  These macrocycles constitute novel promising templates for multimeric ligation of biol. active ligands.  The tetramer was further modified by "click" reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj8e0zRxlA5rVg90H21EOLACvtfcHk0lgnpdYSrziJzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKlsr8%253D&md5=59313449a28e707ce4f3dd49a4da6ba9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fol7030763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol7030763%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DThery%26aufirst%3DV.%26aulast%3DDidierjean%26aufirst%3DC.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DCyclic%2520%25CE%25B2-peptoids%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D921%26epage%3D924%26doi%3D10.1021%2Fol7030763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caumes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">The click triazolium peptoid side chain: A strong cis-amide inducer enabling chemical diversity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">9553</span>– <span class="NLM_lpage">9556</span>, <span class="refDoi"> DOI: 10.1021/ja302342h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja302342h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1WqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9553-9556&author=C.+Caumesauthor=O.+Royauthor=S.+Faureauthor=C.+Taillefumier&title=The+click+triazolium+peptoid+side+chain%3A+A+strong+cis-amide+inducer+enabling+chemical+diversity&doi=10.1021%2Fja302342h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Click Triazolium Peptoid Side Chain: A Strong cis-Amide Inducer Enabling Chemical Diversity</span></div><div class="casAuthors">Caumes, Cecile; Roy, Olivier; Faure, Sophie; Taillefumier, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9553-9556</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Access to homogeneous and discrete folded peptoid structures primarily depends on control of the cis/trans isomerism of backbone tertiary amides.  This can be achieved by designing specific side chains capable of forming local interactions with the backbone.  This is often undertaken at the expense of side-chain diversity, which is a key advantage of peptoids over other families of peptidomimetics.  We report for the first time a pos. charged triazolium-type side chain that does not compromise diversity and exhibits the best ability reported to date for inducing the cis conformation.  The cis-directing effect was studied in N-acetamide dipeptoid model systems and evaluated in terms of Kcis/trans using NMR spectroscopy in aprotic and protic solvents.  Computational geometry optimization and natural bond orbital anal. in combination with NOESY expts. were consistent with a model in which n → π*Ar electronic delocalization [from carbonyl (Oi-1) to the antibonding orbital (π*) of the triazolium motif on residue i] may be operative.  In the computational model (gas-phase) and exptl. in CDCl3, H-bonding between the triazolium C-H proton and the Ci=Oi oxygen was also identified and may act cooperatively with the n → π*Ar delocalization, resulting in the absence of the trans rotamers in CDCl3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaTyAt7um9trVg90H21EOLACvtfcHk0lhOFj52z92ueQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1WqsLY%253D&md5=7bd11f79c77b4e289ac3ce954d93cda5</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fja302342h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja302342h%26sid%3Dliteratum%253Aachs%26aulast%3DCaumes%26aufirst%3DC.%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DThe%2520click%2520triazolium%2520peptoid%2520side%2520chain%253A%2520A%2520strong%2520cis-amide%2520inducer%2520enabling%2520chemical%2520diversity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9553%26epage%3D9556%26doi%3D10.1021%2Fja302342h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caumes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esvan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didierjean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">The <i>tert</i>-butyl side chain: A powerful means to lock peptoid amide bonds in the cis conformation</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2246</span>– <span class="NLM_lpage">2249</span>, <span class="refDoi"> DOI: 10.1021/ol400820y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol400820y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVylsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=2246-2249&author=O.+Royauthor=C.+Caumesauthor=Y.+Esvanauthor=C.+Didierjeanauthor=S.+Faureauthor=C.+Taillefumier&title=The+tert-butyl+side+chain%3A+A+powerful+means+to+lock+peptoid+amide+bonds+in+the+cis+conformation&doi=10.1021%2Fol400820y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The tert-Butyl Side Chain: A Powerful Means to Lock Peptoid Amide Bonds in the Cis Conformation</span></div><div class="casAuthors">Roy, O.; Caumes, C.; Esvan, Y.; Didierjean, C.; Faure, S.; Taillefumier, C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2246-2249</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The very simple sterically hindered tert-Bu side chain exerts complete control over the peptoid amide geometry which only exists in the cis conformation.  It is exemplified in NtBu glycine homo-oligomers and in linear oligopeptoids designed with an alternating cis-trans backbone amide pattern.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHhIHCCJ9rJ7Vg90H21EOLACvtfcHk0lhOFj52z92ueQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVylsbs%253D&md5=38850fc9e2c61679419c99c29782546b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fol400820y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol400820y%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DCaumes%26aufirst%3DC.%26aulast%3DEsvan%26aufirst%3DY.%26aulast%3DDidierjean%26aufirst%3DC.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DThe%2520tert-butyl%2520side%2520chain%253A%2520A%2520powerful%2520means%2520to%2520lock%2520peptoid%2520amide%2520bonds%2520in%2520the%2520cis%2520conformation%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D2246%26epage%3D2249%26doi%3D10.1021%2Fol400820y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angelici, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didierjean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouffret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolibois, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">Weak backbone CH···O═C and side chain tBu···tBu London interactions help promote helix folding of achiral NtBu peptoids</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4573</span>– <span class="NLM_lpage">4576</span>, <span class="refDoi"> DOI: 10.1039/C6CC00375C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1039%2FC6CC00375C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=4573-4576&author=G.+Angeliciauthor=N.+Bhattacharjeeauthor=O.+Royauthor=S.+Faureauthor=C.+Didierjeanauthor=L.+Jouffretauthor=F.+Joliboisauthor=L.+Perrinauthor=C.+Taillefumier&title=Weak+backbone+CH%C2%B7%C2%B7%C2%B7O%E2%95%90C+and+side+chain+tBu%C2%B7%C2%B7%C2%B7tBu+London+interactions+help+promote+helix+folding+of+achiral+NtBu+peptoids&doi=10.1039%2FC6CC00375C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1039%2FC6CC00375C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC00375C%26sid%3Dliteratum%253Aachs%26aulast%3DAngelici%26aufirst%3DG.%26aulast%3DBhattacharjee%26aufirst%3DN.%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DDidierjean%26aufirst%3DC.%26aulast%3DJouffret%26aufirst%3DL.%26aulast%3DJolibois%26aufirst%3DF.%26aulast%3DPerrin%26aufirst%3DL.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DWeak%2520backbone%2520CH%25C2%25B7%25C2%25B7%25C2%25B7O%25E2%2595%2590C%2520and%2520side%2520chain%2520tBu%25C2%25B7%25C2%25B7%25C2%25B7tBu%2520London%2520interactions%2520help%2520promote%2520helix%2520folding%2520of%2520achiral%2520NtBu%2520peptoids%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26spage%3D4573%26epage%3D4576%26doi%3D10.1039%2FC6CC00375C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumonteil, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouffret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriznik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">Homogeneous and robust polyproline type I helices from peptoids with nonaromatic α-chiral side chains</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">13533</span>– <span class="NLM_lpage">13540</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b07475</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b07475" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlygt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=13533-13540&author=O.+Royauthor=G.+Dumonteilauthor=S.+Faureauthor=L.+Jouffretauthor=A.+Kriznikauthor=C.+Taillefumier&title=Homogeneous+and+robust+polyproline+type+I+helices+from+peptoids+with+nonaromatic+%CE%B1-chiral+side+chains&doi=10.1021%2Fjacs.7b07475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous and Robust Polyproline Type I Helices from Peptoids with Nonaromatic α-Chiral Side Chains</span></div><div class="casAuthors">Roy, Olivier; Dumonteil, Geoffrey; Faure, Sophie; Jouffret, Laurent; Kriznik, Alexandre; Taillefumier, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">13533-13540</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptoids which are oligomers of N-substituted glycines represent a class of peptide mimics with great potential in areas ranging from medicinal chem. to biomaterial science.  Controlling the equil. between the cis and trans conformations of their backbone amides is the major hurdle to overcome for the construction of discrete folded structures, particularly for the development of all-cis PolyProline-type I (PPI) helixes, as tools for modulating biol. functions.  The prominent role of backbone to side chain electronic interactions (n→π*) and side chains bulkiness in promoting cis-amides was essentially investigated with peptoid arom. side chains among which the chiral 1-naphthylethyl (1Npe) group yielded the best results.  We have explored for the first time the possibility to achieve similar performances with a sterically hindered α-chiral aliph. side chain.  Herein, we report on the synthesis and detailed conformational anal. of a series of (S)-N-(1-tert-butylethyl)glycine (Ns1tbe) peptoid homooligomers.  The X-ray crystal structure of an Ns1tbe pentamer revealed an all-cis PPI helix and the CD curves of the Ns1tbe oligomers also resemble those of PPI peptide helixes.  Interestingly, the CD data reported here are the first for any conformationally homogeneous helical peptoids contg. only -chiral aliph. side chains.  Finally we also synthesized and analyzed two mixed oligomers composed of NtBu and Ns1tbe monomers.  Strikingly, the solid state structure of the mixed oligomer Ac-(t-Bu)2-(s1tbe)4-(t-Bu)2-COOt-Bu, the longest to be solved for any linear peptoid revealed a PPI helix of great regularity despite the presence of only 50% of chiral side chain in the sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpURNMp8qWMc7Vg90H21EOLACvtfcHk0lhOFj52z92ueQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlygt7fK&md5=3213819882a493732201ef77dce25ffa</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b07475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b07475%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DDumonteil%26aufirst%3DG.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DJouffret%26aufirst%3DL.%26aulast%3DKriznik%26aufirst%3DA.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DHomogeneous%2520and%2520robust%2520polyproline%2520type%2520I%2520helices%2520from%2520peptoids%2520with%2520nonaromatic%2520%25CE%25B1-chiral%2520side%2520chains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D13533%26epage%3D13540%26doi%3D10.1021%2Fjacs.7b07475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soria-Guerra, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto-Gomez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govea-Alonso, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosales-Mendoza, S.</span></span> <span> </span><span class="NLM_article-title">An overview of bioinformatics tools for epitope prediction: Implications on vaccine development</span>. <i>J. Biomed. Inf.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1016/j.jbi.2014.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.jbi.2014.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=25464113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A280%3ADC%252BC2Mzjs12msQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2015&pages=405-414&author=R.+E.+Soria-Guerraauthor=R.+Nieto-Gomezauthor=D.+O.+Govea-Alonsoauthor=S.+Rosales-Mendoza&title=An+overview+of+bioinformatics+tools+for+epitope+prediction%3A+Implications+on+vaccine+development&doi=10.1016%2Fj.jbi.2014.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of bioinformatics tools for epitope prediction: implications on vaccine development</span></div><div class="casAuthors">Soria-Guerra Ruth E; Nieto-Gomez Ricardo; Govea-Alonso Dania O; Rosales-Mendoza Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedical informatics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">405-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Exploitation of recombinant DNA and sequencing technologies has led to a new concept in vaccination in which isolated epitopes, capable of stimulating a specific immune response, have been identified and used to achieve advanced vaccine formulations; replacing those constituted by whole pathogen-formulations.  In this context, bioinformatics approaches play a critical role on analyzing multiple genomes to select the protective epitopes in silico.  It is conceived that cocktails of defined epitopes or chimeric protein arrangements, including the target epitopes, may provide a rationale design capable to elicit convenient humoral or cellular immune responses.  This review presents a comprehensive compilation of the most advantageous online immunological software and searchable, in order to facilitate the design and development of vaccines.  An outlook on how these tools are supporting vaccine development is presented.  HIV and influenza have been taken as examples of promising developments on vaccination against hypervariable viruses.  Perspectives in this field are also envisioned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR83dcVyuRsdiXXDYhVZBdlfW6udTcc2eZ5vve_-A2lgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mzjs12msQ%253D%253D&md5=90b7e8a562831164276a2e323e78bb93</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jbi.2014.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbi.2014.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DSoria-Guerra%26aufirst%3DR.%2BE.%26aulast%3DNieto-Gomez%26aufirst%3DR.%26aulast%3DGovea-Alonso%26aufirst%3DD.%2BO.%26aulast%3DRosales-Mendoza%26aufirst%3DS.%26atitle%3DAn%2520overview%2520of%2520bioinformatics%2520tools%2520for%2520epitope%2520prediction%253A%2520Implications%2520on%2520vaccine%2520development%26jtitle%3DJ.%2520Biomed.%2520Inf.%26date%3D2015%26volume%3D53%26spage%3D405%26epage%3D414%26doi%3D10.1016%2Fj.jbi.2014.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span> α-Peptide/β-peptoid
hybrid oligomers with promising biological activities have also been
synthesized. See the following, for example:<span class="NLM_contrib-group"><span class="NLM_string-name">Skovbakke, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heegaard, P. M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moesby, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzyk, H.</span></span> <span> </span><span class="NLM_article-title">Lipidated α-peptide/β-peptoid hybrids with potent anti-inflammatory activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.1021/jm501341h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501341h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=801-813&author=S.+L.+Skovbakkeauthor=C.+J.+Larsenauthor=P.+M.+H.+Heegaardauthor=L.+Moesbyauthor=H.+Franzyk&title=Lipidated+%CE%B1-peptide%2F%CE%B2-peptoid+hybrids+with+potent+anti-inflammatory+activity&doi=10.1021%2Fjm501341h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm501341h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501341h%26sid%3Dliteratum%253Aachs%26aulast%3DSkovbakke%26aufirst%3DS.%2BL.%26aulast%3DLarsen%26aufirst%3DC.%2BJ.%26aulast%3DHeegaard%26aufirst%3DP.%2BM.%2BH.%26aulast%3DMoesby%26aufirst%3DL.%26aulast%3DFranzyk%26aufirst%3DH.%26atitle%3DLipidated%2520%25CE%25B1-peptide%252F%25CE%25B2-peptoid%2520hybrids%2520with%2520potent%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D801%26epage%3D813%26doi%3D10.1021%2Fjm501341h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, U. K.</span></span> <span> </span><span class="NLM_article-title">Rational design of multivalent glycoconjugate ligands. Synthesis of libraries of conformationally flexible rotamers of poly-N-linked lactosyl glycines</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1039/cc9960000201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1039%2Fcc9960000201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=201-202&author=R.+Royauthor=U.+K.+Saha&title=Rational+design+of+multivalent+glycoconjugate+ligands.+Synthesis+of+libraries+of+conformationally+flexible+rotamers+of+poly-N-linked+lactosyl+glycines&doi=10.1039%2Fcc9960000201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2Fcc9960000201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fcc9960000201%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DR.%26aulast%3DSaha%26aufirst%3DU.%2BK.%26atitle%3DRational%2520design%2520of%2520multivalent%2520glycoconjugate%2520ligands.%2520Synthesis%2520of%2520libraries%2520of%2520conformationally%2520flexible%2520rotamers%2520of%2520poly-N-linked%2520lactosyl%2520glycines%26jtitle%3DChem.%2520Commun.%26date%3D1996%26spage%3D201%26epage%3D202%26doi%3D10.1039%2Fcc9960000201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Culf, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, R. J.</span></span> <span> </span><span class="NLM_article-title">Solid-phase synthesis of N-substituted glycine oligomers (α-peptoids) and derivatives</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5282</span>– <span class="NLM_lpage">5335</span>, <span class="refDoi"> DOI: 10.3390/molecules15085282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.3390%2Fmolecules15085282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=20714299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVagt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=5282-5335&author=A.+S.+Culfauthor=R.+J.+Ouellette&title=Solid-phase+synthesis+of+N-substituted+glycine+oligomers+%28%CE%B1-peptoids%29+and+derivatives&doi=10.3390%2Fmolecules15085282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-phase synthesis of N-substituted glycine oligomers (α-peptoids) and derivatives</span></div><div class="casAuthors">Culf, Adrian S.; Ouellette, Rodney J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5282-5335</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Peptoids (N-substituted polyglycines and extended peptoids with variant backbone amino-acid monomer units) are oligomeric synthetic polymers that are becoming a valuable mol. tool in the biosciences.  The exploration of peptoids in drug design and evaluation of their secondary structures are of particular interest.  Major advantages of peptoids as research and pharmaceutical tools include the ease and economy of synthesis, highly variable backbone and side-chain chem. possibilities.  In addn., peptoids have been shown to be highly active in biol. systems while resistant to proteolytic decay.  This review with 227 refs. discusses the work done by R. N. Zuckermann et al. from 1992 to 2010 on solid-phase synthesis and biochem. applications of peptoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv9ZaCWTLgMrVg90H21EOLACvtfcHk0lgIEtjpzh8zSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVagt7fL&md5=907128401ccbbfc77d78e64042b76ac1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.3390%2Fmolecules15085282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules15085282%26sid%3Dliteratum%253Aachs%26aulast%3DCulf%26aufirst%3DA.%2BS.%26aulast%3DOuellette%26aufirst%3DR.%2BJ.%26atitle%3DSolid-phase%2520synthesis%2520of%2520N-substituted%2520glycine%2520oligomers%2520%2528%25CE%25B1-peptoids%2529%2520and%2520derivatives%26jtitle%3DMolecules%26date%3D2010%26volume%3D15%26spage%3D5282%26epage%3D5335%26doi%3D10.3390%2Fmolecules15085282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herzner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reipen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of glycopeptides containing carbohydrate and peptide recognition motifs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4495</span>– <span class="NLM_lpage">4537</span>, <span class="refDoi"> DOI: 10.1021/cr990308c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr990308c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns12qtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=4495-4537&author=H.+Herznerauthor=T.+Reipenauthor=M.+Schultzauthor=H.+Kunz&title=Synthesis+of+glycopeptides+containing+carbohydrate+and+peptide+recognition+motifs&doi=10.1021%2Fcr990308c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of glycopeptides containing carbohydrate and peptide recognition motifs</span></div><div class="casAuthors">Herzner, Holger; Reipen, Tanja; Schultz, Michael; Kunz, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4495-4537</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 261 refs.  Detailed synthetic schemes for prepg. various O- and N-glycopeptides are given.  Solid-phase synthesis procedures are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpheDOwe106fLVg90H21EOLACvtfcHk0lgIEtjpzh8zSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns12qtLs%253D&md5=75b621e9fb147b78cd1511ce3c619a23</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fcr990308c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr990308c%26sid%3Dliteratum%253Aachs%26aulast%3DHerzner%26aufirst%3DH.%26aulast%3DReipen%26aufirst%3DT.%26aulast%3DSchultz%26aufirst%3DM.%26aulast%3DKunz%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520glycopeptides%2520containing%2520carbohydrate%2520and%2520peptide%2520recognition%2520motifs%26jtitle%3DChem.%2520Rev.%26date%3D2000%26volume%3D100%26spage%3D4495%26epage%3D4537%26doi%3D10.1021%2Fcr990308c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of glycoproteins</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1021/cr0004310</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0004310" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD38XosV2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=579-601&author=B.+G.+Davis&title=Synthesis+of+glycoproteins&doi=10.1021%2Fcr0004310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Glycoproteins</span></div><div class="casAuthors">Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">579-601</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with refs. on the chemo-synthesis and enzymic prepn. of glycopeptides and glycoproteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGtpn6ubEB47Vg90H21EOLACvtfcHk0lgEJrTLez_Avw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosV2hsw%253D%253D&md5=09d957e456e2fc7226cf73206f31a3d5</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fcr0004310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0004310%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DSynthesis%2520of%2520glycoproteins%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D579%26epage%3D601%26doi%3D10.1021%2Fcr0004310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hjelmgaard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caumes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Santis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">Convenient solution-phase synthesis and conformational studies of novel linear and cyclic α,β-alternating peptoids</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">4100</span>– <span class="NLM_lpage">4103</span>, <span class="refDoi"> DOI: 10.1021/ol9015767</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9015767" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVCmu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=4100-4103&author=T.+Hjelmgaardauthor=S.+Faureauthor=C.+Caumesauthor=E.+De+Santisauthor=A.+A.+Edwardsauthor=C.+Taillefumier&title=Convenient+solution-phase+synthesis+and+conformational+studies+of+novel+linear+and+cyclic+%CE%B1%2C%CE%B2-alternating+peptoids&doi=10.1021%2Fol9015767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Convenient Solution-Phase Synthesis and Conformational Studies of Novel Linear and Cyclic α,β-Alternating Peptoids</span></div><div class="casAuthors">Hjelmgaard, Thomas; Faure, Sophie; Caumes, Cecile; De Santis, Emiliana; Edwards, Alison A.; Taillefumier, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4100-4103</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a novel family of peptidomimetics composed of linear and cyclic α,β-alternating peptoids is described.  Oligomers consisting of up to six peptoid residues (n = 1-3) were synthesized on large scale with use of an efficient iterative soln.-phase method and longer oligomers (n = 4, 5) were obtained by the coupling of appropriately protected shorter oligomers.  Preliminary conformational studies of these hybrid peptoids are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqRX74Osa38bVg90H21EOLACvtfcHk0lgEJrTLez_Avw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVCmu7fJ&md5=77a4362731a93dbadcd6e2eed4ec1485</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fol9015767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9015767%26sid%3Dliteratum%253Aachs%26aulast%3DHjelmgaard%26aufirst%3DT.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DCaumes%26aufirst%3DC.%26aulast%3DDe%2BSantis%26aufirst%3DE.%26aulast%3DEdwards%26aufirst%3DA.%2BA.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DConvenient%2520solution-phase%2520synthesis%2520and%2520conformational%2520studies%2520of%2520novel%2520linear%2520and%2520cyclic%2520%25CE%25B1%252C%25CE%25B2-alternating%2520peptoids%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D4100%26epage%3D4103%26doi%3D10.1021%2Fol9015767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caumes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hjelmgaard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">Highly convenient gram-scale solution-phase peptoid synthesis and orthogonal side-chain post-modification</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1055/s-0030-1258351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1055%2Fs-0030-1258351" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=257-264&issue=2&author=C.+Caumesauthor=T.+Hjelmgaardauthor=R.+Remusonauthor=S.+Faureauthor=C.+Taillefumier&title=Highly+convenient+gram-scale+solution-phase+peptoid+synthesis+and+orthogonal+side-chain+post-modification&doi=10.1055%2Fs-0030-1258351"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1258351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1258351%26sid%3Dliteratum%253Aachs%26aulast%3DCaumes%26aufirst%3DC.%26aulast%3DHjelmgaard%26aufirst%3DT.%26aulast%3DRemuson%26aufirst%3DR.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DHighly%2520convenient%2520gram-scale%2520solution-phase%2520peptoid%2520synthesis%2520and%2520orthogonal%2520side-chain%2520post-modification%26jtitle%3DSynthesis%26date%3D2011%26volume%3D2011%26issue%3D2%26spage%3D257%26epage%3D264%26doi%3D10.1055%2Fs-0030-1258351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takabayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiney, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. A.</span></span> <span> </span><span class="NLM_article-title">Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">3990</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1073/pnas.0611624104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1073%2Fpnas.0611624104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=17360465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlaisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=3990-3995&author=C.+C.+N.+Wuauthor=T.+Hayashiauthor=K.+Takabayashiauthor=M.+Sabetauthor=D.+F.+Smeeauthor=D.+D.+Guineyauthor=H.+B.+Cottamauthor=D.+A.+Carson&title=Immunotherapeutic+activity+of+a+conjugate+of+a+Toll-like+receptor+7+ligand&doi=10.1073%2Fpnas.0611624104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand</span></div><div class="casAuthors">Wu, Christina C. N.; Hayashi, Tomoko; Takabayashi, Kenji; Sabet, Mojgan; Smee, Donald F.; Guiney, Donald D.; Cottam, Howard B.; Carson, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3990-3995</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The immunotherapeutic activity of Toll-like receptor (TLR) activators has been difficult to exploit because of side effects related to the release and systemic dispersion of proinflammatory cytokines.  To overcome this barrier, we have synthesized a versatile TLR7 agonist, 4-[6-amino-8-hydroxy-2-(2-methoxyethoxy)purin-9-ylmethyl]benzaldehyde (UC-1V150), bearing a free aldehyde that could be coupled to many different auxiliary chem. entities through a linker mol. with a hydrazine or amino group without any loss of activity.  UC-1V150 was covalently coupled to mouse serum albumin (MSA) at a 5:1 molar ratio to yield a stable mol. with a characteristically altered UV spectrum.  Compared with the unconjugated TLR7 agonist, the UC-1V150/MSA was a 10-to 100-fold more potent inducer of cytokine prodn. in vitro by mouse bone marrow-derived macrophage and human peripheral blood mononuclear cells.  When administered to the lung, the conjugate induced a prolonged local release of cytokines at levels 10-fold or more higher than those found in serum.  Under the same conditions, the untethered TLR7 ligand induced quick systemic cytokine release with resultant toxicity.  In addn., two pulmonary infectious disease models were investigated wherein mice were pretreated with the conjugate and then challenged with either Bacillus anthracis spores or HIN1 influenza A virus.  Significant delay in mortality was obsd. in both disease models with UC-1V150/MSA-pretreated mice, indicating the potential usefulness of the conjugate as a localized and targeted immunotherapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg2MwudVJLMrVg90H21EOLACvtfcHk0lgEJrTLez_Avw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlaisbk%253D&md5=6d7589699bc36c1aed6e8d914a72292d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0611624104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0611624104%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BC.%2BN.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DTakabayashi%26aufirst%3DK.%26aulast%3DSabet%26aufirst%3DM.%26aulast%3DSmee%26aufirst%3DD.%2BF.%26aulast%3DGuiney%26aufirst%3DD.%2BD.%26aulast%3DCottam%26aufirst%3DH.%2BB.%26aulast%3DCarson%26aufirst%3DD.%2BA.%26atitle%3DImmunotherapeutic%2520activity%2520of%2520a%2520conjugate%2520of%2520a%2520Toll-like%2520receptor%25207%2520ligand%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D3990%26epage%3D3995%26doi%3D10.1073%2Fpnas.0611624104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathewson, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawatao, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalenian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterization of PEGylated toll like receptor 7 ligands</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1021/bc1004813</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc1004813" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Wjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=445-454&author=M.+Chanauthor=T.+Hayashiauthor=R.+D.+Mathewsonauthor=S.+Yaoauthor=C.+Grayauthor=R.+I.+Tawataoauthor=K.+Kalenianauthor=Y.+Zhangauthor=Y.+Hayashiauthor=F.+S.+Laoauthor=H.+B.+Cottamauthor=D.+A.+Carson&title=Synthesis+and+characterization+of+PEGylated+toll+like+receptor+7+ligands&doi=10.1021%2Fbc1004813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of PEGylated Toll Like Receptor 7 Ligands</span></div><div class="casAuthors">Chan, Michael; Hayashi, Tomoko; Mathewson, Richard D.; Yao, Shiyin; Gray, Christine; Tawatao, Rommel I.; Kalenian, Kevin; Zhang, Yanmei; Hayashi, Yuki; Lao, Fitzgerald S.; Cottam, Howard B.; Carson, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">445-454</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is located in the endosomal compartment of immune cells.  Signaling through TLR7, mediated by the adaptor protein MyD88, stimulates the innate immune system and shapes adaptive immune responses.  Previously, we characterized TLR7 ligands conjugated to protein, lipid, or poly(ethylene glycol) (PEG).  Among the TLR7 ligand conjugates, the addn. of PEG chains reduced the agonistic potency.  PEGs are safe in humans and widely used for improvement of pharmacokinetics in existing biologics and some low mol. wt. compds.  PEGylation could be a feasible method to alter the pharmacokinetics and pharmacodynamics of TLR7 ligands.  In this study, we systematically studied the influence of PEG chain length on the in vitro and in vivo properties of potent TLR7 ligands.  PEGylation increased soly. of the TLR7 ligands and modulated protein binding.  Adding a 6-10 length PEG to the TLR7 ligand reduced its potency toward induction of interleukin (IL)-6 by murine macrophages in vitro and IL-6 and tumor necrosis factor (TNF) in vivo.  However, PEGylation with 18 or longer chain restored, and even enhanced, the agonistic activity of the drug.  In human peripheral blood mononuclear cells, similar effects of PEGylation were obsd. for secretion of proinflammatory cytokines, IL-6, IL-12, TNF-α, IL-1β, and type 1 interferon, as well as for B cell proliferation.  In summary, these studies demonstrate that conjugation of PEG chains to a synthetic TLR ligand can impact its potency for cytokine induction depending on the size of the PEG moiety.  Thus, PEGylation may be a feasible approach to regulate the pharmacol. properties of TLR7 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7MmNOSt39wbVg90H21EOLACvtfcHk0lhuRpi_0VE11Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Wjurs%253D&md5=26f053bd020f05406f38b3560b00309e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fbc1004813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc1004813%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMathewson%26aufirst%3DR.%2BD.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DC.%26aulast%3DTawatao%26aufirst%3DR.%2BI.%26aulast%3DKalenian%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DLao%26aufirst%3DF.%2BS.%26aulast%3DCottam%26aufirst%3DH.%2BB.%26aulast%3DCarson%26aufirst%3DD.%2BA.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520PEGylated%2520toll%2520like%2520receptor%25207%2520ligands%26jtitle%3DBioconjugate%2520Chem.%26date%3D2011%26volume%3D22%26spage%3D445%26epage%3D454%26doi%3D10.1021%2Fbc1004813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evavold, B. D.</span></span> <span> </span><span class="NLM_article-title">DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323–339 Epitope</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">4706</span>– <span class="NLM_lpage">4712</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.164.9.4706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.4049%2Fjimmunol.164.9.4706" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2000&pages=4706-4712&author=J.+M.+Robertsonauthor=P.+E.+Jensenauthor=B.+D.+Evavold&title=DO11.10+and+OT-II+T+cells+recognize+a+C-terminal+ovalbumin+323%E2%80%93339+Epitope&doi=10.4049%2Fjimmunol.164.9.4706"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.164.9.4706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.164.9.4706%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DJ.%2BM.%26aulast%3DJensen%26aufirst%3DP.%2BE.%26aulast%3DEvavold%26aufirst%3DB.%2BD.%26atitle%3DDO11.10%2520and%2520OT-II%2520T%2520cells%2520recognize%2520a%2520C-terminal%2520ovalbumin%2520323%25E2%2580%2593339%2520Epitope%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D164%26spage%3D4706%26epage%3D4712%26doi%3D10.4049%2Fjimmunol.164.9.4706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima-Adachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totsuka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiraide, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakatsuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyono, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hachimura, S.</span></span> <span> </span><span class="NLM_article-title">Two distinct epitopes on the ovalbumin 323-339 peptide differentiating CD4+T cells into the Th2 or Th1 phenotype</span>. <i>Biosci., Biotechnol., Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1979</span>– <span class="NLM_lpage">1981</span>, <span class="refDoi"> DOI: 10.1271/bbb.120349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1271%2Fbbb.120349" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2012&pages=1979-1981&author=H.+Nakajima-Adachiauthor=E.+Koikeauthor=M.+Totsukaauthor=E.+Hiraideauthor=Y.+Wakatsukiauthor=H.+Kiyonoauthor=S.+Hachimura&title=Two+distinct+epitopes+on+the+ovalbumin+323-339+peptide+differentiating+CD4%2BT+cells+into+the+Th2+or+Th1+phenotype&doi=10.1271%2Fbbb.120349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1271%2Fbbb.120349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb.120349%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima-Adachi%26aufirst%3DH.%26aulast%3DKoike%26aufirst%3DE.%26aulast%3DTotsuka%26aufirst%3DM.%26aulast%3DHiraide%26aufirst%3DE.%26aulast%3DWakatsuki%26aufirst%3DY.%26aulast%3DKiyono%26aufirst%3DH.%26aulast%3DHachimura%26aufirst%3DS.%26atitle%3DTwo%2520distinct%2520epitopes%2520on%2520the%2520ovalbumin%2520323-339%2520peptide%2520differentiating%2520CD4%252BT%2520cells%2520into%2520the%2520Th2%2520or%2520Th1%2520phenotype%26jtitle%3DBiosci.%252C%2520Biotechnol.%252C%2520Biochem.%26date%3D2012%26volume%3D76%26spage%3D1979%26epage%3D1981%26doi%3D10.1271%2Fbbb.120349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsayed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aasen, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Do, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aardal, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florvaag, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaali, K.</span></span> <span> </span><span class="NLM_article-title">Comparison between ovalbumine and ovalbumine peptide 323-339 responses in allergic mice: humoral and cellular aspects</span>. <i>Scand. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1111/j.1365-3083.2010.02382.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1111%2Fj.1365-3083.2010.02382.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=20500683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslCht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2010&pages=329-335&author=L.-Z.+Sunauthor=S.+Elsayedauthor=T.+B.+Aasenauthor=T.+Van+Doauthor=N.+P.+Aardalauthor=E.+Florvaagauthor=K.+Vaali&title=Comparison+between+ovalbumine+and+ovalbumine+peptide+323-339+responses+in+allergic+mice%3A+humoral+and+cellular+aspects&doi=10.1111%2Fj.1365-3083.2010.02382.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison between ovalbumin and ovalbumin peptide 323-339 responses in allergic-mice: humoral and cellular aspects</span></div><div class="casAuthors">Sun, L.-Z.; Elsayed, S.; Aasen, T. B.; Van Do, T.; Aardal, N. P.; Florvaag, E.; Vaali, K.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">329-335</span>CODEN:
                <span class="NLM_cas:coden">SJIMAX</span>;
        ISSN:<span class="NLM_cas:issn">0300-9475</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Ovalbumin (OVA) is widely used in allergy research.  OVA peptide 323-339 has been reported to be responsible for 25-35% of isolated BALB/c mouse T-cell response to intact OVA.  An investigation of whether OVA and OVA 323-339 mols. can induce equiv. in vivo and in vitro immune responses was conducted.  Eight-week-old BALB/c mice were randomly divided into three groups: OVA, OVA 323-339 and saline.  On days 0, 7, 14, mice were i.p. injected with 25 μg OVA or OVA 323-339 absorbed on 300 μg Alum, or saline; on days 21-23, all groups were challenged intranasally with either 20 μl of 1% OVA, 1% OVA 323-339 or saline.  On day 28, after killing, splenocytes were isolated and cultured under the stimulus of each allergen or medium.  Evaluated by hematoxylin/eosin and major basic protein immunohistochem. stainings, OVA and OVA 323-339 induced similar lung inflammation.  Interestingly, significant serum total IgE and OVA-specific IgE were obsd. in OVA mice when compared to saline control.  OVA 323-339 mice showed higher serum OVA-specific IgE, OVA 323-339-specific IgE, IL-4 and lower IFN-γ similar to OVA mice.  The proliferative response to OVA was found in cultured splenocytes of both OVA and OVA 323-339 mice, while the similar proliferative response to OVA 323-339 was only obsd. in the splenocytes of OVA 323-339-sensitized and challenged mice.  Although OVA 323-339 induced a Th2-like response in the mouse model as did OVA, OVA 323-339 has clearly limited immunogenic potency to activate OVA-sensitized and challenged mice splenocytes, unlike OVA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYBGiImC1AX7Vg90H21EOLACvtfcHk0lhuRpi_0VE11Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslCht7k%253D&md5=f031f2b5171b8bfa3f96651d838e5b2b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-3083.2010.02382.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-3083.2010.02382.x%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.-Z.%26aulast%3DElsayed%26aufirst%3DS.%26aulast%3DAasen%26aufirst%3DT.%2BB.%26aulast%3DVan%2BDo%26aufirst%3DT.%26aulast%3DAardal%26aufirst%3DN.%2BP.%26aulast%3DFlorvaag%26aufirst%3DE.%26aulast%3DVaali%26aufirst%3DK.%26atitle%3DComparison%2520between%2520ovalbumine%2520and%2520ovalbumine%2520peptide%2520323-339%2520responses%2520in%2520allergic%2520mice%253A%2520humoral%2520and%2520cellular%2520aspects%26jtitle%3DScand.%2520J.%2520Immunol.%26date%3D2010%26volume%3D71%26spage%3D329%26epage%3D335%26doi%3D10.1111%2Fj.1365-3083.2010.02382.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grey, H. M.</span></span> <span> </span><span class="NLM_article-title">Interaction between a “processed” ovalbumine peptide and Ia molecules</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">3968</span>– <span class="NLM_lpage">3971</span>, <span class="refDoi"> DOI: 10.1073/pnas.83.11.3968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1073%2Fpnas.83.11.3968" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=3968-3971&author=S.+Buusauthor=S.+Colonauthor=C.+Smithauthor=J.+H.+Freedauthor=C.+Milesauthor=H.+M.+Grey&title=Interaction+between+a+%E2%80%9Cprocessed%E2%80%9D+ovalbumine+peptide+and+Ia+molecules&doi=10.1073%2Fpnas.83.11.3968"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.11.3968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.11.3968%26sid%3Dliteratum%253Aachs%26aulast%3DBuus%26aufirst%3DS.%26aulast%3DColon%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DFreed%26aufirst%3DJ.%2BH.%26aulast%3DMiles%26aufirst%3DC.%26aulast%3DGrey%26aufirst%3DH.%2BM.%26atitle%3DInteraction%2520between%2520a%2520%25E2%2580%259Cprocessed%25E2%2580%259D%2520ovalbumine%2520peptide%2520and%2520Ia%2520molecules%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D3968%26epage%3D3971%26doi%3D10.1073%2Fpnas.83.11.3968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valverde, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecaille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalmanach, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aucagne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmas, A. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a biologically active triazole-containing analogue of cystatin a through successive peptidomimetic alkyne-azide ligations</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">722</span>, <span class="refDoi"> DOI: 10.1002/anie.201107222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fanie.201107222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=22144344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOnsb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=718-722&author=I.+E.+Valverdeauthor=F.+Lecailleauthor=G.+Lalmanachauthor=V.+Aucagneauthor=A.+F.+Delmas&title=Synthesis+of+a+biologically+active+triazole-containing+analogue+of+cystatin+a+through+successive+peptidomimetic+alkyne-azide+ligations&doi=10.1002%2Fanie.201107222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Biologically Active Triazole-Containing Analogue of Cystatin A Through Successive Peptidomimetic Alkyne-Azide Ligations</span></div><div class="casAuthors">Valverde, Ibai E.; Lecaille, Fabien; Lalmanach, Gilles; Aucagne, Vincent; Delmas, Agnes F.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">718-722, S718/1-S718/21</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors report the use of copper(I)-mediated cycloaddn. of azides and terminal alkynes for the assembly of unprotected peptide fragments into a bioactive triazole-contg. protein, cystatin A.  A complete biol. characterization of cystatin A was carried out via inhibition kinetics of cathepsin B, H and L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozo_d5az9W67Vg90H21EOLACvtfcHk0lg-FEA9YBjEcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOnsb%252FF&md5=ad4806eaa0e89beaeefcc116573c589c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fanie.201107222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201107222%26sid%3Dliteratum%253Aachs%26aulast%3DValverde%26aufirst%3DI.%2BE.%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DLalmanach%26aufirst%3DG.%26aulast%3DAucagne%26aufirst%3DV.%26aulast%3DDelmas%26aufirst%3DA.%2BF.%26atitle%3DSynthesis%2520of%2520a%2520biologically%2520active%2520triazole-containing%2520analogue%2520of%2520cystatin%2520a%2520through%2520successive%2520peptidomimetic%2520alkyne-azide%2520ligations%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D718%26epage%3D722%26doi%3D10.1002%2Fanie.201107222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aucagne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valverde, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marceau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galibert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dendane, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmas, A. F.</span></span> <span> </span><span class="NLM_article-title">Towards the simplification of protein synthesis: iterative solid-supported ligations with concomitant purifications</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">11320</span>– <span class="NLM_lpage">11324</span>, <span class="refDoi"> DOI: 10.1002/anie.201206428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fanie.201206428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2rsbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=11320-11324&author=V.+Aucagneauthor=I.+E.+Valverdeauthor=P.+Marceauauthor=M.+Galibertauthor=N.+Dendaneauthor=A.+F.+Delmas&title=Towards+the+simplification+of+protein+synthesis%3A+iterative+solid-supported+ligations+with+concomitant+purifications&doi=10.1002%2Fanie.201206428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Towards the Simplification of Protein Synthesis: Iterative Solid-Supported Ligations with Concomitant Purifications</span></div><div class="casAuthors">Aucagne, Vincent; Valverde, Ibai E.; Marceau, Philippe; Galibert, Mathieu; Dendane, Nabil; Delmas, Agnes F.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11320-11324</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors introduced N3-Esoc-ONp 1 as a new reagent for the contemporary tagging of peptides at their N-terminus and demonstrated its potential in capture/release purifications.  The authors extended this concept to a promising self-purifying N-to-C iterative triazole ligation strategy, exemplified by the synthesis of a polypeptide contg. 160 residues.  Solid-phase coupling of four peptide segments led to high purity material without any chromatog. purifn. steps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE0_cC6n5GDLVg90H21EOLACvtfcHk0lg-FEA9YBjEcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2rsbzK&md5=439b8f7f32f53d2ddb59b4a247e1a399</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fanie.201206428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201206428%26sid%3Dliteratum%253Aachs%26aulast%3DAucagne%26aufirst%3DV.%26aulast%3DValverde%26aufirst%3DI.%2BE.%26aulast%3DMarceau%26aufirst%3DP.%26aulast%3DGalibert%26aufirst%3DM.%26aulast%3DDendane%26aufirst%3DN.%26aulast%3DDelmas%26aufirst%3DA.%2BF.%26atitle%3DTowards%2520the%2520simplification%2520of%2520protein%2520synthesis%253A%2520iterative%2520solid-supported%2520ligations%2520with%2520concomitant%2520purifications%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D11320%26epage%3D11324%26doi%3D10.1002%2Fanie.201206428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flood, A. H.</span></span> <span> </span><span class="NLM_article-title">Click chemistry generates privileged CH hydrogen-bonding triazoles: the latest addition to anion supramolecular chemistry</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1039/b818033b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1039%2Fb818033b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=20349532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1Ggtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=1262-1271&author=Y.+Huaauthor=A.+H.+Flood&title=Click+chemistry+generates+privileged+CH+hydrogen-bonding+triazoles%3A+the+latest+addition+to+anion+supramolecular+chemistry&doi=10.1039%2Fb818033b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry generates privileged CH hydrogen-bonding triazoles: the latest addition to anion supramolecular chemistry</span></div><div class="casAuthors">Hua, Yuran; Flood, Amar H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1262-1271</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The supramol. chem. of anions provides a means to sense and manipulate anions in their many chem. and biol. roles.  For this purpose, Click chem. facilitated the synthetic creation of new receptors and thus, an opportunity to aid in the recent re-examn. of CH···anion hydrogen bonding.  This tutorial review will focus on the privileged C-H hydrogen bond donor of the 1,2,3-triazole ring systems as elucidated from anion-binding studies with macrocyclic triazolophanes and other receptors.  Triazolophanes are shape-persistent and planar macrocycles that direct four triazole and four phenylene CH groups into a 3.7 Å cavity.  They display strong (log K(Cl-) = 7), size-dependent halide binding (Cl- > Br- » F- » I-) and a rich set of binding equil.  For instance, the too large iodide (4.4 Å) can be sandwiched between two pyridyl-based triazolophanes with extreme pos. cooperativity.  Computational studies verify the triazole's hydrogen bond strength indicating it approaches the traditional NH donors from pyrrole.  These examples, those of transport, sensing (e.g., ion-selective electrodes), templation, and versatile synthesis herald the use of triazoles in anion-receptor chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKNmfsPTPp6rVg90H21EOLACvtfcHk0lg-FEA9YBjEcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Ggtbw%253D&md5=ae3a71361ee4463726714dc4743343e3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1039%2Fb818033b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb818033b%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DFlood%26aufirst%3DA.%2BH.%26atitle%3DClick%2520chemistry%2520generates%2520privileged%2520CH%2520hydrogen-bonding%2520triazoles%253A%2520the%2520latest%2520addition%2520to%2520anion%2520supramolecular%2520chemistry%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2010%26volume%3D39%26spage%3D1262%26epage%3D1271%26doi%3D10.1039%2Fb818033b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horne, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, Y. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghadiri, M. R.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic peptide backbone modifications in an α-helical coiled coil</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">15366</span>– <span class="NLM_lpage">15367</span>, <span class="refDoi"> DOI: 10.1021/ja0450408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0450408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlSgtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=15366-15367&author=W.+S.+Horneauthor=M.+K.+Yadavauthor=Y.+C.+D.+Stoutauthor=M.+R.+Ghadiri&title=Heterocyclic+peptide+backbone+modifications+in+an+%CE%B1-helical+coiled+coil&doi=10.1021%2Fja0450408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic Peptide Backbone Modifications in an α-Helical Coiled Coil</span></div><div class="casAuthors">Horne, W. Seth; Yadav, Maneesh K.; Stout, C. David; Ghadiri, M. Reza</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">15366-15367</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, we present 1,2,3-triazole ε2-amino acids incorporated as a dipeptide surrogate at three positions in the sequence of a known α-helical coiled coil.  Biophys. characterization indicates that the modified peptides retain much of the helical structure of the parent sequence, and that the thermodn. stability of the coiled coil depends on the position of the incorporation of the ε-residue.  Crystal structures obtained for each peptide give insight into the chem. behavior and conformational preferences of the non-natural amino acid and show that the triazole ring can participate in the backbone hydrogen bonding of the α-helix as well as template an interhelical crossing between chains in the bundle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-BCwZtNvceLVg90H21EOLACvtfcHk0lg8mISY_XzidQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlSgtrw%253D&md5=6f4573960370cdded62c2ca77ad25b04</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fja0450408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0450408%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DYadav%26aufirst%3DM.%2BK.%26aulast%3DStout%26aufirst%3DY.%2BC.%2BD.%26aulast%3DGhadiri%26aufirst%3DM.%2BR.%26atitle%3DHeterocyclic%2520peptide%2520backbone%2520modifications%2520in%2520an%2520%25CE%25B1-helical%2520coiled%2520coil%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D15366%26epage%3D15367%26doi%3D10.1021%2Fja0450408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, K.</span></span> <span> </span><span class="NLM_article-title">Universal peptidomimetics</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">462</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1021/ja1071916</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja1071916" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SrsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=462-477&author=E.+Koauthor=J.+Liuauthor=L.+M.+Perezauthor=G.+Luauthor=A.+Schaeferauthor=K.+Burgess&title=Universal+peptidomimetics&doi=10.1021%2Fja1071916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Universal Peptidomimetics</span></div><div class="casAuthors">Ko, Eunhwa; Liu, Jing; Perez, Lisa M.; Lu, Genliang; Schaefer, Amber; Burgess, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">462-477</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptidomimetic scaffolds that can present side chains in conformations resembling those of amino acids in secondary structures without incurring excessive entropic or enthalpic penalties were discussed.  Compds. of this type were referred to as minimalist mimics.  The core hypothesis of the paper was that small sets of such scaffolds can be designed to analog local pairs of amino acids (including noncontiguous ones) in any secondary structure; i.e., they are universal peptidomimetics.  To illustrate this concept, a set of four peptidomimetic scaffolds, I-IV, were designed.  Libraries based on them were made bearing side chains corresponding to many of the protein-derived amino acids.  Modeling expts. were performed to give an indication of kinetic and thermodn. accessibilities of conformations that can mimic secondary structures.  Together, peptidomimetics based on these four scaffolds can adopt conformations that resemble almost any combination of local amino acid side chains in any secondary structure.  Universal peptidomimetics of this kind are likely to be most useful in the design of libraries for high-throughput screening against diverse targets.  Consequently, data arising from submission of these mols. to the NIH Mol. Libraries Small Mol. Repository (MLSMR) were outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjryjrFh6s0bVg90H21EOLACvtfcHk0lg8mISY_XzidQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SrsbrM&md5=4c95046d25118b6d77e46668d88580b3</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fja1071916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja1071916%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DL.%2BM.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DSchaefer%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DUniversal%2520peptidomimetics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D462%26epage%3D477%26doi%3D10.1021%2Fja1071916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szekely, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">From Glycopeptides to glycopeptoids</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">5641</span>– <span class="NLM_lpage">5657</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201402238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fejoc.201402238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=5641-5657&author=T.+Szekelyauthor=O.+Royauthor=S.+Faureauthor=C.+Taillefumier&title=From+Glycopeptides+to+glycopeptoids&doi=10.1002%2Fejoc.201402238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201402238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201402238%26sid%3Dliteratum%253Aachs%26aulast%3DSzekely%26aufirst%3DT.%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DFrom%2520Glycopeptides%2520to%2520glycopeptoids%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2014%26volume%3D2014%26spage%3D5641%26epage%3D5657%26doi%3D10.1002%2Fejoc.201402238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Presolski, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span> <span> </span><span class="NLM_article-title">Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">9879</span>– <span class="NLM_lpage">9883</span>, <span class="refDoi"> DOI: 10.1002/anie.200905087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fanie.200905087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=19943299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2hsrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=9879-9883&author=V.+Hongauthor=S.+I.+Presolskiauthor=C.+Maauthor=M.+G.+Finn&title=Analysis+and+optimization+of+copper-catalyzed+azide-alkyne+cycloaddition+for+bioconjugation&doi=10.1002%2Fanie.200905087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis and Optimization of Copper-Catalyzed Azide-Alkyne Cycloaddition for Bioconjugation</span></div><div class="casAuthors">Hong, Vu; Presolski, Stanislav I.; Ma, Celia; Finn, M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">9879-9883, S9879/1-S9879/10</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Copper-catalyzed azide-alkyne cycloaddn. (CuAAC) has been optimized for use with biol. mols.  The key development is the addn. of two reagents that allow ascorbate to be used as reducing agent while eliminating problems caused by copper ascorbate side reactions.  The result is a robust, rapid, and convenient procedure for the modification of proteins, DNA, RNA, and other biomols.  Sodium ascorbate is the preferred reducing agent for most applications, due to its convenience and effectiveness at generating the catalytically active Cu1 oxidn. state.  Cu concns. should generally be between 50 and 100 μM.  A fluorogenic or colorimetric assay, such as that enabled by a coumarin deriv. is strongly recommended for optimization of specific cases.  At least five equiv. of THPTA (other water-sol. variants) relative to Cu should be employed.  Aminoguanidine is a useful additive to intercept byproducts of ascorbate oxidn. that can covalently modify or crosslink proteins.  Compatible buffers include phosphate, carbonate, or HEPES in the pH 6.5-8.0 range.  Tris buffer should be avoided as it is a competitive and inhibitory ligand for Cu; sodium chloride (as in phosphate-buffered saline) up to 0.5 M can be used.  Ascorbate should not be added to copper-contg. solns. in the absence of the ligand.  As a matter of routine, the authors first mix CuSO4 with the ligand, add this mixt. to a soln. of the azide and alkyne substrates, and then initiate the CuAAC reaction by the addn. of sodium ascorbate to the desired concn.  The Cu-THPTA catalyst in water is inhibited by excess alkyne, and so the procedure described here is useful for alkyne concns. less than approx. 5 mM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn_BOP5hVYDbVg90H21EOLACvtfcHk0lg8mISY_XzidQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2hsrnL&md5=2b85650bce37933080d02c417848f1e2</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1002%2Fanie.200905087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200905087%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DV.%26aulast%3DPresolski%26aufirst%3DS.%2BI.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26atitle%3DAnalysis%2520and%2520optimization%2520of%2520copper-catalyzed%2520azide-alkyne%2520cycloaddition%2520for%2520bioconjugation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D9879%26epage%3D9883%26doi%3D10.1002%2Fanie.200905087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Vliet, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuist, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Vallejo, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kooyk, Y.</span></span> <span> </span><span class="NLM_article-title">MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1189/jlb.1012520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1189%2Fjlb.1012520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=23744646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1elt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2013&pages=315-323&author=S.+J.+Van%0AVlietauthor=S.+Bayauthor=I.+M.+Vuistauthor=H.+Kalayauthor=J.+J.+Garc%C3%ADa-Vallejoauthor=C.+Leclercauthor=Y.+Van+Kooyk&title=MGL+signaling+augments+TLR2-mediated+responses+for+enhanced+IL-10+and+TNF-%CE%B1+secretion&doi=10.1189%2Fjlb.1012520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion</span></div><div class="casAuthors">van Vliet, Sandra J.; Bay, Sylvie; Vuist, Ilona M.; Kalay, Hakan; Garcia-Vallejo, Juan J.; Leclerc, Claude; van Kooyk, Yvette</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">315-323</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">DCs orchestrate immune responses to infectious pathogens and disturbances in tissue integrity.  Equipped with C-type lectins, DCs can respond to environmental changes in glycosylation.  Many C-type lectins are capable of modulating TLR activation, thereby facilitating tailor-made immune reactions.  Here, we investigated the signaling properties of the C-type lectin MGL and show that MGL engagement by agonistic antibodies or carbohydrate ligands couples to TLR signal transduction for increased IL-10 and TNF-α secretion by human monocyte-derived DCs.  MGL triggering esp. synergized with TLR2-induced pathways, leading to elevated IL-10 mRNA levels and enhanced TNF-α mRNA stability.  In addn., MGL signaling promoted phosphorylation of the MAPK ERK and the transcription factor CREB.  Whereas specific inhibitors of p90RSK blocked the MGL-induced cytokine secretion, AP-1 was not involved.  Strikingly, NF-κB was only crucial for the IL-10 response and dispensable for TNF-α prodn.  Together, our results demonstrate that MGL activation of the ERK-p90RSK-CREB axis converges with TLR2-induced pathways, thereby fine-tuning the DC maturation phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwXUxmsNrez7Vg90H21EOLACvtfcHk0lj4D1x9WWSbAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1elt7rJ&md5=1e622b2d5235df9b162ba095362fc95d</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1189%2Fjlb.1012520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.1012520%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BVliet%26aufirst%3DS.%2BJ.%26aulast%3DBay%26aufirst%3DS.%26aulast%3DVuist%26aufirst%3DI.%2BM.%26aulast%3DKalay%26aufirst%3DH.%26aulast%3DGarc%25C3%25ADa-Vallejo%26aufirst%3DJ.%2BJ.%26aulast%3DLeclerc%26aufirst%3DC.%26aulast%3DVan%2BKooyk%26aufirst%3DY.%26atitle%3DMGL%2520signaling%2520augments%2520TLR2-mediated%2520responses%2520for%2520enhanced%2520IL-10%2520and%2520TNF-%25CE%25B1%2520secretion%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2013%26volume%3D94%26spage%3D315%26epage%3D323%26doi%3D10.1189%2Fjlb.1012520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laubreton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dériaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puaux, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amigorena, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gérard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Man, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span> <span> </span><span class="NLM_article-title">The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1007/s00262-016-1802-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1007%2Fs00262-016-1802-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=26847142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=315-325&author=D.+Laubretonauthor=S.+Bayauthor=C.+Sedlikauthor=C.+Artaudauthor=C.+Ganneauauthor=E.+D%C3%A9riaudauthor=S.+Vielauthor=A.-L.+Puauxauthor=S.+Amigorenaauthor=C.+G%C3%A9rardauthor=R.+Lo-Manauthor=C.+Leclerc&title=The+fully+synthetic+MAG-Tn3+therapeutic+vaccine+containing+the+tetanus+toxoid-derived+TT830-844+universal+epitope+provides+anti-tumor+immunity&doi=10.1007%2Fs00262-016-1802-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity</span></div><div class="casAuthors">Laubreton, Daphne; Bay, Sylvie; Sedlik, Christine; Artaud, Cecile; Ganneau, Christelle; Deriaud, Edith; Viel, Sophie; Puaux, Anne-Laure; Amigorena, Sebastian; Gerard, Catherine; Lo-Man, Richard; Leclerc, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-325</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Malignant transformations are often assocd. with aberrant glycosylation processes that lead to the expression of new carbohydrate antigens at the surface of tumor cells.  Of these carbohydrate antigens, the Tn antigen is particularly highly expressed in many carcinomas, esp. in breast carcinoma.  We designed MAG-Tn3, a fully synthetic vaccine based on three consecutive Tn moieties that are O-linked to a CD4+ T cell epitope, to induce anti-Tn antibody responses that could be helpful for therapeutic vaccination against cancer.  To ensure broad coverage within the human population, the tetanus toxoid-derived peptide TT830-844 was selected as a T-helper epitope because it can bind to various HLA-DRB mols.  We showed that the MAG-Tn3 vaccine, which was formulated with the GSK proprietary immunostimulant AS15 and designed for human cancer therapy, is able to induce an anti-Tn antibody response in mice of various H-2 haplotypes, and this response correlates with the ability to induce a specific T cell response against the TT830-844 peptide.  The universality of the TT830-844 peptide was extended to new H-2 and HLA-DRB mols. that were capable of binding this T cell epitope.  Finally, the MAG-Tn3 vaccine was able to induce anti-Tn antibody responses in cynomolgus monkeys, which targeted Tn-expressing tumor cells and mediated tumor cell death both in vitro and in vivo.  Thus, MAG-Tn3 is a highly promising anticancer vaccine that is currently under evaluation in a phase I clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0weeQQxHabVg90H21EOLACvtfcHk0lj4D1x9WWSbAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSmsr4%253D&md5=913211d77c205902ac2a681ce07698a5</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs00262-016-1802-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-016-1802-0%26sid%3Dliteratum%253Aachs%26aulast%3DLaubreton%26aufirst%3DD.%26aulast%3DBay%26aufirst%3DS.%26aulast%3DSedlik%26aufirst%3DC.%26aulast%3DArtaud%26aufirst%3DC.%26aulast%3DGanneau%26aufirst%3DC.%26aulast%3DD%25C3%25A9riaud%26aufirst%3DE.%26aulast%3DViel%26aufirst%3DS.%26aulast%3DPuaux%26aufirst%3DA.-L.%26aulast%3DAmigorena%26aufirst%3DS.%26aulast%3DG%25C3%25A9rard%26aufirst%3DC.%26aulast%3DLo-Man%26aufirst%3DR.%26aulast%3DLeclerc%26aufirst%3DC.%26atitle%3DThe%2520fully%2520synthetic%2520MAG-Tn3%2520therapeutic%2520vaccine%2520containing%2520the%2520tetanus%2520toxoid-derived%2520TT830-844%2520universal%2520epitope%2520provides%2520anti-tumor%2520immunity%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2016%26volume%3D65%26spage%3D315%26epage%3D325%26doi%3D10.1007%2Fs00262-016-1802-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Celhar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, A. M.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">265</span>, <span class="refDoi"> DOI: 10.3389/fphar.2014.00265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.3389%2Ffphar.2014.00265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=25538618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A280%3ADC%252BC2MvhsFOntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=265&author=T.+Celharauthor=A.+M.+Fairhurst&title=Toll-like+receptors+in+systemic+lupus+erythematosus%3A+potential+for+personalized+treatment&doi=10.3389%2Ffphar.2014.00265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment</span></div><div class="casAuthors">Celhar Teja; Fairhurst Anna-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by the loss of tolerance to self-nuclear antigens.  The symptoms of SLE, progression of pathology and the array of autoantibodies present in the serum differ significantly from patient to patient, which calls for a personalized approach to treatment.  SLE is polygenic and strongly influenced by gender, ethnicity, and environmental factors.  Data from genome-wide association studies suggests that polymorphisms in as many as 100 genes contribute to SLE susceptibility.  Recent research has focused on genes associated with Toll-like receptors (TLRs), type I interferons, immune regulation pathways, and immune-complex clearance.  TLR7 and TLR9 have been extensively studied using lupus-prone mouse models.  In multiple systems overexpression of TLR7 drives disease progression but interestingly, a loss of TLR9 results in an almost identical phenotype.  While TLR7 overexpression has been linked to human SLE, the possible role of TLR9 in human disease remains elusive.  In the present review, we focus on TLR polymorphisms and TLR expression in SLE patients and discuss their potential as biomarkers for individualized treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFYLBm7yT-jrYtC3U5jeOifW6udTcc2earfAKMkz_qqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvhsFOntA%253D%253D&md5=78557b5a30213ee8398108943df8ebf3</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2014.00265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2014.00265%26sid%3Dliteratum%253Aachs%26aulast%3DCelhar%26aufirst%3DT.%26aulast%3DFairhurst%26aufirst%3DA.%2BM.%26atitle%3DToll-like%2520receptors%2520in%2520systemic%2520lupus%2520erythematosus%253A%2520potential%2520for%2520personalized%2520treatment%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D5%26spage%3D265%26doi%3D10.3389%2Ffphar.2014.00265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b'],'ref26':['cit26a','cit26b','cit26c'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b'],'ref32':['cit32'],'ref33':['cit33a','cit33b'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wen-Hao Li, <span class="NLM_string-name hlFld-ContribAuthor">Yan-Mei Li</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Strategies to Boost Cancer Vaccines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2020,</strong> <em>120 </em>
                                    (20)
                                     , 11420-11478. <a href="https://doi.org/10.1021/acs.chemrev.9b00833" title="DOI URL">https://doi.org/10.1021/acs.chemrev.9b00833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.9b00833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.9b00833%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DChemical%252BStrategies%252Bto%252BBoost%252BCancer%252BVaccines%26aulast%3DLi%26aufirst%3DWen-Hao%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D23122019%26date%3D11092020%26volume%3D120%26issue%3D20%26spage%3D11420%26epage%3D11478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yonghui Liu, Bocheng Yan, Zhaoyu Wang, Haomiao Zhu, Xiaona Yin, Kun Wang, Menglei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Wei Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Preliminary Immunological Studies of MUC1-Based Antitumor Vaccines Adjuvanted with R- and S-FSL-1. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (7)
                                     , 1371-1376. <a href="https://doi.org/10.1021/acsmedchemlett.9b00579" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00579%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPreliminary%252BImmunological%252BStudies%252Bof%252BMUC1-Based%252BAntitumor%252BVaccines%252BAdjuvanted%252Bwith%252BR-%252Band%252BS-FSL-1%26aulast%3DLiu%26aufirst%3DYonghui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D06122019%26date%3D22062020%26date%3D24062020%26date%3D22062020%26volume%3D11%26issue%3D7%26spage%3D1371%26epage%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harlei  Martin</span>, <span class="hlFld-ContribAuthor ">Hannah  Masterson</span>, <span class="hlFld-ContribAuthor ">Kevin  Kavanagh</span>, <span class="hlFld-ContribAuthor ">Trinidad  Velasco-Torrijos</span>. </span><span class="cited-content_cbyCitation_article-title">The Synthesis and Evaluation of Multivalent Glycopeptoids as Inhibitors of the Adhesion of Candida albicans. </span><span class="cited-content_cbyCitation_journal-name">Pathogens</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 572. <a href="https://doi.org/10.3390/pathogens10050572" title="DOI URL">https://doi.org/10.3390/pathogens10050572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pathogens10050572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpathogens10050572%26sid%3Dliteratum%253Aachs%26jtitle%3DPathogens%26atitle%3DThe%252BSynthesis%252Band%252BEvaluation%252Bof%252BMultivalent%252BGlycopeptoids%252Bas%252BInhibitors%252Bof%252Bthe%252BAdhesion%252Bof%252BCandida%252Balbicans%26aulast%3DMartin%26aufirst%3DHarlei%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D5%26spage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aapo  Aho</span>, <span class="hlFld-ContribAuthor ">Antti  Äärelä</span>, <span class="hlFld-ContribAuthor ">Heidi  Korhonen</span>, <span class="hlFld-ContribAuthor ">Pasi  Virta</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding the Scope of the Cleavable N-(Methoxy)oxazolidine Linker for the Synthesis of Oligonucleotide Conjugates. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (2)
                                     , 490. <a href="https://doi.org/10.3390/molecules26020490" title="DOI URL">https://doi.org/10.3390/molecules26020490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26020490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26020490%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DExpanding%252Bthe%252BScope%252Bof%252Bthe%252BCleavable%252BN-%252528Methoxy%252529oxazolidine%252BLinker%252Bfor%252Bthe%252BSynthesis%252Bof%252BOligonucleotide%252BConjugates%26aulast%3DAho%26aufirst%3DAapo%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D2%26spage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-He  Luo</span>, <span class="hlFld-ContribAuthor ">Kai  Yang</span>, <span class="hlFld-ContribAuthor ">Jian-Yun  Lin</span>, <span class="hlFld-ContribAuthor ">Juan-Juan  Gao</span>, <span class="hlFld-ContribAuthor ">Xin-Yan  Wu</span>, <span class="hlFld-ContribAuthor ">Zhao-Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amino acid derivatives of 5-alkoxy-3,4-dihalo-2(5
              H
              )-furanones and their preliminary bioactivity investigation as linkers. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (20)
                                     , 5138-5147. <a href="https://doi.org/10.1039/C9OB00736A" title="DOI URL">https://doi.org/10.1039/C9OB00736A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00736A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00736A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bamino%252Bacid%252Bderivatives%252Bof%252B5-alkoxy-3%25252C4-dihalo-2%2525285%252BH%252B%252529-furanones%252Band%252Btheir%252Bpreliminary%252Bbioactivity%252Binvestigation%252Bas%252Blinkers%26aulast%3DLuo%26aufirst%3DShi-He%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D20%26spage%3D5138%26epage%3D5147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Strategy for the synthesis of the three-component carbohydrate-based constructs <b>35</b> and <b>36</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the C-Terminus Alkyne-Functionalized β-Glycotripeptoids <b>15</b> and <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Fmoc-Cl, NaHCO<sub>3</sub>, 1,4-dioxane, rt, 4 h, 84% (<b>3</b>), 91% (<b>4</b>); (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub> (1:1, v/v), rt, 1 h, quantitative, then <b>1</b> or <b>2</b>, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, DMF, rt, overnight, 81% (<b>5</b> from <b>1</b> and <b>3</b>), 90% (<b>6</b> from <b>2</b> and <b>4</b>); (iii) TFA, CH<sub>2</sub>Cl<sub>2</sub> (1:1, v/v), rt, 1 h, quantitative, then <b>1</b> or <b>2</b>, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, DMF, rt, overnight, 75% (<b>7</b> from <b>1</b> and <b>5</b>), 87% (<b>8</b> from <b>2</b> and <b>6</b>); (iv) Et<sub>2</sub>NH, CH<sub>3</sub>CN (1:2, v/v), rt, 4 h, quantitative; (v) NaOMe, MeOH, rt, 1 h, quantitative; (vi) <b>7</b> or <b>8</b>, TFA, CH<sub>2</sub>Cl<sub>2</sub> (1:1, v/v), rt, 1 h, quantitative then H<sub>2</sub>NCH<sub>2</sub>CCH, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, CH<sub>3</sub>CN, rt, overnight, 95% (<b>13</b>), 86% (<b>14</b>).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Biotinylation of Glycopeptoid Platforms <b>9</b> and <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <b>9</b> or <b>10</b>, HO<sub>2</sub>C(CH<sub>2</sub>)<sub>5</sub>NH-Fmoc, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, DMF, rt, 14 h, 50% (<b>9</b>), 90% (<b>10</b>); (ii) <b>17</b> or <b>18</b>, Et<sub>2</sub>NH, CH<sub>3</sub>CN (1:2, v/v), rt, 4 h; (iii) biotin <i>N</i>-hydroxysuccinimide, Et<sub>3</sub>N, DMF, rt, 16 h, 81% (<b>17</b>), 37% (<b>18</b>); (iv) NaOMe, MeOH, rt, 1 h, quantitative.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Biotinylation of TLR7 Agonist <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) biotin (1 equiv), IBCF 1.2 equiv, Bu<sub>3</sub>N 1.3 equiv., DMF, rt, then 0 °C, BocNH(CH<sub>2</sub>)<sub>4</sub>NH<sub>2</sub> in DMF, 4h, rt; (ii) TFA/DCM 1/1; (iii) HATU 2 equiv, DIEA 5 equiv, <b>24</b> (1 equiv) DMF.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Three-Component Carbohydrate-Based Constructs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) aminocaproic acid, IBCF, N(Bu)<sub>3</sub>, DMF, H<sub>2</sub>O (3:1, v/v), 0 °C, 24 h, 55%; (ii) <b>9</b> or <b>10</b> or <b>15</b> or <b>16</b>, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, DMF, rt, overnight, 53% (<b>27</b> from <b>9</b>), 53% (<b>28</b> from <b>10</b>), 48% (<b>29</b> from <b>15</b>), 50% (<b>30</b> from <b>16</b>); (iii) NaOMe, MeOH, rt, 1 h, quantitative; (iv) N<sub>3</sub>-OVA 323–339, THPTA, aminoguanidine hydrochloride, HEPES buffer (100 mM, pH 7.5), H<sub>2</sub>O, HFIP, 1–3 h, 80% (<b>35</b> from <b>33</b>), 77% (<b>36</b> from <b>34</b>).</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. In vitro adjuvanticity and T-antigenicity of the glycoconjugates <b>31</b>, <b>35</b>, and <b>36</b>. Mouse BMDCs (10<sup>5</sup>) were cultured at 37 °C either with increasing concentrations of <b>11</b>, <b>24</b>, <b>31</b>, <b>35</b>, or <b>36</b> for 48 h or with increasing concentrations of the same compounds for 3 days in the presence of OT-II CD4<sup>+</sup> T lymphocytes isolated from OT-II transgenic mice. IL-12p40 (A), IL-6 (B), and IFN-γ (C) were measured in cell supernatants by ELISA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vivo T-immunogenicity of the three-component glycopeptoids <b>35</b> and <b>36</b>. After administration of 2 × 10<sup>5</sup> OT-II CD4<sup>+</sup> T cells, C57BL/6 mice (<i>n</i> = 3 per group) were intradermally immunized with <b>24</b>, <b>31</b>, <b>35</b>, <b>36</b>, or OVA 323–339 (11.7 nmol per mouse). After 5 days, mice were sacrificed and then the spleen and draining lymph node were collected. OT-II CD4<sup>+</sup> T cells proliferation (A) was detected by flow cytometry using FITC labeled antibodies anti-CD4, anti-Vα2, and anti-Vβ5. Among CD4<sup>+</sup> population, the number of OT-II CD4<sup>+</sup> T cells in lymph node that produce IFN-γ (Β) was determined using FITC labeled antibody anti-IFN-γ. The splenocytes were cultured (5 × 10<sup>5</sup>) in the presence or not of OVA 323–339 (1 μg/mL) at 37 °C for 48 h, and IFN-γ (C) and IL-5 (D) levels were measured in the supernatants by ELISA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo B-immunogenicity of the three-component glycopeptoids <b>35</b>. C57BL/6 mice (<i>n</i> = 3 per group) were intradermally immunized on days 0 and 21 with 11.7 nmol of <b>31</b>, <b>35</b>, or OVA 323–339. Sera were collected on day 0 and before (day 20) or after (day 28) the second injection and were tested for IgG antibodies by ELISA using <b>31</b>, OVA 323–339, or biotinylated Tn3G7K coated at 1 μg/mL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/medium/jm-2018-00960w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Superior efficacy of the three-component glycopeptoids <b>35</b> and <b>36</b> in their ability to induce anti-TLR7 agonist IgG. (A–H) C57BL/6 mice (<i>n</i> = 3 per group) were intradermally immunized on days 1 and 20 and then intravenously on day 92 with 11.7 nmol of the compounds <b>24</b>, <b>31</b>, <b>35</b>, <b>36</b> or the peptide OVA 323–339. Sera were collected after the second (A–D, day 27) and the third (E–H, day 111) injections and were analyzed for IgG antibodies by ELISA using <b>21</b>, <b>22</b>, <b>25</b>, or biotinylated Tn3G7K coated at 1 μg/mL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00960/20181101/images/large/jm-2018-00960w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00960&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 77 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span>; <span class="NLM_string-name">Manjili, M. H.</span>; <span class="NLM_string-name">Subjeck, J. R.</span>; <span class="NLM_string-name">Sarkar, D.</span>; <span class="NLM_string-name">Fisher, P. B.</span>; <span class="NLM_string-name">Wang, X. Y.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Cancer Vaccines: Past, Present, and Future</span>. In  <i>Advances in Cancer Research</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, K. D.</span>, <span class="NLM_string-name">Fisher, P. B.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">119</span>, Chapter 7, pp  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-407190-2.00007-1</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2FB978-0-12-407190-2.00007-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=421-475&author=C.+Guo&author=M.+H.+Manjili&author=J.+R.+Subjeck&author=D.+Sarkar&author=P.+B.+Fisher&author=X.+Y.+Wangauthor=K.+D.+Tew&author=P.+B.+Fisher&title=Advances+in+Cancer+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-407190-2.00007-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-407190-2.00007-1%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DC.%26atitle%3DTherapeutic%2520Cancer%2520Vaccines%253A%2520Past%252C%2520Present%252C%2520and%2520Future%26btitle%3DAdvances%2520in%2520Cancer%2520Research%26aulast%3DTew%26aufirst%3DK.%2BD.%26pub%3DAcademic%2520Press%26date%3D2013%26volume%3D119%26spage%3D421%26epage%3D475%26doi%3D10.1016%2FB978-0-12-407190-2.00007-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. d.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. h.</span></span> <span> </span><span class="NLM_article-title">Therapeutic cancer vaccines: From initial findings to prospects</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2018.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.imlet.2018.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=29407608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2018&pages=11-21&author=Q.+Songauthor=C.+d.+Zhangauthor=X.+h.+Wu&title=Therapeutic+cancer+vaccines%3A+From+initial+findings+to+prospects&doi=10.1016%2Fj.imlet.2018.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic cancer vaccines: From initial findings to prospects</span></div><div class="casAuthors">Song, Qian; Zhang, Cheng-dong; Wu, Xiang-hua</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-21</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With the approval of the first therapeutic cancer vaccine by US Food and Drug Administration, numerous therapeutic cancer vaccines have been under clin. trials with an inspiring antitumor immune response in cancer patients.  Though there is no therapeutic cancer vaccine showing clin. efficacy in phase III trials, recent advances in personalized cancer vaccine based on neoantigens have emerged as an efficient way to induce tumor regression.  In this review, we discuss the selection methods of tumor specific antigen and mainly focus on the development of therapeutic cancer vaccine strategies.  Besides, we highlight the newly developed personalized cancer vaccine as a novel therapeutic approach for cancer patients.  Finally, we outline the recent development of therapeutic cancer vaccine in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAVsFvJGfZCbVg90H21EOLACvtfcHk0lhBPhbsbWzgrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOrtLg%253D&md5=388c83100cd941a32c2250e7ccdd13f4</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2018.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2018.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%2Bd.%26aulast%3DWu%26aufirst%3DX.%2Bh.%26atitle%3DTherapeutic%2520cancer%2520vaccines%253A%2520From%2520initial%2520findings%2520to%2520prospects%26jtitle%3DImmunol.%2520Lett.%26date%3D2018%26volume%3D196%26spage%3D11%26epage%3D21%26doi%3D10.1016%2Fj.imlet.2018.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W. W.</span></span> <span> </span><span class="NLM_article-title">Overview of research and development for anticancer drugs</span>. <i>J. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.4236/jct.2016.710077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.4236%2Fjct.2016.710077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFWjsLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=762-772&author=J.+J.+Xuauthor=W.+W.+Mao&title=Overview+of+research+and+development+for+anticancer+drugs&doi=10.4236%2Fjct.2016.710077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of research and development for anticancer drugs</span></div><div class="casAuthors">Xu, Junjie; Mao, Wenwei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">762-772</span>CODEN:
                <span class="NLM_cas:coden">JCTOBF</span>;
        ISSN:<span class="NLM_cas:issn">2151-1942</span>.
    
            (<span class="NLM_cas:orgname">Scientific Research Publishing, Inc.</span>)
        </div><div class="casAbstract">Anticancer drugs research and development have been the largest market area in the pharmaceutical industry in terms of the no. of project, clin. trials and spending.  In the last 10 - 30 years, targeting therapy for cancers has been developed and achieved enormous clin. effectiveness by transforming some previously deadly malignancies into chronically manageable conditions, but cure problem still remains.  This mini review outlined the current status of anticancer drugs development and hinted the opinions of how to further increase the accuracy and efficacy of discovery for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0NJgYBS4S-bVg90H21EOLACvtfcHk0lhbqqMjLdukxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFWjsLnM&md5=25cbfa273ff779cc503f9a8bc5fa8275</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4236%2Fjct.2016.710077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fjct.2016.710077%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%2BJ.%26aulast%3DMao%26aufirst%3DW.%2BW.%26atitle%3DOverview%2520of%2520research%2520and%2520development%2520for%2520anticancer%2520drugs%26jtitle%3DJ.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D7%26spage%3D762%26epage%3D772%26doi%3D10.4236%2Fjct.2016.710077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, M.</span></span> <span> </span><span class="NLM_article-title">Possible roles of tumor-associated carbohydrate antigens</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2237</span>– <span class="NLM_lpage">2244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=8625291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK28XivF2rtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=2237-2244&author=M.+Fukuda&title=Possible+roles+of+tumor-associated+carbohydrate+antigens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Possible roles of tumor-associated carbohydrate antigens</span></div><div class="casAuthors">Fukuda, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2237-2244</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review with 92 refs.  Recent progress in the studies on the roles of carbohydrates has brought about crit. discoveries, which allow the development of working hypotheses for understanding the roles of tumor-assocd. carbohydrate antigens.  In this report, the author focuses on 3 different aspects of this progress.  (1) The immunol. response to oligosaccharides aberrantly expressed under pathol. conditions; (2) possible roles of carbohydrate-dependent cell adhesion during tumor metastasis; and (3) the roles of carbohydrates in modulating the functions of proteins that attach those carbohydrates.  These 3 areas in the roles of carbohydrates will likely be the target for continuous research efforts to reveal the roles of tumor-assocd. carbohydrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNzJG8k-m2qrVg90H21EOLACvtfcHk0lhbqqMjLdukxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivF2rtbo%253D&md5=6f38724f27b221f93c85ab1e2fedf6ee</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukuda%26aufirst%3DM.%26atitle%3DPossible%2520roles%2520of%2520tumor-associated%2520carbohydrate%2520antigens%26jtitle%3DCancer%2520Res.%26date%3D1996%26volume%3D56%26spage%3D2237%26epage%3D2244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hakomori, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Glycosphingolipid antigens and cancer therapy</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(97)90253-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2FS1074-5521%2897%2990253-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=9190292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK2sXitVygt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=97-104&author=S.-I.+Hakomoriauthor=Y.+Zhang&title=Glycosphingolipid+antigens+and+cancer+therapy&doi=10.1016%2FS1074-5521%2897%2990253-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Glycosphingolipid antigens and cancer therapy</span></div><div class="casAuthors">Hakomori, Sen-itiroh; Zhang, Yongmin</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-104</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 47 refs.  Specific types of glycosphingolipid (GSL), which are chem. detectable in normal cells, are more highly expressed in tumors.  The high level of expression on the surfaces of tumor cells causes antibody response to these GSLs, which can therefore be described as tumor-assocd. antigens.  Some of these GSLs have been shown to be adhesion mols. involved in tumor cell metastasis, and to be modulators of signal transduction controlling tumor cell growth and motility.  Tumor-assocd. GSL antigens have been used in the development of antitumor vaccines.  GSLs and sphingolipids involved in adhesion and signaling are therefore targets for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS-QevOK-PY7Vg90H21EOLACvtfcHk0lhbqqMjLdukxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitVygt7o%253D&md5=783df93cd6ace5757184ac8f9a150999</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2897%2990253-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252897%252990253-2%26sid%3Dliteratum%253Aachs%26aulast%3DHakomori%26aufirst%3DS.-I.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DGlycosphingolipid%2520antigens%2520and%2520cancer%2520therapy%26jtitle%3DChem.%2520Biol.%26date%3D1997%26volume%3D4%26spage%3D97%26epage%3D104%26doi%3D10.1016%2FS1074-5521%2897%2990253-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span> <span> </span><span class="NLM_article-title">Recent advance in tumor-associated carbohydrate antigens (TACAs)-based antitumor vaccines</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">850</span>– <span class="NLM_lpage">863</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00084</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00084" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=850-863&author=D.+Fengauthor=A.+S.+Shaikhauthor=F.+Wang&title=Recent+advance+in+tumor-associated+carbohydrate+antigens+%28TACAs%29-based+antitumor+vaccines&doi=10.1021%2Facschembio.6b00084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines</span></div><div class="casAuthors">Feng, Danyang; Shaikh, Abdul Sami; Wang, Fengshan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">850-863</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cancer cells can be distinguished from normal cells by displaying aberrant levels and types of carbohydrate structures on their surfaces.  These carbohydrate structures are known as tumor-assocd. carbohydrate antigens (TACAs).  TACAs were considered as promising targets for the design of anticancer vaccines.  Unfortunately, carbohydrates alone can only evoke poor immunogenicity because they are unable to induce T-cell-dependent immune responses, which is crit. for cancer therapy.  Moreover, immunotolerance and immunosuppression are easily induced by using natural occurring TACAs as antigens due to their endogenous property.  This review summarizes the recent strategies to overcome these obstacles: (1) covalently coupling TACAs to proper carriers to improve immunogenicity, including clustered or multivalent conjugate vaccines, (2) coupling TACAs to T-cell peptide epitopes or the built-in adjuvant to form multicomponent glycoconjugate vaccines, and (3) developing vaccines based on chem. modified TACAs, which is combined with metabolic engineering of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ASHeSykribVg90H21EOLACvtfcHk0lhbqqMjLdukxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVSgtLo%253D&md5=d9dfadd80fc9d72e7ed2bd1ec9b0b29b</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00084%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DShaikh%26aufirst%3DA.%2BS.%26aulast%3DWang%26aufirst%3DF.%26atitle%3DRecent%2520advance%2520in%2520tumor-associated%2520carbohydrate%2520antigens%2520%2528TACAs%2529-based%2520antitumor%2520vaccines%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D850%26epage%3D863%26doi%3D10.1021%2Facschembio.6b00084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slovin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keding, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragupathi, G.</span></span> <span> </span><span class="NLM_article-title">Carbohydrate vaccines as immunotherapy for cancer</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">418</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1111/j.1440-1711.2005.01350.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1111%2Fj.1440-1711.2005.01350.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=16033538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVars74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2005&pages=418-428&author=S.+F.+Slovinauthor=S.+J.+Kedingauthor=G.+Ragupathi&title=Carbohydrate+vaccines+as+immunotherapy+for+cancer&doi=10.1111%2Fj.1440-1711.2005.01350.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate vaccines as immunotherapy for cancer</span></div><div class="casAuthors">Slovin, Susan F.; Keding, Stacy J.; Ragupathi, Govind</div><div class="citationInfo"><span class="NLM_cas:title">Immunology and Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">418-428</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">0818-9641</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Carbohydrates have established themselves as the most clin. relevant antigens of those tested and subsequently developed for vaccines against infectious diseases.  However, in cancer patients, many of the defined carbohydrate antigens are really altered 'self' antigens and for unclear reasons, the body does not react to them immunol.  Although these self antigens have been found to be potentially suitable targets for immune recognition and killing, the development of vaccines for cancer treatment is actually more challenging compared with those for infectious diseases mainly because of the difficulty assocd. with breaking the body's immunol. tolerance to the antigen.  These antigens lack the inherent immunogenicity assocd. with bacterial antigens and, therefore, methods to enhance immunol. recognition and induction of immunity in vivo are under investigation.  These include defining the appropriate tumor-assocd. antigen, successfully synthesizing the antigen to mimic the original mol., inducing an immune response, and subsequently enhancing the immunol. reactivity so that all components can work together.  This has been successfully accomplished with several glycolipid and glycoprotein antigens using carriers such as keyhole limpet haemocyanin (KLH) together with a saponin adjuvant, QS-21.  Not only can high titer IgM and IgG antibodies be induced, which are specific for the antigen used for immunization, but the antibodies can mediate complement lysis.  The approaches for synthesis, conjugation, clin. administration and immunol. potential are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiS9v7I16EzLVg90H21EOLACvtfcHk0limL7JWJWCfBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVars74%253D&md5=b2c969e6d5dbb50c89dbf40ce6a4d35a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1711.2005.01350.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1711.2005.01350.x%26sid%3Dliteratum%253Aachs%26aulast%3DSlovin%26aufirst%3DS.%2BF.%26aulast%3DKeding%26aufirst%3DS.%2BJ.%26aulast%3DRagupathi%26aufirst%3DG.%26atitle%3DCarbohydrate%2520vaccines%2520as%2520immunotherapy%2520for%2520cancer%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2005%26volume%3D83%26spage%3D418%26epage%3D428%26doi%3D10.1111%2Fj.1440-1711.2005.01350.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kuduk, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glunz, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragupathi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span> <span> </span><span class="NLM_article-title">Synthetic and immunological studies on clustered modes of mucin-related Tn and TF O-linked antigens: the preparation of a glycopeptide-based vaccine for clinical trials against prostate cancer</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">12474</span>– <span class="NLM_lpage">12485</span>, <span class="refDoi"> DOI: 10.1021/ja9825128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9825128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK1cXnsVaqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=12474-12485&author=S.+D.+Kudukauthor=J.+B.+Schwarzauthor=X.-T.+Chenauthor=P.+W.+Glunzauthor=D.+Samesauthor=G.+Ragupathiauthor=P.+O.+Livingstonauthor=S.+J.+Danishefsky&title=Synthetic+and+immunological+studies+on+clustered+modes+of+mucin-related+Tn+and+TF+O-linked+antigens%3A+the+preparation+of+a+glycopeptide-based+vaccine+for+clinical+trials+against+prostate+cancer&doi=10.1021%2Fja9825128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic and immunological studies on clustered modes of mucin-related Tn and TF O-linked antigens: The preparation of a glycopeptide-based vaccine for clinical trials against prostate cancer</span></div><div class="casAuthors">Kuduk, Scott D.; Schwarz, Jacob B.; Chen, Xiao-Tao; Glunz, Peter W.; Sames, Dalibor; Ragupathi, Govindaswami; Livingston, Philip O.; Danishefsky, Samuel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">12474-12485</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The syntheses of two tumor-assocd. carbohydrate antigens, Tn and TF, have been achieved using glycal assembly and cassette methodologies.  These synthetic antigens were subsequently clustered (c) and immunoconjugated to a carrier protein (KLH or BSA) or a synthetic lipopeptide (pam) for immunol. study.  Three Tn conjugates were used to vaccinate groups of mice, and all prepns. proved to be immunogenic.  The Tn(c) covalently linked to KLH (27-KLH) plus the adjuvant QS-21 was the optimal vaccine, inducing high median IgM and IgG titers against Tn(c) by ELISA.  These antibodies were strongly reactive with the Tn(c) pos. human colon cancer cell line LS-C but not the Tn(c) neg. colon cancer cell line LS-B by FACS.  The antibody reactivities with natural antigens were inhibited with synthetic Tn(c) but not with structurally unrelated compds.  On the basis of these results, vaccines contg. 27-KLH and 30-pam plus QS-21 are being tested in patients with prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrtZH2AMtJ7Vg90H21EOLACvtfcHk0limL7JWJWCfBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsVaqsLs%253D&md5=2e5d2f149079292339a75ab475815b42</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1021%2Fja9825128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9825128%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DX.-T.%26aulast%3DGlunz%26aufirst%3DP.%2BW.%26aulast%3DSames%26aufirst%3DD.%26aulast%3DRagupathi%26aufirst%3DG.%26aulast%3DLivingston%26aufirst%3DP.%2BO.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26atitle%3DSynthetic%2520and%2520immunological%2520studies%2520on%2520clustered%2520modes%2520of%2520mucin-related%2520Tn%2520and%2520TF%2520O-linked%2520antigens%253A%2520the%2520preparation%2520of%2520a%2520glycopeptide-based%2520vaccine%2520for%2520clinical%2520trials%2520against%2520prostate%2520cancer%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D12474%26epage%3D12485%26doi%3D10.1021%2Fja9825128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragupathi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildersleeve, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, P. O.</span></span> <span> </span><span class="NLM_article-title">Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1007/s00262-004-0584-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1007%2Fs00262-004-0584-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=15625606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFyrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=424-430&author=E.+Kaganauthor=G.+Ragupathiauthor=S.+S.+Yiauthor=C.+A.+Reisauthor=J.+Gildersleeveauthor=D.+Kahneauthor=H.+Clausenauthor=S.+J.+Danishefskyauthor=P.+O.+Livingston&title=Comparison+of+antigen+constructs+and+carrier+molecules+for+augmenting+the+immunogenicity+of+the+monosaccharide+epithelial+cancer+antigen+Tn&doi=10.1007%2Fs00262-004-0584-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn</span></div><div class="casAuthors">Kagan, Ella; Ragupathi, Govind; Yi, San San; Reis, Celso A.; Gildersleeve, Jeff; Kahne, Daniel; Clausen, Henrik; Danishefsky, Samuel J.; Livingston, Philip O.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">424-430</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">The authors have demonstrated previously that the optimal method for inducing an antibody response against defined cancer antigens is covalent conjugation of the antigen to keyhole limpet hemocyanin (KLH) and use of the potent saponin adjuvant QS-21.  Single mols. of glycolipids (tetrasaccharides, pentasaccharides, or hexasaccharides) and MUC1 peptides (contg. between 1 and 5 MUC1 tandem repeats) conjugated to KLH have proven sufficient for antibody recognition and vaccine construction.  However, cancer specificity of monoclonal antibodies against the monosaccharide Tn and disaccharide sTn comes largely from recognition of clusters (c) of these mols. on the cell surface.  Tn consists of a monosaccharide (GalNAc) O-linked to serine or threonine on epithelial cancer mucins which are uniquely rich in serines and threonines.  The authors tested here several Tn constructs: Tn monosaccharide, Tn(c) prepd. on a triple threonine backbone, and Tn prepd. on a partially or fully glycosylated MUC1 backbone.  They det. that Tn(c) is more effective than Tn, and conjugation to KLH is more effective than conjugation to BSA or polystyrene beads for inducing ELISA reactivity against Tn, and FACS reactivity against Tn-pos. tumor cells.  Surprisingly, MUC1 glycosylated with Tn at 3 or 5 sites per 20 amino acid MUC1 tandem repeat and conjugated to KLH, induced the strongest antibody response against Tn and tumor cells expressing Tn, and had the addnl. advantage of inducing antibodies against MUC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX272MGCVGvrVg90H21EOLACvtfcHk0limL7JWJWCfBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFyrsbk%253D&md5=011cd6ba4f64ff9f83a341dfb2a31ff9</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1007%2Fs00262-004-0584-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-004-0584-y%26sid%3Dliteratum%253Aachs%26aulast%3DKagan%26aufirst%3DE.%26aulast%3DRagupathi%26aufirst%3DG.%26aulast%3DYi%26aufirst%3DS.%2BS.%26aulast%3DReis%26aufirst%3DC.%2BA.%26aulast%3DGildersleeve%26aufirst%3DJ.%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DClausen%26aufirst%3DH.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DLivingston%26aufirst%3DP.%2BO.%26atitle%3DComparison%2520of%2520antigen%2520constructs%2520and%2520carrier%2520molecules%2520for%2520augmenting%2520the%2520immunogenicity%2520of%2520the%2520monosaccharide%2520epithelial%2520cancer%2520antigen%2520Tn%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2005%26volume%3D54%26spage%3D424%26epage%3D430%26doi%3D10.1007%2Fs00262-004-0584-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slovin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragupathi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musselli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olkiewicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuduk, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span> <span> </span><span class="NLM_article-title">Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with α-<i>n</i>-acetylgalactosamine-<i>o</i>-serine/threonine conjugate vaccine</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4292</span>– <span class="NLM_lpage">4298</span>, <span class="refDoi"> DOI: 10.1200/JCO.2003.04.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1200%2FJCO.2003.04.112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=14645418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVWqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=4292-4298&author=S.+F.+Slovinauthor=G.+Ragupathiauthor=C.+Musselliauthor=K.+Olkiewiczauthor=D.+Verbelauthor=S.+D.+Kudukauthor=J.+B.+Schwarzauthor=D.+Samesauthor=S.+J.+Danishefskyauthor=P.+O.+Livingstonauthor=H.+I.+Scher&title=Fully+synthetic+carbohydrate-based+vaccines+in+biochemically+relapsed+prostate+cancer%3A+clinical+trial+results+with+%CE%B1-n-acetylgalactosamine-o-serine%2Fthreonine+conjugate+vaccine&doi=10.1200%2FJCO.2003.04.112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with α-N-acetylgalactosamine-O-serine/threonine conjugate vaccine</span></div><div class="casAuthors">Slovin, Susan F.; Ragupathi, Govindaswami; Musselli, Cristina; Olkiewicz, Krystyna; Verbel, David; Kuduk, Scott D.; Schwarz, Jacob B.; Sames, Dalibor; Danishefsky, Samuel; Livingston, Philip O.; Scher, Howard I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4292-4298</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Reported is the synthesis of a mucin-related O-linked glycopeptide, α-N-acetylgalactosamine-O-serine/ threonine (Tn), which is highly simplistic in its structure and can induce a relevant humoral response when given in a trimer or clustered (c) formation.  The authors tested it for an antitumor effect, in the form of a change in the posttreatment vs. pretreatment prostate-specific antigen (PSA) slopes, that might serve as a surrogate for effectiveness of vaccines in delaying the time to radiog. progression.  The antibody response was compared to immunization with 2 conjugates, Tn(c)-keyhole limpet hemocyanin (KLH) and Tn(c)-palmitic acid (PAM) with the saponin immune adjuvant QS21, in a phase I clin. trial in patients with biochem. relapsed prostate cancer.  Patients received Tn(c)-KLH vaccine contg. either 3, 7, or 15 μg of Tn(c) per vaccination.  Ten patients received 100 μg of Tn(c)-PAM.  QS21 was included in all vaccines.  Five vaccinations were administered s.c. during 26 wk with an addnl. booster vaccine at week 50.  Tn(c), when given with the carrier mol. KLH and QS21, stimulated the prodn. of high-titer IgM and IgG antibodies.  Inferior antibody responses were seen with T(c)-PAM.  There was no evidence of enhanced immunogenicity with increasing doses of vaccine.  An antitumor effect in the form of a decline in posttreatment vs. pretreatment PSA slopes was also obsd.  Thus, a safe synthetic conjugate vaccine in a trimer formation was developed that can break immunol. tolerance by inducing specific humoral responses.  It seemed to affect the biochem. progression of the disease as detd. by a change in PSA log slope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc21sECCCiL7Vg90H21EOLACvtfcHk0lhTn1-exuiLYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVWqu7o%253D&md5=10b4ef9ca865d7ced343ad29ff0e58fc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1200%2FJCO.2003.04.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2003.04.112%26sid%3Dliteratum%253Aachs%26aulast%3DSlovin%26aufirst%3DS.%2BF.%26aulast%3DRagupathi%26aufirst%3DG.%26aulast%3DMusselli%26aufirst%3DC.%26aulast%3DOlkiewicz%26aufirst%3DK.%26aulast%3DVerbel%26aufirst%3DD.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DSames%26aufirst%3DD.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DLivingston%26aufirst%3DP.%2BO.%26aulast%3DScher%26aufirst%3DH.%2BI.%26atitle%3DFully%2520synthetic%2520carbohydrate-based%2520vaccines%2520in%2520biochemically%2520relapsed%2520prostate%2520cancer%253A%2520clinical%2520trial%2520results%2520with%2520%25CE%25B1-n-acetylgalactosamine-o-serine%252Fthreonine%2520conjugate%2520vaccine%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2003%26volume%3D21%26spage%3D4292%26epage%3D4298%26doi%3D10.1200%2FJCO.2003.04.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buskas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G.-J.</span></span> <span> </span><span class="NLM_article-title">The immunogenicity of the tumor-associated antigen lewis<sup>y</sup> may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3517</span>– <span class="NLM_lpage">3524</span>, <span class="refDoi"> DOI: 10.1002/chem.200400074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fchem.200400074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=15252797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFKrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3517-3524&author=T.+Buskasauthor=Y.+Liauthor=G.-J.+Boons&title=The+immunogenicity+of+the+tumor-associated+antigen+lewisy+may+be+suppressed+by+a+bifunctional+cross-linker+required+for+coupling+to+a+carrier+protein&doi=10.1002%2Fchem.200400074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The immunogenicity of the tumor-associated antigen Lewisy may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein</span></div><div class="casAuthors">Buskas, Therese; Li, Yanhong; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3517-3524</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A Lewisy (Ley) tetrasaccharide modified by an artificial amino-Pr spacer was synthesized by a highly convergent approach that employed a levulinoyl ester and a 9-fluorenylmethoxycarbonate for temporary protection of the hydroxy groups and a trichloroethyloxycarbonyl as an amino protecting group.  The artificial amino-Pr moiety was modified by a thioacetyl group, which allowed efficient conjugation to keyhole limpet hemocyanin (KLH) modified by electrophilic 4-(maleimidomethyl)cyclohexane-1-carboxylate (MI).  Mice were immunized with the KLH-MI-Ley antigen.  A detailed anal. of sera by ELISA established that a strong IgG (IgG) antibody response was elicited against the linker region.  The use of a smaller and more flexible 3-(bromoacetamido)propionate for the attachment of Ley to KLH not only reduced the IgG antibody response against the linker but also led to a significantly improved immune response against the Ley antigen.  This study shows that highly antigenic linkers suppress antibody responses to weak antigens such as self-antigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoERazblnNOibVg90H21EOLACvtfcHk0lhTn1-exuiLYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFKrtbg%253D&md5=99a4659d3fbbee0508f1a318d6d49659</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fchem.200400074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200400074%26sid%3Dliteratum%253Aachs%26aulast%3DBuskas%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBoons%26aufirst%3DG.-J.%26atitle%3DThe%2520immunogenicity%2520of%2520the%2520tumor-associated%2520antigen%2520lewisy%2520may%2520be%2520suppressed%2520by%2520a%2520bifunctional%2520cross-linker%2520required%2520for%2520coupling%2520to%2520a%2520carrier%2520protein%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2004%26volume%3D10%26spage%3D3517%26epage%3D3524%26doi%3D10.1002%2Fchem.200400074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buskas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G.-J.</span></span> <span> </span><span class="NLM_article-title">Immunotherapy for cancer: synthetic carbohydrate-based vaccines</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_fpage">5335</span>– <span class="NLM_lpage">5349</span>, <span class="refDoi"> DOI: 10.1039/b908664c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1039%2Fb908664c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=19724783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOntL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=5335-5349&author=T.+Buskasauthor=P.+Thompsonauthor=G.-J.+Boons&title=Immunotherapy+for+cancer%3A+synthetic+carbohydrate-based+vaccines&doi=10.1039%2Fb908664c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy for cancer: synthetic carbohydrate-based vaccines</span></div><div class="casAuthors">Buskas, Therese; Thompson, Pamela; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">5335-5349</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Aberrant glycosylation of glycoproteins and glycolipids of cancer cells, which correlates with poor survival rates, is being exploited for the development of immunotherapies for cancer.  In particular, advances in the knowledge of cooperation between the innate and adaptive system combined with the implementation of efficient synthetic methods for assembly of oligosaccharides and glycopeptides is providing avenues for the rationale design of vaccine candidates.  In this respect, fully synthetic vaccine candidates show great promise because they incorporate only those elements requires for relevant immune responses, and hence do not suffer from immune suppression obsd. with classical carbohydrate-protein conjugate vaccines.  Such vaccines are chem. well-defined and it is to be expected that they can be produced in a reproducible fashion.  In this feature article, recent advances in the development of fully synthetic sub-unit carbohydrate-based cancer vaccines will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7lAV5HqWTRLVg90H21EOLACvtfcHk0lhTn1-exuiLYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOntL3M&md5=4da7e01785f9dfd0c17bf243f833613a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1039%2Fb908664c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb908664c%26sid%3Dliteratum%253Aachs%26aulast%3DBuskas%26aufirst%3DT.%26aulast%3DThompson%26aufirst%3DP.%26aulast%3DBoons%26aufirst%3DG.-J.%26atitle%3DImmunotherapy%2520for%2520cancer%253A%2520synthetic%2520carbohydrate-based%2520vaccines%26jtitle%3DChem.%2520Commun.%26date%3D2009%26spage%3D5335%26epage%3D5349%26doi%3D10.1039%2Fb908664c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span> <span> </span><span class="NLM_article-title">A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinic</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">14462</span>– <span class="NLM_lpage">14472</span>, <span class="refDoi"> DOI: 10.1021/ja405932r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja405932r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OjtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=14462-14472&author=R.+M.+Wilsonauthor=S.+J.+Danishefsky&title=A+vision+for+vaccines+built+from+fully+synthetic+tumor-associated+antigens%3A+from+the+laboratory+to+the+clinic&doi=10.1021%2Fja405932r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A Vision for Vaccines Built from Fully Synthetic Tumor-Associated Antigens: From the Laboratory to the Clinic</span></div><div class="casAuthors">Wilson, Rebecca M.; Danishefsky, Samuel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">14462-14472</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Cancer cells may be distinguished from normal cells by cell surface displays of aberrant levels and types of carbohydrate domains.  Accordingly, these tumor-assocd. carbohydrate antigens (TACAs) represent promising target structures for the design of anticancer vaccines.  Over the past 20 years, the authors' lab. has sought to use the tools of chem. synthesis to develop TACA-based anticancer vaccine candidates.  The authors provide herein a personal accounting of the authors' lab.'s progress toward the long-standing goal of developing clin. viable fully synthetic carbohydrate-based anticancer vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCIfwl0ydsrLVg90H21EOLACvtfcHk0ljhHgZcaB6GUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OjtbnF&md5=5d3a7dd5fcbf3d34744cfd65c6ee50e3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fja405932r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja405932r%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DR.%2BM.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26atitle%3DA%2520vision%2520for%2520vaccines%2520built%2520from%2520fully%2520synthetic%2520tumor-associated%2520antigens%253A%2520from%2520the%2520laboratory%2520to%2520the%2520clinic%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D14462%26epage%3D14472%26doi%3D10.1021%2Fja405932r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westerlind, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidzik, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span> <span> </span><span class="NLM_article-title">Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">7551</span>– <span class="NLM_lpage">7556</span>, <span class="refDoi"> DOI: 10.1002/anie.200802102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fanie.200802102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Sju7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=7551-7556&author=U.+Westerlindauthor=A.+Hobelauthor=N.+Gaidzikauthor=E.+Schmittauthor=H.+Kunz&title=Synthetic+vaccines+consisting+of+tumor-associated+MUC1+glycopeptide+antigens+and+a+T-cell+epitope+for+the+induction+of+a+highly+specific+humoral+immune+response&doi=10.1002%2Fanie.200802102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response</span></div><div class="casAuthors">Westerlind, Ulrika; Hobel, Alexandra; Gaidzik, Nikola; Schmitt, Edgar; Kunz, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">7551-7556</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selective response: The fully synthetic vaccine shown, which contains a glycopeptide antigen from the tumor-assocd. mucin MUC1 and an immunostimulating T-cell epitope from ovalbumin, induces a highly specific immune response in mice.  The induced antibody reacts with the glycopeptides and analogs that carry addnl. tumor-assocd. TN antigen monosaccharides in their sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOC7boYRUe6bVg90H21EOLACvtfcHk0ljhHgZcaB6GUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Sju7nP&md5=187b508536642af782088ded756d135e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fanie.200802102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200802102%26sid%3Dliteratum%253Aachs%26aulast%3DWesterlind%26aufirst%3DU.%26aulast%3DHobel%26aufirst%3DA.%26aulast%3DGaidzik%26aufirst%3DN.%26aulast%3DSchmitt%26aufirst%3DE.%26aulast%3DKunz%26aufirst%3DH.%26atitle%3DSynthetic%2520vaccines%2520consisting%2520of%2520tumor-associated%2520MUC1%2520glycopeptide%2520antigens%2520and%2520a%2520T-cell%2520epitope%2520for%2520the%2520induction%2520of%2520a%2520highly%2520specific%2520humoral%2520immune%2520response%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D7551%26epage%3D7556%26doi%3D10.1002%2Fanie.200802102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cremer, G.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bureaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piller, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piller, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmas, A. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a multiantigenic Tn/TF-containing glycopeptide mimic of the tumor-related MUC1 glycoprotein</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200600104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fcmdc.200600104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=965-968&author=G.-A.+Cremerauthor=N.+Bureaudauthor=V.+Pillerauthor=H.+Kunzauthor=F.+Pillerauthor=A.+F.+Delmas&title=Synthesis+and+biological+evaluation+of+a+multiantigenic+Tn%2FTF-containing+glycopeptide+mimic+of+the+tumor-related+MUC1+glycoprotein&doi=10.1002%2Fcmdc.200600104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600104%26sid%3Dliteratum%253Aachs%26aulast%3DCremer%26aufirst%3DG.-A.%26aulast%3DBureaud%26aufirst%3DN.%26aulast%3DPiller%26aufirst%3DV.%26aulast%3DKunz%26aufirst%3DH.%26aulast%3DPiller%26aufirst%3DF.%26aulast%3DDelmas%26aufirst%3DA.%2BF.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520multiantigenic%2520Tn%252FTF-containing%2520glycopeptide%2520mimic%2520of%2520the%2520tumor-related%2520MUC1%2520glycoprotein%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D965%26epage%3D968%26doi%3D10.1002%2Fcmdc.200600104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geraci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Consoli, G. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galante, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bousquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappalardo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadaro, A.</span></span> <span> </span><span class="NLM_article-title">Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">758</span>, <span class="refDoi"> DOI: 10.1021/bc700411w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc700411w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlOmtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=751-758&author=C.+Geraciauthor=G.+M.+L.+Consoliauthor=E.+Galanteauthor=E.+Bousquetauthor=M.+Pappalardoauthor=A.+Spadaro&title=Calix%5B4%5Darene+decorated+with+four+Tn+antigen+glycomimetic+units+and+P3CS+immunoadjuvant%3A+synthesis%2C+characterization%2C+and+anticancer+immunological+evaluation&doi=10.1021%2Fbc700411w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Calix[4]arene Decorated with Four Tn Antigen Glycomimetic Units and P3CS Immunoadjuvant: Synthesis, Characterization, and Anticancer Immunological Evaluation</span></div><div class="casAuthors">Geraci, Corrada; Consoli, Grazia M. L.; Galante, Eva; Bousquet, Ennio; Pappalardo, Maria; Spadaro, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">751-758</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel anticancer vaccine candidate built on a nonpeptidic scaffold has been synthesized.  Four S-Tn tumor-assocd. glycomimetic antigens have been clustered onto a calix[4]arene scaffold bearing an immunoadjuvant moiety (P3CS).  The immunogenicity of the synthetic construct has been investigated by immunization of mice in vivo.  ELISA assay has evidenced that the tetravalent construct stimulates a higher prodn. of anti-Tn antigen IgG antibodies when compared to an analogous monovalent compd.  This result is ascribable to an antigen cluster effect and makes the reported vaccine candidate a good mimic of the natural motifs present on the mucine surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKLOhDRAYZ9bVg90H21EOLACvtfcHk0ljhHgZcaB6GUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlOmtr4%253D&md5=480c518b15c9025b2443200fb03f7964</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fbc700411w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700411w%26sid%3Dliteratum%253Aachs%26aulast%3DGeraci%26aufirst%3DC.%26aulast%3DConsoli%26aufirst%3DG.%2BM.%2BL.%26aulast%3DGalante%26aufirst%3DE.%26aulast%3DBousquet%26aufirst%3DE.%26aulast%3DPappalardo%26aufirst%3DM.%26aulast%3DSpadaro%26aufirst%3DA.%26atitle%3DCalix%255B4%255Darene%2520decorated%2520with%2520four%2520Tn%2520antigen%2520glycomimetic%2520units%2520and%2520P3CS%2520immunoadjuvant%253A%2520synthesis%252C%2520characterization%252C%2520and%2520anticancer%2520immunological%2520evaluation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D751%26epage%3D758%26doi%3D10.1021%2Fbc700411w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grigalevicius, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chierici, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaudet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Man, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dériaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumy, P.</span></span> <span> </span><span class="NLM_article-title">Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.1021/bc050010v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc050010v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsleqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=1149-1159&author=S.+Grigaleviciusauthor=S.+Chiericiauthor=O.+Renaudetauthor=R.+Lo-Manauthor=E.+D%C3%A9riaudauthor=C.+Leclercauthor=P.+Dumy&title=Chemoselective+assembly+and+immunological+evaluation+of+multiepitopic+glycoconjugates+bearing+clustered+Tn+antigen+as+synthetic+anticancer+vaccines&doi=10.1021%2Fbc050010v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective Assembly and Immunological Evaluation of Multiepitopic Glycoconjugates Bearing Clustered Tn Antigen as Synthetic Anticancer Vaccines</span></div><div class="casAuthors">Grigalevicius, Saulius; Chierici, Sabine; Renaudet, Olivier; Lo-Man, Richard; Deriaud, Edith; Leclerc, Claude; Dumy, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1149-1159</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper the authors investigated the use of regioselectively addressable functionalized templates (RAFTs) as new scaffolds for the design of anticancer vaccine candidates.  The authors report the synthesis of well-defined multiepitopic RAFT scaffolds and their immunol. evaluation.  These conjugates exhibit clustered Tn analog as tumor-assocd. carbohydrate antigen (TACA, B-cell epitope) and the CD4+ helper T-cell peptide from the type 1 poliovirus.  The saccharidic and peptidic epitopes were both synthesized sep. and combined regioselectively to the RAFT core using a sequential oxime bond formation strategy.  B- and T-antigenicity and immunogenicity of the vaccine candidates were investigated in vitro and in vivo.  These studies clearly demonstrate that the saccharidic part of the conjugates is recognized by Tn-specific monoclonal antibodies.  Moreover, the antibodies elicited by immunization of mice with the authors' vaccine candidates recognize the native form of Tn epitope expressed on human tumor cells.  Together with oxime ligation technique, these results suggest that the RAFT scaffold provides a promising and suitable tool for engineering potent synthetic anticancer vaccine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6L1fae8AZmLVg90H21EOLACvtfcHk0lgrTvrBsPcxXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsleqsr0%253D&md5=60553713d78e1cd915e3b82b7cf10995</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbc050010v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc050010v%26sid%3Dliteratum%253Aachs%26aulast%3DGrigalevicius%26aufirst%3DS.%26aulast%3DChierici%26aufirst%3DS.%26aulast%3DRenaudet%26aufirst%3DO.%26aulast%3DLo-Man%26aufirst%3DR.%26aulast%3DD%25C3%25A9riaud%26aufirst%3DE.%26aulast%3DLeclerc%26aufirst%3DC.%26aulast%3DDumy%26aufirst%3DP.%26atitle%3DChemoselective%2520assembly%2520and%2520immunological%2520evaluation%2520of%2520multiepitopic%2520glycoconjugates%2520bearing%2520clustered%2520Tn%2520antigen%2520as%2520synthetic%2520anticancer%2520vaccines%26jtitle%3DBioconjugate%2520Chem.%26date%3D2005%26volume%3D16%26spage%3D1149%26epage%3D1159%26doi%3D10.1021%2Fbc050010v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Renaudet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BenMohamed, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettahi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumy, P.</span></span> <span> </span><span class="NLM_article-title">Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycopeptide cancer vaccine</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fcmdc.200700315" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=737-741&author=O.+Renaudetauthor=L.+BenMohamedauthor=G.+Dasguptaauthor=I.+Bettahiauthor=P.+Dumy&title=Towards+a+self-adjuvanting+multivalent+B+and+T+cell+epitope+containing+synthetic+glycopeptide+cancer+vaccine&doi=10.1002%2Fcmdc.200700315"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700315%26sid%3Dliteratum%253Aachs%26aulast%3DRenaudet%26aufirst%3DO.%26aulast%3DBenMohamed%26aufirst%3DL.%26aulast%3DDasgupta%26aufirst%3DG.%26aulast%3DBettahi%26aufirst%3DI.%26aulast%3DDumy%26aufirst%3DP.%26atitle%3DTowards%2520a%2520self-adjuvanting%2520multivalent%2520B%2520and%2520T%2520cell%2520epitope%2520containing%2520synthetic%2520glycopeptide%2520cancer%2520vaccine%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D737%26epage%3D741%26doi%3D10.1002%2Fcmdc.200700315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Man, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vichier-Guerre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dériaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantacuzène, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span> <span> </span><span class="NLM_article-title">Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">2849</span>– <span class="NLM_lpage">2854</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.166.4.2849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.4049%2Fjimmunol.166.4.2849" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2001&pages=2849-2854&author=R.+Lo-Manauthor=S.+Vichier-Guerreauthor=S.+Bayauthor=E.+D%C3%A9riaudauthor=D.+Cantacuz%C3%A8neauthor=C.+Leclerc&title=Anti-tumor+immunity+provided+by+a+synthetic+multiple+antigenic+glycopeptide+displaying+a+tri-Tn+glycotope&doi=10.4049%2Fjimmunol.166.4.2849"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.166.4.2849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.166.4.2849%26sid%3Dliteratum%253Aachs%26aulast%3DLo-Man%26aufirst%3DR.%26aulast%3DVichier-Guerre%26aufirst%3DS.%26aulast%3DBay%26aufirst%3DS.%26aulast%3DD%25C3%25A9riaud%26aufirst%3DE.%26aulast%3DCantacuz%25C3%25A8ne%26aufirst%3DD.%26aulast%3DLeclerc%26aufirst%3DC.%26atitle%3DAnti-tumor%2520immunity%2520provided%2520by%2520a%2520synthetic%2520multiple%2520antigenic%2520glycopeptide%2520displaying%2520a%2520tri-Tn%2520glycotope%26jtitle%3DJ.%2520Immunol.%26date%3D2001%26volume%3D166%26spage%3D2849%26epage%3D2854%26doi%3D10.4049%2Fjimmunol.166.4.2849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Man, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vichier-Guerre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perraut, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dériaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huteau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BenMohamed, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diop, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span> <span> </span><span class="NLM_article-title">A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">4987</span>– <span class="NLM_lpage">4994</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-0252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1158%2F0008-5472.CAN-04-0252" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4987-4994&author=R.+Lo-Manauthor=S.+Vichier-Guerreauthor=R.+Perrautauthor=E.+D%C3%A9riaudauthor=V.+Huteauauthor=L.+BenMohamedauthor=O.+M.+Diopauthor=P.+O.+Livingstonauthor=S.+Bayauthor=C.+Leclerc&title=A+fully+synthetic+therapeutic+vaccine+candidate+targeting+carcinoma-associated+Tn+carbohydrate+antigen+induces+tumor-specific+antibodies+in+nonhuman+primates&doi=10.1158%2F0008-5472.CAN-04-0252"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-0252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-0252%26sid%3Dliteratum%253Aachs%26aulast%3DLo-Man%26aufirst%3DR.%26aulast%3DVichier-Guerre%26aufirst%3DS.%26aulast%3DPerraut%26aufirst%3DR.%26aulast%3DD%25C3%25A9riaud%26aufirst%3DE.%26aulast%3DHuteau%26aufirst%3DV.%26aulast%3DBenMohamed%26aufirst%3DL.%26aulast%3DDiop%26aufirst%3DO.%2BM.%26aulast%3DLivingston%26aufirst%3DP.%2BO.%26aulast%3DBay%26aufirst%3DS.%26aulast%3DLeclerc%26aufirst%3DC.%26atitle%3DA%2520fully%2520synthetic%2520therapeutic%2520vaccine%2520candidate%2520targeting%2520carcinoma-associated%2520Tn%2520carbohydrate%2520antigen%2520induces%2520tumor-specific%2520antibodies%2520in%2520nonhuman%2520primates%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4987%26epage%3D4994%26doi%3D10.1158%2F0008-5472.CAN-04-0252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freire, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dériaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vichier-Guerre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azria, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Man, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span> <span> </span><span class="NLM_article-title">Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">3526</span>– <span class="NLM_lpage">3536</span>, <span class="refDoi"> DOI: 10.1182/blood-2010-04-279133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1182%2Fblood-2010-04-279133" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=3526-3536&author=T.+Freireauthor=X.+Zhangauthor=E.+D%C3%A9riaudauthor=C.+Ganneauauthor=S.+Vichier-Guerreauthor=E.+Azriaauthor=O.+Launayauthor=R.+Lo-Manauthor=S.+Bayauthor=C.+Leclerc&title=Glycosidic+Tn-based+vaccines+targeting+dermal+dendritic+cells+favor+germinal+center+B-cell+development+and+potent+antibody+response+in+the+absence+of+adjuvant&doi=10.1182%2Fblood-2010-04-279133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-04-279133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-04-279133%26sid%3Dliteratum%253Aachs%26aulast%3DFreire%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DD%25C3%25A9riaud%26aufirst%3DE.%26aulast%3DGanneau%26aufirst%3DC.%26aulast%3DVichier-Guerre%26aufirst%3DS.%26aulast%3DAzria%26aufirst%3DE.%26aulast%3DLaunay%26aufirst%3DO.%26aulast%3DLo-Man%26aufirst%3DR.%26aulast%3DBay%26aufirst%3DS.%26aulast%3DLeclerc%26aufirst%3DC.%26atitle%3DGlycosidic%2520Tn-based%2520vaccines%2520targeting%2520dermal%2520dendritic%2520cells%2520favor%2520germinal%2520center%2520B-cell%2520development%2520and%2520potent%2520antibody%2520response%2520in%2520the%2520absence%2520of%2520adjuvant%26jtitle%3DBlood%26date%3D2010%26volume%3D116%26spage%3D3526%26epage%3D3536%26doi%3D10.1182%2Fblood-2010-04-279133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Medzhitov, R.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors and innate immunity</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1038/35100529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2F35100529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=11905821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=135-145&author=R.+Medzhitov&title=Toll-like+receptors+and+innate+immunity&doi=10.1038%2F35100529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors and innate immunity</span></div><div class="casAuthors">Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-145</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors have a crucial role in the detection of microbial infection in mammals and insects.  In mammals, these receptors have evolved to recognize conserved products unique to microbial metab.  This specificity allows the Toll proteins to detect the presence of infection and to induce activation of inflammatory and antimicrobial innate immune responses.  Recognition of microbial products by Toll-like receptors expressed on dendritic cells triggers functional maturation of dendritic cells and leads to initiation of antigen-specific adaptive immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouf0HceqTgkrVg90H21EOLACvtfcHk0lj68o3toUrYIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qu74%253D&md5=d88de3ef802486ba2611b056bcfd0c41</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F35100529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35100529%26sid%3Dliteratum%253Aachs%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DToll-like%2520receptors%2520and%2520innate%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2001%26volume%3D1%26spage%3D135%26epage%3D145%26doi%3D10.1038%2F35100529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banchereau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, R. M.</span></span> <span> </span><span class="NLM_article-title">Dendritic cells and the control of immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>392</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1038/32588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2F32588" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=9521319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK1cXitFWrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=1998&pages=245-252&author=J.+Banchereauauthor=R.+M.+Steinman&title=Dendritic+cells+and+the+control+of+immunity&doi=10.1038%2F32588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic cells and the control of immunity</span></div><div class="casAuthors">Banchereau, Jacques; Steinman, Ralph M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">392</span>
        (<span class="NLM_cas:issue">6673</span>),
    <span class="NLM_cas:pages">245-252</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">A review with 103 refs.  B and T lymphocytes are the mediators of immunity, but their function is under the control of dendritic cells.  Dendritic cells in the periphery capture and process antigens, express lymphocyte co-stimulatory mols., migrate to lymphoid organs, and secrete cytokines to initiate immune responses.  They not only activate lymphocytes, they also tolerize T cells to antigens that are innate to the body (self-antigens), thereby minimizing autoimmune reactions.  Once a neglected cell type, dendritic cells can now be readily obtained in sufficient quantities to allow mol. and cell biol. anal.  With knowledge comes the realization that these cells are a powerful tool for manipulating the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3cFu9pwhnSrVg90H21EOLACvtfcHk0lj68o3toUrYIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFWrsr8%253D&md5=af17ace619fc543c7260cb04146d4c30</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2F32588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F32588%26sid%3Dliteratum%253Aachs%26aulast%3DBanchereau%26aufirst%3DJ.%26aulast%3DSteinman%26aufirst%3DR.%2BM.%26atitle%3DDendritic%2520cells%2520and%2520the%2520control%2520of%2520immunity%26jtitle%3DNature%26date%3D1998%26volume%3D392%26spage%3D245%26epage%3D252%26doi%3D10.1038%2F32588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banchereau, J.</span></span> <span> </span><span class="NLM_article-title">Taking dendritic cells into medicine</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1038/nature06175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2Fnature06175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=17898760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtV2is7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2007&pages=419-426&author=R.+M.+Steinmanauthor=J.+Banchereau&title=Taking+dendritic+cells+into+medicine&doi=10.1038%2Fnature06175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Taking dendritic cells into medicine</span></div><div class="casAuthors">Steinman, Ralph M.; Banchereau, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue">7161</span>),
    <span class="NLM_cas:pages">419-426</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dendritic cells (DCs) orchestrate a repertoire of immune responses that bring about resistance to infection and silencing or tolerance to self.  In the settings of infection and cancer, microbes and tumors can exploit DCs to evade immunity, but DCs also can generate resistance, a capacity that is readily enhanced with DC-targeted vaccines.  During allergy, autoimmunity and transplant rejection, DCs instigate unwanted responses that cause disease, but again, DCs can be harnessed to silence these conditions with novel therapies.  Here we present some medical implications of DC biol. that account for illness and provide opportunities for prevention and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTxgb4Ibv24LVg90H21EOLACvtfcHk0lj68o3toUrYIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtV2is7%252FI&md5=3cfe810550de853b1189ed73cc062846</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature06175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06175%26sid%3Dliteratum%253Aachs%26aulast%3DSteinman%26aufirst%3DR.%2BM.%26aulast%3DBanchereau%26aufirst%3DJ.%26atitle%3DTaking%2520dendritic%2520cells%2520into%2520medicine%26jtitle%3DNature%26date%3D2007%26volume%3D449%26spage%3D419%26epage%3D426%26doi%3D10.1038%2Fnature06175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, R. M.</span></span> <span> </span><span class="NLM_article-title">Dendritic cells in vivo: A key target for a new vaccine science</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2008.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.immuni.2008.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=18799140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2jtLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=319-324&author=R.+M.+Steinman&title=Dendritic+cells+in+vivo%3A+A+key+target+for+a+new+vaccine+science&doi=10.1016%2Fj.immuni.2008.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic cells in vivo: a key target for a new vaccine science</span></div><div class="casAuthors">Steinman, Ralph M.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-324</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Dendritic cells (DCs) are the antigen presenting cells that initiate and regulate immunity.  By studying these cells in vivo, we will be able to move beyond std. approaches and design vaccines that directly harness the elaborate properties of DCs to control immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN4RNZGWc0z7Vg90H21EOLACvtfcHk0lj1eOIv0w_eQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2jtLvI&md5=d296ae55e7542a23956b1074269ce518</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2008.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2008.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DSteinman%26aufirst%3DR.%2BM.%26atitle%3DDendritic%2520cells%2520in%2520vivo%253A%2520A%2520key%2520target%2520for%2520a%2520new%2520vaccine%2520science%26jtitle%3DImmunity%26date%3D2008%26volume%3D29%26spage%3D319%26epage%3D324%26doi%3D10.1016%2Fj.immuni.2008.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">TLR signaling</span>. <i>Semin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.smim.2006.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.smim.2006.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=17275323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjslGrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=24-32&author=T.+Kawaiauthor=S.+Akira&title=TLR+signaling&doi=10.1016%2Fj.smim.2006.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">TLR signaling</span></div><div class="casAuthors">Kawai, Taro; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-32</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The TLR family senses the mol. signatures of microbial pathogens, and plays a fundamental role in innate immune responses.  TLRs signal via a common pathway that leads to the expression of diverse inflammatory genes.  In addn., each TLR elicits specific cellular responses to pathogens owing to differential usage of intracellular adapter proteins.  Recent studies have revealed the importance of the subcellular localization of TLRs in pathogen recognition and signaling.  TLR signaling pathways is neg. regulated by a no. of cellular proteins to attenuate inflammation.  Here, we describe recent advances in our understanding of the regulation of TLR-mediated signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3eiABFM-DQrVg90H21EOLACvtfcHk0lj1eOIv0w_eQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjslGrsLY%253D&md5=78f43a7a817574b6c8688f6e442b4701</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.smim.2006.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.smim.2006.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DKawai%26aufirst%3DT.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DTLR%2520signaling%26jtitle%3DSemin.%2520Immunol.%26date%3D2007%26volume%3D19%26spage%3D24%26epage%3D32%26doi%3D10.1016%2Fj.smim.2006.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaisho, T.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors: critical proteins linking and acquired immunity</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1038/90609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2F90609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=11477402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=675-680&author=S.+Akiraauthor=K.+Takedaauthor=T.+Kaisho&title=Toll-like+receptors%3A+critical+proteins+linking+and+acquired+immunity&doi=10.1038%2F90609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors: Critical proteins linking innate and acquired immunity</span></div><div class="casAuthors">Akira, Shizuo; Takeda, Kiyoshi; Kaisho, Tsuneyasu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">675-680</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A review with 84 refs.  Recognition of pathogens is mediated by a set of germline-encoded receptors that are referred to as pattern-recognition receptors (PRRs).  These receptors recognize conserved mol. patterns (pathogen-assocd. mol. patterns), which are shared by large groups of microorganisms.  Toll-like receptors (TLRs) function as the PRRs in mammals and play an essential role in the recognition of microbial components.  The TLRs may also recognize endogenous ligands induced during the inflammatory response.  Similar cytoplasmic domains allow TLRs to use the same signaling mols. used by the interleukin 1 receptors (IL-1Rs): these include MyD88, IL-1R-assocd. protein kinase and tumor necrosis factor receptor-activated factor 6.  However, evidence is accumulating that the signaling pathways assocd. with each TLR are not identical and may, therefore, result in different biol. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom8I2sSl7FK7Vg90H21EOLACvtfcHk0lj1eOIv0w_eQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D&md5=3fd5a975d63e0384c8cffa960159b063</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2F90609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F90609%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26atitle%3DToll-like%2520receptors%253A%2520critical%2520proteins%2520linking%2520and%2520acquired%2520immunity%26jtitle%3DNat.%2520Immunol.%26date%3D2001%26volume%3D2%26spage%3D675%26epage%3D680%26doi%3D10.1038%2F90609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span> <span> </span><span class="NLM_article-title">Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant</span>. <i>Chin. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/j.cclet.2017.09.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.cclet.2017.09.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1egsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=19-26&author=Z.+Zhouauthor=H.+Linauthor=C.+Liauthor=Z.+Wu&title=Recent+progress+of+fully+synthetic+carbohydrate-based+vaccine+using+TLR+agonist+as+build-in+adjuvant&doi=10.1016%2Fj.cclet.2017.09.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant</span></div><div class="casAuthors">Zhou, Zhifang; Lin, Han; Li, Chen; Wu, Zhimeng</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-26</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Fully synthetic vaccine, in which one or multi-mol. antigens are conjugated to a synthetic carrier with well-defined chem. structure, is a new direction to develop carbohydrate-based vaccine against cancer and pathogens.  Toll like receptor (TLR) agonists with the ability to stimulate immune response have been widely investigated and been applied as build-in adjuvants to construct fully synthetic vaccines.  In particular, remarkable progress has been achieved in recent years in the development of vaccines constructed with the agonists of TLR1/2, TLR2/6 and TLR4 and tumor-assocd. carbohydrate antigens (TACAs).  These di-, tri- or multi-component vaccine candidates showed attractive immunol. properties.  This review highlights recent advances in developing full synthetic carbohydrate antigen based vaccines, with an emphasis on the structure-activity relationships that provide a primary basis for future vaccine design and immunotherapy developing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvdlC50ATOC7Vg90H21EOLACvtfcHk0lj1eOIv0w_eQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1egsbfL&md5=297461b2b1543e0fcb0cd5a2603a92b0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cclet.2017.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cclet.2017.09.047%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DZ.%26atitle%3DRecent%2520progress%2520of%2520fully%2520synthetic%2520carbohydrate-based%2520vaccine%2520using%2520TLR%2520agonist%2520as%2520build-in%2520adjuvant%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D29%26spage%3D19%26epage%3D26%26doi%3D10.1016%2Fj.cclet.2017.09.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Toyokuni, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boivin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakomori, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhal, A. K.</span></span> <span> </span><span class="NLM_article-title">Synthetic vaccines: synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1021/ja00080a055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00080a055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=395-396&author=T.+Toyokuniauthor=B.+Deanauthor=S.+Caiauthor=D.+Boivinauthor=S.-I.+Hakomoriauthor=A.+K.+Singhal&title=Synthetic+vaccines%3A+synthesis+of+a+dimeric+Tn+antigen-lipopeptide+conjugate+that+elicits+immune+responses+against+Tn-expressing+glycoproteins&doi=10.1021%2Fja00080a055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fja00080a055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00080a055%26sid%3Dliteratum%253Aachs%26aulast%3DToyokuni%26aufirst%3DT.%26aulast%3DDean%26aufirst%3DB.%26aulast%3DCai%26aufirst%3DS.%26aulast%3DBoivin%26aufirst%3DD.%26aulast%3DHakomori%26aufirst%3DS.-I.%26aulast%3DSinghal%26aufirst%3DA.%2BK.%26atitle%3DSynthetic%2520vaccines%253A%2520synthesis%2520of%2520a%2520dimeric%2520Tn%2520antigen-lipopeptide%2520conjugate%2520that%2520elicits%2520immune%2520responses%2520against%2520Tn-expressing%2520glycoproteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26spage%3D395%26epage%3D396%26doi%3D10.1021%2Fja00080a055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kudryashov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glunz, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, K. O.</span></span> <span> </span><span class="NLM_article-title">Toward optimized carbohydrate-based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis<sup>y</sup> conjugates in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">3264</span>– <span class="NLM_lpage">3269</span>, <span class="refDoi"> DOI: 10.1073/pnas.051623598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1073%2Fpnas.051623598" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=3264-3269&author=V.+Kudryashovauthor=P.+W.+Glunzauthor=L.+J.+Williamsauthor=S.+Hintermannauthor=S.+J.+Danishefskyauthor=K.+O.+Lloyd&title=Toward+optimized+carbohydrate-based+anticancer+vaccines%3A+Epitope+clustering%2C+carrier+structure%2C+and+adjuvant+all+influence+antibody+responses+to+Lewisy+conjugates+in+mice&doi=10.1073%2Fpnas.051623598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.051623598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.051623598%26sid%3Dliteratum%253Aachs%26aulast%3DKudryashov%26aufirst%3DV.%26aulast%3DGlunz%26aufirst%3DP.%2BW.%26aulast%3DWilliams%26aufirst%3DL.%2BJ.%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DLloyd%26aufirst%3DK.%2BO.%26atitle%3DToward%2520optimized%2520carbohydrate-based%2520anticancer%2520vaccines%253A%2520Epitope%2520clustering%252C%2520carrier%2520structure%252C%2520and%2520adjuvant%2520all%2520influence%2520antibody%2520responses%2520to%2520Lewisy%2520conjugates%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D3264%26epage%3D3269%26doi%3D10.1073%2Fpnas.051623598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aal, A.
B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Naggar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batzloff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, I.</span></span> <span> </span><span class="NLM_article-title">Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based toll-like receptor 2 ligand</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6968</span>– <span class="NLM_lpage">6974</span>, <span class="refDoi"> DOI: 10.1021/jm300822g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300822g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVemtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6968-6974&author=A.%0AB.+Abdel-Aalauthor=D.+El-Naggarauthor=M.+Zamanauthor=M.+Batzloffauthor=I.+Toth&title=Design+of+fully+synthetic%2C+self-adjuvanting+vaccine+incorporating+the+tumor-associated+carbohydrate+Tn+antigen+and+lipoamino+acid-based+toll-like+receptor+2+ligand&doi=10.1021%2Fjm300822g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Fully Synthetic, Self-Adjuvanting Vaccine Incorporating the Tumor-Associated Carbohydrate Tn Antigen and Lipoamino Acid-Based Toll-like Receptor 2 Ligand</span></div><div class="casAuthors">Abdel-Aal, Abu-Baker M.; El-Naggar, Dina; Zaman, Mehfuz; Batzloff, Michael; Toth, Istvan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6968-6974</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of certain tumor-assocd. carbohydrate antigens (TACA) caused by malignant transformation offers promising targets to develop novel antitumor vaccines, provided the ability to break their inherent low immunogenicity and overcome the tolerance of the immune system.  The authors designed, synthesized, and immunol. evaluated a no. of fully synthetic new chimeric constructs incorporating a cluster of the most common TACA (known as Tn antigen) covalently attached to T-cell peptide epitopes derived from polio virus and ovalbumin and included a synthetic built-in adjuvant consisting of two 16-carbon lipoamino acids.  Vaccine candidates were able to induce significantly strong antibody responses in mice without the need for any addnl. adjuvant, carrier protein, or special pharmaceutical prepn. (e.g., liposomes).  Vaccine constructs were assembled either in a linear or in a branched architecture, which demonstrated the intervening effects of the incorporation and arrangement of T-cell epitopes on antibody recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YLaYPOuPbrVg90H21EOLACvtfcHk0lhUfD3AAjdfZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVemtbfE&md5=6ccc4ff15dd4183b2cab970fdf55cf8d</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm300822g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300822g%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Aal%26aufirst%3DA.%2BB.%26aulast%3DEl-Naggar%26aufirst%3DD.%26aulast%3DZaman%26aufirst%3DM.%26aulast%3DBatzloff%26aufirst%3DM.%26aulast%3DToth%26aufirst%3DI.%26atitle%3DDesign%2520of%2520fully%2520synthetic%252C%2520self-adjuvanting%2520vaccine%2520incorporating%2520the%2520tumor-associated%2520carbohydrate%2520Tn%2520antigen%2520and%2520lipoamino%2520acid-based%2520toll-like%2520receptor%25202%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6968%26epage%3D6974%26doi%3D10.1021%2Fjm300822g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malins, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, C. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, R. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of MUC1-lipopeptide chimeras</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">6249</span>– <span class="NLM_lpage">6251</span>, <span class="refDoi"> DOI: 10.1039/c0cc01360a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1039%2Fc0cc01360a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=6249-6251&author=B.+L.+Wilkinsonauthor=L.+R.+Malinsauthor=C.+K.+Y.+Chunauthor=R.+J.+Payne&title=Synthesis+of+MUC1-lipopeptide+chimeras&doi=10.1039%2Fc0cc01360a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1039%2Fc0cc01360a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cc01360a%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DB.%2BL.%26aulast%3DMalins%26aufirst%3DL.%2BR.%26aulast%3DChun%26aufirst%3DC.%2BK.%2BY.%26aulast%3DPayne%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520of%2520MUC1-lipopeptide%2520chimeras%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D6249%26epage%3D6251%26doi%3D10.1039%2Fc0cc01360a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Synthetic MUC1 antitumor vaccine candidates with varied glycosylation pattern bearing R/S-configured Pam3CysSerLys4</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1415</span>, <span class="refDoi"> DOI: 10.1002/cbic.201600206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fcbic.201600206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=27188544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1412-1415&author=L.+Shiauthor=H.+Caiauthor=Z.+Huangauthor=Z.+Sunauthor=Y.+Chenauthor=Y.+Zhaoauthor=H.+Kunzauthor=Y.+Li&title=Synthetic+MUC1+antitumor+vaccine+candidates+with+varied+glycosylation+pattern+bearing+R%2FS-configured+Pam3CysSerLys4&doi=10.1002%2Fcbic.201600206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26cR"><div class="casContent"><span class="casTitleNuber">26c</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic MUC1 Antitumor Vaccine Candidates with Varied Glycosylation Pattern Bearing R/S-configured Pam3CysSerLys4</span></div><div class="casAuthors">Shi, Lei; Cai, Hui; Huang, Zhi-Hua; Sun, Zhan-Yi; Chen, Yong-Xiang; Zhao, Yu-Fen; Kunz, Horst; Li, Yan-Mei</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1412-1415</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The Toll-like receptor 2 ligand Pam3CysSer is of particular interest for the construction synthetic vaccines because of its ability to stimulate of the innate immune system.  Such vaccines usually comprise Pam3CysSer with the natural R-configuration at the glycerol 2-position.  Pam3CysSer peptide vaccines with natural configuration have been shown to be more efficient than the corresponding R/S diastereomers.  In order to clarify whether the effect of the configuration of Pam3Cys on the immune response also applies to glycopeptide vaccines, MUC1 glycopeptide-lipopeptide vaccines bearing either R- or R/S-configured Pam3CysSerLys4 were compared for their immunol. effects.  In order to find out whether glycosylated MUC1 tandem repeat domains comprise not only B-cell epitopes but also T-cell epitopes, two-component vaccines contg. the Pam3CysSerLys4 lipopeptide and MUC1 glycopeptides with various glycosylation patterns were synthesized, and their immune reactions in mice were studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3xao-AnfR3LVg90H21EOLACvtfcHk0lhUfD3AAjdfZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFeqtrk%253D&md5=05b43ca881281de75651738cf0b1ba79</span></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201600206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201600206%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DKunz%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DSynthetic%2520MUC1%2520antitumor%2520vaccine%2520candidates%2520with%2520varied%2520glycosylation%2520pattern%2520bearing%2520R%252FS-configured%2520Pam3CysSerLys4%26jtitle%3DChemBioChem%26date%3D2016%26volume%3D17%26spage%3D1412%26epage%3D1415%26doi%3D10.1002%2Fcbic.201600206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ingale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaekwad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buskas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G.-J.</span></span> <span> </span><span class="NLM_article-title">Robust immune responses elicited by a fully synthetic three-component vaccine</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2007.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2Fnchembio.2007.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=17767155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=663-667&author=S.+Ingaleauthor=M.+A.+Wolfertauthor=J.+Gaekwadauthor=T.+Buskasauthor=G.-J.+Boons&title=Robust+immune+responses+elicited+by+a+fully+synthetic+three-component+vaccine&doi=10.1038%2Fnchembio.2007.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Robust immune responses elicited by a fully synthetic three-component vaccine</span></div><div class="casAuthors">Ingale, Sampat; Wolfert, Margreet A.; Gaekwad, Jidnyasa; Buskas, Therese; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The overexpression of saccharides such as globo-H, LewisY, and Tn antigen is a common feature of oncogenic transformed cells.  Endeavors to exploit this aberrant glycosylation for cancer vaccine development have been complicated by difficulties in eliciting high titers of IgG antibodies against classical conjugates of tumor-assocd. carbohydrates to carrier proteins.  The authors designed, chem. synthesized, and immunol. evaluated a no. of fully synthetic vaccine candidates to establish strategies to overcome the poor immunogenicity of tumor-assocd. carbohydrates and glycopeptides.  The have found that a 3-component vaccine composed of a TLR2 agonist, a promiscuous peptide T-helper epitope, and a tumor-assocd. glycopeptide can elicit in mice exceptionally high titers of IgG antibodies that can recognize cancer cells expressing the tumor-assocd. carbohydrate.  The superior properties of the vaccine candidate are attributed to the local prodn. of cytokines, upregulation of co-stimulatory proteins, enhanced uptake by macrophages and dendritic cells, and avoidance of epitope suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdz62dPelB7Vg90H21EOLACvtfcHk0lhh0Sdp6v-mBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtrnO&md5=43cb22b797d84c8b60bedca1a5aee7ea</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2007.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2007.25%26sid%3Dliteratum%253Aachs%26aulast%3DIngale%26aufirst%3DS.%26aulast%3DWolfert%26aufirst%3DM.%2BA.%26aulast%3DGaekwad%26aufirst%3DJ.%26aulast%3DBuskas%26aufirst%3DT.%26aulast%3DBoons%26aufirst%3DG.-J.%26atitle%3DRobust%2520immune%2520responses%2520elicited%2520by%2520a%2520fully%2520synthetic%2520three-component%2520vaccine%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D663%26epage%3D667%26doi%3D10.1038%2Fnchembio.2007.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ingale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buskas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G.-J.</span></span> <span> </span><span class="NLM_article-title">Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting toll-like receptors</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">463</span>, <span class="refDoi"> DOI: 10.1002/cbic.200800596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fcbic.200800596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=19145607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1amsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=455-463&author=S.+Ingaleauthor=M.+A.+Wolfertauthor=T.+Buskasauthor=G.-J.+Boons&title=Increasing+the+antigenicity+of+synthetic+tumor-associated+carbohydrate+antigens+by+targeting+toll-like+receptors&doi=10.1002%2Fcbic.200800596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors</span></div><div class="casAuthors">Ingale, Sampat; Wolfert, Margreet A.; Buskas, Therese; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-463</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Epithelial cancer cells often overexpress mucins that are aberrantly glycosylated.  Although it has been realized that these compds. offer exciting opportunities for the development of immunotherapy for cancer, their use is hampered by the low antigenicity of classical immunogens composed of a glycopeptide derived from a mucin conjugated to a foreign carrier protein.  We have designed, chem. synthesized, and immunol. evaluated a no. of fully synthetic vaccine candidates to establish a strategy to overcome the poor immunogenicity of tumor-assocd. carbohydrates and glycopeptides.  The compds. were also designed to allow study of the importance of Toll-like receptor (TLR) engagement for these antigenic responses in detail.  We have found that covalent attachment of a TLR2 agonist, a promiscuous peptide T-helper epitope, and a tumor-assocd. glycopeptide gives a compd. (1) that elicits in mice exceptionally high titers of IgG antibodies that recognize MCF7 cancer cells expressing the tumor-assocd. carbohydrate.  Immunizations with glycolipopeptide 2, which contains lipidated amino acids instead of a TLR2 ligand, gave significantly lower titers of IgG antibodies; this demonstrates that TLR engagement is crit. for optimum antigenic responses.  Although mixts. of compd. 2 with Pam3CysSK4 (3) or monophosphoryl lipid A (4) elicited titers of IgG antibodies similar to those seen with 1, the resulting antisera had impaired ability to recognize cancer cells.  It was also found that covalent linkage of the helper T-epitope to the B-epitope is essential, probably because internalization of the helper T-epitope by B-cells requires assistance of the B-epitope.  The results presented here show that synthetic vaccine development is amenable to structure-activity relationship studies for successful optimization of carbohydrate-based cancer vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4OtTwjYj5B7Vg90H21EOLACvtfcHk0lhh0Sdp6v-mBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1amsL4%253D&md5=d5fc76855b718ae347d13f2dbd484d52</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200800596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200800596%26sid%3Dliteratum%253Aachs%26aulast%3DIngale%26aufirst%3DS.%26aulast%3DWolfert%26aufirst%3DM.%2BA.%26aulast%3DBuskas%26aufirst%3DT.%26aulast%3DBoons%26aufirst%3DG.-J.%26atitle%3DIncreasing%2520the%2520antigenicity%2520of%2520synthetic%2520tumor-associated%2520carbohydrate%2520antigens%2520by%2520targeting%2520toll-like%2520receptors%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D455%26epage%3D463%26doi%3D10.1002%2Fcbic.200800596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malins, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apostolopoulos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, R. J.</span></span> <span> </span><span class="NLM_article-title">Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the toll-like receptor 2 agonist Pam3CysSer</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1635</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.1002/anie.201006115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fanie.201006115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslygs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=1635-1639&author=B.+L.+Wilkinsonauthor=S.+Dayauthor=L.+R.+Malinsauthor=V.+Apostolopoulosauthor=R.+J.+Payne&title=Self-adjuvanting+multicomponent+cancer+vaccine+candidates+combining+per-glycosylated+MUC1+glycopeptides+and+the+toll-like+receptor+2+agonist+Pam3CysSer&doi=10.1002%2Fanie.201006115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer</span></div><div class="casAuthors">Wilkinson, Brendan L.; Day, Stephanie; Malins, Lara R.; Apostolopoulos, Vasso; Payne, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1635-1639, S1635/1-S1635/55</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The aberrant glycosylation of cell surface mucin glycoproteins such as MUCl and the overexpression of highly truncated, tumor-assocd. carbohydrate antigens (TACAs) are strongly correlated with tumor metastasis and poor prognosis.  Such TACAs, including the well-studied TN and T antigens and their sialylated derivs., are important targets for the development of antigen-specific carbohydrate vaccines.  However, these structures are self antigens that generally elicit T-cell independent immune responses which are tolerated by the immune system and lead to poor immunogenicity.  One approach aimed at enhancing the immune recognition of TACAs utilizes conjugation of tumor-assocd. MUCl glycopeptides or TACAs alone to foreign carrier proteins such as keyhole limpet hemocyanin (KLH) or bovine serum albumin (BSA).  Kunz and coworkers have described several impressive examples of MUCl glycopeptide carrier protein vaccine candidates which have elicited significant antibody responses in murine models.  While conjugate vaccines have shown promise in tumor vaccinol., the inherent immunogenicity of the carrier protein has been assocd. with suppression of the immune response towards the desired carbohydrate/glycopeptide epitope.  Self-adjuvanting, multicomponent vaccines however, avoid anti-carrier immune responses while incorporating the necessary structural features for evoking an essential class switch from low-affinity and short lived IgM antibodies, to high-affinity IgG antibodies.  Here, we exploit this strategy for the convergent assembly and immunol. investigation of dicomponent vaccines, comprised of multiple copies of TN or T antigens conjugated to the TLR2 ligand Pam3CysSer, and tricomponent vaccines incorporating the tetanus toxin-derived helper T-cell epitope1131 between a per-glycosylated MUCl B-cell epitope and Pam3CysSer.  We chose to install flexible, immunogenically silent ethylene glycol spacer units between each component to minimize conformational distortion and to allow for optimal display of each recognition element to the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYKL6cJxj1xbVg90H21EOLACvtfcHk0lhh0Sdp6v-mBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslygs7Y%253D&md5=22e7aa8cea662cc5a1d5f7986f8e99eb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fanie.201006115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201006115%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DB.%2BL.%26aulast%3DDay%26aufirst%3DS.%26aulast%3DMalins%26aufirst%3DL.%2BR.%26aulast%3DApostolopoulos%26aufirst%3DV.%26aulast%3DPayne%26aufirst%3DR.%2BJ.%26atitle%3DSelf-adjuvanting%2520multicomponent%2520cancer%2520vaccine%2520candidates%2520combining%2520per-glycosylated%2520MUC1%2520glycopeptides%2520and%2520the%2520toll-like%2520receptor%25202%2520agonist%2520Pam3CysSer%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D1635%26epage%3D1639%26doi%3D10.1002%2Fanie.201006115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuy, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrasidlo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1194</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1021/bc900054q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc900054q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFCrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1194-1200&author=M.+Chanauthor=T.+Hayashiauthor=C.+S.+Kuyauthor=C.+S.+Grayauthor=C.+C.+N.+Wuauthor=M.+Corrauthor=W.+Wrasidloauthor=H.+B.+Cottamauthor=D.+A.+Carson&title=Synthesis+and+immunological+characterization+of+toll-like+receptor+7+agonistic+conjugates&doi=10.1021%2Fbc900054q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates</span></div><div class="casAuthors">Chan, Michael; Hayashi, Tomoko; Kuy, Crystal S.; Gray, Christine S.; Wu, Christina C. N.; Corr, Maripat; Wrasidlo, Wolfgang; Cottam, Howard B.; Carson, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1194-1200</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of toll-like receptors (TLRs) on cells of the innate immune system initiates, amplifies, and directs the antigen-specific acquired immune response.  Ligands that stimulate TLRs, therefore, represent potential immune adjuvants.  In this study, a potent TLR7 agonist was conjugated to phospholipids, poly(ethylene glycol) (PEG), or phospholipid-PEG via a versatile benzoic acid functional group.  Compared to the unmodified TLR7 agonist, each conjugate displayed a distinctive immunol. profile in vitro and in vivo.  In mouse macrophages and human peripheral blood mononuclear cells, the phospholipid TLR7 agonist conjugate was at least 100-fold more potent than the free TLR7 ligands, while the potency of PEG-phospholipid conjugate was similar to that of the unmodified TLR7 agonist.  When administered systemically in mice, the phospholipid and phospholipid-PEG TLR7 conjugates induced prolonged increases in the levels of proinflammatory cytokines in serum, compared to the unmodified TLR7 activator.  When the conjugates were used as adjuvants during vaccination, only the phospholipid TLR7 agonist conjugates induced both Th1 and Th2 antigen-specific immune responses.  These data show that the immunostimulatory activity of a TLR7 ligand can be amplified and focused by conjugation, thus broadening the potential therapeutic application of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXiX-Vp0VhrrVg90H21EOLACvtfcHk0lip5r2CaNFfCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFCrs7Y%253D&md5=945810b3e5d1a5ab14fc998ce1c0989d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbc900054q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc900054q%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DKuy%26aufirst%3DC.%2BS.%26aulast%3DGray%26aufirst%3DC.%2BS.%26aulast%3DWu%26aufirst%3DC.%2BC.%2BN.%26aulast%3DCorr%26aufirst%3DM.%26aulast%3DWrasidlo%26aufirst%3DW.%26aulast%3DCottam%26aufirst%3DH.%2BB.%26aulast%3DCarson%26aufirst%3DD.%2BA.%26atitle%3DSynthesis%2520and%2520immunological%2520characterization%2520of%2520toll-like%2520receptor%25207%2520agonistic%2520conjugates%26jtitle%3DBioconjugate%2520Chem.%26date%3D2009%26volume%3D20%26spage%3D1194%26epage%3D1200%26doi%3D10.1021%2Fbc900054q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blasius, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beutler, B.</span></span> <span> </span><span class="NLM_article-title">Intracellular toll-like receptors</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2010.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.immuni.2010.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=20346772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=305-315&author=A.+L.+Blasiusauthor=B.+Beutler&title=Intracellular+toll-like+receptors&doi=10.1016%2Fj.immuni.2010.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular toll-like receptors</span></div><div class="casAuthors">Blasius, Amanda L.; Beutler, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-315</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Foreign nucleic acids, the signature of invading viruses and certain bacteria, are sensed intracellularly.  The nucleic acid-specific Toll-like receptors (TLRs) detect and signal within endolysosomal compartments, triggering the induction of cytokines essential for the innate immune response.  These cytokines include proinflammatory mols. produced mainly by macrophages and conventional dendritic cells, as well as type I interferons, which are produced in great quantities by plasmacytoid dendritic cells.  The cellular and mol. pathways by which nucleic acids and TLRs meet within the endosome assure host protection yet also place the host at risk for the development of autoimmunity.  Here, we review the latest findings on the intracellular TLRs, with special emphasis on ligand uptake, receptor trafficking, signaling, and regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5-SJKSbEwurVg90H21EOLACvtfcHk0lip5r2CaNFfCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSntr4%253D&md5=84f54e99249e52a6424c7c3975e8c7ea</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2010.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2010.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DBlasius%26aufirst%3DA.%2BL.%26aulast%3DBeutler%26aufirst%3DB.%26atitle%3DIntracellular%2520toll-like%2520receptors%26jtitle%3DImmunity%26date%3D2010%26volume%3D32%26spage%3D305%26epage%3D315%26doi%3D10.1016%2Fj.immuni.2010.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shupe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashgarian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shlomchik, M. J.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2006.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.immuni.2006.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=16973389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOjtLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=417-428&author=S.+R.+Christensenauthor=J.+Shupeauthor=K.+Nickersonauthor=M.+Kashgarianauthor=R.+Flavellauthor=M.+J.+Shlomchik&title=Toll-like+receptor+7+and+TLR9+dictate+autoantibody+specificity+and+have+opposing+inflammatory+and+regulatory+roles+in+a+murine+model+of+lupus&doi=10.1016%2Fj.immuni.2006.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31aR"><div class="casContent"><span class="casTitleNuber">31a</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus</span></div><div class="casAuthors">Christensen, Sean R.; Shupe, Jonathan; Nickerson, Kevin; Kashgarian, Michael; Flavell, Richard A.; Shlomchik, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">417-428</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Antibodies (Abs) to RNA- and DNA-contg. autoantigens are characteristic of systemic lupus erythematosus (SLE).  The authors showed previously that Toll-like receptor (TLR) 9, recognizing DNA, is required for the spontaneous generation of DNA autoantibodies, but not for the development of lupus nephritis in susceptible mice.  The authors report that lupus-prone mice deficient in TLR7, a receptor for ssRNA, failed to generate Abs to RNA-contg. antigens (Ags) such as Smith (Sm) Ag.  TLR9 and TLR7 also had dramatic effects on clin. disease in lupus-prone mice.  In the absence of TLR9, autoimmune disease was exacerbated, lymphocytes and plasmacytoid DCs were more activated, and serum IgG and IFN-α were increased.  In contrast, TLR7-deficient mice had ameliorated disease, decreased lymphocyte activation, and decreased serum IgG.  These findings reveal opposing inflammatory and regulatory roles for TLR7 and TLR9, despite similar tissue expression and signaling pathways.  These results have important implications for TLR-directed therapy of autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsGKX6qua9FLVg90H21EOLACvtfcHk0lip5r2CaNFfCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOjtLzN&md5=8c062e4f69b246777598249d500da41b</span></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2006.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2006.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DS.%2BR.%26aulast%3DShupe%26aufirst%3DJ.%26aulast%3DNickerson%26aufirst%3DK.%26aulast%3DKashgarian%26aufirst%3DM.%26aulast%3DFlavell%26aufirst%3DR.%26aulast%3DShlomchik%26aufirst%3DM.%2BJ.%26atitle%3DToll-like%2520receptor%25207%2520and%2520TLR9%2520dictate%2520autoantibody%2520specificity%2520and%2520have%2520opposing%2520inflammatory%2520and%2520regulatory%2520roles%2520in%2520a%2520murine%2520model%2520of%2520lupus%26jtitle%3DImmunity%26date%3D2006%26volume%3D25%26spage%3D417%26epage%3D428%26doi%3D10.1016%2Fj.immuni.2006.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Santiago-Raber, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunand-Sauthier, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reith, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotzin, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izui, S.</span></span> <span> </span><span class="NLM_article-title">Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice</span>. <i>J. Autoimmun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1016/j.jaut.2009.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.jaut.2009.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=19944565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltF2ms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=339-348&author=M.+L.+Santiago-Raberauthor=I.+Dunand-Sauthierauthor=T.+Wuauthor=Q.+Z.+Liauthor=S.+Uematsuauthor=S.+Akiraauthor=W.+Reithauthor=C.+Mohanauthor=B.+L.+Kotzinauthor=S.+Izui&title=Critical+role+of+TLR7+in+the+acceleration+of+systemic+lupus+erythematosus+in+TLR9-deficient+mice&doi=10.1016%2Fj.jaut.2009.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31bR"><div class="casContent"><span class="casTitleNuber">31b</span><div class="casTitle"><span class="NLM_cas:atitle">Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice</span></div><div class="casAuthors">Santiago-Raber, Marie-Laure; Dunand-Sauthier, Isabelle; Wu, Tianfu; Li, Quan-Zhen; Uematsu, Satoshi; Akira, Shizuo; Reith, Walter; Mohan, Chandra; Kotzin, Brian L.; Izui, Shozo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Autoimmunity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">339-348</span>CODEN:
                <span class="NLM_cas:coden">JOAUEP</span>;
        ISSN:<span class="NLM_cas:issn">0896-8411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Accumulating evidence supports the idea that TLR7 and TLR9 play pathogenic and protective roles, resp., in the development of murine systemic lupus erythematosus (SLE).  However, the mol. mechanism responsible for the accelerated development of SLE resulting from the deletion of TLR9 and the resp. contributions of TLR7 and TLR9 to the development of different autoimmune responses against nuclear and non-nuclear autoantigens implicated in lupus nephritis have not been well defined.  In the present study, the authors addressed these questions by assessing the effect of the TLR9 and/or TLR7 deletion on the prodn. of various autoantibodies and the development of lupus nephritis in C57BL/6 mice congenic for the Nba2 (NZB autoimmunity 2) locus (B6.Nba2).  TLR9-deficient B6.Nba2 mice displayed increased prodn. of autoantibodies against nuclear antigens, serum retroviral gp70 and glomerular matrix antigens, and developed a markedly accelerated form of lupus nephritis.  Enhanced disease was assocd. with functionally upregulated expression of TLR7, as documented by an increased TLR7-dependent activation of B cells and plasmacytoid dendritic cells.  Notably, disease exacerbation in TLR9-deficient mice was completely suppressed by the deletion of TLR7.  The authors' results indicate that TLR7 has a pivotal role in a wide variety of autoimmune responses against DNA- and RNA-contg. nuclear antigens, retroviral gp70 and glomerular matrix antigens implicated in murine SLE, and that enhanced TLR7 activity is crit. for the accelerated development of SLE in TLR9-deficient lupus-prone mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ-44-46k3FrVg90H21EOLACvtfcHk0liQMgxYKbCgnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltF2ms7g%253D&md5=d7553a8823cbf199b73cf4bfed6fb0c3</span></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=10.1016%2Fj.jaut.2009.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaut.2009.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DSantiago-Raber%26aufirst%3DM.%2BL.%26aulast%3DDunand-Sauthier%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DQ.%2BZ.%26aulast%3DUematsu%26aufirst%3DS.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DReith%26aufirst%3DW.%26aulast%3DMohan%26aufirst%3DC.%26aulast%3DKotzin%26aufirst%3DB.%2BL.%26aulast%3DIzui%26aufirst%3DS.%26atitle%3DCritical%2520role%2520of%2520TLR7%2520in%2520the%2520acceleration%2520of%2520systemic%2520lupus%2520erythematosus%2520in%2520TLR9-deficient%2520mice%26jtitle%3DJ.%2520Autoimmun.%26date%3D2010%26volume%3D34%26spage%3D339%26epage%3D348%26doi%3D10.1016%2Fj.jaut.2009.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimozato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara-Tobinai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, S. i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span> <span> </span><span class="NLM_article-title">Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">6119</span>, <span class="refDoi"> DOI: 10.1038/ncomms7119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2Fncomms7119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=25648980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlGlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6119&author=A.+Kannoauthor=N.+Tanimuraauthor=M.+Ishizakiauthor=K.+Ohkoauthor=Y.+Motoiauthor=M.+Onjiauthor=R.+Fukuiauthor=T.+Shimozatoauthor=K.+Yamamotoauthor=T.+Shibataauthor=S.+Sanoauthor=A.+Sugahara-Tobinaiauthor=T.+Takaiauthor=U.+Ohtoauthor=T.+Shimizuauthor=S.+i.+Saitohauthor=K.+Miyake&title=Targeting+cell+surface+TLR7+for+therapeutic+intervention+in+autoimmune+diseases&doi=10.1038%2Fncomms7119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases</span></div><div class="casAuthors">Kanno, Atsuo; Tanimura, Natsuko; Ishizaki, Masayuki; Ohko, Kentaro; Motoi, Yuji; Onji, Masahiro; Fukui, Ryutaro; Shimozato, Takaichi; Yamamoto, Kazuhide; Shibata, Takuma; Sano, Shigetoshi; Sugahara-Tobinai, Akiko; Takai, Toshiyuki; Ohto, Umeharu; Shimizu, Toshiyuki; Saitoh, Shin-ichiroh; Miyake, Kensuke</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6119</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) senses microbial-derived RNA but can also potentially respond to self-derived RNA.  To prevent autoimmune responses, TLR7 is thought to localize in endolysosomes.  Contrary to this view, we show here that TLR7 is present on the cell surface of immune cells and that TLR7 responses can be inhibited by an anti-TLR7 antibody.  The anti-TLR7 antibody is internalized with TLR7 and accumulates in endolysosomes as an immune complex.  TLR7 responses in dendritic cells, macrophages and B cells are all inhibited by the anti-TLR7 antibody.  Furthermore, the anti-TLR7 antibody inhibits in vivo cytokine prodn. induced by a TLR7 ligand.  Spontaneous TLR7 activation in Unc93b1D34A/D34A mice causes lethal inflammation.  Progressive inflammation such as splenomegaly, thrombocytopenia and chronic active hepatitis are ameliorated by anti-TLR7 antibody treatment.  These results demonstrate that cell surface TLR7 is a promising target for therapeutic intervention in autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO9GMC9fjDKLVg90H21EOLACvtfcHk0liQMgxYKbCgnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlGlur8%253D&md5=6d508a5137d5c47103be9c4f53690416</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fncomms7119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7119%26sid%3Dliteratum%253Aachs%26aulast%3DKanno%26aufirst%3DA.%26aulast%3DTanimura%26aufirst%3DN.%26aulast%3DIshizaki%26aufirst%3DM.%26aulast%3DOhko%26aufirst%3DK.%26aulast%3DMotoi%26aufirst%3DY.%26aulast%3DOnji%26aufirst%3DM.%26aulast%3DFukui%26aufirst%3DR.%26aulast%3DShimozato%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DSano%26aufirst%3DS.%26aulast%3DSugahara-Tobinai%26aufirst%3DA.%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DSaitoh%26aufirst%3DS.%2Bi.%26aulast%3DMiyake%26aufirst%3DK.%26atitle%3DTargeting%2520cell%2520surface%2520TLR7%2520for%2520therapeutic%2520intervention%2520in%2520autoimmune%2520diseases%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6119%26doi%3D10.1038%2Fncomms7119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hamm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgartner, R.</span></span> <span> </span><span class="NLM_article-title">Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists</span>. <i>J. Immunotoxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.3109/15476910903286733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.3109%2F15476910903286733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=19848448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=257-265&author=S.+Hammauthor=S.+Rathauthor=S.+Michelauthor=R.+Baumgartner&title=Cancer+immunotherapeutic+potential+of+novel+small+molecule+TLR7+and+TLR8+agonists&doi=10.3109%2F15476910903286733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists</span></div><div class="casAuthors">Hamm, Svetlana; Rath, Sandra; Michel, Susanne; Baumgartner, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunotoxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">257-265</span>CODEN:
                <span class="NLM_cas:coden">JIOMAP</span>;
        ISSN:<span class="NLM_cas:issn">1547-691X</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR)-mediated signaling is proposed as an immunotherapeutic target against tumorigenesis.  Natural killer (NK) cells play a crit. role in host defense against tumors.  Specifically, formation of tumor metastasis in various organs can be suppressed by the local activity of NK cells.  In this study, we present a novel TLR7 agonist (termed SC-1) that induces pro-inflammatory cytokines in human blood cells, activates NK cell function, and is highly efficient in preventing lung metastases in a pulmonary metastatic Renca model.  Furthermore, a second compd. (termed SC-2), acting as dual-specific TLR7 and TLR8 agonist, was evaluated with respect to its immunostimulatory and NK cell-activating capacities.  The release of pro-inflammatory cytokines was shown to be even more pronounced with this compd.  Addnl. expts. showed a significant up-regulation of activation marker CD69 on NK cells and increased cytolytic activity of peripheral blood cells compared to the effect of a monospecific TLR7 agonist SC-1.  Normally, TLR7 and TLR8 are expressed on different immune cell subpopulations.  TLR7 expression on antigen-presenting cells is detected in plasmacytoid dendritic cells, CD34+-derived dendritic cells, and B-cells, whereas TLR8 is mainly expressed on cells of the myeloid lineage, such as monocytes, macrophages, and myeloid dendritic cells.  Therefore, a compd. that activates both TLR7 and TLR8 would result in a highly efficient immune system activation and may give rise to an enhanced anti-tumor activity in vivo compared to that elicited by a monospecific TLR7 agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjZBxf5X74dbVg90H21EOLACvtfcHk0liQMgxYKbCgnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7jJ&md5=3e97727ac2866bef69244a1a627ec319</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.3109%2F15476910903286733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F15476910903286733%26sid%3Dliteratum%253Aachs%26aulast%3DHamm%26aufirst%3DS.%26aulast%3DRath%26aufirst%3DS.%26aulast%3DMichel%26aufirst%3DS.%26aulast%3DBaumgartner%26aufirst%3DR.%26atitle%3DCancer%2520immunotherapeutic%2520potential%2520of%2520novel%2520small%2520molecule%2520TLR7%2520and%2520TLR8%2520agonists%26jtitle%3DJ.%2520Immunotoxicol.%26date%3D2009%26volume%3D6%26spage%3D257%26epage%3D265%26doi%3D10.3109%2F15476910903286733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smits, E. L. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponsaerts, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berneman, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tendeloo, V. F. I.</span></span> <span> </span><span class="NLM_article-title">The Use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">875</span>, <span class="refDoi"> DOI: 10.1634/theoncologist.2008-0097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1634%2Ftheoncologist.2008-0097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=18701762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2qs7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=859-875&author=E.+L.+J.+M.+Smitsauthor=P.+Ponsaertsauthor=Z.+N.+Bernemanauthor=V.+F.+I.+Van+Tendeloo&title=The+Use+of+TLR7+and+TLR8+ligands+for+the+enhancement+of+cancer+immunotherapy&doi=10.1634%2Ftheoncologist.2008-0097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy</span></div><div class="casAuthors">Smits, Evelien L. J. M.; Ponsaerts, Peter; Berneman, Zwi N.; van Tendeloo, Viggo F. I.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">859-875</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review.  The importance of Toll-like receptors (TLRs) in stimulating innate and adaptive immunity is now well established.  In view of this, TLR ligands have become interesting targets to use as stand-alone immunotherapeutics or vaccine adjuvants for cancer treatment.  TLR7 and TLR8 were found to be closely related, sharing their intracellular endosomal location, as well as their ligands.  In this review, we describe the agonists of TLR7 and TLR8 that are known so far, as well as their contribution to antitumor responses by affecting immune cells, tumor cells, and the tumor microenvironment.  The major benefit of TLR7/8 agonists as immune response enhancers is their simultaneous stimulation of several cell types, resulting in a mix of activated immune cells, cytokines and chemokines at the tumor site.  We discuss the studies that used TLR7/8 agonists as stand-alone immunotherapeutics or cancer vaccine adjuvants, as well as the potential of TLR7/8 ligands to enhance antitumor responses in passive immunotherapy approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9kjvmUDLKcLVg90H21EOLACvtfcHk0liQMgxYKbCgnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2qs7vL&md5=7deddd96b00b6c7dfe657f942e72184e</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2008-0097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2008-0097%26sid%3Dliteratum%253Aachs%26aulast%3DSmits%26aufirst%3DE.%2BL.%2BJ.%2BM.%26aulast%3DPonsaerts%26aufirst%3DP.%26aulast%3DBerneman%26aufirst%3DZ.%2BN.%26aulast%3DVan%2BTendeloo%26aufirst%3DV.%2BF.%2BI.%26atitle%3DThe%2520Use%2520of%2520TLR7%2520and%2520TLR8%2520ligands%2520for%2520the%2520enhancement%2520of%2520cancer%2520immunotherapy%26jtitle%3DOncologist%26date%3D2008%26volume%3D13%26spage%3D859%26epage%3D875%26doi%3D10.1634%2Ftheoncologist.2008-0097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamper, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolodziej, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scates, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortez, E.</span></span> <span> </span><span class="NLM_article-title">Solid phase synthesis of β-Peptoids: N-Substituted β-aminopropionic acid oligomers</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1021/jo971675w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971675w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK1cXksFCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=708-718&author=B.+C.+Hamperauthor=S.+A.+Kolodziejauthor=A.+M.+Scatesauthor=R.+G.+Smithauthor=E.+Cortez&title=Solid+phase+synthesis+of+%CE%B2-Peptoids%3A+N-Substituted+%CE%B2-aminopropionic+acid+oligomers&doi=10.1021%2Fjo971675w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Solid Phase Synthesis of β-Peptoids: N-Substituted β-Aminopropionic Acid Oligomers</span></div><div class="casAuthors">Hamper, Bruce C.; Kolodziej, Stephen A.; Scates, Angela M.; Smith, Ronald G.; Cortez, Enriqueta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">708-718</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A solid-phase org. synthesis method has been developed for the prepn. of N-substituted-β-aminopropionic acid oligomers or β-peptoids I.  Treatment of polymer-bound 4-(benzyloxy)benzyl acrylate with primary amines afforded N-substituted β-alanines.  Polymer loadings and product conversions were detd. by direct cleavage of resin-bound materials and measurement by 1H NMR with an internal std.  The NMR method was used to establish loading of all resin-bound intermediates including acrylic acid.  Acylation with acryloyl chloride followed by Michael addn. of primary amines to the acrylamide allowed prepn. of di-β-peptoids.  By a linear set of seven reactions, trimeric N-benzyl-β-aminopropionic acid was prepd. in 67% overall yield.  Single-bead FT-IR microspectroscopy was used to acquire spectra of the resin bound mono-β-peptoids, di-β-peptoids, and acrylamide intermediates.  A combinatorial library of defined mixts. of tri-β-peptoids was prepd. by mixing equimolar amts. of the mono-β-peptoid resins and carrying them through two sequences of the acylation-Michael addn.  The identity of a sample mixt. II (R = Me, CH2Ph, CH2CH2Ph, CH2C6H4OMe-4, allyl, CH2CHMe2, CHMeEt, CHMe2) was detd. by LC-MS anal. of the cleavage product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopnt4vnxPi4rVg90H21EOLACvtfcHk0lg4WWKDYBsjug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksFCltg%253D%253D&md5=3cf025948e0425ce6f72bcb817f051b4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo971675w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971675w%26sid%3Dliteratum%253Aachs%26aulast%3DHamper%26aufirst%3DB.%2BC.%26aulast%3DKolodziej%26aufirst%3DS.%2BA.%26aulast%3DScates%26aufirst%3DA.%2BM.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DCortez%26aufirst%3DE.%26atitle%3DSolid%2520phase%2520synthesis%2520of%2520%25CE%25B2-Peptoids%253A%2520N-Substituted%2520%25CE%25B2-aminopropionic%2520acid%2520oligomers%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D708%26epage%3D718%26doi%3D10.1021%2Fjo971675w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel-Andreasen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, C. A.</span></span> <span> </span><span class="NLM_article-title">β-Peptoid foldamers at last</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2696</span>– <span class="NLM_lpage">2704</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.5b00257</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.5b00257" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyqsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=2696-2704&author=J.+S.+Laursenauthor=J.+Engel-Andreasenauthor=C.+A.+Olsen&title=%CE%B2-Peptoid+foldamers+at+last&doi=10.1021%2Facs.accounts.5b00257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">β-Peptoid foldamers at last</span></div><div class="casAuthors">Laursen, Jonas S.; Engel-Andreasen, Jens; Olsen, Christian A.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2696-2704</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  For a long time, peptides were considered unsuitable for drug development due to their inherently poor pharmacokinetic properties and proteolytic susceptibility.  However, this paradigm has changed significantly in the past decade with the approval of numerous antibodies and proteins as drugs.  In parallel, research in the field of synthetic mols. that are able to mimic or complement folding patterns exhibited by biopolymers, but are not recognized by proteases, have received considerable attention as well.  Such entities were coined "foldamers" by S. H. Gellman (1998).  Oligomers of N-alkylated 3-aminopropionic acid residues have been called β-peptoids due to their structural similarity to β-peptides and peptoids (N-alkylglycines), resp.  Because bona fide foldamer behavior has been demonstrated for both parent architectures, the authors wondered if the β-peptoids could serve as a successful addn. to the known ensemble of peptidomimetic foldamers.  When the authors entered this field, only the seminal description of libraries of β-peptoid dimers and trimers by B. C. Hamper et al. (1998) had been published a no. of years earlier.  Perhaps somewhat naively in retrospect, the authors envisioned that elongation of chain length combined with introduction of bulky α-chiral side-chains would deliver folded structures as reported for the α-peptoid counterparts.  Initially, the authors, and others, were unsuccessful in obtaining stable secondary structures of β-peptoid oligomers, and instead, these residues were either incorporated in cyclic structures or in combination with other types of residues to give peptidomimetic constructs with heterogeneous backbones.  Amphiphilic architectures with various membrane-targeting activities, such as mimics of antimicrobial peptides or cell-penetrating peptides, have thus been particularly successful.  The introduction of β-peptoid residues in histone deacetylase inhibitors mimicking non-ribosomal cyclotetrapeptides have also been reported.  Here, the authors sketch the scientific journey that ultimately delivered robustly folded β-peptoid oligomers.  Contributions involving biol. evaluation of peptidomimetic constructs contg. β-peptoid residues, as mentioned above, which were investigated leading up to these recently reported high-resoln. helical structures, are discussed.  On the basis of the work described here, the authors envision that β-peptoids will find future utility as peptidomimetics for biomedical investigation contg. both heterogeneous and homogeneous backbones.  The recent demonstration of control over the secondary structure of a homogeneous β-peptoid backbone now enables structure-based design of scaffolds with predictable display of desired functionalities in 3 dimensions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT21EhTRrT-rVg90H21EOLACvtfcHk0lg4WWKDYBsjug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyqsr%252FO&md5=61ec8510e6cf821887c1af9695ad22b8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.5b00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.5b00257%26sid%3Dliteratum%253Aachs%26aulast%3DLaursen%26aufirst%3DJ.%2BS.%26aulast%3DEngel-Andreasen%26aufirst%3DJ.%26aulast%3DOlsen%26aufirst%3DC.%2BA.%26atitle%3D%25CE%25B2-Peptoid%2520foldamers%2520at%2520last%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26spage%3D2696%26epage%3D2704%26doi%3D10.1021%2Facs.accounts.5b00257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckermann, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huebner, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlowe, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spellmeyer, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santi, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, P. A.</span></span> <span> </span><span class="NLM_article-title">Peptoids: a modular approach to drug discovery</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">9367</span>– <span class="NLM_lpage">9371</span>, <span class="refDoi"> DOI: 10.1073/pnas.89.20.9367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1073%2Fpnas.89.20.9367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1409642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK3sXhtFKhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=9367-9371&author=R.+J.+Simonauthor=R.+S.+Kaniaauthor=R.+N.+Zuckermannauthor=V.+D.+Huebnerauthor=D.+A.+Jewellauthor=S.+Banvilleauthor=S.+Ngauthor=L.+Wangauthor=S.+Rosenbergauthor=C.+K.+Marloweauthor=D.+C.+Spellmeyerauthor=R.+Tanauthor=A.+D.+Frankelauthor=D.+V.+Santiauthor=F.+E.+Cohenauthor=P.+A.+Bartlett&title=Peptoids%3A+a+modular+approach+to+drug+discovery&doi=10.1073%2Fpnas.89.20.9367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Peptoids:  a modular approach to drug discovery</span></div><div class="casAuthors">Simon, Reyna J.; Kania, Robert S.; Zuckermann, Ronald N.; Huebner, Verena D.; Jewell, David A.; Banville, Steven; Ng, Simon; Wang, Liang; Rosenberg, Steven; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9367-71</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Peptoids, oligomers of N-substituted glycines, are described as a motif for the generation of chem. diverse libraries of novel mols.  Ramachandran-type plots were calcd. and indicate a greater diversity of conformational states available for peptoids than for peptides.  The monomers incorporate t-butyl-based side-chain and 9-fluorenylmethoxy-carbonyl α-amine protection.  The controlled oligomerization of the peptoid monomers was performed manually and robotically with in situ activation by either benzotriazol-1-yloxytris(pyrrolidino)phosphonium hexafluorophosphate or bromotris(pyrrolidino)phosphonium hexafluorophosphate.  Other steps were identical to peptide synthesis using α-(9-fluorenylmethoxycarbonyl)amino acids.  A total of 15 monomers and 10 oligomers (peptoids) are described.  Preliminary data are presented on the stability of a representative oligopeptoid to enzymic hydrolysis.  Peptoid versions of peptide ligands of three biol. systems (bovine pancreatic α-amylase, hepatitis A virus 3C proteinase, and human immunodeficiency virus transactivator-responsive element RNA) were found with affinities comparable to those of the corresponding peptides.  The potential use of libraries of these compds. in receptor- or enzyme-based assays is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqjYjAnzlZWbVg90H21EOLACvtfcHk0lg4WWKDYBsjug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtFKhsro%253D&md5=072eed656364cd7cf06c71aa9fb001c3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.20.9367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.20.9367%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DR.%2BJ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DZuckermann%26aufirst%3DR.%2BN.%26aulast%3DHuebner%26aufirst%3DV.%2BD.%26aulast%3DJewell%26aufirst%3DD.%2BA.%26aulast%3DBanville%26aufirst%3DS.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRosenberg%26aufirst%3DS.%26aulast%3DMarlowe%26aufirst%3DC.%2BK.%26aulast%3DSpellmeyer%26aufirst%3DD.%2BC.%26aulast%3DTan%26aufirst%3DR.%26aulast%3DFrankel%26aufirst%3DA.%2BD.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DCohen%26aufirst%3DF.%2BE.%26aulast%3DBartlett%26aufirst%3DP.%2BA.%26atitle%3DPeptoids%253A%2520a%2520modular%2520approach%2520to%2520drug%2520discovery%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26spage%3D9367%26epage%3D9371%26doi%3D10.1073%2Fpnas.89.20.9367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dohm, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barron, A. E.</span></span> <span> </span><span class="NLM_article-title">Peptoids: bio-inspired polymers as potential pharmaceuticals</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2732</span>– <span class="NLM_lpage">2747</span>, <span class="refDoi"> DOI: 10.2174/138161211797416066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.2174%2F138161211797416066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=21728985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2732-2747&author=M.+T.+Dohmauthor=R.+Kapoorauthor=A.+E.+Barron&title=Peptoids%3A+bio-inspired+polymers+as+potential+pharmaceuticals&doi=10.2174%2F138161211797416066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Peptoids: bio-inspired polymers as potential pharmaceuticals</span></div><div class="casAuthors">Dohm, Michelle T.; Kapoor, Rinki; Barron, Annelise E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2732-2747</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Peptoids are a developing class of peptide-like oligomers originally invented for drug discovery in the early 1990s.  While peptides hold great promise for therapeutic applications, current development of peptide-based pharmaceuticals is hindered by their potential for misfolding and aggregation, and particularly, for rapid in vivo degrdn. post-administration.  Researchers have investigated alternative peptide-like constructs that may be able to circumvent such complications.  Peptoids comprise a peptide-based backbone and N-substituted glycines for side-chain residues, resulting in complete protease-resistance.  The synthesis of peptoid sequences of ≥50 units in length allows for controlled sequence compn. and incorporation of diverse side-chain chemistries.  Although the landscape of peptoid structure is not clearly defined, secondary, tertiary, loop, turn, and random structures have been identified.  As protease-resistant isomers of peptides, peptoids are being developed as versatile mol. tools in biochem. and biophysics, and are becoming attractive candidates for therapeutic and diagnostic applications.  Peptoids have thus far demonstrated bioactivity as protein mimics and as replacements for small mol. drugs.  Here, the authors discuss the most recent advances in peptoid research on the therapeutic front in the last few years, including in vitro and in vivo studies in the fields of lung surfactant therapy, antimicrobial agents, diagnostics, and cancer.  The authors particularly focus on the biophys. activity of lipid-assocd. peptoids and their potential therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiBxZGVggsOrVg90H21EOLACvtfcHk0ljScm1XR1GZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7vP&md5=82bd66d1f8aca7f39df8c7a2b312f967</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F138161211797416066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211797416066%26sid%3Dliteratum%253Aachs%26aulast%3DDohm%26aufirst%3DM.%2BT.%26aulast%3DKapoor%26aufirst%3DR.%26aulast%3DBarron%26aufirst%3DA.%2BE.%26atitle%3DPeptoids%253A%2520bio-inspired%2520polymers%2520as%2520potential%2520pharmaceuticals%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D2732%26epage%3D2747%26doi%3D10.2174%2F138161211797416066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckermann, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moos, W. H.</span></span> <span> </span><span class="NLM_article-title">Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2657</span>– <span class="NLM_lpage">2662</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)80691-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2FS0960-894X%2801%2980691-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK2MXisVWgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=2657-2662&author=S.+M.+Millerauthor=R.+J.+Simonauthor=S.+Ngauthor=R.+N.+Zuckermannauthor=J.+M.+Kerrauthor=W.+H.+Moos&title=Proteolytic+studies+of+homologous+peptide+and+N-substituted+glycine+peptoid+oligomers&doi=10.1016%2FS0960-894X%2801%2980691-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers</span></div><div class="casAuthors">Miller, Susan M.; Simon, Reyna J.; Ng, Simon; Zuckermann, Ronald N.; Kerr, Janice M.; Moos, Walter H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2657-62</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Homologous L-amino acid, D-amino acid, and parallel and anti-parallel (retro) sequence N-substituted glycine peptide and peptoid oligomers were prepd. and incubated with proteases from each major class.  The L-amino acid contg. peptides were readily cleaved by the appropriate enzymes, while equiv. D-amino acid contg. and N-substituted glycine contg. oligomers were essentially untouched.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYEcOwl9xkKLVg90H21EOLACvtfcHk0ljScm1XR1GZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXisVWgsrY%253D&md5=e4d7f92ec34aef019f8e21999667b867</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2980691-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252980691-0%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%2BM.%26aulast%3DSimon%26aufirst%3DR.%2BJ.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DZuckermann%26aufirst%3DR.%2BN.%26aulast%3DKerr%26aufirst%3DJ.%2BM.%26aulast%3DMoos%26aufirst%3DW.%2BH.%26atitle%3DProteolytic%2520studies%2520of%2520homologous%2520peptide%2520and%2520N-substituted%2520glycine%2520peptoid%2520oligomers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D2657%26epage%3D2662%26doi%3D10.1016%2FS0960-894X%2801%2980691-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckermann, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moos, W. H.</span></span> <span> </span><span class="NLM_article-title">Comparison of the proteolytic susceptibilities of homologous L-amino-Acid, D-amino-Acid, and N-substituted glycine peptide and peptoid oligomers</span>. <i>Drug Dev. Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1002/ddr.430350105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fddr.430350105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADyaK2MXlvFyqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1995&pages=20-32&author=S.+M.+Millerauthor=R.+J.+Simonauthor=S.+Ngauthor=R.+N.+Zuckermannauthor=J.+M.+Kerrauthor=W.+H.+Moos&title=Comparison+of+the+proteolytic+susceptibilities+of+homologous+L-amino-Acid%2C+D-amino-Acid%2C+and+N-substituted+glycine+peptide+and+peptoid+oligomers&doi=10.1002%2Fddr.430350105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide and peptoid oligomers</span></div><div class="casAuthors">Miller, Susan M.; Simon, Reyna J.; Ng, Simon; Zuckermann, Ronald N.; Kerr, Janice M.; Moos, Walter H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-32</span>CODEN:
                <span class="NLM_cas:coden">DDREDK</span>;
        ISSN:<span class="NLM_cas:issn">0272-4391</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">A series of homologous L-amino acid, D-amino acid, and both parallel and antiparallel (retro) sequence N-substituted glycine peptide and peptoid oligomers were prepd. and incubated with a series of enzymes representative of the major classes of proteases.  Each resp. L-amino acid contg. peptide sequence was readily cleaved by the appropriate enzyme.  In contrast, equiv. D-amino acid contg. and N-substituted glycine contg. oligomers were cleaved minimally or not at all by the resp. enzymes.  The N-substituted glycine peptoids represent a new class of combinatorial diversity for lead discovery with improved pharmaceutical characteristics relative to L-amino acid contg. peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Jas0JrkWiLVg90H21EOLACvtfcHk0ljScm1XR1GZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlvFyqt7s%253D&md5=222dfee4425a13e008ccf17343485329</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fddr.430350105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.430350105%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%2BM.%26aulast%3DSimon%26aufirst%3DR.%2BJ.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DZuckermann%26aufirst%3DR.%2BN.%26aulast%3DKerr%26aufirst%3DJ.%2BM.%26aulast%3DMoos%26aufirst%3DW.%2BH.%26atitle%3DComparison%2520of%2520the%2520proteolytic%2520susceptibilities%2520of%2520homologous%2520L-amino-Acid%252C%2520D-amino-Acid%252C%2520and%2520N-substituted%2520glycine%2520peptide%2520and%2520peptoid%2520oligomers%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1995%26volume%3D35%26spage%3D20%26epage%3D32%26doi%3D10.1002%2Fddr.430350105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodadek, T.</span></span> <span> </span><span class="NLM_article-title">Quantitative evaluation of the relative cell permeability of peptoids and peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1508</span>– <span class="NLM_lpage">1509</span>, <span class="refDoi"> DOI: 10.1021/ja0668623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0668623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsVyntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1508-1509&author=Y.+U.+Kwonauthor=T.+Kodadek&title=Quantitative+evaluation+of+the+relative+cell+permeability+of+peptoids+and+peptides&doi=10.1021%2Fja0668623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative evaluation of the relative cell permeability of peptoids and peptides</span></div><div class="casAuthors">Kwon, Yong-Uk; Kodadek, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1508-1509</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We evaluated quant. the relative cell permeability of peptoids and peptides using a cell-based reporter gene-based assay.  Generally, peptoids were much more cell permeable than the corresponding peptides, though the difference decreased with increasing length.  These results suggest that peptoids may be useful reagents for manipulating the activities of intracellular proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXlBNGq3RO2rVg90H21EOLACvtfcHk0ljioQgzv5mEZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsVyntA%253D%253D&md5=1eda9f9a2e73a1d43dda65b33447fdeb</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja0668623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0668623%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DY.%2BU.%26aulast%3DKodadek%26aufirst%3DT.%26atitle%3DQuantitative%2520evaluation%2520of%2520the%2520relative%2520cell%2520permeability%2520of%2520peptoids%2520and%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D1508%26epage%3D1509%26doi%3D10.1021%2Fja0668623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodadek, T.</span></span> <span> </span><span class="NLM_article-title">High-throughput evaluation of relative cell permeability between peptoids and peptides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5853</span>– <span class="NLM_lpage">5861</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.04.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.bmc.2008.04.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=18490170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFegtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=5853-5861&author=N.+C.+Tanauthor=P.+Yuauthor=Y.+U.+Kwonauthor=T.+Kodadek&title=High-throughput+evaluation+of+relative+cell+permeability+between+peptoids+and+peptides&doi=10.1016%2Fj.bmc.2008.04.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput evaluation of relative cell permeability between peptoids and peptides</span></div><div class="casAuthors">Tan, Niclas C.; Yu, Peng; Kwon, Yong-Uk; Kodadek, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5853-5861</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Peptides are limited in their use as drugs due to low cell permeability and vulnerability to proteases.  In contrast, peptoids are immune to enzymic degrdn. and some peptoids have been shown to be relatively cell permeable.  In order to facilitate future design of peptoid libraries for screening expts., it would be useful to have a high-throughput method to est. the cell permeability of peptoids contg. different residues.  In this paper, the authors report the strengths and limitations of a high-throughput cell-based permeability assay that registers the relative ability of steroid-conjugated peptides and peptoids to enter a cell.  A comparative investigation of the physicochem. properties and side chain compn. of peptoids and peptides is described to explain the obsd. higher cell permeability of peptoids over peptides.  These data suggest that the conversion of the monomeric residues in peptides to an N-alkylglycine moiety in peptoids reduced the hydrogen-bonding potential of the mols. and is the main contributor to the obsd. permeability improvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2wizMpfmhVrVg90H21EOLACvtfcHk0ljioQgzv5mEZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFegtr8%253D&md5=be7c6b4b6fb01319af99315758045387</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.04.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.04.074%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DN.%2BC.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DKwon%26aufirst%3DY.%2BU.%26aulast%3DKodadek%26aufirst%3DT.%26atitle%3DHigh-throughput%2520evaluation%2520of%2520relative%2520cell%2520permeability%2520between%2520peptoids%2520and%2520peptides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D5853%26epage%3D5861%26doi%3D10.1016%2Fj.bmc.2008.04.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwochert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkeley, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponkey, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khunte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span> <span> </span><span class="NLM_article-title">Peptide to peptoid substitutions increase cell permeability in cyclic hexapeptides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2928</span>– <span class="NLM_lpage">2931</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.5b01162</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.5b01162" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps1arsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=2928-2931&author=J.+Schwochertauthor=R.+Turnerauthor=M.+Thangauthor=R.+F.+Berkeleyauthor=A.+R.+Ponkeyauthor=K.+M.+Rodriguezauthor=S.+S.+F.+Leungauthor=B.+Khunteauthor=G.+Goetzauthor=C.+Limberakisauthor=A.+S.+Kalgutkarauthor=H.+Engauthor=M.+J.+Shapiroauthor=A.+M.+Mathiowetzauthor=D.+A.+Priceauthor=S.+Lirasauthor=M.+P.+Jacobsonauthor=R.+S.+Lokey&title=Peptide+to+peptoid+substitutions+increase+cell+permeability+in+cyclic+hexapeptides&doi=10.1021%2Facs.orglett.5b01162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide to Peptoid Substitutions Increase Cell Permeability in Cyclic Hexapeptides</span></div><div class="casAuthors">Schwochert, Joshua; Turner, Rushia; Thang, Melissa; Berkeley, Ray F.; Ponkey, Alexandra R.; Rodriguez, Kelsie M.; Leung, Siegfried S. F.; Khunte, Bhagyashree; Goetz, Gilles; Limberakis, Chris; Kalgutkar, Amit S.; Eng, Heather; Shapiro, Michael J.; Mathiowetz, Alan M.; Price, David A.; Liras, Spiros; Jacobson, Matthew P.; Lokey, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2928-2931</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The effect of peptide-to-peptoid substitutions on the passive membrane permeability of an N-methylated cyclic hexapeptide is examd.  In general, substitutions maintained permeability but increased conformational heterogeneity.  Diversification with nonproteinogenic side chains increased permeability up to 3-fold.  Addnl., the conformational impact of peptoid substitutions within a β-turn are explored.  Based on these results, the strategic incorporation of peptoid residues into cyclic peptides can maintain or improve cell permeability, while increasing access to diverse side-chain functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofUG1_hYdVn7Vg90H21EOLACvtfcHk0li8iAR5Rac6jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps1arsrs%253D&md5=156985175ddcafd34a67e81713934040</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.5b01162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.5b01162%26sid%3Dliteratum%253Aachs%26aulast%3DSchwochert%26aufirst%3DJ.%26aulast%3DTurner%26aufirst%3DR.%26aulast%3DThang%26aufirst%3DM.%26aulast%3DBerkeley%26aufirst%3DR.%2BF.%26aulast%3DPonkey%26aufirst%3DA.%2BR.%26aulast%3DRodriguez%26aufirst%3DK.%2BM.%26aulast%3DLeung%26aufirst%3DS.%2BS.%2BF.%26aulast%3DKhunte%26aufirst%3DB.%26aulast%3DGoetz%26aufirst%3DG.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26atitle%3DPeptide%2520to%2520peptoid%2520substitutions%2520increase%2520cell%2520permeability%2520in%2520cyclic%2520hexapeptides%26jtitle%3DOrg.%2520Lett.%26date%3D2015%26volume%3D17%26spage%3D2928%26epage%3D2931%26doi%3D10.1021%2Facs.orglett.5b01162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterfoss, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renfrew, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhlman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirshenbaum, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, R.</span></span> <span> </span><span class="NLM_article-title">A Preliminary survey of the peptoid folding landscape</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">16798</span>– <span class="NLM_lpage">16807</span>, <span class="refDoi"> DOI: 10.1021/ja905267k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja905267k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtleisL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=16798-16807&author=G.+L.+Butterfossauthor=P.+D.+Renfrewauthor=B.+Kuhlmanauthor=K.+Kirshenbaumauthor=R.+Bonneau&title=A+Preliminary+survey+of+the+peptoid+folding+landscape&doi=10.1021%2Fja905267k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A preliminary survey of the peptoid folding landscape</span></div><div class="casAuthors">Butterfoss, Glenn L.; Renfrew, P. Douglas; Kuhlman, Brian; Kirshenbaum, Kent; Bonneau, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16798-16807</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an anal. of the conformational preferences of N-substituted glycine peptoid oligomers.  We survey the backbone conformations obsd. in exptl. detd. peptoid structures and provide a comparison with high-level quantum mechanics calcns. of short peptoid oligomers.  The dominant sources of structural variation derive from: side-chain dependent cis/trans isomerization of backbone amide bonds, side chain stereochem., and flexibility in the psi dihedral angle.  We find good agreement between the clustering of exptl. detd. peptoid torsion angles and local torsional min. predicted by theory for a disarcosine model.  The calcns. describe a well-defined conformational map featuring distinct energy min.  The general features of the peptoid backbone conformational landscape are consistent across a range of N-alkyl glycine side chains.  Alteration of side chain types, however, creates subtle but potentially significant variations in local folding propensities.  We identify a limited no. of low energy local conformations, which may be preferentially favored by incorporation of particular monomer units.  Greater variation in backbone dihedral angles are accessible in peptoids featuring trans amide bond geometries.  These results confirm that computational approaches can play a valuable role in guiding the design of complex peptoid architectures and may lead to strategies for introducing constraints that select among a limited no. of low energy local conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaQxvmt0lvKbVg90H21EOLACvtfcHk0li8iAR5Rac6jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtleisL3P&md5=f9cf6f5b10ff0b5607bd1d00d94a6a50</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja905267k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja905267k%26sid%3Dliteratum%253Aachs%26aulast%3DButterfoss%26aufirst%3DG.%2BL.%26aulast%3DRenfrew%26aufirst%3DP.%2BD.%26aulast%3DKuhlman%26aufirst%3DB.%26aulast%3DKirshenbaum%26aufirst%3DK.%26aulast%3DBonneau%26aufirst%3DR.%26atitle%3DA%2520Preliminary%2520survey%2520of%2520the%2520peptoid%2520folding%2520landscape%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D16798%26epage%3D16807%26doi%3D10.1021%2Fja905267k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sui, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabenstein, D. L.</span></span> <span> </span><span class="NLM_article-title">Kinetics and equilibria of cis/trans isomerization of backbone amide bonds in peptoids</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">12042</span>– <span class="NLM_lpage">12048</span>, <span class="refDoi"> DOI: 10.1021/ja0740925</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0740925" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvFOhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=12042-12048&author=Q.+Suiauthor=D.+Borchardtauthor=D.+L.+Rabenstein&title=Kinetics+and+equilibria+of+cis%2Ftrans+isomerization+of+backbone+amide+bonds+in+peptoids&doi=10.1021%2Fja0740925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics and Equilibria of Cis/Trans Isomerization of Backbone Amide Bonds in Peptoids</span></div><div class="casAuthors">Sui, Qiang; Borchardt, Dan; Rabenstein, Dallas L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">12042-12048</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The biol. activities of N-substituted glycine oligomers (peptoids) have been the subject of extensive research.  As compared to peptides, both the cis and trans conformations of the backbone amide bonds of peptoids can be significantly populated.  Thus, peptoids are mixts. of configurational isomers, with the no. of isomers increasing by a factor of 2 with each addnl. monomer residue.  Here, the authors report the results of a study of the kinetics and equil. of cis/trans isomerization of the amide bonds of N-acetylated peptoid monomers, dipeptoids, and tripeptoids by NMR spectroscopy.  Resonance intensities indicate the cis conformation of the backbone amide bonds of the peptoids studied is more populated than is generally the case for the analogous secondary amide bond to proline residues in acyclic peptides.  Rate consts. were measured by inversion-magnetization transfer techniques over a range of temps., and activation parameters were derived from the temp. dependence of the rate consts.  The rate of cis/trans isomerization by rotation around the amide bonds in the peptoids studied is generally slower than that around amide bonds to proline residues and takes place on the NMR inversion-magnetization transfer time scale only by rotation around the amide bond to the C-terminal peptoid residue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYolNa9NHLi7Vg90H21EOLACvtfcHk0ljbk1QIjE_MTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvFOhs70%253D&md5=f9c41f1342aa801b453a37fbf215acab</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fja0740925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0740925%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DQ.%26aulast%3DBorchardt%26aufirst%3DD.%26aulast%3DRabenstein%26aufirst%3DD.%2BL.%26atitle%3DKinetics%2520and%2520equilibria%2520of%2520cis%252Ftrans%2520isomerization%2520of%2520backbone%2520amide%2520bonds%2520in%2520peptoids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D12042%26epage%3D12048%26doi%3D10.1021%2Fja0740925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel-Andreasen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fristrup, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, C. A.</span></span> <span> </span><span class="NLM_article-title">Cis–trans amide bond rotamers in β-peptoids and peptoids: evaluation of stereoelectronic effects in backbone and side chains</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">2835</span>– <span class="NLM_lpage">2844</span>, <span class="refDoi"> DOI: 10.1021/ja312532x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja312532x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtleltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=2835-2844&author=J.+S.+Laursenauthor=J.+Engel-Andreasenauthor=P.+Fristrupauthor=P.+Harrisauthor=C.+A.+Olsen&title=Cis%E2%80%93trans+amide+bond+rotamers+in+%CE%B2-peptoids+and+peptoids%3A+evaluation+of+stereoelectronic+effects+in+backbone+and+side+chains&doi=10.1021%2Fja312532x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cis-Trans Amide Bond Rotamers in β-Peptoids and Peptoids: Evaluation of Stereoelectronic Effects in Backbone and Side Chains</span></div><div class="casAuthors">Laursen, Jonas S.; Engel-Andreasen, Jens; Fristrup, Peter; Harris, Pernille; Olsen, Christian A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2835-2844</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonnatural peptide analogs have significant potential for the development of new materials and pharmacol. active ligands.  One such architecture, the β-peptoids (N-alkyl-β-alanines), found use in a variety of biol. active compds. but was sparsely studied with respect to folding propensity.  Thus, the authors here report a study of the effect of structural variations on the cis-trans amide bond rotamer equil. in a selection of monomer model systems.  In addn. to various side chain effects, which correlated well with previous studies of α-peptoids, the authors present the synthesis and study of cis-trans isomerism in the first examples of peptoids and β-peptoids contg. thioamide bonds as well as trifluoroacetylated peptoids and β-peptoids.  These systems revealed an increase in the preference for cis-amides as compared to their parent compds. and thus provide novel strategies for affecting the folding of peptoid constructs.  By using NMR spectroscopy, x-ray crystallog. anal., and d. functional theory calcns., the authors present evidence for the presence of thioamide-arom. interactions through Csp2 -H···Samide hydrogen bonding, which stabilize certain peptoid conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdqXidNft09rVg90H21EOLACvtfcHk0lg2uS1a6XrcmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtleltL0%253D&md5=5af65208996e55a516a95461a1c728db</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fja312532x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja312532x%26sid%3Dliteratum%253Aachs%26aulast%3DLaursen%26aufirst%3DJ.%2BS.%26aulast%3DEngel-Andreasen%26aufirst%3DJ.%26aulast%3DFristrup%26aufirst%3DP.%26aulast%3DHarris%26aufirst%3DP.%26aulast%3DOlsen%26aufirst%3DC.%2BA.%26atitle%3DCis%25E2%2580%2593trans%2520amide%2520bond%2520rotamers%2520in%2520%25CE%25B2-peptoids%2520and%2520peptoids%253A%2520evaluation%2520of%2520stereoelectronic%2520effects%2520in%2520backbone%2520and%2520side%2520chains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D2835%26epage%3D2844%26doi%3D10.1021%2Fja312532x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorske, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastian, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwell, H. E.</span></span> <span> </span><span class="NLM_article-title">New strategies for the design of folded peptoids revealed by a survey of noncovalent interactions in model systems</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">16555</span>– <span class="NLM_lpage">16567</span>, <span class="refDoi"> DOI: 10.1021/ja907184g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja907184g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWmu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=16555-16567&author=B.+C.+Gorskeauthor=J.+R.+Stringerauthor=B.+L.+Bastianauthor=S.+A.+Fowlerauthor=H.+E.+Blackwell&title=New+strategies+for+the+design+of+folded+peptoids+revealed+by+a+survey+of+noncovalent+interactions+in+model+systems&doi=10.1021%2Fja907184g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">New strategies for the design of folded peptoids revealed by a survey of noncovalent interactions in model systems</span></div><div class="casAuthors">Gorske, Benjamin C.; Stringer, Joseph R.; Bastian, Brent L.; Fowler, Sarah A.; Blackwell, Helen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">16555-16567</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Controlling the equil. between backbone cis- and trans-amides in peptoids, or N-substituted glycine oligomers, constitutes a significant challenge in the construction of discretely folded peptoid structures.  Through the anal. of a set of monomeric peptoid model systems, we have developed new and general strategies for controlling peptoid conformation that utilize local noncovalent interactions to regulate backbone amide rotameric equil., including n→π*, steric, and hydrogen bonding interactions.  The chem. functionalities required to implement these strategies are typically confined to the peptoid side chains, preserve chirality at the side chain N-α-carbon known to engender peptoid structure, and are fully compatible with std. peptoid synthesis techniques.  Our examns. of peptoid model systems have also elucidated how solvents affect various side chain-backbone interactions, revealing fundamental aspects of these noncovalent interactions in peptoids that were largely uncharacterized previously.  As validation of our monomeric model systems, we extended the scope of this study to include peptoid oligomers and have now demonstrated the importance of local steric and n→π* interactions in dictating the structures of larger, folded peptoids.  This new, modular design strategy has guided the construction of peptoids contg. 1-naphthylethyl side chains, which we show can be utilized to effectively eliminate trans-amide rotamers from the peptoid backbone, yielding the most conformationally homogeneous class of peptoid structures yet reported in terms of amide rotamerism.  Overall, this research has afforded a valuable and expansive set of design tools for the construction of both discretely folded peptoids and structurally biased peptoid libraries and should shape our understanding of peptoid folding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSttiMduihm7Vg90H21EOLACvtfcHk0lg1zC3mMKS6dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWmu7rF&md5=42055d12a773d30bd21a344906c4e6ce</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja907184g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja907184g%26sid%3Dliteratum%253Aachs%26aulast%3DGorske%26aufirst%3DB.%2BC.%26aulast%3DStringer%26aufirst%3DJ.%2BR.%26aulast%3DBastian%26aufirst%3DB.%2BL.%26aulast%3DFowler%26aufirst%3DS.%2BA.%26aulast%3DBlackwell%26aufirst%3DH.%2BE.%26atitle%3DNew%2520strategies%2520for%2520the%2520design%2520of%2520folded%2520peptoids%2520revealed%2520by%2520a%2520survey%2520of%2520noncovalent%2520interactions%2520in%2520model%2520systems%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D16555%26epage%3D16567%26doi%3D10.1021%2Fja907184g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, J.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fristrup, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, C. A.</span></span> <span> </span><span class="NLM_article-title">Triangular prism-shaped β-peptoid helices as unique biomimetic scaffolds</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7013</span>, <span class="refDoi"> DOI: 10.1038/ncomms8013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1038%2Fncomms8013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=25943784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFylt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7013&author=J.%0AS.+Laursenauthor=P.+Harrisauthor=P.+Fristrupauthor=C.+A.+Olsen&title=Triangular+prism-shaped+%CE%B2-peptoid+helices+as+unique+biomimetic+scaffolds&doi=10.1038%2Fncomms8013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Triangular prism-shaped β-peptoid helices as unique biomimetic scaffolds</span></div><div class="casAuthors">Laursen, Jonas S.; Harris, Pernille; Fristrup, Peter; Olsen, Christian A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7013</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Peptoids are peptidomimetics based on N-alkylated β-aminopropionic acid residues (or N-alkyl-β-alanines).  This type of peptide mimic has previously been incorporated in biol. active ligands and has been hypothesized to be able to exhibit foldamer properties.  Here we show, for the first time, that β-peptoids can be tuned to fold into stable helical structures.  We provide high-resoln. X-ray crystal structures of homomeric β-peptoid hexamers, which reveal right-handed helical conformations with exactly three residues per turn and a helical pitch of 9.6-9.8 Å between turns.  The presence of folded conformations in soln. is supported by CD spectroscopy showing length- and solvent dependency, and mol. dynamics simulations provide further support for a stabilized helical secondary structure in org. solvent.  We thus outline a framework for future design of novel biomimetics that display functional groups with high accuracy in three dimensions, which has potential for development of new functional materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEynUbb3geprVg90H21EOLACvtfcHk0lg1zC3mMKS6dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFylt7jN&md5=2ae2ab87cd0f7faf8eab3774ed77ca42</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fncomms8013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8013%26sid%3Dliteratum%253Aachs%26aulast%3DLaursen%26aufirst%3DJ.%2BS.%26aulast%3DHarris%26aufirst%3DP.%26aulast%3DFristrup%26aufirst%3DP.%26aulast%3DOlsen%26aufirst%3DC.%2BA.%26atitle%3DTriangular%2520prism-shaped%2520%25CE%25B2-peptoid%2520helices%2520as%2520unique%2520biomimetic%2520scaffolds%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7013%26doi%3D10.1038%2Fncomms8013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crapster, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzei, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwell, H. E.</span></span> <span> </span><span class="NLM_article-title">Extraordinarily robust polyproline type I peptoid helices generated via the incorporation of alpha-chiral aromatic N-1-naphthylethyl side chains</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">15559</span>– <span class="NLM_lpage">15567</span>, <span class="refDoi"> DOI: 10.1021/ja204755p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja204755p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKrs7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=15559-15567&author=J.+R.+Stringerauthor=J.+A.+Crapsterauthor=I.+A.+Guzeiauthor=H.+E.+Blackwell&title=Extraordinarily+robust+polyproline+type+I+peptoid+helices+generated+via+the+incorporation+of+alpha-chiral+aromatic+N-1-naphthylethyl+side+chains&doi=10.1021%2Fja204755p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Extraordinarily robust polyproline type I peptoid helices generated via the incorporation of α-chiral aromatic N-1-naphthylethyl side chains</span></div><div class="casAuthors">Stringer, Joseph R.; Crapster, J. Aaron; Guzei, Ilia A.; Blackwell, Helen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">15559-15567</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptoids, or oligomers of N-substituted glycines, are a class of foldamers that have shown extraordinary functional potential since their inception nearly two decades ago.  However, the generation of well-defined peptoid secondary structures remains a difficult task.  This challenge is due, in part, to the lack of a thorough understanding of peptoid sequence-structure relationships and, consequently, an incomplete understanding of the peptoid folding process.  We seek to delineate sequence-structure relationships through the systematic study of noncovalent interactions in peptoids and the design of novel amide side chains capable of such interactions.  Herein, we report the synthesis and detailed structural anal. of a series of (S)-N-(1-naphthylethyl)glycine (Ns1npe) peptoid homo-oligomers by X-ray crystallog., NMR spectroscopy, and CD spectroscopy.  Four of these peptoids were found to adopt well-defined structures in the solid state, with dihedral angles similar to those obsd. in polyproline type I (PPI) peptide helixes and in peptoids with α-chiral side chains.  The X-ray crystal structure of a representative Ns1npe tetramer revealed an all cis-amide helix, with approx. three residues per turn, and a helical pitch of approx. 6.0 Å.  2D-NMR anal. of the length-dependent Ns1npe series showed that these peptoids have very high overall backbone amide Kcis/trans values in acetonitrile, indicative of conformationally homogeneous structures in soln.  Addnl., CD spectroscopy studies of the Ns1npe homo-oligomers in acetonitrile and methanol revealed a striking length-dependent increase in ellipticity per amide.  These Ns1npe helixes represent the most robust peptoid helixes to be reported, and the incorporation of (S)-N-(1-naphthylethyl)glycines provides a new approach for the generation of stable helical structure in this important class of foldamers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWOAhoe5DJ0bVg90H21EOLACvtfcHk0lgjHA1XPa875Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKrs7vO&md5=58c83f67e4dc7954a39bb09f8120dbfb</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fja204755p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja204755p%26sid%3Dliteratum%253Aachs%26aulast%3DStringer%26aufirst%3DJ.%2BR.%26aulast%3DCrapster%26aufirst%3DJ.%2BA.%26aulast%3DGuzei%26aufirst%3DI.%2BA.%26aulast%3DBlackwell%26aufirst%3DH.%2BE.%26atitle%3DExtraordinarily%2520robust%2520polyproline%2520type%2520I%2520peptoid%2520helices%2520generated%2520via%2520the%2520incorporation%2520of%2520alpha-chiral%2520aromatic%2520N-1-naphthylethyl%2520side%2520chains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D15559%26epage%3D15567%26doi%3D10.1021%2Fja204755p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thery, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didierjean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic β-peptoids</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1021/ol7030763</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol7030763" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=921-924&author=O.+Royauthor=S.+Faureauthor=V.+Theryauthor=C.+Didierjeanauthor=C.+Taillefumier&title=Cyclic+%CE%B2-peptoids&doi=10.1021%2Fol7030763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic β-Peptoids</span></div><div class="casAuthors">Roy, Olivier; Faure, Sophie; Thery, Vincent; Didierjean, Claude; Taillefumier, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">921-924</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first synthesis of functionalized β-peptoid macrocycles, cyclo{[-N(CH2C≡CH)CH2CH2CO-]n} (n = 2-6), is reported.  X-ray crystallog. structure of the tetramer, cyclo{[-N(CH2C≡CH)CH2CH2CO-]4}, reveals a C2-sym. deriv. with unexpected all-cis-amide bonds and spatial disposition of the appendages toward the two opposite faces of the ring.  Quantum calcns. suggest that the tetramer is locked in this layout.  These macrocycles constitute novel promising templates for multimeric ligation of biol. active ligands.  The tetramer was further modified by "click" reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj8e0zRxlA5rVg90H21EOLACvtfcHk0lhwJaR1JaZN5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKlsr8%253D&md5=59313449a28e707ce4f3dd49a4da6ba9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fol7030763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol7030763%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DThery%26aufirst%3DV.%26aulast%3DDidierjean%26aufirst%3DC.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DCyclic%2520%25CE%25B2-peptoids%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D921%26epage%3D924%26doi%3D10.1021%2Fol7030763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caumes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">The click triazolium peptoid side chain: A strong cis-amide inducer enabling chemical diversity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">9553</span>– <span class="NLM_lpage">9556</span>, <span class="refDoi"> DOI: 10.1021/ja302342h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja302342h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1WqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9553-9556&author=C.+Caumesauthor=O.+Royauthor=S.+Faureauthor=C.+Taillefumier&title=The+click+triazolium+peptoid+side+chain%3A+A+strong+cis-amide+inducer+enabling+chemical+diversity&doi=10.1021%2Fja302342h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Click Triazolium Peptoid Side Chain: A Strong cis-Amide Inducer Enabling Chemical Diversity</span></div><div class="casAuthors">Caumes, Cecile; Roy, Olivier; Faure, Sophie; Taillefumier, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9553-9556</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Access to homogeneous and discrete folded peptoid structures primarily depends on control of the cis/trans isomerism of backbone tertiary amides.  This can be achieved by designing specific side chains capable of forming local interactions with the backbone.  This is often undertaken at the expense of side-chain diversity, which is a key advantage of peptoids over other families of peptidomimetics.  We report for the first time a pos. charged triazolium-type side chain that does not compromise diversity and exhibits the best ability reported to date for inducing the cis conformation.  The cis-directing effect was studied in N-acetamide dipeptoid model systems and evaluated in terms of Kcis/trans using NMR spectroscopy in aprotic and protic solvents.  Computational geometry optimization and natural bond orbital anal. in combination with NOESY expts. were consistent with a model in which n → π*Ar electronic delocalization [from carbonyl (Oi-1) to the antibonding orbital (π*) of the triazolium motif on residue i] may be operative.  In the computational model (gas-phase) and exptl. in CDCl3, H-bonding between the triazolium C-H proton and the Ci=Oi oxygen was also identified and may act cooperatively with the n → π*Ar delocalization, resulting in the absence of the trans rotamers in CDCl3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaTyAt7um9trVg90H21EOLACvtfcHk0lhwJaR1JaZN5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1WqsLY%253D&md5=7bd11f79c77b4e289ac3ce954d93cda5</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fja302342h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja302342h%26sid%3Dliteratum%253Aachs%26aulast%3DCaumes%26aufirst%3DC.%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DThe%2520click%2520triazolium%2520peptoid%2520side%2520chain%253A%2520A%2520strong%2520cis-amide%2520inducer%2520enabling%2520chemical%2520diversity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9553%26epage%3D9556%26doi%3D10.1021%2Fja302342h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caumes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esvan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didierjean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">The <i>tert</i>-butyl side chain: A powerful means to lock peptoid amide bonds in the cis conformation</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2246</span>– <span class="NLM_lpage">2249</span>, <span class="refDoi"> DOI: 10.1021/ol400820y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol400820y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVylsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=2246-2249&author=O.+Royauthor=C.+Caumesauthor=Y.+Esvanauthor=C.+Didierjeanauthor=S.+Faureauthor=C.+Taillefumier&title=The+tert-butyl+side+chain%3A+A+powerful+means+to+lock+peptoid+amide+bonds+in+the+cis+conformation&doi=10.1021%2Fol400820y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The tert-Butyl Side Chain: A Powerful Means to Lock Peptoid Amide Bonds in the Cis Conformation</span></div><div class="casAuthors">Roy, O.; Caumes, C.; Esvan, Y.; Didierjean, C.; Faure, S.; Taillefumier, C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2246-2249</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The very simple sterically hindered tert-Bu side chain exerts complete control over the peptoid amide geometry which only exists in the cis conformation.  It is exemplified in NtBu glycine homo-oligomers and in linear oligopeptoids designed with an alternating cis-trans backbone amide pattern.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHhIHCCJ9rJ7Vg90H21EOLACvtfcHk0lhwJaR1JaZN5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVylsbs%253D&md5=38850fc9e2c61679419c99c29782546b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fol400820y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol400820y%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DCaumes%26aufirst%3DC.%26aulast%3DEsvan%26aufirst%3DY.%26aulast%3DDidierjean%26aufirst%3DC.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DThe%2520tert-butyl%2520side%2520chain%253A%2520A%2520powerful%2520means%2520to%2520lock%2520peptoid%2520amide%2520bonds%2520in%2520the%2520cis%2520conformation%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D2246%26epage%3D2249%26doi%3D10.1021%2Fol400820y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angelici, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didierjean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouffret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolibois, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">Weak backbone CH···O═C and side chain tBu···tBu London interactions help promote helix folding of achiral NtBu peptoids</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4573</span>– <span class="NLM_lpage">4576</span>, <span class="refDoi"> DOI: 10.1039/C6CC00375C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1039%2FC6CC00375C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=4573-4576&author=G.+Angeliciauthor=N.+Bhattacharjeeauthor=O.+Royauthor=S.+Faureauthor=C.+Didierjeanauthor=L.+Jouffretauthor=F.+Joliboisauthor=L.+Perrinauthor=C.+Taillefumier&title=Weak+backbone+CH%C2%B7%C2%B7%C2%B7O%E2%95%90C+and+side+chain+tBu%C2%B7%C2%B7%C2%B7tBu+London+interactions+help+promote+helix+folding+of+achiral+NtBu+peptoids&doi=10.1039%2FC6CC00375C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1039%2FC6CC00375C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC00375C%26sid%3Dliteratum%253Aachs%26aulast%3DAngelici%26aufirst%3DG.%26aulast%3DBhattacharjee%26aufirst%3DN.%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DDidierjean%26aufirst%3DC.%26aulast%3DJouffret%26aufirst%3DL.%26aulast%3DJolibois%26aufirst%3DF.%26aulast%3DPerrin%26aufirst%3DL.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DWeak%2520backbone%2520CH%25C2%25B7%25C2%25B7%25C2%25B7O%25E2%2595%2590C%2520and%2520side%2520chain%2520tBu%25C2%25B7%25C2%25B7%25C2%25B7tBu%2520London%2520interactions%2520help%2520promote%2520helix%2520folding%2520of%2520achiral%2520NtBu%2520peptoids%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26spage%3D4573%26epage%3D4576%26doi%3D10.1039%2FC6CC00375C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumonteil, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouffret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriznik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">Homogeneous and robust polyproline type I helices from peptoids with nonaromatic α-chiral side chains</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">13533</span>– <span class="NLM_lpage">13540</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b07475</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b07475" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlygt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=13533-13540&author=O.+Royauthor=G.+Dumonteilauthor=S.+Faureauthor=L.+Jouffretauthor=A.+Kriznikauthor=C.+Taillefumier&title=Homogeneous+and+robust+polyproline+type+I+helices+from+peptoids+with+nonaromatic+%CE%B1-chiral+side+chains&doi=10.1021%2Fjacs.7b07475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous and Robust Polyproline Type I Helices from Peptoids with Nonaromatic α-Chiral Side Chains</span></div><div class="casAuthors">Roy, Olivier; Dumonteil, Geoffrey; Faure, Sophie; Jouffret, Laurent; Kriznik, Alexandre; Taillefumier, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">13533-13540</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptoids which are oligomers of N-substituted glycines represent a class of peptide mimics with great potential in areas ranging from medicinal chem. to biomaterial science.  Controlling the equil. between the cis and trans conformations of their backbone amides is the major hurdle to overcome for the construction of discrete folded structures, particularly for the development of all-cis PolyProline-type I (PPI) helixes, as tools for modulating biol. functions.  The prominent role of backbone to side chain electronic interactions (n→π*) and side chains bulkiness in promoting cis-amides was essentially investigated with peptoid arom. side chains among which the chiral 1-naphthylethyl (1Npe) group yielded the best results.  We have explored for the first time the possibility to achieve similar performances with a sterically hindered α-chiral aliph. side chain.  Herein, we report on the synthesis and detailed conformational anal. of a series of (S)-N-(1-tert-butylethyl)glycine (Ns1tbe) peptoid homooligomers.  The X-ray crystal structure of an Ns1tbe pentamer revealed an all-cis PPI helix and the CD curves of the Ns1tbe oligomers also resemble those of PPI peptide helixes.  Interestingly, the CD data reported here are the first for any conformationally homogeneous helical peptoids contg. only -chiral aliph. side chains.  Finally we also synthesized and analyzed two mixed oligomers composed of NtBu and Ns1tbe monomers.  Strikingly, the solid state structure of the mixed oligomer Ac-(t-Bu)2-(s1tbe)4-(t-Bu)2-COOt-Bu, the longest to be solved for any linear peptoid revealed a PPI helix of great regularity despite the presence of only 50% of chiral side chain in the sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpURNMp8qWMc7Vg90H21EOLACvtfcHk0lhDSVbKBfeVtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlygt7fK&md5=3213819882a493732201ef77dce25ffa</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b07475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b07475%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DDumonteil%26aufirst%3DG.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DJouffret%26aufirst%3DL.%26aulast%3DKriznik%26aufirst%3DA.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DHomogeneous%2520and%2520robust%2520polyproline%2520type%2520I%2520helices%2520from%2520peptoids%2520with%2520nonaromatic%2520%25CE%25B1-chiral%2520side%2520chains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D13533%26epage%3D13540%26doi%3D10.1021%2Fjacs.7b07475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soria-Guerra, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto-Gomez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govea-Alonso, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosales-Mendoza, S.</span></span> <span> </span><span class="NLM_article-title">An overview of bioinformatics tools for epitope prediction: Implications on vaccine development</span>. <i>J. Biomed. Inf.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1016/j.jbi.2014.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1016%2Fj.jbi.2014.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=25464113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A280%3ADC%252BC2Mzjs12msQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2015&pages=405-414&author=R.+E.+Soria-Guerraauthor=R.+Nieto-Gomezauthor=D.+O.+Govea-Alonsoauthor=S.+Rosales-Mendoza&title=An+overview+of+bioinformatics+tools+for+epitope+prediction%3A+Implications+on+vaccine+development&doi=10.1016%2Fj.jbi.2014.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of bioinformatics tools for epitope prediction: implications on vaccine development</span></div><div class="casAuthors">Soria-Guerra Ruth E; Nieto-Gomez Ricardo; Govea-Alonso Dania O; Rosales-Mendoza Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedical informatics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">405-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Exploitation of recombinant DNA and sequencing technologies has led to a new concept in vaccination in which isolated epitopes, capable of stimulating a specific immune response, have been identified and used to achieve advanced vaccine formulations; replacing those constituted by whole pathogen-formulations.  In this context, bioinformatics approaches play a critical role on analyzing multiple genomes to select the protective epitopes in silico.  It is conceived that cocktails of defined epitopes or chimeric protein arrangements, including the target epitopes, may provide a rationale design capable to elicit convenient humoral or cellular immune responses.  This review presents a comprehensive compilation of the most advantageous online immunological software and searchable, in order to facilitate the design and development of vaccines.  An outlook on how these tools are supporting vaccine development is presented.  HIV and influenza have been taken as examples of promising developments on vaccination against hypervariable viruses.  Perspectives in this field are also envisioned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR83dcVyuRsdiXXDYhVZBdlfW6udTcc2eYfpBRnTVLrp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mzjs12msQ%253D%253D&md5=90b7e8a562831164276a2e323e78bb93</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jbi.2014.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbi.2014.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DSoria-Guerra%26aufirst%3DR.%2BE.%26aulast%3DNieto-Gomez%26aufirst%3DR.%26aulast%3DGovea-Alonso%26aufirst%3DD.%2BO.%26aulast%3DRosales-Mendoza%26aufirst%3DS.%26atitle%3DAn%2520overview%2520of%2520bioinformatics%2520tools%2520for%2520epitope%2520prediction%253A%2520Implications%2520on%2520vaccine%2520development%26jtitle%3DJ.%2520Biomed.%2520Inf.%26date%3D2015%26volume%3D53%26spage%3D405%26epage%3D414%26doi%3D10.1016%2Fj.jbi.2014.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span> α-Peptide/β-peptoid
hybrid oligomers with promising biological activities have also been
synthesized. See the following, for example:<span class="NLM_contrib-group"><span class="NLM_string-name">Skovbakke, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heegaard, P. M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moesby, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzyk, H.</span></span> <span> </span><span class="NLM_article-title">Lipidated α-peptide/β-peptoid hybrids with potent anti-inflammatory activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.1021/jm501341h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501341h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=801-813&author=S.+L.+Skovbakkeauthor=C.+J.+Larsenauthor=P.+M.+H.+Heegaardauthor=L.+Moesbyauthor=H.+Franzyk&title=Lipidated+%CE%B1-peptide%2F%CE%B2-peptoid+hybrids+with+potent+anti-inflammatory+activity&doi=10.1021%2Fjm501341h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm501341h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501341h%26sid%3Dliteratum%253Aachs%26aulast%3DSkovbakke%26aufirst%3DS.%2BL.%26aulast%3DLarsen%26aufirst%3DC.%2BJ.%26aulast%3DHeegaard%26aufirst%3DP.%2BM.%2BH.%26aulast%3DMoesby%26aufirst%3DL.%26aulast%3DFranzyk%26aufirst%3DH.%26atitle%3DLipidated%2520%25CE%25B1-peptide%252F%25CE%25B2-peptoid%2520hybrids%2520with%2520potent%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D801%26epage%3D813%26doi%3D10.1021%2Fjm501341h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, U. K.</span></span> <span> </span><span class="NLM_article-title">Rational design of multivalent glycoconjugate ligands. Synthesis of libraries of conformationally flexible rotamers of poly-N-linked lactosyl glycines</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1039/cc9960000201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1039%2Fcc9960000201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=201-202&author=R.+Royauthor=U.+K.+Saha&title=Rational+design+of+multivalent+glycoconjugate+ligands.+Synthesis+of+libraries+of+conformationally+flexible+rotamers+of+poly-N-linked+lactosyl+glycines&doi=10.1039%2Fcc9960000201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2Fcc9960000201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fcc9960000201%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DR.%26aulast%3DSaha%26aufirst%3DU.%2BK.%26atitle%3DRational%2520design%2520of%2520multivalent%2520glycoconjugate%2520ligands.%2520Synthesis%2520of%2520libraries%2520of%2520conformationally%2520flexible%2520rotamers%2520of%2520poly-N-linked%2520lactosyl%2520glycines%26jtitle%3DChem.%2520Commun.%26date%3D1996%26spage%3D201%26epage%3D202%26doi%3D10.1039%2Fcc9960000201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Culf, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, R. J.</span></span> <span> </span><span class="NLM_article-title">Solid-phase synthesis of N-substituted glycine oligomers (α-peptoids) and derivatives</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5282</span>– <span class="NLM_lpage">5335</span>, <span class="refDoi"> DOI: 10.3390/molecules15085282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.3390%2Fmolecules15085282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=20714299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVagt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=5282-5335&author=A.+S.+Culfauthor=R.+J.+Ouellette&title=Solid-phase+synthesis+of+N-substituted+glycine+oligomers+%28%CE%B1-peptoids%29+and+derivatives&doi=10.3390%2Fmolecules15085282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-phase synthesis of N-substituted glycine oligomers (α-peptoids) and derivatives</span></div><div class="casAuthors">Culf, Adrian S.; Ouellette, Rodney J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5282-5335</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Peptoids (N-substituted polyglycines and extended peptoids with variant backbone amino-acid monomer units) are oligomeric synthetic polymers that are becoming a valuable mol. tool in the biosciences.  The exploration of peptoids in drug design and evaluation of their secondary structures are of particular interest.  Major advantages of peptoids as research and pharmaceutical tools include the ease and economy of synthesis, highly variable backbone and side-chain chem. possibilities.  In addn., peptoids have been shown to be highly active in biol. systems while resistant to proteolytic decay.  This review with 227 refs. discusses the work done by R. N. Zuckermann et al. from 1992 to 2010 on solid-phase synthesis and biochem. applications of peptoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv9ZaCWTLgMrVg90H21EOLACvtfcHk0lgbgGQHYnP9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVagt7fL&md5=907128401ccbbfc77d78e64042b76ac1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.3390%2Fmolecules15085282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules15085282%26sid%3Dliteratum%253Aachs%26aulast%3DCulf%26aufirst%3DA.%2BS.%26aulast%3DOuellette%26aufirst%3DR.%2BJ.%26atitle%3DSolid-phase%2520synthesis%2520of%2520N-substituted%2520glycine%2520oligomers%2520%2528%25CE%25B1-peptoids%2529%2520and%2520derivatives%26jtitle%3DMolecules%26date%3D2010%26volume%3D15%26spage%3D5282%26epage%3D5335%26doi%3D10.3390%2Fmolecules15085282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herzner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reipen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of glycopeptides containing carbohydrate and peptide recognition motifs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4495</span>– <span class="NLM_lpage">4537</span>, <span class="refDoi"> DOI: 10.1021/cr990308c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr990308c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns12qtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=4495-4537&author=H.+Herznerauthor=T.+Reipenauthor=M.+Schultzauthor=H.+Kunz&title=Synthesis+of+glycopeptides+containing+carbohydrate+and+peptide+recognition+motifs&doi=10.1021%2Fcr990308c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of glycopeptides containing carbohydrate and peptide recognition motifs</span></div><div class="casAuthors">Herzner, Holger; Reipen, Tanja; Schultz, Michael; Kunz, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4495-4537</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 261 refs.  Detailed synthetic schemes for prepg. various O- and N-glycopeptides are given.  Solid-phase synthesis procedures are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpheDOwe106fLVg90H21EOLACvtfcHk0lgbgGQHYnP9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns12qtLs%253D&md5=75b621e9fb147b78cd1511ce3c619a23</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fcr990308c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr990308c%26sid%3Dliteratum%253Aachs%26aulast%3DHerzner%26aufirst%3DH.%26aulast%3DReipen%26aufirst%3DT.%26aulast%3DSchultz%26aufirst%3DM.%26aulast%3DKunz%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520glycopeptides%2520containing%2520carbohydrate%2520and%2520peptide%2520recognition%2520motifs%26jtitle%3DChem.%2520Rev.%26date%3D2000%26volume%3D100%26spage%3D4495%26epage%3D4537%26doi%3D10.1021%2Fcr990308c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of glycoproteins</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1021/cr0004310</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0004310" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD38XosV2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=579-601&author=B.+G.+Davis&title=Synthesis+of+glycoproteins&doi=10.1021%2Fcr0004310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Glycoproteins</span></div><div class="casAuthors">Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">579-601</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with refs. on the chemo-synthesis and enzymic prepn. of glycopeptides and glycoproteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGtpn6ubEB47Vg90H21EOLACvtfcHk0lho6hnHuq-xPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosV2hsw%253D%253D&md5=09d957e456e2fc7226cf73206f31a3d5</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fcr0004310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0004310%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DSynthesis%2520of%2520glycoproteins%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D579%26epage%3D601%26doi%3D10.1021%2Fcr0004310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hjelmgaard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caumes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Santis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">Convenient solution-phase synthesis and conformational studies of novel linear and cyclic α,β-alternating peptoids</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">4100</span>– <span class="NLM_lpage">4103</span>, <span class="refDoi"> DOI: 10.1021/ol9015767</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9015767" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVCmu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=4100-4103&author=T.+Hjelmgaardauthor=S.+Faureauthor=C.+Caumesauthor=E.+De+Santisauthor=A.+A.+Edwardsauthor=C.+Taillefumier&title=Convenient+solution-phase+synthesis+and+conformational+studies+of+novel+linear+and+cyclic+%CE%B1%2C%CE%B2-alternating+peptoids&doi=10.1021%2Fol9015767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Convenient Solution-Phase Synthesis and Conformational Studies of Novel Linear and Cyclic α,β-Alternating Peptoids</span></div><div class="casAuthors">Hjelmgaard, Thomas; Faure, Sophie; Caumes, Cecile; De Santis, Emiliana; Edwards, Alison A.; Taillefumier, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4100-4103</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a novel family of peptidomimetics composed of linear and cyclic α,β-alternating peptoids is described.  Oligomers consisting of up to six peptoid residues (n = 1-3) were synthesized on large scale with use of an efficient iterative soln.-phase method and longer oligomers (n = 4, 5) were obtained by the coupling of appropriately protected shorter oligomers.  Preliminary conformational studies of these hybrid peptoids are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqRX74Osa38bVg90H21EOLACvtfcHk0lho6hnHuq-xPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVCmu7fJ&md5=77a4362731a93dbadcd6e2eed4ec1485</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fol9015767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9015767%26sid%3Dliteratum%253Aachs%26aulast%3DHjelmgaard%26aufirst%3DT.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DCaumes%26aufirst%3DC.%26aulast%3DDe%2BSantis%26aufirst%3DE.%26aulast%3DEdwards%26aufirst%3DA.%2BA.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DConvenient%2520solution-phase%2520synthesis%2520and%2520conformational%2520studies%2520of%2520novel%2520linear%2520and%2520cyclic%2520%25CE%25B1%252C%25CE%25B2-alternating%2520peptoids%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D4100%26epage%3D4103%26doi%3D10.1021%2Fol9015767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caumes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hjelmgaard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">Highly convenient gram-scale solution-phase peptoid synthesis and orthogonal side-chain post-modification</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1055/s-0030-1258351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1055%2Fs-0030-1258351" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=257-264&issue=2&author=C.+Caumesauthor=T.+Hjelmgaardauthor=R.+Remusonauthor=S.+Faureauthor=C.+Taillefumier&title=Highly+convenient+gram-scale+solution-phase+peptoid+synthesis+and+orthogonal+side-chain+post-modification&doi=10.1055%2Fs-0030-1258351"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1258351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1258351%26sid%3Dliteratum%253Aachs%26aulast%3DCaumes%26aufirst%3DC.%26aulast%3DHjelmgaard%26aufirst%3DT.%26aulast%3DRemuson%26aufirst%3DR.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DHighly%2520convenient%2520gram-scale%2520solution-phase%2520peptoid%2520synthesis%2520and%2520orthogonal%2520side-chain%2520post-modification%26jtitle%3DSynthesis%26date%3D2011%26volume%3D2011%26issue%3D2%26spage%3D257%26epage%3D264%26doi%3D10.1055%2Fs-0030-1258351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takabayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiney, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. A.</span></span> <span> </span><span class="NLM_article-title">Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">3990</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1073/pnas.0611624104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1073%2Fpnas.0611624104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=17360465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlaisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=3990-3995&author=C.+C.+N.+Wuauthor=T.+Hayashiauthor=K.+Takabayashiauthor=M.+Sabetauthor=D.+F.+Smeeauthor=D.+D.+Guineyauthor=H.+B.+Cottamauthor=D.+A.+Carson&title=Immunotherapeutic+activity+of+a+conjugate+of+a+Toll-like+receptor+7+ligand&doi=10.1073%2Fpnas.0611624104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand</span></div><div class="casAuthors">Wu, Christina C. N.; Hayashi, Tomoko; Takabayashi, Kenji; Sabet, Mojgan; Smee, Donald F.; Guiney, Donald D.; Cottam, Howard B.; Carson, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3990-3995</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The immunotherapeutic activity of Toll-like receptor (TLR) activators has been difficult to exploit because of side effects related to the release and systemic dispersion of proinflammatory cytokines.  To overcome this barrier, we have synthesized a versatile TLR7 agonist, 4-[6-amino-8-hydroxy-2-(2-methoxyethoxy)purin-9-ylmethyl]benzaldehyde (UC-1V150), bearing a free aldehyde that could be coupled to many different auxiliary chem. entities through a linker mol. with a hydrazine or amino group without any loss of activity.  UC-1V150 was covalently coupled to mouse serum albumin (MSA) at a 5:1 molar ratio to yield a stable mol. with a characteristically altered UV spectrum.  Compared with the unconjugated TLR7 agonist, the UC-1V150/MSA was a 10-to 100-fold more potent inducer of cytokine prodn. in vitro by mouse bone marrow-derived macrophage and human peripheral blood mononuclear cells.  When administered to the lung, the conjugate induced a prolonged local release of cytokines at levels 10-fold or more higher than those found in serum.  Under the same conditions, the untethered TLR7 ligand induced quick systemic cytokine release with resultant toxicity.  In addn., two pulmonary infectious disease models were investigated wherein mice were pretreated with the conjugate and then challenged with either Bacillus anthracis spores or HIN1 influenza A virus.  Significant delay in mortality was obsd. in both disease models with UC-1V150/MSA-pretreated mice, indicating the potential usefulness of the conjugate as a localized and targeted immunotherapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg2MwudVJLMrVg90H21EOLACvtfcHk0lho6hnHuq-xPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlaisbk%253D&md5=6d7589699bc36c1aed6e8d914a72292d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0611624104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0611624104%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BC.%2BN.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DTakabayashi%26aufirst%3DK.%26aulast%3DSabet%26aufirst%3DM.%26aulast%3DSmee%26aufirst%3DD.%2BF.%26aulast%3DGuiney%26aufirst%3DD.%2BD.%26aulast%3DCottam%26aufirst%3DH.%2BB.%26aulast%3DCarson%26aufirst%3DD.%2BA.%26atitle%3DImmunotherapeutic%2520activity%2520of%2520a%2520conjugate%2520of%2520a%2520Toll-like%2520receptor%25207%2520ligand%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D3990%26epage%3D3995%26doi%3D10.1073%2Fpnas.0611624104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathewson, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawatao, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalenian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterization of PEGylated toll like receptor 7 ligands</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1021/bc1004813</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc1004813" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Wjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=445-454&author=M.+Chanauthor=T.+Hayashiauthor=R.+D.+Mathewsonauthor=S.+Yaoauthor=C.+Grayauthor=R.+I.+Tawataoauthor=K.+Kalenianauthor=Y.+Zhangauthor=Y.+Hayashiauthor=F.+S.+Laoauthor=H.+B.+Cottamauthor=D.+A.+Carson&title=Synthesis+and+characterization+of+PEGylated+toll+like+receptor+7+ligands&doi=10.1021%2Fbc1004813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of PEGylated Toll Like Receptor 7 Ligands</span></div><div class="casAuthors">Chan, Michael; Hayashi, Tomoko; Mathewson, Richard D.; Yao, Shiyin; Gray, Christine; Tawatao, Rommel I.; Kalenian, Kevin; Zhang, Yanmei; Hayashi, Yuki; Lao, Fitzgerald S.; Cottam, Howard B.; Carson, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">445-454</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is located in the endosomal compartment of immune cells.  Signaling through TLR7, mediated by the adaptor protein MyD88, stimulates the innate immune system and shapes adaptive immune responses.  Previously, we characterized TLR7 ligands conjugated to protein, lipid, or poly(ethylene glycol) (PEG).  Among the TLR7 ligand conjugates, the addn. of PEG chains reduced the agonistic potency.  PEGs are safe in humans and widely used for improvement of pharmacokinetics in existing biologics and some low mol. wt. compds.  PEGylation could be a feasible method to alter the pharmacokinetics and pharmacodynamics of TLR7 ligands.  In this study, we systematically studied the influence of PEG chain length on the in vitro and in vivo properties of potent TLR7 ligands.  PEGylation increased soly. of the TLR7 ligands and modulated protein binding.  Adding a 6-10 length PEG to the TLR7 ligand reduced its potency toward induction of interleukin (IL)-6 by murine macrophages in vitro and IL-6 and tumor necrosis factor (TNF) in vivo.  However, PEGylation with 18 or longer chain restored, and even enhanced, the agonistic activity of the drug.  In human peripheral blood mononuclear cells, similar effects of PEGylation were obsd. for secretion of proinflammatory cytokines, IL-6, IL-12, TNF-α, IL-1β, and type 1 interferon, as well as for B cell proliferation.  In summary, these studies demonstrate that conjugation of PEG chains to a synthetic TLR ligand can impact its potency for cytokine induction depending on the size of the PEG moiety.  Thus, PEGylation may be a feasible approach to regulate the pharmacol. properties of TLR7 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7MmNOSt39wbVg90H21EOLACvtfcHk0lgAZ3iU7s9qyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Wjurs%253D&md5=26f053bd020f05406f38b3560b00309e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fbc1004813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc1004813%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMathewson%26aufirst%3DR.%2BD.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DC.%26aulast%3DTawatao%26aufirst%3DR.%2BI.%26aulast%3DKalenian%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DLao%26aufirst%3DF.%2BS.%26aulast%3DCottam%26aufirst%3DH.%2BB.%26aulast%3DCarson%26aufirst%3DD.%2BA.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520PEGylated%2520toll%2520like%2520receptor%25207%2520ligands%26jtitle%3DBioconjugate%2520Chem.%26date%3D2011%26volume%3D22%26spage%3D445%26epage%3D454%26doi%3D10.1021%2Fbc1004813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evavold, B. D.</span></span> <span> </span><span class="NLM_article-title">DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323–339 Epitope</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">4706</span>– <span class="NLM_lpage">4712</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.164.9.4706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.4049%2Fjimmunol.164.9.4706" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2000&pages=4706-4712&author=J.+M.+Robertsonauthor=P.+E.+Jensenauthor=B.+D.+Evavold&title=DO11.10+and+OT-II+T+cells+recognize+a+C-terminal+ovalbumin+323%E2%80%93339+Epitope&doi=10.4049%2Fjimmunol.164.9.4706"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.164.9.4706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.164.9.4706%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DJ.%2BM.%26aulast%3DJensen%26aufirst%3DP.%2BE.%26aulast%3DEvavold%26aufirst%3DB.%2BD.%26atitle%3DDO11.10%2520and%2520OT-II%2520T%2520cells%2520recognize%2520a%2520C-terminal%2520ovalbumin%2520323%25E2%2580%2593339%2520Epitope%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D164%26spage%3D4706%26epage%3D4712%26doi%3D10.4049%2Fjimmunol.164.9.4706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima-Adachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totsuka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiraide, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakatsuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyono, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hachimura, S.</span></span> <span> </span><span class="NLM_article-title">Two distinct epitopes on the ovalbumin 323-339 peptide differentiating CD4+T cells into the Th2 or Th1 phenotype</span>. <i>Biosci., Biotechnol., Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1979</span>– <span class="NLM_lpage">1981</span>, <span class="refDoi"> DOI: 10.1271/bbb.120349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1271%2Fbbb.120349" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2012&pages=1979-1981&author=H.+Nakajima-Adachiauthor=E.+Koikeauthor=M.+Totsukaauthor=E.+Hiraideauthor=Y.+Wakatsukiauthor=H.+Kiyonoauthor=S.+Hachimura&title=Two+distinct+epitopes+on+the+ovalbumin+323-339+peptide+differentiating+CD4%2BT+cells+into+the+Th2+or+Th1+phenotype&doi=10.1271%2Fbbb.120349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1271%2Fbbb.120349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb.120349%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima-Adachi%26aufirst%3DH.%26aulast%3DKoike%26aufirst%3DE.%26aulast%3DTotsuka%26aufirst%3DM.%26aulast%3DHiraide%26aufirst%3DE.%26aulast%3DWakatsuki%26aufirst%3DY.%26aulast%3DKiyono%26aufirst%3DH.%26aulast%3DHachimura%26aufirst%3DS.%26atitle%3DTwo%2520distinct%2520epitopes%2520on%2520the%2520ovalbumin%2520323-339%2520peptide%2520differentiating%2520CD4%252BT%2520cells%2520into%2520the%2520Th2%2520or%2520Th1%2520phenotype%26jtitle%3DBiosci.%252C%2520Biotechnol.%252C%2520Biochem.%26date%3D2012%26volume%3D76%26spage%3D1979%26epage%3D1981%26doi%3D10.1271%2Fbbb.120349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsayed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aasen, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Do, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aardal, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florvaag, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaali, K.</span></span> <span> </span><span class="NLM_article-title">Comparison between ovalbumine and ovalbumine peptide 323-339 responses in allergic mice: humoral and cellular aspects</span>. <i>Scand. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1111/j.1365-3083.2010.02382.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1111%2Fj.1365-3083.2010.02382.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=20500683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslCht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2010&pages=329-335&author=L.-Z.+Sunauthor=S.+Elsayedauthor=T.+B.+Aasenauthor=T.+Van+Doauthor=N.+P.+Aardalauthor=E.+Florvaagauthor=K.+Vaali&title=Comparison+between+ovalbumine+and+ovalbumine+peptide+323-339+responses+in+allergic+mice%3A+humoral+and+cellular+aspects&doi=10.1111%2Fj.1365-3083.2010.02382.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison between ovalbumin and ovalbumin peptide 323-339 responses in allergic-mice: humoral and cellular aspects</span></div><div class="casAuthors">Sun, L.-Z.; Elsayed, S.; Aasen, T. B.; Van Do, T.; Aardal, N. P.; Florvaag, E.; Vaali, K.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">329-335</span>CODEN:
                <span class="NLM_cas:coden">SJIMAX</span>;
        ISSN:<span class="NLM_cas:issn">0300-9475</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Ovalbumin (OVA) is widely used in allergy research.  OVA peptide 323-339 has been reported to be responsible for 25-35% of isolated BALB/c mouse T-cell response to intact OVA.  An investigation of whether OVA and OVA 323-339 mols. can induce equiv. in vivo and in vitro immune responses was conducted.  Eight-week-old BALB/c mice were randomly divided into three groups: OVA, OVA 323-339 and saline.  On days 0, 7, 14, mice were i.p. injected with 25 μg OVA or OVA 323-339 absorbed on 300 μg Alum, or saline; on days 21-23, all groups were challenged intranasally with either 20 μl of 1% OVA, 1% OVA 323-339 or saline.  On day 28, after killing, splenocytes were isolated and cultured under the stimulus of each allergen or medium.  Evaluated by hematoxylin/eosin and major basic protein immunohistochem. stainings, OVA and OVA 323-339 induced similar lung inflammation.  Interestingly, significant serum total IgE and OVA-specific IgE were obsd. in OVA mice when compared to saline control.  OVA 323-339 mice showed higher serum OVA-specific IgE, OVA 323-339-specific IgE, IL-4 and lower IFN-γ similar to OVA mice.  The proliferative response to OVA was found in cultured splenocytes of both OVA and OVA 323-339 mice, while the similar proliferative response to OVA 323-339 was only obsd. in the splenocytes of OVA 323-339-sensitized and challenged mice.  Although OVA 323-339 induced a Th2-like response in the mouse model as did OVA, OVA 323-339 has clearly limited immunogenic potency to activate OVA-sensitized and challenged mice splenocytes, unlike OVA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYBGiImC1AX7Vg90H21EOLACvtfcHk0lgAZ3iU7s9qyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslCht7k%253D&md5=f031f2b5171b8bfa3f96651d838e5b2b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-3083.2010.02382.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-3083.2010.02382.x%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.-Z.%26aulast%3DElsayed%26aufirst%3DS.%26aulast%3DAasen%26aufirst%3DT.%2BB.%26aulast%3DVan%2BDo%26aufirst%3DT.%26aulast%3DAardal%26aufirst%3DN.%2BP.%26aulast%3DFlorvaag%26aufirst%3DE.%26aulast%3DVaali%26aufirst%3DK.%26atitle%3DComparison%2520between%2520ovalbumine%2520and%2520ovalbumine%2520peptide%2520323-339%2520responses%2520in%2520allergic%2520mice%253A%2520humoral%2520and%2520cellular%2520aspects%26jtitle%3DScand.%2520J.%2520Immunol.%26date%3D2010%26volume%3D71%26spage%3D329%26epage%3D335%26doi%3D10.1111%2Fj.1365-3083.2010.02382.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grey, H. M.</span></span> <span> </span><span class="NLM_article-title">Interaction between a “processed” ovalbumine peptide and Ia molecules</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">3968</span>– <span class="NLM_lpage">3971</span>, <span class="refDoi"> DOI: 10.1073/pnas.83.11.3968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1073%2Fpnas.83.11.3968" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=3968-3971&author=S.+Buusauthor=S.+Colonauthor=C.+Smithauthor=J.+H.+Freedauthor=C.+Milesauthor=H.+M.+Grey&title=Interaction+between+a+%E2%80%9Cprocessed%E2%80%9D+ovalbumine+peptide+and+Ia+molecules&doi=10.1073%2Fpnas.83.11.3968"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.11.3968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.11.3968%26sid%3Dliteratum%253Aachs%26aulast%3DBuus%26aufirst%3DS.%26aulast%3DColon%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DFreed%26aufirst%3DJ.%2BH.%26aulast%3DMiles%26aufirst%3DC.%26aulast%3DGrey%26aufirst%3DH.%2BM.%26atitle%3DInteraction%2520between%2520a%2520%25E2%2580%259Cprocessed%25E2%2580%259D%2520ovalbumine%2520peptide%2520and%2520Ia%2520molecules%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D3968%26epage%3D3971%26doi%3D10.1073%2Fpnas.83.11.3968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valverde, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecaille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalmanach, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aucagne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmas, A. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a biologically active triazole-containing analogue of cystatin a through successive peptidomimetic alkyne-azide ligations</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">722</span>, <span class="refDoi"> DOI: 10.1002/anie.201107222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fanie.201107222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=22144344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOnsb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=718-722&author=I.+E.+Valverdeauthor=F.+Lecailleauthor=G.+Lalmanachauthor=V.+Aucagneauthor=A.+F.+Delmas&title=Synthesis+of+a+biologically+active+triazole-containing+analogue+of+cystatin+a+through+successive+peptidomimetic+alkyne-azide+ligations&doi=10.1002%2Fanie.201107222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Biologically Active Triazole-Containing Analogue of Cystatin A Through Successive Peptidomimetic Alkyne-Azide Ligations</span></div><div class="casAuthors">Valverde, Ibai E.; Lecaille, Fabien; Lalmanach, Gilles; Aucagne, Vincent; Delmas, Agnes F.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">718-722, S718/1-S718/21</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors report the use of copper(I)-mediated cycloaddn. of azides and terminal alkynes for the assembly of unprotected peptide fragments into a bioactive triazole-contg. protein, cystatin A.  A complete biol. characterization of cystatin A was carried out via inhibition kinetics of cathepsin B, H and L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozo_d5az9W67Vg90H21EOLACvtfcHk0lgnAVvKQM95Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOnsb%252FF&md5=ad4806eaa0e89beaeefcc116573c589c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fanie.201107222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201107222%26sid%3Dliteratum%253Aachs%26aulast%3DValverde%26aufirst%3DI.%2BE.%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DLalmanach%26aufirst%3DG.%26aulast%3DAucagne%26aufirst%3DV.%26aulast%3DDelmas%26aufirst%3DA.%2BF.%26atitle%3DSynthesis%2520of%2520a%2520biologically%2520active%2520triazole-containing%2520analogue%2520of%2520cystatin%2520a%2520through%2520successive%2520peptidomimetic%2520alkyne-azide%2520ligations%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D718%26epage%3D722%26doi%3D10.1002%2Fanie.201107222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aucagne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valverde, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marceau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galibert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dendane, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmas, A. F.</span></span> <span> </span><span class="NLM_article-title">Towards the simplification of protein synthesis: iterative solid-supported ligations with concomitant purifications</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">11320</span>– <span class="NLM_lpage">11324</span>, <span class="refDoi"> DOI: 10.1002/anie.201206428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fanie.201206428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2rsbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=11320-11324&author=V.+Aucagneauthor=I.+E.+Valverdeauthor=P.+Marceauauthor=M.+Galibertauthor=N.+Dendaneauthor=A.+F.+Delmas&title=Towards+the+simplification+of+protein+synthesis%3A+iterative+solid-supported+ligations+with+concomitant+purifications&doi=10.1002%2Fanie.201206428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Towards the Simplification of Protein Synthesis: Iterative Solid-Supported Ligations with Concomitant Purifications</span></div><div class="casAuthors">Aucagne, Vincent; Valverde, Ibai E.; Marceau, Philippe; Galibert, Mathieu; Dendane, Nabil; Delmas, Agnes F.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11320-11324</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors introduced N3-Esoc-ONp 1 as a new reagent for the contemporary tagging of peptides at their N-terminus and demonstrated its potential in capture/release purifications.  The authors extended this concept to a promising self-purifying N-to-C iterative triazole ligation strategy, exemplified by the synthesis of a polypeptide contg. 160 residues.  Solid-phase coupling of four peptide segments led to high purity material without any chromatog. purifn. steps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE0_cC6n5GDLVg90H21EOLACvtfcHk0lgnAVvKQM95Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2rsbzK&md5=439b8f7f32f53d2ddb59b4a247e1a399</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fanie.201206428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201206428%26sid%3Dliteratum%253Aachs%26aulast%3DAucagne%26aufirst%3DV.%26aulast%3DValverde%26aufirst%3DI.%2BE.%26aulast%3DMarceau%26aufirst%3DP.%26aulast%3DGalibert%26aufirst%3DM.%26aulast%3DDendane%26aufirst%3DN.%26aulast%3DDelmas%26aufirst%3DA.%2BF.%26atitle%3DTowards%2520the%2520simplification%2520of%2520protein%2520synthesis%253A%2520iterative%2520solid-supported%2520ligations%2520with%2520concomitant%2520purifications%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D11320%26epage%3D11324%26doi%3D10.1002%2Fanie.201206428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flood, A. H.</span></span> <span> </span><span class="NLM_article-title">Click chemistry generates privileged CH hydrogen-bonding triazoles: the latest addition to anion supramolecular chemistry</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1039/b818033b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1039%2Fb818033b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=20349532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1Ggtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=1262-1271&author=Y.+Huaauthor=A.+H.+Flood&title=Click+chemistry+generates+privileged+CH+hydrogen-bonding+triazoles%3A+the+latest+addition+to+anion+supramolecular+chemistry&doi=10.1039%2Fb818033b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry generates privileged CH hydrogen-bonding triazoles: the latest addition to anion supramolecular chemistry</span></div><div class="casAuthors">Hua, Yuran; Flood, Amar H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1262-1271</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The supramol. chem. of anions provides a means to sense and manipulate anions in their many chem. and biol. roles.  For this purpose, Click chem. facilitated the synthetic creation of new receptors and thus, an opportunity to aid in the recent re-examn. of CH···anion hydrogen bonding.  This tutorial review will focus on the privileged C-H hydrogen bond donor of the 1,2,3-triazole ring systems as elucidated from anion-binding studies with macrocyclic triazolophanes and other receptors.  Triazolophanes are shape-persistent and planar macrocycles that direct four triazole and four phenylene CH groups into a 3.7 Å cavity.  They display strong (log K(Cl-) = 7), size-dependent halide binding (Cl- > Br- » F- » I-) and a rich set of binding equil.  For instance, the too large iodide (4.4 Å) can be sandwiched between two pyridyl-based triazolophanes with extreme pos. cooperativity.  Computational studies verify the triazole's hydrogen bond strength indicating it approaches the traditional NH donors from pyrrole.  These examples, those of transport, sensing (e.g., ion-selective electrodes), templation, and versatile synthesis herald the use of triazoles in anion-receptor chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKNmfsPTPp6rVg90H21EOLACvtfcHk0lgnAVvKQM95Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Ggtbw%253D&md5=ae3a71361ee4463726714dc4743343e3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1039%2Fb818033b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb818033b%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DFlood%26aufirst%3DA.%2BH.%26atitle%3DClick%2520chemistry%2520generates%2520privileged%2520CH%2520hydrogen-bonding%2520triazoles%253A%2520the%2520latest%2520addition%2520to%2520anion%2520supramolecular%2520chemistry%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2010%26volume%3D39%26spage%3D1262%26epage%3D1271%26doi%3D10.1039%2Fb818033b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horne, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, Y. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghadiri, M. R.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic peptide backbone modifications in an α-helical coiled coil</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">15366</span>– <span class="NLM_lpage">15367</span>, <span class="refDoi"> DOI: 10.1021/ja0450408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0450408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlSgtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=15366-15367&author=W.+S.+Horneauthor=M.+K.+Yadavauthor=Y.+C.+D.+Stoutauthor=M.+R.+Ghadiri&title=Heterocyclic+peptide+backbone+modifications+in+an+%CE%B1-helical+coiled+coil&doi=10.1021%2Fja0450408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic Peptide Backbone Modifications in an α-Helical Coiled Coil</span></div><div class="casAuthors">Horne, W. Seth; Yadav, Maneesh K.; Stout, C. David; Ghadiri, M. Reza</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">15366-15367</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, we present 1,2,3-triazole ε2-amino acids incorporated as a dipeptide surrogate at three positions in the sequence of a known α-helical coiled coil.  Biophys. characterization indicates that the modified peptides retain much of the helical structure of the parent sequence, and that the thermodn. stability of the coiled coil depends on the position of the incorporation of the ε-residue.  Crystal structures obtained for each peptide give insight into the chem. behavior and conformational preferences of the non-natural amino acid and show that the triazole ring can participate in the backbone hydrogen bonding of the α-helix as well as template an interhelical crossing between chains in the bundle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-BCwZtNvceLVg90H21EOLACvtfcHk0ljpTydPs2E0ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlSgtrw%253D&md5=6f4573960370cdded62c2ca77ad25b04</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fja0450408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0450408%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DYadav%26aufirst%3DM.%2BK.%26aulast%3DStout%26aufirst%3DY.%2BC.%2BD.%26aulast%3DGhadiri%26aufirst%3DM.%2BR.%26atitle%3DHeterocyclic%2520peptide%2520backbone%2520modifications%2520in%2520an%2520%25CE%25B1-helical%2520coiled%2520coil%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D15366%26epage%3D15367%26doi%3D10.1021%2Fja0450408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, K.</span></span> <span> </span><span class="NLM_article-title">Universal peptidomimetics</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">462</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1021/ja1071916</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja1071916" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SrsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=462-477&author=E.+Koauthor=J.+Liuauthor=L.+M.+Perezauthor=G.+Luauthor=A.+Schaeferauthor=K.+Burgess&title=Universal+peptidomimetics&doi=10.1021%2Fja1071916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Universal Peptidomimetics</span></div><div class="casAuthors">Ko, Eunhwa; Liu, Jing; Perez, Lisa M.; Lu, Genliang; Schaefer, Amber; Burgess, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">462-477</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptidomimetic scaffolds that can present side chains in conformations resembling those of amino acids in secondary structures without incurring excessive entropic or enthalpic penalties were discussed.  Compds. of this type were referred to as minimalist mimics.  The core hypothesis of the paper was that small sets of such scaffolds can be designed to analog local pairs of amino acids (including noncontiguous ones) in any secondary structure; i.e., they are universal peptidomimetics.  To illustrate this concept, a set of four peptidomimetic scaffolds, I-IV, were designed.  Libraries based on them were made bearing side chains corresponding to many of the protein-derived amino acids.  Modeling expts. were performed to give an indication of kinetic and thermodn. accessibilities of conformations that can mimic secondary structures.  Together, peptidomimetics based on these four scaffolds can adopt conformations that resemble almost any combination of local amino acid side chains in any secondary structure.  Universal peptidomimetics of this kind are likely to be most useful in the design of libraries for high-throughput screening against diverse targets.  Consequently, data arising from submission of these mols. to the NIH Mol. Libraries Small Mol. Repository (MLSMR) were outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjryjrFh6s0bVg90H21EOLACvtfcHk0ljpTydPs2E0ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SrsbrM&md5=4c95046d25118b6d77e46668d88580b3</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fja1071916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja1071916%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DL.%2BM.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DSchaefer%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DUniversal%2520peptidomimetics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D462%26epage%3D477%26doi%3D10.1021%2Fja1071916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szekely, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillefumier, C.</span></span> <span> </span><span class="NLM_article-title">From Glycopeptides to glycopeptoids</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">5641</span>– <span class="NLM_lpage">5657</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201402238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fejoc.201402238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=5641-5657&author=T.+Szekelyauthor=O.+Royauthor=S.+Faureauthor=C.+Taillefumier&title=From+Glycopeptides+to+glycopeptoids&doi=10.1002%2Fejoc.201402238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201402238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201402238%26sid%3Dliteratum%253Aachs%26aulast%3DSzekely%26aufirst%3DT.%26aulast%3DRoy%26aufirst%3DO.%26aulast%3DFaure%26aufirst%3DS.%26aulast%3DTaillefumier%26aufirst%3DC.%26atitle%3DFrom%2520Glycopeptides%2520to%2520glycopeptoids%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2014%26volume%3D2014%26spage%3D5641%26epage%3D5657%26doi%3D10.1002%2Fejoc.201402238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Presolski, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span> <span> </span><span class="NLM_article-title">Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">9879</span>– <span class="NLM_lpage">9883</span>, <span class="refDoi"> DOI: 10.1002/anie.200905087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1002%2Fanie.200905087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=19943299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2hsrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=9879-9883&author=V.+Hongauthor=S.+I.+Presolskiauthor=C.+Maauthor=M.+G.+Finn&title=Analysis+and+optimization+of+copper-catalyzed+azide-alkyne+cycloaddition+for+bioconjugation&doi=10.1002%2Fanie.200905087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis and Optimization of Copper-Catalyzed Azide-Alkyne Cycloaddition for Bioconjugation</span></div><div class="casAuthors">Hong, Vu; Presolski, Stanislav I.; Ma, Celia; Finn, M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">9879-9883, S9879/1-S9879/10</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Copper-catalyzed azide-alkyne cycloaddn. (CuAAC) has been optimized for use with biol. mols.  The key development is the addn. of two reagents that allow ascorbate to be used as reducing agent while eliminating problems caused by copper ascorbate side reactions.  The result is a robust, rapid, and convenient procedure for the modification of proteins, DNA, RNA, and other biomols.  Sodium ascorbate is the preferred reducing agent for most applications, due to its convenience and effectiveness at generating the catalytically active Cu1 oxidn. state.  Cu concns. should generally be between 50 and 100 μM.  A fluorogenic or colorimetric assay, such as that enabled by a coumarin deriv. is strongly recommended for optimization of specific cases.  At least five equiv. of THPTA (other water-sol. variants) relative to Cu should be employed.  Aminoguanidine is a useful additive to intercept byproducts of ascorbate oxidn. that can covalently modify or crosslink proteins.  Compatible buffers include phosphate, carbonate, or HEPES in the pH 6.5-8.0 range.  Tris buffer should be avoided as it is a competitive and inhibitory ligand for Cu; sodium chloride (as in phosphate-buffered saline) up to 0.5 M can be used.  Ascorbate should not be added to copper-contg. solns. in the absence of the ligand.  As a matter of routine, the authors first mix CuSO4 with the ligand, add this mixt. to a soln. of the azide and alkyne substrates, and then initiate the CuAAC reaction by the addn. of sodium ascorbate to the desired concn.  The Cu-THPTA catalyst in water is inhibited by excess alkyne, and so the procedure described here is useful for alkyne concns. less than approx. 5 mM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn_BOP5hVYDbVg90H21EOLACvtfcHk0ljpTydPs2E0ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2hsrnL&md5=2b85650bce37933080d02c417848f1e2</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1002%2Fanie.200905087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200905087%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DV.%26aulast%3DPresolski%26aufirst%3DS.%2BI.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26atitle%3DAnalysis%2520and%2520optimization%2520of%2520copper-catalyzed%2520azide-alkyne%2520cycloaddition%2520for%2520bioconjugation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D9879%26epage%3D9883%26doi%3D10.1002%2Fanie.200905087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Vliet, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuist, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Vallejo, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kooyk, Y.</span></span> <span> </span><span class="NLM_article-title">MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1189/jlb.1012520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1189%2Fjlb.1012520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=23744646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1elt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2013&pages=315-323&author=S.+J.+Van%0AVlietauthor=S.+Bayauthor=I.+M.+Vuistauthor=H.+Kalayauthor=J.+J.+Garc%C3%ADa-Vallejoauthor=C.+Leclercauthor=Y.+Van+Kooyk&title=MGL+signaling+augments+TLR2-mediated+responses+for+enhanced+IL-10+and+TNF-%CE%B1+secretion&doi=10.1189%2Fjlb.1012520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion</span></div><div class="casAuthors">van Vliet, Sandra J.; Bay, Sylvie; Vuist, Ilona M.; Kalay, Hakan; Garcia-Vallejo, Juan J.; Leclerc, Claude; van Kooyk, Yvette</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">315-323</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">DCs orchestrate immune responses to infectious pathogens and disturbances in tissue integrity.  Equipped with C-type lectins, DCs can respond to environmental changes in glycosylation.  Many C-type lectins are capable of modulating TLR activation, thereby facilitating tailor-made immune reactions.  Here, we investigated the signaling properties of the C-type lectin MGL and show that MGL engagement by agonistic antibodies or carbohydrate ligands couples to TLR signal transduction for increased IL-10 and TNF-α secretion by human monocyte-derived DCs.  MGL triggering esp. synergized with TLR2-induced pathways, leading to elevated IL-10 mRNA levels and enhanced TNF-α mRNA stability.  In addn., MGL signaling promoted phosphorylation of the MAPK ERK and the transcription factor CREB.  Whereas specific inhibitors of p90RSK blocked the MGL-induced cytokine secretion, AP-1 was not involved.  Strikingly, NF-κB was only crucial for the IL-10 response and dispensable for TNF-α prodn.  Together, our results demonstrate that MGL activation of the ERK-p90RSK-CREB axis converges with TLR2-induced pathways, thereby fine-tuning the DC maturation phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwXUxmsNrez7Vg90H21EOLACvtfcHk0lhA2TsFd_fvdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1elt7rJ&md5=1e622b2d5235df9b162ba095362fc95d</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1189%2Fjlb.1012520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.1012520%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BVliet%26aufirst%3DS.%2BJ.%26aulast%3DBay%26aufirst%3DS.%26aulast%3DVuist%26aufirst%3DI.%2BM.%26aulast%3DKalay%26aufirst%3DH.%26aulast%3DGarc%25C3%25ADa-Vallejo%26aufirst%3DJ.%2BJ.%26aulast%3DLeclerc%26aufirst%3DC.%26aulast%3DVan%2BKooyk%26aufirst%3DY.%26atitle%3DMGL%2520signaling%2520augments%2520TLR2-mediated%2520responses%2520for%2520enhanced%2520IL-10%2520and%2520TNF-%25CE%25B1%2520secretion%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2013%26volume%3D94%26spage%3D315%26epage%3D323%26doi%3D10.1189%2Fjlb.1012520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laubreton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dériaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puaux, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amigorena, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gérard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Man, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, C.</span></span> <span> </span><span class="NLM_article-title">The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1007/s00262-016-1802-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.1007%2Fs00262-016-1802-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=26847142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=315-325&author=D.+Laubretonauthor=S.+Bayauthor=C.+Sedlikauthor=C.+Artaudauthor=C.+Ganneauauthor=E.+D%C3%A9riaudauthor=S.+Vielauthor=A.-L.+Puauxauthor=S.+Amigorenaauthor=C.+G%C3%A9rardauthor=R.+Lo-Manauthor=C.+Leclerc&title=The+fully+synthetic+MAG-Tn3+therapeutic+vaccine+containing+the+tetanus+toxoid-derived+TT830-844+universal+epitope+provides+anti-tumor+immunity&doi=10.1007%2Fs00262-016-1802-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity</span></div><div class="casAuthors">Laubreton, Daphne; Bay, Sylvie; Sedlik, Christine; Artaud, Cecile; Ganneau, Christelle; Deriaud, Edith; Viel, Sophie; Puaux, Anne-Laure; Amigorena, Sebastian; Gerard, Catherine; Lo-Man, Richard; Leclerc, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-325</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Malignant transformations are often assocd. with aberrant glycosylation processes that lead to the expression of new carbohydrate antigens at the surface of tumor cells.  Of these carbohydrate antigens, the Tn antigen is particularly highly expressed in many carcinomas, esp. in breast carcinoma.  We designed MAG-Tn3, a fully synthetic vaccine based on three consecutive Tn moieties that are O-linked to a CD4+ T cell epitope, to induce anti-Tn antibody responses that could be helpful for therapeutic vaccination against cancer.  To ensure broad coverage within the human population, the tetanus toxoid-derived peptide TT830-844 was selected as a T-helper epitope because it can bind to various HLA-DRB mols.  We showed that the MAG-Tn3 vaccine, which was formulated with the GSK proprietary immunostimulant AS15 and designed for human cancer therapy, is able to induce an anti-Tn antibody response in mice of various H-2 haplotypes, and this response correlates with the ability to induce a specific T cell response against the TT830-844 peptide.  The universality of the TT830-844 peptide was extended to new H-2 and HLA-DRB mols. that were capable of binding this T cell epitope.  Finally, the MAG-Tn3 vaccine was able to induce anti-Tn antibody responses in cynomolgus monkeys, which targeted Tn-expressing tumor cells and mediated tumor cell death both in vitro and in vivo.  Thus, MAG-Tn3 is a highly promising anticancer vaccine that is currently under evaluation in a phase I clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0weeQQxHabVg90H21EOLACvtfcHk0lhA2TsFd_fvdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSmsr4%253D&md5=913211d77c205902ac2a681ce07698a5</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs00262-016-1802-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-016-1802-0%26sid%3Dliteratum%253Aachs%26aulast%3DLaubreton%26aufirst%3DD.%26aulast%3DBay%26aufirst%3DS.%26aulast%3DSedlik%26aufirst%3DC.%26aulast%3DArtaud%26aufirst%3DC.%26aulast%3DGanneau%26aufirst%3DC.%26aulast%3DD%25C3%25A9riaud%26aufirst%3DE.%26aulast%3DViel%26aufirst%3DS.%26aulast%3DPuaux%26aufirst%3DA.-L.%26aulast%3DAmigorena%26aufirst%3DS.%26aulast%3DG%25C3%25A9rard%26aufirst%3DC.%26aulast%3DLo-Man%26aufirst%3DR.%26aulast%3DLeclerc%26aufirst%3DC.%26atitle%3DThe%2520fully%2520synthetic%2520MAG-Tn3%2520therapeutic%2520vaccine%2520containing%2520the%2520tetanus%2520toxoid-derived%2520TT830-844%2520universal%2520epitope%2520provides%2520anti-tumor%2520immunity%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2016%26volume%3D65%26spage%3D315%26epage%3D325%26doi%3D10.1007%2Fs00262-016-1802-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Celhar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, A. M.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">265</span>, <span class="refDoi"> DOI: 10.3389/fphar.2014.00265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=10.3389%2Ffphar.2014.00265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=25538618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;key=1%3ACAS%3A280%3ADC%252BC2MvhsFOntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=265&author=T.+Celharauthor=A.+M.+Fairhurst&title=Toll-like+receptors+in+systemic+lupus+erythematosus%3A+potential+for+personalized+treatment&doi=10.3389%2Ffphar.2014.00265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment</span></div><div class="casAuthors">Celhar Teja; Fairhurst Anna-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by the loss of tolerance to self-nuclear antigens.  The symptoms of SLE, progression of pathology and the array of autoantibodies present in the serum differ significantly from patient to patient, which calls for a personalized approach to treatment.  SLE is polygenic and strongly influenced by gender, ethnicity, and environmental factors.  Data from genome-wide association studies suggests that polymorphisms in as many as 100 genes contribute to SLE susceptibility.  Recent research has focused on genes associated with Toll-like receptors (TLRs), type I interferons, immune regulation pathways, and immune-complex clearance.  TLR7 and TLR9 have been extensively studied using lupus-prone mouse models.  In multiple systems overexpression of TLR7 drives disease progression but interestingly, a loss of TLR9 results in an almost identical phenotype.  While TLR7 overexpression has been linked to human SLE, the possible role of TLR9 in human disease remains elusive.  In the present review, we focus on TLR polymorphisms and TLR expression in SLE patients and discuss their potential as biomarkers for individualized treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFYLBm7yT-jrYtC3U5jeOifW6udTcc2eYBImDSFhMgobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvhsFOntA%253D%253D&md5=78557b5a30213ee8398108943df8ebf3</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2014.00265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2014.00265%26sid%3Dliteratum%253Aachs%26aulast%3DCelhar%26aufirst%3DT.%26aulast%3DFairhurst%26aufirst%3DA.%2BM.%26atitle%3DToll-like%2520receptors%2520in%2520systemic%2520lupus%2520erythematosus%253A%2520potential%2520for%2520personalized%2520treatment%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D5%26spage%3D265%26doi%3D10.3389%2Ffphar.2014.00265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i48"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00960">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_55676"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00960">10.1021/acs.jmedchem.8b00960</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis of compounds <b>1</b> and <b>2</b> and TLR7 agonist <b>24</b>; HPLC chromatograms for compounds <b>3</b>–<b>8</b>, <b>13</b>, <b>14</b>, <b>29</b>, <b>30</b>, <b>31</b>, <b>33</b>–<b>36</b>; HRMS results for compounds <b>3</b>, <b>4</b>, <b>6</b>, <b>9</b>, <b>10</b>, <b>12</b>, <b>13</b>, <b>15</b>–<b>17</b>, <b>19</b>–<b>22</b>, <b>24</b>, <b>26</b>–<b>36</b>; HSQC spectra for compounds <b>3</b>, <b>4</b>, <b>6</b>, <b>9</b>, <b>11</b>, <b>13</b>, <b>15</b>, <b>16</b>, <b>27</b>, <b>29</b>, <b>30</b>, <b>31</b>, <b>33</b>, <b>34</b>, and MALDI-TOF spectra for <b>35</b> and <b>36</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_001.pdf">jm8b00960_si_001.pdf (3.52 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00960/suppl_file/jm8b00960_si_002.csv">jm8b00960_si_002.csv (8.36 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00960&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00960%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-21%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00960" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996fe7cc8d3c28","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
